.
isoindoles - Ontology Report - Rat Genome Database

Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term:isoindoles
go back to main search page
Accession:CHEBI:24897 term browser browse the term
Synonyms:xref_mesh: MESH:D054833

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
X
Y

show annotations for term's descendants           Sort by:
isoindoles term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ALG12 ALG12 alpha-1,6-mannosyltransferase affects response to substance EXP ALG12 gene SNP affects the susceptibility to Isoindoles analog CTD PMID:25622337 NCBI chr22:49,859,311...49,918,438
Ensembl chr22:49,900,229...49,918,438 		JBrowse link
G KSR2 kinase suppressor of ras 2 affects response to substance EXP KSR2 gene SNP affects the susceptibility to Isoindoles analog CTD PMID:25622337 NCBI chr12:117,453,012...117,968,990
Ensembl chr12:117,453,012...117,968,990 		JBrowse link
G MRPS27 mitochondrial ribosomal protein S27 affects response to substance EXP MRPS27 gene SNP affects the susceptibility to Isoindoles analog CTD PMID:25622337 NCBI chr 5:72,219,403...72,320,240
Ensembl chr 5:72,214,953...72,321,717 		JBrowse link
G NEBL nebulette affects response to substance EXP NEBL gene SNP affects the susceptibility to Isoindoles analog CTD PMID:25622337 NCBI chr10:20,779,973...21,293,050
Ensembl chr10:20,779,973...21,293,011 		JBrowse link
4,5-dianilinophthalimide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G EGF epidermal growth factor multiple interactions ISO 4,5-dianilinophthalimide inhibits the reaction [EGF protein results in increased susceptibility to Desoxycorticosterone] CTD PMID:11751714 NCBI chr 4:109,912,883...110,013,766
Ensembl chr 4:109,912,883...110,013,766 		JBrowse link
5-Hydroxythalidomide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ADH1B alcohol dehydrogenase 1B (class I), beta polypeptide affects binding EXP 5-hydroxythalidomide binds to ADH1B protein CTD PMID:27464947 NCBI chr 4:99,304,971...99,321,401
Ensembl chr 4:99,304,971...99,321,401 		JBrowse link
G ALDH1A1 aldehyde dehydrogenase 1 family member A1 affects binding EXP
ISO 		5-hydroxythalidomide binds to ALDH1A1 protein CTD PMID:27464947 NCBI chr 9:72,900,671...72,953,053
Ensembl chr 9:72,900,671...73,080,442 		JBrowse link
G ASS1 argininosuccinate synthase 1 affects binding EXP
ISO 		5-hydroxythalidomide binds to ASS1 protein CTD PMID:27464947 NCBI chr 9:130,444,707...130,501,274
Ensembl chr 9:130,444,961...130,501,274 		JBrowse link
G ATP5F1A ATP synthase F1 subunit alpha affects binding EXP
ISO 		5-hydroxythalidomide binds to ATP5F1A protein CTD PMID:27464947 NCBI chr18:46,080,248...46,104,227
Ensembl chr18:46,080,248...46,104,334 		JBrowse link
G ATP5ME ATP synthase membrane subunit e affects binding EXP
ISO 		5-hydroxythalidomide binds to ATP5ME protein CTD PMID:27464947 NCBI chr 4:672,436...674,276
Ensembl chr 4:672,436...674,330 		JBrowse link
G BDH1 3-hydroxybutyrate dehydrogenase 1 affects binding ISO
EXP 		5-hydroxythalidomide binds to BDH1 protein CTD PMID:27464947 NCBI chr 3:197,509,783...197,573,343
Ensembl chr 3:197,509,783...197,573,323 		JBrowse link
G CA3 carbonic anhydrase 3 affects binding EXP
ISO 		5-hydroxythalidomide binds to CA3 protein
5-hydroxythalidomide binds to CAR3 protein 		CTD PMID:27464947 NCBI chr 8:85,438,859...85,449,040
Ensembl chr 8:85,373,436...85,449,040 		JBrowse link
G COX6A1 cytochrome c oxidase subunit 6A1 affects binding ISO
EXP 		5-hydroxythalidomide binds to COX6A1 protein CTD PMID:27464947 NCBI chr12:120,438,113...120,440,730
Ensembl chr12:120,438,090...120,440,737 		JBrowse link
G COX6B1 cytochrome c oxidase subunit 6B1 affects binding EXP
ISO 		5-hydroxythalidomide binds to COX6B1 protein CTD PMID:27464947 NCBI chr19:35,648,323...35,658,782
Ensembl chr19:35,648,323...35,658,782 		JBrowse link
G CYP2C18 cytochrome P450 family 2 subfamily C member 18 increases metabolic processing EXP CYP2C18 protein results in increased metabolism of 5-hydroxythalidomide CTD PMID:24350712 NCBI chr10:94,683,729...94,736,190
Ensembl chr10:94,683,729...94,736,190 		JBrowse link
G CYP2C19 cytochrome P450 family 2 subfamily C member 19 increases abundance
multiple interactions 		EXP CYP2C19 protein results in increased abundance of 5'-hydroxythalidomide; CYP2C19 protein results in increased abundance of 5-hydroxythalidomide
[CYP2C19 protein results in increased hydroxylation of Thalidomide] which results in increased chemical synthesis of 5'-hydroxythalidomide; [CYP2C19 protein results in increased hydroxylation of Thalidomide] which results in increased chemical synthesis of 5-hydroxythalidomide; [CYP2C19 protein results in increased oxidation of Thalidomide] which results in increased abundance of 5'-hydroxythalidomide; [CYP2C19 protein results in increased oxidation of Thalidomide] which results in increased abundance of 5-hydroxythalidomide 		CTD PMID:20443640 PMID:24350712 NCBI chr10:94,762,681...94,855,547
Ensembl chr10:94,762,681...94,855,547 		JBrowse link
G CYP2J2 cytochrome P450 family 2 subfamily J member 2 increases metabolic processing EXP CYP2J2 protein results in increased metabolism of 5-hydroxythalidomide CTD PMID:24350712 NCBI chr 1:59,893,308...59,969,212
Ensembl chr 1:59,893,308...59,926,773 		JBrowse link
G CYP3A4 cytochrome P450 family 3 subfamily A member 4 multiple interactions EXP [CYP3A4 protein results in increased hydroxylation of Thalidomide] which results in increased chemical synthesis of 5-hydroxythalidomide; CYP3A4 protein results in increased oxidation of and results in increased glutathionylation of 5-hydroxythalidomide CTD PMID:20443640 NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248 		JBrowse link
G CYP3A5 cytochrome P450 family 3 subfamily A member 5 multiple interactions EXP [CYP3A5 protein results in increased hydroxylation of Thalidomide] which results in increased chemical synthesis of 5-hydroxythalidomide; CYP3A5 protein results in increased oxidation of and results in increased glutathionylation of 5-hydroxythalidomide CTD PMID:20443640 NCBI chr 7:99,648,194...99,679,996
Ensembl chr 7:99,648,194...99,679,996 		JBrowse link
G CYP3A7 cytochrome P450 family 3 subfamily A member 7 multiple interactions EXP [CYP3A7 protein results in increased hydroxylation of Thalidomide] which results in increased chemical synthesis of 5-hydroxythalidomide CTD PMID:20443640 NCBI chr 7:99,705,036...99,735,196
Ensembl chr 7:99,705,036...99,735,196 		JBrowse link
G CYP4A11 cytochrome P450 family 4 subfamily A member 11 increases metabolic processing EXP CYP4A11 protein results in increased metabolism of 5-hydroxythalidomide CTD PMID:24350712 NCBI chr 1:46,929,188...46,941,476
Ensembl chr 1:46,929,177...46,941,484 		JBrowse link
G ENO1 enolase 1 affects binding ISO
EXP 		5-hydroxythalidomide binds to ENO1 protein CTD PMID:27464947 NCBI chr 1:8,861,000...8,878,686
Ensembl chr 1:8,861,000...8,879,190 		JBrowse link
G FABP1 fatty acid binding protein 1 affects binding EXP
ISO 		5-hydroxythalidomide binds to FABP1 protein CTD PMID:27464947 NCBI chr 2:88,122,982...88,128,062
Ensembl chr 2:88,122,982...88,128,062 		JBrowse link
G FTL ferritin light chain affects binding EXP
ISO 		5-hydroxythalidomide binds to FTL protein
5-hydroxythalidomide binds to FTL1 protein 		CTD PMID:27464947 NCBI chr19:48,965,309...48,966,879
Ensembl chr19:48,965,309...48,967,896 		JBrowse link
G GSTA1 glutathione S-transferase alpha 1 affects binding EXP 5-hydroxythalidomide binds to GSTA1 protein CTD PMID:27464947 NCBI chr 6:52,791,371...52,803,816
Ensembl chr 6:52,791,371...52,803,860 		JBrowse link
G GSTA3 glutathione S-transferase alpha 3 affects binding ISO 5-hydroxythalidomide binds to GSTA1 protein CTD PMID:27464947 NCBI chr 6:52,896,646...52,909,698
Ensembl chr 6:52,896,639...52,909,698 		JBrowse link
G GSTM1 glutathione S-transferase mu 1 affects binding EXP
ISO 		5-hydroxythalidomide binds to GSTM1 protein CTD PMID:27464947 NCBI chr 1:109,687,817...109,693,745
Ensembl chr 1:109,687,814...109,709,039 		JBrowse link
G PEBP1 phosphatidylethanolamine binding protein 1 affects binding EXP
ISO 		5-hydroxythalidomide binds to PEBP1 protein CTD PMID:27464947 NCBI chr12:118,136,124...118,145,584
Ensembl chr12:118,136,124...118,145,584 		JBrowse link
G RGN regucalcin affects binding ISO
EXP 		5-hydroxythalidomide binds to RGN protein CTD PMID:27464947 NCBI chr  X:47,078,443...47,093,313
Ensembl chr  X:47,078,355...47,093,314 		JBrowse link
G UQCRB ubiquinol-cytochrome c reductase binding protein affects binding ISO
EXP 		5-hydroxythalidomide binds to UQCRB protein CTD PMID:27464947 NCBI chr 8:96,222,947...96,235,545
Ensembl chr 8:96,222,947...96,235,546 		JBrowse link
apremilast term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CASP3 caspase 3 multiple interactions ISO apremilast inhibits the reaction [carfilzomib results in increased activity of CASP3 protein] CTD PMID:27785949 NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062 		JBrowse link
G CKM creatine kinase, M-type multiple interactions ISO apremilast inhibits the reaction [carfilzomib results in increased secretion of CKM protein] CTD PMID:27785949 NCBI chr19:45,306,413...45,322,875
Ensembl chr19:45,306,413...45,322,875 		JBrowse link
G GOT1 glutamic-oxaloacetic transaminase 1 multiple interactions ISO apremilast inhibits the reaction [carfilzomib results in increased secretion of GOT1 protein] CTD PMID:27785949 NCBI chr10:99,396,870...99,430,624
Ensembl chr10:99,396,870...99,430,624 		JBrowse link
G LDHA lactate dehydrogenase A multiple interactions ISO apremilast inhibits the reaction [carfilzomib results in increased secretion of LDHA protein] CTD PMID:27785949 NCBI chr11:18,394,563...18,408,425
Ensembl chr11:18,394,560...18,408,425 		JBrowse link
G MAPK1 mitogen-activated protein kinase 1 multiple interactions ISO apremilast inhibits the reaction [carfilzomib results in increased expression of MAPK1 mRNA] CTD PMID:27785949 NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680 		JBrowse link
G MAPK8 mitogen-activated protein kinase 8 multiple interactions ISO apremilast inhibits the reaction [carfilzomib results in increased expression of MAPK8 mRNA] CTD PMID:27785949 NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360 		JBrowse link
G NFKBIA NFKB inhibitor alpha multiple interactions ISO apremilast inhibits the reaction [carfilzomib results in decreased expression of NFKBIA protein] CTD PMID:27785949 NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749 		JBrowse link
G RELA RELA proto-oncogene, NF-kB subunit multiple interactions ISO apremilast inhibits the reaction [carfilzomib results in increased expression of RELA mRNA] CTD PMID:27785949 NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090 		JBrowse link
captafol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G DIO1 iodothyronine deiodinase 1 decreases activity EXP captafol results in decreased activity of DIO1 protein CTD PMID:29228274 PMID:30561685 NCBI chr 1:53,894,187...53,911,086
Ensembl chr 1:53,891,239...53,911,086 		JBrowse link
G DIO2 iodothyronine deiodinase 2 decreases activity EXP captafol results in decreased activity of DIO2 protein CTD PMID:30561685 NCBI chr14:80,197,526...80,231,057
Ensembl chr14:80,197,526...80,387,757 		JBrowse link
G DIO3 iodothyronine deiodinase 3 decreases activity EXP captafol results in decreased activity of DIO3 protein CTD PMID:30561685 NCBI chr14:101,561,495...101,563,452
Ensembl chr14:101,560,139...101,563,452 		JBrowse link
G GSTP1 glutathione S-transferase pi 1 multiple interactions
decreases activity 		EXP hexylglutathione inhibits the reaction [captafol results in decreased activity of GSTP1 protein] CTD PMID:8678907 NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656 		JBrowse link
G PCNA proliferating cell nuclear antigen increases expression
multiple interactions 		ISO captafol results in increased expression of PCNA protein
Cysteine inhibits the reaction [captafol results in increased expression of PCNA protein] 		CTD PMID:9022123 NCBI chr20:5,114,953...5,126,622
Ensembl chr20:5,114,953...5,126,626 		JBrowse link
G TFF1 trefoil factor 1 decreases expression EXP captafol results in decreased expression of TFF1 mRNA CTD PMID:33352482 NCBI chr21:42,362,282...42,366,535
Ensembl chr21:42,362,282...42,366,535 		JBrowse link
G TOP1 DNA topoisomerase I decreases activity ISO captafol results in decreased activity of TOP1 protein CTD PMID:12113771 NCBI chr20:41,028,822...41,124,487
Ensembl chr20:41,028,822...41,124,487 		JBrowse link
G TOP2A DNA topoisomerase II alpha decreases activity ISO captafol results in decreased activity of TOP2A protein CTD PMID:12113771 NCBI chr17:40,388,525...40,417,896
Ensembl chr17:40,388,525...40,417,896 		JBrowse link
captan term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB1 ATP binding cassette subfamily B member 1 increases expression ISO Captan results in increased expression of ABCB1A mRNA CTD PMID:31558096 NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323 		JBrowse link
G ABCC2 ATP binding cassette subfamily C member 2 multiple interactions ISO [Dietary Fats co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with thiacloprid co-treated with Thiophanate co-treated with Ziram] results in increased expression of ABCC2 mRNA CTD PMID:32745781 NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594 		JBrowse link
G ABCC3 ATP binding cassette subfamily C member 3 multiple interactions
increases expression 		ISO [Dietary Fats co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with thiacloprid co-treated with Thiophanate co-treated with Ziram] results in increased expression of ABCC3 mRNA
Captan results in increased expression of ABCC3 mRNA 		CTD PMID:31558096 PMID:32745781 NCBI chr17:50,634,881...50,692,253
Ensembl chr17:50,634,777...50,692,253 		JBrowse link
G ABCC5 ATP binding cassette subfamily C member 5 increases expression ISO Captan results in increased expression of ABCC5 mRNA CTD PMID:31558096 NCBI chr 3:183,919,934...184,017,884
Ensembl chr 3:183,919,934...184,017,939 		JBrowse link
G ABCC9 ATP binding cassette subfamily C member 9 decreases expression ISO Captan results in decreased expression of ABCC9 mRNA CTD PMID:31558096 NCBI chr12:21,797,389...21,941,426
Ensembl chr12:21,797,389...21,942,543 		JBrowse link
G ABCF1 ATP binding cassette subfamily F member 1 increases expression ISO Captan results in increased expression of ABCF1 mRNA CTD PMID:31558096 NCBI chr 6:30,571,442...30,591,522
Ensembl chr 6:30,571,393...30,597,179 		JBrowse link
G ABHD6 abhydrolase domain containing 6, acylglycerol lipase increases expression ISO Captan results in increased expression of ABHD6 mRNA CTD PMID:31558096 NCBI chr 3:58,237,792...58,294,734
Ensembl chr 3:58,237,532...58,295,693 		JBrowse link
G ACAA1 acetyl-CoA acyltransferase 1 increases expression ISO Captan results in increased expression of ACAA1B mRNA CTD PMID:31558096 NCBI chr 3:38,122,715...38,137,127
Ensembl chr 3:38,103,129...38,137,242 		JBrowse link
G ACAT2 acetyl-CoA acetyltransferase 2 increases expression ISO Captan results in increased expression of ACAT2 mRNA CTD PMID:31558096 NCBI chr 6:159,762,045...159,779,112
Ensembl chr 6:159,762,045...159,779,112 		JBrowse link
G ACE angiotensin I converting enzyme decreases expression ISO Captan results in decreased expression of ACE mRNA CTD PMID:31558096 NCBI chr17:63,477,061...63,498,373
Ensembl chr17:63,477,061...63,498,380 		JBrowse link
G ACOX1 acyl-CoA oxidase 1 multiple interactions
increases expression 		ISO [Ziram co-treated with Thiophanate co-treated with Captan co-treated with Chlorpyrifos co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with thiacloprid] results in increased expression of ACOX1 mRNA
Captan results in increased expression of ACOX1 mRNA 		CTD PMID:31558096 PMID:32736067 NCBI chr17:75,941,507...75,979,166
Ensembl chr17:75,941,507...75,979,177 		JBrowse link
G ACTA2 actin alpha 2, smooth muscle decreases expression ISO Captan results in decreased expression of ACTA2 mRNA CTD PMID:31558096 NCBI chr10:88,935,074...88,991,337
Ensembl chr10:88,934,822...88,991,339 		JBrowse link
G AKR1B10 aldo-keto reductase family 1 member B10 increases expression ISO Captan results in increased expression of AKR1B10 mRNA CTD PMID:31558096 NCBI chr 7:134,527,567...134,541,412
Ensembl chr 7:134,527,567...134,541,412 		JBrowse link
G AKT1 AKT serine/threonine kinase 1 multiple interactions ISO [alachlor co-treated with Captan co-treated with Diazinon co-treated with Endosulfan co-treated with mancozeb co-treated with Maneb] affects the phosphorylation of AKT1 protein; [alachlor co-treated with Captan co-treated with Diazinon co-treated with Endosulfan co-treated with mancozeb co-treated with Maneb] results in decreased expression of AKT1 protein CTD PMID:19883720 NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,759 		JBrowse link
G ALAS1 5'-aminolevulinate synthase 1 increases expression ISO Captan results in increased expression of ALAS1 mRNA CTD PMID:31558096 NCBI chr 3:52,198,083...52,214,327
Ensembl chr 3:52,198,086...52,214,327 		JBrowse link
G ALDH1A1 aldehyde dehydrogenase 1 family member A1 increases expression ISO Captan results in increased expression of ALDH1A1 mRNA CTD PMID:31558096 NCBI chr 9:72,900,671...72,953,053
Ensembl chr 9:72,900,671...73,080,442 		JBrowse link
G ALDH2 aldehyde dehydrogenase 2 family member increases expression ISO Captan results in increased expression of ALDH2 mRNA CTD PMID:31558096 NCBI chr12:111,766,933...111,817,532
Ensembl chr12:111,766,887...111,817,532 		JBrowse link
G ALDH3A2 aldehyde dehydrogenase 3 family member A2 increases expression ISO Captan results in increased expression of ALDH3A2 mRNA CTD PMID:31558096 NCBI chr17:19,648,136...19,677,596
Ensembl chr17:19,648,136...19,685,760 		JBrowse link
G ALDH7A1 aldehyde dehydrogenase 7 family member A1 decreases expression ISO Captan results in decreased expression of ALDH7A1 mRNA CTD PMID:31558096 NCBI chr 5:126,541,841...126,595,219
Ensembl chr 5:126,531,200...126,595,362 		JBrowse link
G ALDOA aldolase, fructose-bisphosphate A increases expression ISO Captan results in increased expression of ALDOA mRNA CTD PMID:31558096 NCBI chr16:30,053,151...30,070,414
Ensembl chr16:30,053,090...30,070,420
Ensembl chr16:30,053,090...30,070,420
Ensembl chr16:30,053,090...30,070,420 		JBrowse link
G ALDOB aldolase, fructose-bisphosphate B increases expression ISO Captan results in increased expression of ALDOB mRNA CTD PMID:31558096 NCBI chr 9:101,420,560...101,435,774
Ensembl chr 9:101,420,560...101,449,664 		JBrowse link
G ALDOC aldolase, fructose-bisphosphate C increases expression ISO Captan results in increased expression of ALDOC mRNA CTD PMID:31558096 NCBI chr17:28,573,120...28,576,895
Ensembl chr17:28,573,115...28,576,948 		JBrowse link
G ALOX5AP arachidonate 5-lipoxygenase activating protein decreases expression ISO Captan results in decreased expression of ALOX5AP mRNA CTD PMID:31558096 NCBI chr13:30,713,485...30,764,426
Ensembl chr13:30,713,478...30,764,426 		JBrowse link
G AMH anti-Mullerian hormone decreases expression ISO Captan results in decreased expression of AMH protein CTD PMID:34303901 NCBI chr19:2,249,323...2,252,073
Ensembl chr19:2,249,309...2,252,073 		JBrowse link
G AP2M1 adaptor related protein complex 2 subunit mu 1 increases expression ISO Captan results in increased expression of AP2M1 mRNA CTD PMID:31558096 NCBI chr 3:184,174,855...184,184,091
Ensembl chr 3:184,174,689...184,184,214 		JBrowse link
G APOA1 apolipoprotein A1 increases expression ISO Captan results in increased expression of APOA1 mRNA CTD PMID:31558096 NCBI chr11:116,835,751...116,837,622
Ensembl chr11:116,835,751...116,837,622 		JBrowse link
G APOC3 apolipoprotein C3 increases expression ISO Captan results in increased expression of APOC3 mRNA CTD PMID:31558096 NCBI chr11:116,829,907...116,833,072
Ensembl chr11:116,829,706...116,833,072 		JBrowse link
G APOE apolipoprotein E decreases expression ISO Captan results in decreased expression of APOE mRNA CTD PMID:31558096 NCBI chr19:44,905,796...44,909,393
Ensembl chr19:44,905,791...44,909,393 		JBrowse link
G AQP1 aquaporin 1 (Colton blood group) decreases expression ISO Captan results in decreased expression of AQP1 mRNA CTD PMID:31558096 NCBI chr 7:30,911,853...30,925,516
Ensembl chr 7:30,911,853...30,925,517 		JBrowse link
G AQP3 aquaporin 3 (Gill blood group) increases expression ISO Captan results in increased expression of AQP3 mRNA CTD PMID:31558096 NCBI chr 9:33,441,160...33,447,593
Ensembl chr 9:33,441,156...33,447,596 		JBrowse link
G ARF1 ARF GTPase 1 increases expression ISO Captan results in increased expression of ARF1 mRNA CTD PMID:31558096 NCBI chr 1:228,082,708...228,099,212
Ensembl chr 1:228,082,708...228,099,212 		JBrowse link
G ARHGAP9 Rho GTPase activating protein 9 decreases expression ISO Captan results in decreased expression of ARHGAP9 mRNA CTD PMID:31558096 NCBI chr12:57,472,269...57,488,824
Ensembl chr12:57,472,264...57,488,814 		JBrowse link
G ARID4B AT-rich interaction domain 4B decreases expression ISO Captan results in decreased expression of ARID4B mRNA CTD PMID:31558096 NCBI chr 1:235,166,902...235,328,179
Ensembl chr 1:235,131,634...235,328,219 		JBrowse link
G ARL1 ARF like GTPase 1 increases expression ISO Captan results in increased expression of ARL1 mRNA CTD PMID:31558096 NCBI chr12:101,393,116...101,407,820
Ensembl chr12:101,393,116...101,407,772 		JBrowse link
G ARNT aryl hydrocarbon receptor nuclear translocator decreases expression ISO Captan results in decreased expression of ARNT mRNA CTD PMID:31558096 NCBI chr 1:150,809,713...150,876,599
Ensembl chr 1:150,809,713...150,876,708 		JBrowse link
G ARNT2 aryl hydrocarbon receptor nuclear translocator 2 increases expression ISO Captan results in increased expression of ARNT2 mRNA CTD PMID:31558096 NCBI chr15:80,404,382...80,597,933
Ensembl chr15:80,404,350...80,597,933 		JBrowse link
G ARPC3 actin related protein 2/3 complex subunit 3 decreases expression ISO Captan results in decreased expression of ARPC3 mRNA CTD PMID:31558096 NCBI chr12:110,434,823...110,450,337
Ensembl chr12:110,434,823...110,450,422 		JBrowse link
G ARPP19 cAMP regulated phosphoprotein 19 increases expression ISO Captan results in increased expression of ARPP19 mRNA CTD PMID:31558096 NCBI chr15:52,547,045...52,569,446
Ensembl chr15:52,547,045...52,569,883 		JBrowse link
G ARSA arylsulfatase A increases expression ISO Captan results in increased expression of ARSA mRNA CTD PMID:31558096 NCBI chr22:50,622,754...50,628,152
Ensembl chr22:50,622,754...50,628,173 		JBrowse link
G ASPN asporin decreases expression ISO Captan results in decreased expression of ASPN mRNA CTD PMID:31558096 NCBI chr 9:92,456,205...92,482,506
Ensembl chr 9:92,456,205...92,482,506 		JBrowse link
G ASS1 argininosuccinate synthase 1 decreases expression ISO Captan results in decreased expression of ASS1 mRNA CTD PMID:31558096 NCBI chr 9:130,444,707...130,501,274
Ensembl chr 9:130,444,961...130,501,274 		JBrowse link
G ATAD3A ATPase family AAA domain containing 3A increases expression ISO Captan results in increased expression of ATAD3A mRNA CTD PMID:31558096 NCBI chr 1:1,512,162...1,534,685
Ensembl chr 1:1,512,162...1,534,685 		JBrowse link
G ATG3 autophagy related 3 increases expression ISO Captan results in increased expression of ATG3 mRNA CTD PMID:31558096 NCBI chr 3:112,532,510...112,561,962
Ensembl chr 3:112,532,510...112,562,046 		JBrowse link
G ATMIN ATM interactor decreases expression ISO Captan results in decreased expression of ATMIN mRNA CTD PMID:31558096 NCBI chr16:81,035,842...81,047,350
Ensembl chr16:81,035,842...81,047,350 		JBrowse link
G ATP1A2 ATPase Na+/K+ transporting subunit alpha 2 decreases expression ISO Captan results in decreased expression of ATP1A2 mRNA CTD PMID:31558096 NCBI chr 1:160,115,759...160,143,591
Ensembl chr 1:160,115,759...160,143,591 		JBrowse link
G ATP5F1B ATP synthase F1 subunit beta increases expression ISO Captan results in increased expression of ATP5F1B mRNA CTD PMID:31558096 NCBI chr12:56,638,175...56,645,984
Ensembl chr12:56,638,175...56,645,984 		JBrowse link
G ATP5F1E ATP synthase F1 subunit epsilon increases expression ISO Captan results in increased expression of ATP5F1E mRNA CTD PMID:31558096 NCBI chr20:59,025,475...59,032,335
Ensembl chr20:59,025,475...59,032,345 		JBrowse link
G ATP6V0D1 ATPase H+ transporting V0 subunit d1 increases expression ISO Captan results in increased expression of ATP6V0D1 mRNA CTD PMID:31558096 NCBI chr16:67,438,019...67,481,157
Ensembl chr16:67,438,014...67,481,181 		JBrowse link
G ATP6V1D ATPase H+ transporting V1 subunit D increases expression ISO Captan results in increased expression of ATP6V1D mRNA CTD PMID:31558096 NCBI chr14:67,337,872...67,359,804
Ensembl chr14:67,294,371...67,360,265 		JBrowse link
G B4GALT1 beta-1,4-galactosyltransferase 1 increases expression ISO Captan results in increased expression of B4GALT1 mRNA CTD PMID:31558096 NCBI chr 9:33,104,077...33,185,089
Ensembl chr 9:33,100,493...33,167,336 		JBrowse link
G BAX BCL2 associated X, apoptosis regulator increases expression ISO Captan results in increased expression of BAX protein CTD PMID:34303901 NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798 		JBrowse link
G BBC3 BCL2 binding component 3 decreases expression ISO Captan results in decreased expression of BBC3 mRNA CTD PMID:31558096 NCBI chr19:47,220,824...47,232,860
Ensembl chr19:47,220,822...47,232,766 		JBrowse link
G BCL2 BCL2 apoptosis regulator decreases expression ISO Captan results in decreased expression of BCL2 mRNA; Captan results in decreased expression of BCL2 protein CTD PMID:34303901 NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128 		JBrowse link
G BECN1 beclin 1 increases expression ISO Captan results in increased expression of BECN1 mRNA CTD PMID:31558096 PMID:34303901 NCBI chr17:42,810,132...42,824,282
Ensembl chr17:42,810,134...42,833,350 		JBrowse link
G BGN biglycan decreases expression ISO Captan results in decreased expression of BGN mRNA CTD PMID:31558096 NCBI chr  X:153,494,980...153,509,546
Ensembl chr  X:153,494,980...153,509,546 		JBrowse link
G BHLHE40 basic helix-loop-helix family member e40 increases expression ISO Captan results in increased expression of BHLHE40 mRNA CTD PMID:31558096 NCBI chr 3:4,979,437...4,985,323
Ensembl chr 3:4,979,437...4,985,323 		JBrowse link
G BLOC1S2 biogenesis of lysosomal organelles complex 1 subunit 2 increases expression ISO Captan results in increased expression of BLOC1S2 mRNA CTD PMID:31558096 NCBI chr10:100,273,278...100,286,680
Ensembl chr10:100,273,280...100,286,680 		JBrowse link
G BNIP3 BCL2 interacting protein 3 increases expression ISO Captan results in increased expression of BNIP3 mRNA CTD PMID:31558096 NCBI chr10:131,967,684...131,981,923
Ensembl chr10:131,967,684...131,981,967 		JBrowse link
G BPGM bisphosphoglycerate mutase increases expression ISO Captan results in increased expression of BPGM mRNA CTD PMID:31558096 NCBI chr 7:134,646,853...134,679,816
Ensembl chr 7:134,646,811...134,679,816 		JBrowse link
G BPNT1 3'(2'), 5'-bisphosphate nucleotidase 1 increases expression ISO Captan results in increased expression of BPNT1 mRNA CTD PMID:31558096 NCBI chr 1:220,057,482...220,089,788
Ensembl chr 1:220,057,482...220,090,462 		JBrowse link
G C1QA complement C1q A chain decreases expression ISO Captan results in decreased expression of C1QA mRNA CTD PMID:31558096 NCBI chr 1:22,636,463...22,639,678
Ensembl chr 1:22,635,077...22,639,678 		JBrowse link
G C1QB complement C1q B chain decreases expression ISO Captan results in decreased expression of C1QB mRNA CTD PMID:31558096 NCBI chr 1:22,653,236...22,661,637
Ensembl chr 1:22,652,762...22,661,637 		JBrowse link
G C1QC complement C1q C chain decreases expression ISO Captan results in decreased expression of C1QC mRNA CTD PMID:31558096 NCBI chr 1:22,643,633...22,648,108
Ensembl chr 1:22,643,014...22,648,110 		JBrowse link
G C2CD2 C2 calcium dependent domain containing 2 decreases expression ISO Captan results in decreased expression of C2CD2 mRNA CTD PMID:31558096 NCBI chr21:41,885,112...41,954,018
Ensembl chr21:41,885,112...41,954,018 		JBrowse link
G CA9 carbonic anhydrase 9 increases expression ISO Captan results in increased expression of CAR9 mRNA CTD PMID:31558096 NCBI chr 9:35,673,928...35,681,159
Ensembl chr 9:35,673,928...35,681,159 		JBrowse link
G CALCOCO1 calcium binding and coiled-coil domain 1 decreases expression ISO Captan results in decreased expression of CALCOCO1 mRNA CTD PMID:31558096 NCBI chr12:53,708,517...53,727,452
Ensembl chr12:53,708,517...53,727,745 		JBrowse link
G CALR calreticulin increases expression ISO Captan results in increased expression of CALR mRNA CTD PMID:31558096 NCBI chr19:12,938,609...12,944,489
Ensembl chr19:12,938,578...12,944,489 		JBrowse link
G CANX calnexin decreases expression ISO Captan results in decreased expression of CANX mRNA CTD PMID:31558096 NCBI chr 5:179,678,656...179,731,641
Ensembl chr 5:179,678,628...179,731,641 		JBrowse link
G CAPG capping actin protein, gelsolin like increases expression ISO Captan results in increased expression of CAPG mRNA CTD PMID:31558096 NCBI chr 2:85,391,602...85,419,540
Ensembl chr 2:85,394,753...85,418,432 		JBrowse link
G CARMIL1 capping protein regulator and myosin 1 linker 1 increases expression ISO Captan results in increased expression of CARMIL1 mRNA CTD PMID:31558096 NCBI chr 6:25,279,374...25,620,530
Ensembl chr 6:25,279,078...25,620,530 		JBrowse link
G CASP3 caspase 3 increases cleavage
increases expression 		ISO Captan results in increased cleavage of CASP3 protein
Captan results in increased expression of CASP3 mRNA 		CTD PMID:34303901 NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062 		JBrowse link
G CAT catalase increases expression ISO Captan results in increased expression of CAT mRNA CTD PMID:31558096 NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060 		JBrowse link
G CAV1 caveolin 1 decreases expression ISO Captan results in decreased expression of CAV1 mRNA CTD PMID:31558096 NCBI chr 7:116,525,009...116,561,185
Ensembl chr 7:116,524,994...116,561,179 		JBrowse link
G CAVIN2 caveolae associated protein 2 decreases expression ISO Captan results in decreased expression of CAVIN2 mRNA CTD PMID:31558096 NCBI chr 2:191,834,310...191,847,088
Ensembl chr 2:191,834,310...191,847,088 		JBrowse link
G CBR1 carbonyl reductase 1 increases expression ISO Captan results in increased expression of CBR1 mRNA CTD PMID:31558096 NCBI chr21:36,070,024...36,073,164
Ensembl chr21:36,069,941...36,073,166 		JBrowse link
G CBR3 carbonyl reductase 3 increases expression ISO Captan results in increased expression of CBR3 mRNA CTD PMID:31558096 NCBI chr21:36,135,079...36,146,562
Ensembl chr21:36,135,079...36,146,562 		JBrowse link
G CCND1 cyclin D1 multiple interactions ISO [alachlor co-treated with Captan co-treated with Diazinon co-treated with Endosulfan co-treated with mancozeb co-treated with Maneb] results in increased expression of CCND1 protein CTD PMID:19883720 NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474 		JBrowse link
G CCND2 cyclin D2 decreases expression ISO Captan results in decreased expression of CCND2 mRNA CTD PMID:31558096 NCBI chr12:4,273,762...4,305,353
Ensembl chr12:4,269,771...4,305,353 		JBrowse link
G CCT5 chaperonin containing TCP1 subunit 5 decreases expression ISO Captan results in decreased expression of CCT5 mRNA CTD PMID:31558096 NCBI chr 5:10,249,921...10,266,412
Ensembl chr 5:10,249,929...10,266,389 		JBrowse link
G CCT6A chaperonin containing TCP1 subunit 6A decreases expression ISO Captan results in decreased expression of CCT6A mRNA CTD PMID:31558096 NCBI chr 7:56,051,765...56,063,989
Ensembl chr 7:56,051,685...56,063,989 		JBrowse link
G CD36 CD36 molecule (CD36 blood group) multiple interactions ISO [Ziram co-treated with Thiophanate co-treated with Captan co-treated with Chlorpyrifos co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with thiacloprid] results in increased expression of CD36 mRNA CTD PMID:32736067 NCBI chr 7:80,602,207...80,679,274
Ensembl chr 7:80,369,575...80,679,277 		JBrowse link
G CD74 CD74 molecule decreases expression ISO Captan results in decreased expression of CD74 mRNA CTD PMID:31558096 NCBI chr 5:150,401,639...150,412,910
Ensembl chr 5:150,401,637...150,412,969 		JBrowse link
G CDA cytidine deaminase increases expression ISO Captan results in increased expression of CDA mRNA CTD PMID:31558096 NCBI chr 1:20,589,097...20,618,903
Ensembl chr 1:20,589,086...20,618,903 		JBrowse link
G CDK19 cyclin dependent kinase 19 decreases expression ISO Captan results in decreased expression of CDK19 mRNA CTD PMID:31558096 NCBI chr 6:110,609,978...110,815,855
Ensembl chr 6:110,609,978...110,815,958 		JBrowse link
G CDK4 cyclin dependent kinase 4 decreases expression ISO Captan results in decreased expression of CDK4 mRNA CTD PMID:31558096 NCBI chr12:57,747,727...57,752,310
Ensembl chr12:57,747,727...57,756,013 		JBrowse link
G CDKN1B cyclin dependent kinase inhibitor 1B decreases expression ISO Captan results in decreased expression of CDKN1B mRNA CTD PMID:31558096 NCBI chr12:12,717,368...12,722,369
Ensembl chr12:12,685,498...12,722,369 		JBrowse link
G CETN2 centrin 2 decreases expression ISO Captan results in decreased expression of CETN2 mRNA CTD PMID:31558096 NCBI chr  X:152,826,994...152,830,757
Ensembl chr  X:152,826,994...152,830,757 		JBrowse link
G CHIC2 cysteine rich hydrophobic domain 2 decreases expression ISO Captan results in decreased expression of CHIC2 mRNA CTD PMID:31558096 NCBI chr 4:54,009,789...54,091,879
Ensembl chr 4:53,994,803...54,064,605 		JBrowse link
G CHMP6 charged multivesicular body protein 6 increases expression ISO Captan results in increased expression of CHMP6 mRNA CTD PMID:31558096 NCBI chr17:80,991,841...81,000,133
Ensembl chr17:80,991,598...81,009,517 		JBrowse link
G CIDEC cell death inducing DFFA like effector c increases expression ISO Captan results in increased expression of CIDEC mRNA CTD PMID:31558096 NCBI chr 3:9,866,710...9,880,253
Ensembl chr 3:9,866,711...9,880,255 		JBrowse link
G CIRBP cold inducible RNA binding protein decreases expression ISO Captan results in decreased expression of CIRBP mRNA CTD PMID:31558096 NCBI chr19:1,269,332...1,274,880
Ensembl chr19:1,259,384...1,274,880 		JBrowse link
G CKM creatine kinase, M-type decreases expression ISO Captan results in decreased expression of CKM mRNA CTD PMID:31558096 NCBI chr19:45,306,413...45,322,875
Ensembl chr19:45,306,413...45,322,875 		JBrowse link
G CLIP3 CAP-Gly domain containing linker protein 3 decreases expression ISO Captan results in decreased expression of CLIP3 mRNA CTD PMID:31558096 NCBI chr19:36,014,660...36,032,873
Ensembl chr19:36,014,660...36,033,343 		JBrowse link
G CLSTN1 calsyntenin 1 decreases expression ISO Captan results in decreased expression of CLSTN1 mRNA CTD PMID:31558096 NCBI chr 1:9,728,926...9,824,526
Ensembl chr 1:9,728,926...9,823,984 		JBrowse link
G CLTB clathrin light chain B increases expression ISO Captan results in increased expression of CLTB mRNA CTD PMID:31558096 NCBI chr 5:176,392,455...176,416,569
Ensembl chr 5:176,392,501...176,416,539 		JBrowse link
G CMPK2 cytidine/uridine monophosphate kinase 2 increases expression ISO Captan results in increased expression of CMPK2 mRNA CTD PMID:31558096 NCBI chr 2:6,840,553...6,866,635
Ensembl chr 2:6,840,570...6,866,635 		JBrowse link
G CNDP2 carnosine dipeptidase 2 increases expression ISO Captan results in increased expression of CNDP2 mRNA CTD PMID:31558096 NCBI chr18:74,496,363...74,523,454
Ensembl chr18:74,495,816...74,523,454 		JBrowse link
G CNN3 calponin 3 decreases expression ISO Captan results in decreased expression of CNN3 mRNA CTD PMID:31558096 NCBI chr 1:94,896,957...94,927,110
Ensembl chr 1:94,896,949...94,927,223 		JBrowse link
G COG4 component of oligomeric golgi complex 4 increases expression ISO Captan results in increased expression of COG4 mRNA CTD PMID:31558096 NCBI chr16:70,480,567...70,523,554
Ensembl chr16:70,480,568...70,523,560 		JBrowse link
G COL6A2 collagen type VI alpha 2 chain decreases expression ISO Captan results in decreased expression of COL6A2 mRNA CTD PMID:31558096 NCBI chr21:46,098,112...46,132,848
Ensembl chr21:46,098,112...46,132,848 		JBrowse link
G COL6A3 collagen type VI alpha 3 chain decreases expression ISO Captan results in decreased expression of COL6A3 mRNA CTD PMID:31558096 NCBI chr 2:237,324,018...237,414,164
Ensembl chr 2:237,324,003...237,414,328 		JBrowse link
G COMT catechol-O-methyltransferase increases expression ISO Captan results in increased expression of COMT mRNA CTD PMID:31558096 NCBI chr22:19,941,772...19,969,975
Ensembl chr22:19,941,371...19,969,975 		JBrowse link
G COPB2 COPI coat complex subunit beta 2 increases expression ISO Captan results in increased expression of COPB2 mRNA CTD PMID:31558096 NCBI chr 3:139,357,406...139,389,680
Ensembl chr 3:139,353,946...139,389,736 		JBrowse link
G COPS5 COP9 signalosome subunit 5 increases expression ISO Captan results in increased expression of COPS5 mRNA CTD PMID:31558096 NCBI chr 8:67,043,079...67,062,133
Ensembl chr 8:67,043,079...67,083,783 		JBrowse link
G COPS7A COP9 signalosome subunit 7A decreases expression ISO Captan results in decreased expression of COPS7A mRNA CTD PMID:31558096 NCBI chr12:6,724,046...6,731,865
Ensembl chr12:6,724,014...6,731,875 		JBrowse link
G COQ8A coenzyme Q8A decreases expression ISO Captan results in decreased expression of ADCK3 mRNA CTD PMID:31558096 NCBI chr 1:226,940,294...226,987,544
Ensembl chr 1:226,940,286...226,987,544 		JBrowse link
G COX6B1 cytochrome c oxidase subunit 6B1 increases expression ISO Captan results in increased expression of COX6B1 mRNA CTD PMID:31558096 NCBI chr19:35,648,323...35,658,782
Ensembl chr19:35,648,323...35,658,782 		JBrowse link
G CPS1 carbamoyl-phosphate synthase 1 increases expression ISO Captan results in increased expression of CPS1 mRNA CTD PMID:31558096 NCBI chr 2:210,477,685...210,679,107
Ensembl chr 2:210,477,682...210,679,107 		JBrowse link
G CPT1A carnitine palmitoyltransferase 1A multiple interactions ISO [Ziram co-treated with Thiophanate co-treated with Captan co-treated with Chlorpyrifos co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with thiacloprid] results in increased expression of CPT1A mRNA CTD PMID:32736067 NCBI chr11:68,754,620...68,844,277
Ensembl chr11:68,754,620...68,844,410 		JBrowse link
G CREB3L3 cAMP responsive element binding protein 3 like 3 increases expression ISO Captan results in increased expression of CREB3L3 mRNA CTD PMID:31558096 NCBI chr19:4,153,631...4,173,054
Ensembl chr19:4,153,631...4,173,054 		JBrowse link
G CRELD2 cysteine rich with EGF like domains 2 decreases expression ISO Captan results in decreased expression of CRELD2 mRNA CTD PMID:31558096 NCBI chr22:49,918,634...49,927,537
Ensembl chr22:49,918,167...49,927,540 		JBrowse link
G CRYAB crystallin alpha B decreases expression ISO Captan results in decreased expression of CRYAB mRNA CTD PMID:31558096 NCBI chr11:111,908,564...111,923,740
Ensembl chr11:111,908,564...111,923,722 		JBrowse link
G CS citrate synthase increases expression ISO Captan results in increased expression of CS mRNA CTD PMID:31558096 NCBI chr12:56,271,699...56,300,330
Ensembl chr12:56,271,699...56,300,391 		JBrowse link
G CSRP1 cysteine and glycine rich protein 1 decreases expression ISO Captan results in decreased expression of CSRP1 mRNA CTD PMID:31558096 NCBI chr 1:201,483,530...201,507,123
Ensembl chr 1:201,483,530...201,509,456 		JBrowse link
G CTH cystathionine gamma-lyase increases expression ISO Captan results in increased expression of CTH mRNA CTD PMID:31558096 NCBI chr 1:70,411,268...70,439,851
Ensembl chr 1:70,411,218...70,439,851 		JBrowse link
G CTNND1 catenin delta 1 increases expression ISO Captan results in increased expression of CTNND1 mRNA CTD PMID:31558096 NCBI chr11:57,761,802...57,819,540
Ensembl chr11:57,753,243...57,819,546 		JBrowse link
G CYBB cytochrome b-245 beta chain decreases expression ISO Captan results in decreased expression of CYBB mRNA CTD PMID:31558096 NCBI chr  X:37,780,059...37,813,461
Ensembl chr  X:37,780,018...37,813,461 		JBrowse link
G CYP1A1 cytochrome P450 family 1 subfamily A member 1 increases expression ISO Captan results in increased expression of CYP1A1 mRNA CTD PMID:31558096 NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536 		JBrowse link
G CYP2A6 cytochrome P450 family 2 subfamily A member 6 increases expression ISO Captan results in increased expression of CYP2A5 mRNA CTD PMID:31558096 NCBI chr19:40,843,541...40,850,447
Ensembl chr19:40,843,541...40,850,447 		JBrowse link
G CYP2B6 cytochrome P450 family 2 subfamily B member 6 multiple interactions
increases expression 		ISO [Dietary Fats co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with thiacloprid co-treated with Thiophanate co-treated with Ziram] results in increased expression of CYP2B10 mRNA; [Ziram co-treated with Thiophanate co-treated with Captan co-treated with Chlorpyrifos co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with thiacloprid] results in increased expression of CYP2B10 mRNA
Captan results in increased expression of CYP2B10 mRNA 		CTD PMID:31558096 PMID:32736067 PMID:32745781 NCBI chr19:40,991,282...41,018,398
Ensembl chr19:40,991,282...41,018,398 		JBrowse link
G CYP2C19 cytochrome P450 family 2 subfamily C member 19 decreases expression
increases expression 		EXP
ISO 		Captan results in decreased expression of CYP2C19 protein
Captan results in increased expression of CYP2C38 mRNA 		CTD PMID:31558096 PMID:32194361 NCBI chr10:94,762,681...94,855,547
Ensembl chr10:94,762,681...94,855,547 		JBrowse link
G CYP2C8 cytochrome P450 family 2 subfamily C member 8 multiple interactions
increases expression 		ISO [Dietary Fats co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with thiacloprid co-treated with Thiophanate co-treated with Ziram] results in increased expression of CYP2C29 mRNA
Captan results in increased expression of CYP2C29 mRNA 		CTD PMID:31558096 PMID:32745781 NCBI chr10:95,036,772...95,069,497
Ensembl chr10:95,036,772...95,069,497 		JBrowse link
G CYP2C9 cytochrome P450 family 2 subfamily C member 9 increases expression ISO Captan results in increased expression of CYP2C65 mRNA CTD PMID:31558096 NCBI chr10:94,938,658...94,990,091
Ensembl chr10:94,938,658...94,990,091 		JBrowse link
G CYP3A4 cytochrome P450 family 3 subfamily A member 4 multiple interactions EXP [Omite co-treated with Diphenylamine co-treated with phosalone co-treated with Captan co-treated with N-dichlorofluoromethylthio-N',N'-dimethyl-N-p-tolylsulfamide] results in increased expression of CYP3A4 mRNA CTD PMID:25028461 NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248 		JBrowse link
G CYP3A7-CYP3A51P CYP3A7-CYP3A51P readthrough decreases expression ISO Captan results in decreased expression of CYP3A41A mRNA CTD PMID:31558096 NCBI chr 7:99,684,677...99,735,196
Ensembl chr 7:99,684,957...99,735,102 		JBrowse link
G DBP D-box binding PAR bZIP transcription factor increases expression ISO Captan results in increased expression of DBP mRNA CTD PMID:31558096 NCBI chr19:48,630,030...48,637,379
Ensembl chr19:48,630,030...48,637,379 		JBrowse link
G DCTPP1 dCTP pyrophosphatase 1 decreases expression ISO Captan results in decreased expression of DCTPP1 mRNA CTD PMID:31558096 NCBI chr16:30,423,615...30,430,030
Ensembl chr16:30,423,615...30,430,030 		JBrowse link
G DDIT3 DNA damage inducible transcript 3 increases expression EXP
ISO 		Captan results in increased expression of DDIT3 mRNA
Captan results in increased expression of DDIT3 protein 		CTD PMID:32870474 PMID:34303901 NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737 		JBrowse link
G DERA deoxyribose-phosphate aldolase increases expression ISO Captan results in increased expression of DERA mRNA CTD PMID:31558096 NCBI chr12:15,911,332...16,037,381
Ensembl chr12:15,911,302...16,037,381 		JBrowse link
G DHFR dihydrofolate reductase increases expression ISO Captan results in increased expression of DHFR mRNA CTD PMID:31558096 NCBI chr 5:80,626,226...80,654,983
Ensembl chr 5:80,626,226...80,654,983 		JBrowse link
G DIO1 iodothyronine deiodinase 1 decreases activity
decreases expression
multiple interactions 		EXP
ISO 		Captan results in decreased activity of DIO1 protein
Captan results in decreased expression of DIO1 mRNA
[Dietary Fats co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with thiacloprid co-treated with Thiophanate co-treated with Ziram] results in increased expression of DIO1 mRNA 		CTD PMID:29228274 PMID:31558096 PMID:32745781 NCBI chr 1:53,894,187...53,911,086
Ensembl chr 1:53,891,239...53,911,086 		JBrowse link
G DNAJB6 DnaJ heat shock protein family (Hsp40) member B6 increases expression ISO Captan results in increased expression of DNAJB6 mRNA CTD PMID:31558096 NCBI chr 7:157,337,004...157,417,439
Ensembl chr 7:157,335,381...157,417,439 		JBrowse link
G DPPA5 developmental pluripotency associated 5 increases expression ISO Captan results in increased expression of DPPA5A mRNA CTD PMID:31558096 NCBI chr 6:73,353,063...73,354,276
Ensembl chr 6:73,353,063...73,354,276 		JBrowse link
G DSC2 desmocollin 2 increases expression ISO Captan results in increased expression of DSC2 mRNA CTD PMID:31558096 NCBI chr18:31,058,840...31,102,421
Ensembl chr18:31,058,545...31,102,600 		JBrowse link
G DUSP3 dual specificity phosphatase 3 decreases expression ISO Captan results in decreased expression of DUSP3 mRNA CTD PMID:31558096 NCBI chr17:43,766,125...43,778,977
Ensembl chr17:43,766,125...43,778,977 		JBrowse link
G DUSP6 dual specificity phosphatase 6 increases expression ISO Captan results in increased expression of DUSP6 mRNA CTD PMID:31558096 NCBI chr12:89,347,235...89,352,501
Ensembl chr12:89,347,235...89,352,501 		JBrowse link
G DYNLT3 dynein light chain Tctex-type 3 increases expression ISO Captan results in increased expression of DYNLT3 mRNA CTD PMID:31558096 NCBI chr  X:37,838,836...37,847,571
Ensembl chr  X:37,836,757...37,847,571 		JBrowse link
G E2F8 E2F transcription factor 8 decreases expression ISO Captan results in decreased expression of E2F8 mRNA CTD PMID:31558096 NCBI chr11:19,224,063...19,241,655
Ensembl chr11:19,224,063...19,241,620 		JBrowse link
G ECI1 enoyl-CoA delta isomerase 1 multiple interactions
increases expression 		ISO [Ziram co-treated with Thiophanate co-treated with Captan co-treated with Chlorpyrifos co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with thiacloprid] results in increased expression of ECI1 mRNA
Captan results in increased expression of ECI1 mRNA 		CTD PMID:31558096 PMID:32736067 NCBI chr16:2,239,402...2,251,587
Ensembl chr16:2,239,402...2,252,300 		JBrowse link
G EIF2AK2 eukaryotic translation initiation factor 2 alpha kinase 2 increases expression ISO Captan results in increased expression of EIF2AK2 mRNA CTD PMID:31558096 NCBI chr 2:37,099,210...37,156,980
Ensembl chr 2:37,099,210...37,157,522 		JBrowse link
G EIF2S3 eukaryotic translation initiation factor 2 subunit gamma decreases expression ISO Captan results in decreased expression of EIF2S3X mRNA CTD PMID:31558096 NCBI chr  X:24,054,956...24,078,810
Ensembl chr  X:24,054,946...24,078,810 		JBrowse link
G EIF4G1 eukaryotic translation initiation factor 4 gamma 1 decreases expression ISO Captan results in decreased expression of EIF4G1 mRNA CTD PMID:31558096 NCBI chr 3:184,314,606...184,335,358
Ensembl chr 3:184,314,495...184,335,358 		JBrowse link
G ELOVL5 ELOVL fatty acid elongase 5 decreases expression ISO Captan results in decreased expression of ELOVL5 mRNA CTD PMID:31558096 NCBI chr 6:53,267,404...53,348,950
Ensembl chr 6:53,267,398...53,349,179 		JBrowse link
G ELOVL6 ELOVL fatty acid elongase 6 increases expression ISO Captan results in increased expression of ELOVL6 mRNA CTD PMID:31558096 NCBI chr 4:110,045,846...110,199,202
Ensembl chr 4:110,045,846...110,199,199 		JBrowse link
G EPHX1 epoxide hydrolase 1 increases expression ISO Captan results in increased expression of EPHX1 mRNA CTD PMID:31558096 NCBI chr 1:225,810,124...225,845,563
Ensembl chr 1:225,810,124...225,845,563 		JBrowse link
G EPHX2 epoxide hydrolase 2 increases expression ISO Captan results in increased expression of EPHX2 mRNA CTD PMID:31558096 NCBI chr 8:27,491,143...27,548,626
Ensembl chr 8:27,490,781...27,545,564 		JBrowse link
G ERBB2 erb-b2 receptor tyrosine kinase 2 decreases expression ISO Captan results in decreased expression of ERBB2 mRNA CTD PMID:31558096 NCBI chr17:39,688,094...39,728,658
Ensembl chr17:39,687,914...39,730,426 		JBrowse link
G ERBB3 erb-b2 receptor tyrosine kinase 3 decreases expression ISO Captan results in decreased expression of ERBB3 mRNA CTD PMID:31558096 NCBI chr12:56,080,108...56,103,505
Ensembl chr12:56,076,799...56,103,505 		JBrowse link
G ERO1B endoplasmic reticulum oxidoreductase 1 beta decreases expression ISO Captan results in decreased expression of ERO1B mRNA CTD PMID:31558096 NCBI chr 1:236,215,101...236,281,958
Ensembl chr 1:236,214,681...236,282,019 		JBrowse link
G ESR1 estrogen receptor 1 affects binding EXP Captan binds to ESR1 protein CTD PMID:15253041 NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619 		JBrowse link
G ESR2 estrogen receptor 2 decreases expression ISO Captan results in decreased expression of ESR2 protein CTD PMID:34303901 NCBI chr14:64,226,707...64,338,613
Ensembl chr14:64,084,232...64,338,112 		JBrowse link
G ETFB electron transfer flavoprotein subunit beta increases expression ISO Captan results in increased expression of ETFB mRNA CTD PMID:31558096 NCBI chr19:51,345,155...51,366,388
Ensembl chr19:51,345,169...51,366,388 		JBrowse link
G EVL Enah/Vasp-like decreases expression ISO Captan results in decreased expression of EVL mRNA CTD PMID:31558096 NCBI chr14:99,971,422...100,144,236
Ensembl chr14:99,971,449...100,144,236 		JBrowse link
G FABP1 fatty acid binding protein 1 increases expression ISO Captan results in increased expression of FABP1 mRNA CTD PMID:31558096 NCBI chr 2:88,122,982...88,128,062
Ensembl chr 2:88,122,982...88,128,062 		JBrowse link
G FABP2 fatty acid binding protein 2 increases expression ISO Captan results in increased expression of FABP2 mRNA CTD PMID:31558096 NCBI chr 4:119,317,250...119,322,138
Ensembl chr 4:119,317,250...119,322,138 		JBrowse link
G FAT1 FAT atypical cadherin 1 increases expression ISO Captan results in increased expression of FAT1 mRNA CTD PMID:31558096 NCBI chr 4:186,587,794...186,726,696
Ensembl chr 4:186,587,794...186,726,722 		JBrowse link
G FBN1 fibrillin 1 decreases expression ISO Captan results in decreased expression of FBN1 mRNA CTD PMID:31558096 NCBI chr15:48,408,313...48,645,709
Ensembl chr15:48,408,313...48,645,721 		JBrowse link
G FBXO5 F-box protein 5 decreases expression ISO Captan results in decreased expression of FBXO5 mRNA CTD PMID:31558096 NCBI chr 6:152,970,535...152,983,579
Ensembl chr 6:152,970,519...152,983,579 		JBrowse link
G FDFT1 farnesyl-diphosphate farnesyltransferase 1 increases expression ISO Captan results in increased expression of FDFT1 mRNA CTD PMID:31558096 NCBI chr 8:11,795,582...11,839,298
Ensembl chr 8:11,795,573...11,839,395 		JBrowse link
G FGF1 fibroblast growth factor 1 decreases expression ISO Captan results in decreased expression of FGF1 mRNA CTD PMID:31558096 NCBI chr 5:142,592,178...142,698,070
Ensembl chr 5:142,592,178...142,698,070 		JBrowse link
G FIS1 fission, mitochondrial 1 increases expression ISO Captan results in increased expression of FIS1 mRNA CTD PMID:31558096 NCBI chr 7:101,239,472...101,245,081
Ensembl chr 7:101,239,458...101,252,316 		JBrowse link
G FLNA filamin A decreases expression ISO Captan results in decreased expression of FLNA mRNA CTD PMID:31558096 NCBI chr  X:154,348,531...154,374,634
Ensembl chr  X:154,348,524...154,374,634 		JBrowse link
G FMO5 flavin containing dimethylaniline monoxygenase 5 increases expression ISO Captan results in increased expression of FMO5 mRNA CTD PMID:31558096 NCBI chr 1:147,184,305...147,227,284
Ensembl chr 1:147,175,351...147,243,050 		JBrowse link
G FOS Fos proto-oncogene, AP-1 transcription factor subunit increases expression ISO Captan results in increased expression of FOS mRNA CTD PMID:31558096 NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,283,190 		JBrowse link
G FOXJ3 forkhead box J3 increases expression ISO Captan results in increased expression of FOXJ3 mRNA CTD PMID:31558096 NCBI chr 1:42,176,548...42,335,880
Ensembl chr 1:42,176,539...42,335,877 		JBrowse link
G FYN FYN proto-oncogene, Src family tyrosine kinase decreases expression ISO Captan results in decreased expression of FYN mRNA CTD PMID:31558096 NCBI chr 6:111,660,332...111,873,452
Ensembl chr 6:111,660,332...111,873,452 		JBrowse link
G FZD7 frizzled class receptor 7 decreases expression ISO Captan results in decreased expression of FZD7 mRNA CTD PMID:31558096 NCBI chr 2:202,033,855...202,038,441
Ensembl chr 2:202,033,855...202,038,441 		JBrowse link
G G0S2 G0/G1 switch 2 increases expression ISO Captan results in increased expression of G0S2 mRNA CTD PMID:31558096 NCBI chr 1:209,675,412...209,676,390
Ensembl chr 1:209,675,412...209,676,390 		JBrowse link
G GABARAP GABA type A receptor-associated protein increases expression ISO Captan results in increased expression of GABARAP mRNA CTD PMID:31558096 NCBI chr17:7,240,008...7,242,449
Ensembl chr17:7,240,008...7,242,449 		JBrowse link
G GADD45G growth arrest and DNA damage inducible gamma decreases expression ISO Captan results in decreased expression of GADD45G mRNA CTD PMID:31558096 NCBI chr 9:89,605,012...89,606,555
Ensembl chr 9:89,605,012...89,606,555 		JBrowse link
G GALE UDP-galactose-4-epimerase increases expression ISO Captan results in increased expression of GALE mRNA CTD PMID:31558096 NCBI chr 1:23,795,599...23,800,754
Ensembl chr 1:23,795,599...23,800,781 		JBrowse link
G GAPDH glyceraldehyde-3-phosphate dehydrogenase increases expression ISO Captan results in increased expression of GAPDH mRNA CTD PMID:31558096 NCBI chr12:6,534,517...6,538,371
Ensembl chr12:6,534,512...6,538,374 		JBrowse link
G GARS1 glycyl-tRNA synthetase 1 decreases expression ISO Captan results in decreased expression of GARS1 mRNA CTD PMID:31558096 NCBI chr 7:30,594,735...30,634,033
Ensembl chr 7:30,580,533...30,634,033 		JBrowse link
G GCLC glutamate-cysteine ligase catalytic subunit increases expression ISO Captan results in increased expression of GCLC mRNA CTD PMID:31558096 NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970 		JBrowse link
G GCLM glutamate-cysteine ligase modifier subunit increases expression ISO Captan results in increased expression of GCLM mRNA CTD PMID:31558096 NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456 		JBrowse link
G GFAP glial fibrillary acidic protein multiple interactions ISO [Ziram co-treated with Thiophanate co-treated with Captan co-treated with Chlorpyrifos co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with thiacloprid] results in increased expression of GFAP protein CTD PMID:32736067 NCBI chr17:44,903,159...44,915,500
Ensembl chr17:44,903,159...44,916,937 		JBrowse link
G GIMAP4 GTPase, IMAP family member 4 decreases expression ISO Captan results in decreased expression of GIMAP4 mRNA CTD PMID:31558096 NCBI chr 7:150,567,390...150,573,953
Ensembl chr 7:150,567,369...150,573,953 		JBrowse link
G GIMAP6 GTPase, IMAP family member 6 decreases expression ISO Captan results in decreased expression of GIMAP6 mRNA CTD PMID:31558096 NCBI chr 7:150,625,375...150,632,385
Ensembl chr 7:150,625,375...150,632,648 		JBrowse link
G GLUL glutamate-ammonia ligase decreases expression ISO Captan results in decreased expression of GLUL mRNA CTD PMID:31558096 NCBI chr 1:182,378,098...182,391,790
Ensembl chr 1:182,378,098...182,392,206 		JBrowse link
G GNAI2 G protein subunit alpha i2 decreases expression ISO Captan results in decreased expression of GNAI2 mRNA CTD PMID:31558096 NCBI chr 3:50,227,068...50,263,358
Ensembl chr 3:50,226,292...50,259,362 		JBrowse link
G GNMT glycine N-methyltransferase decreases expression ISO Captan results in decreased expression of GNMT mRNA CTD PMID:31558096 NCBI chr 6:42,960,754...42,963,880
Ensembl chr 6:42,960,754...42,963,880 		JBrowse link
G GNPDA1 glucosamine-6-phosphate deaminase 1 increases expression ISO Captan results in increased expression of GNPDA1 mRNA CTD PMID:31558096 NCBI chr 5:142,000,671...142,013,027
Ensembl chr 5:141,991,749...142,013,041 		JBrowse link
G GOLT1B golgi transport 1B decreases expression ISO Captan results in decreased expression of GOLT1B mRNA CTD PMID:31558096 NCBI chr12:21,501,789...21,518,408
Ensembl chr12:21,501,781...21,518,408 		JBrowse link
G GPR17 G protein-coupled receptor 17 increases expression ISO Captan results in increased expression of GPR17 mRNA CTD PMID:31558096 NCBI chr 2:127,646,153...127,652,639
Ensembl chr 2:127,645,864...127,652,639 		JBrowse link
G GPX3 glutathione peroxidase 3 increases expression ISO Captan results in increased expression of GPX3 mRNA CTD PMID:34303901 NCBI chr 5:151,020,591...151,028,988
Ensembl chr 5:151,020,591...151,028,988 		JBrowse link
G GPX4 glutathione peroxidase 4 increases expression ISO Captan results in increased expression of GPX4 mRNA CTD PMID:31558096 NCBI chr19:1,103,994...1,106,779
Ensembl chr19:1,103,982...1,106,791 		JBrowse link
G GSK3B glycogen synthase kinase 3 beta multiple interactions ISO [alachlor co-treated with Captan co-treated with Diazinon co-treated with Endosulfan co-treated with mancozeb co-treated with Maneb] affects the phosphorylation of GSK3B protein CTD PMID:19883720 NCBI chr 3:119,821,321...120,094,447
Ensembl chr 3:119,821,321...120,094,994 		JBrowse link
G GSR glutathione-disulfide reductase increases expression ISO Captan results in increased expression of GSR mRNA CTD PMID:31558096 NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846 		JBrowse link
G GSTA3 glutathione S-transferase alpha 3 increases expression ISO Captan results in increased expression of GSTA1 mRNA; Captan results in increased expression of GSTA2 mRNA; Captan results in increased expression of GSTA3 mRNA CTD PMID:31558096 NCBI chr 6:52,896,646...52,909,698
Ensembl chr 6:52,896,639...52,909,698 		JBrowse link
G GSTM2 glutathione S-transferase mu 2 increases expression ISO Captan results in increased expression of GSTM2 mRNA CTD PMID:31558096 NCBI chr 1:109,668,057...109,683,997
Ensembl chr 1:109,668,022...109,709,551 		JBrowse link
G GSTM3 glutathione S-transferase mu 3 increases expression ISO Captan results in increased expression of GSTM3 mRNA CTD PMID:31558096 NCBI chr 1:109,733,937...109,741,038
Ensembl chr 1:109,733,932...109,741,038 		JBrowse link
G GSTP1 glutathione S-transferase pi 1 multiple interactions
increases expression
decreases activity 		EXP
ISO 		hexylglutathione inhibits the reaction [Captan results in decreased activity of GSTP1 protein]
Captan results in increased expression of GSTP1 mRNA 		CTD PMID:8678907 PMID:31558096 NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656 		JBrowse link
G GXYLT1 glucoside xylosyltransferase 1 increases expression ISO Captan results in increased expression of GXYLT1 mRNA CTD PMID:31558096 NCBI chr12:42,081,845...42,144,874
Ensembl chr12:42,081,845...42,144,874 		JBrowse link
G H2AZ2 H2A.Z variant histone 2 decreases expression ISO Captan results in decreased expression of H2AZ2 mRNA CTD PMID:31558096 NCBI chr 7:44,826,889...44,848,126
Ensembl chr 7:44,826,791...44,848,087 		JBrowse link
G H3C1 H3 clustered histone 1 decreases expression ISO Captan results in decreased expression of H3C1 mRNA CTD PMID:31558096 NCBI chr 6:26,020,451...26,020,958
Ensembl chr 6:26,020,451...26,020,958 		JBrowse link
G H3C3 H3 clustered histone 3 decreases expression ISO Captan results in decreased expression of H3C3 mRNA CTD PMID:31558096 NCBI chr 6:26,045,384...26,045,869
Ensembl chr 6:26,045,384...26,045,869 		JBrowse link
G HAT1 histone acetyltransferase 1 increases expression ISO Captan results in increased expression of HAT1 mRNA CTD PMID:31558096 NCBI chr 2:171,922,461...171,983,686
Ensembl chr 2:171,922,448...171,983,686 		JBrowse link
G HDAC1 histone deacetylase 1 increases expression ISO Captan results in increased expression of HDAC1 mRNA CTD PMID:31558096 NCBI chr 1:32,292,083...32,333,626
Ensembl chr 1:32,292,083...32,333,635 		JBrowse link
G HEBP1 heme binding protein 1 increases expression ISO Captan results in increased expression of HEBP1 mRNA CTD PMID:31558096 NCBI chr12:12,974,870...13,000,265
Ensembl chr12:12,974,870...13,000,265 		JBrowse link
G HES1 hes family bHLH transcription factor 1 decreases expression ISO Captan results in decreased expression of HES1 mRNA CTD PMID:31558096 NCBI chr 3:194,136,148...194,138,732
Ensembl chr 3:194,136,148...194,138,732 		JBrowse link
G HGF hepatocyte growth factor increases expression ISO Captan results in increased expression of HGF mRNA CTD PMID:31558096 NCBI chr 7:81,699,010...81,770,047
Ensembl chr 7:81,699,010...81,770,438 		JBrowse link
G HJURP Holliday junction recognition protein increases expression ISO Captan results in increased expression of HJURP mRNA CTD PMID:31558096 NCBI chr 2:233,836,702...233,854,535
Ensembl chr 2:233,833,416...233,854,566 		JBrowse link
G HLA-DQA1 major histocompatibility complex, class II, DQ alpha 1 decreases expression ISO Captan results in decreased expression of H2-AA mRNA CTD PMID:31558096 NCBI chr 6:32,637,406...32,655,272
Ensembl chr 6:32,628,179...32,647,062 		JBrowse link
G HMGCS2 3-hydroxy-3-methylglutaryl-CoA synthase 2 multiple interactions
decreases expression 		ISO [Dietary Fats co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with thiacloprid co-treated with Thiophanate co-treated with Ziram] results in increased expression of HMGCS2 mRNA
Captan results in decreased expression of HMGCS2 mRNA 		CTD PMID:31558096 PMID:32745781 NCBI chr 1:119,747,996...119,768,932
Ensembl chr 1:119,748,002...119,768,905 		JBrowse link
G HMOX1 heme oxygenase 1 increases expression EXP Captan results in increased expression of HMOX1 mRNA CTD PMID:35395341 NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214 		JBrowse link
G HNRNPH1 heterogeneous nuclear ribonucleoprotein H1 decreases expression ISO Captan results in decreased expression of HNRNPH1 mRNA CTD PMID:31558096 NCBI chr 5:179,614,178...179,634,784
Ensembl chr 5:179,614,178...179,634,784 		JBrowse link
G HOOK2 hook microtubule tethering protein 2 increases expression ISO Captan results in increased expression of HOOK2 mRNA CTD PMID:31558096 NCBI chr19:12,763,003...12,792,350
Ensembl chr19:12,763,003...12,872,740 		JBrowse link
G HSD17B10 hydroxysteroid 17-beta dehydrogenase 10 decreases expression ISO Captan results in decreased expression of HSD17B10 mRNA CTD PMID:31558096 NCBI chr  X:53,431,258...53,434,376
Ensembl chr  X:53,431,258...53,434,370 		JBrowse link
G HSD17B11 hydroxysteroid 17-beta dehydrogenase 11 increases expression ISO Captan results in increased expression of HSD17B11 mRNA CTD PMID:31558096 NCBI chr 4:87,336,515...87,391,188
Ensembl chr 4:87,336,515...87,391,188 		JBrowse link
G HSD17B6 hydroxysteroid 17-beta dehydrogenase 6 increases expression ISO Captan results in increased expression of HSD17B6 mRNA CTD PMID:31558096 NCBI chr12:56,763,324...56,787,790
Ensembl chr12:56,752,161...56,787,790 		JBrowse link
G HSD3B1 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 increases expression ISO Captan results in increased expression of HSD3B2 mRNA CTD PMID:31558096 NCBI chr 1:119,507,203...119,515,058
Ensembl chr 1:119,507,198...119,515,054 		JBrowse link
G HSP90AA1 heat shock protein 90 alpha family class A member 1 increases expression ISO Captan results in increased expression of HSP90AA1 mRNA CTD PMID:31558096 NCBI chr14:102,080,742...102,139,749
Ensembl chr14:102,080,742...102,139,699 		JBrowse link
G HSP90B1 heat shock protein 90 beta family member 1 decreases expression ISO Captan results in decreased expression of HSP90B1 mRNA CTD PMID:31558096 NCBI chr12:103,930,410...103,947,926
Ensembl chr12:103,930,107...103,953,931 		JBrowse link
G HSPA1B heat shock protein family A (Hsp70) member 1B increases expression ISO Captan results in increased expression of HSPA1B mRNA CTD PMID:31558096 NCBI chr 6:31,827,738...31,830,254
Ensembl chr 6:31,827,738...31,830,254 		JBrowse link
G HSPA5 heat shock protein family A (Hsp70) member 5 increases expression ISO Captan results in increased expression of HSPA5 protein CTD PMID:34303901 NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382 		JBrowse link
G HSPB1 heat shock protein family B (small) member 1 decreases expression ISO Captan results in decreased expression of HSPB1 mRNA CTD PMID:31558096 NCBI chr 7:76,302,673...76,304,292
Ensembl chr 7:76,302,673...76,305,813 		JBrowse link
G HSPB6 heat shock protein family B (small) member 6 decreases expression ISO Captan results in decreased expression of HSPB6 mRNA CTD PMID:31558096 NCBI chr19:35,754,566...35,757,029
Ensembl chr19:35,754,566...35,758,079 		JBrowse link
G HSPD1 heat shock protein family D (Hsp60) member 1 decreases expression ISO Captan results in decreased expression of HSPD1 mRNA CTD PMID:31558096 NCBI chr 2:197,486,584...197,500,274
Ensembl chr 2:197,486,584...197,516,737 		JBrowse link
G HTRA1 HtrA serine peptidase 1 decreases expression ISO Captan results in decreased expression of HTRA1 mRNA CTD PMID:31558096 NCBI chr10:122,461,553...122,514,907
Ensembl chr10:122,458,551...122,514,907 		JBrowse link
G ID4 inhibitor of DNA binding 4 decreases expression ISO Captan results in decreased expression of ID4 mRNA CTD PMID:31558096 NCBI chr 6:19,837,370...19,842,197
Ensembl chr 6:19,837,370...19,842,197 		JBrowse link
G IDI1 isopentenyl-diphosphate delta isomerase 1 decreases expression ISO Captan results in decreased expression of IDI1 mRNA CTD PMID:31558096 NCBI chr10:1,039,152...1,056,704
Ensembl chr10:1,039,152...1,049,119 		JBrowse link
G IFITM2 interferon induced transmembrane protein 2 decreases expression ISO Captan results in decreased expression of IFITM2 mRNA CTD PMID:31558096 NCBI chr11:307,816...309,395
Ensembl chr11:303,655...309,397 		JBrowse link
G IFITM3 interferon induced transmembrane protein 3 decreases expression ISO Captan results in decreased expression of IFITM3 mRNA CTD PMID:31558096 NCBI chr11:319,676...320,860
Ensembl chr11:319,676...329,475 		JBrowse link
G IGF1 insulin like growth factor 1 decreases expression ISO Captan results in decreased expression of IGF1 mRNA CTD PMID:31558096 NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744 		JBrowse link
G IGF1R insulin like growth factor 1 receptor decreases expression ISO Captan results in decreased expression of IGF1R mRNA CTD PMID:31558096 NCBI chr15:98,648,539...98,964,530
Ensembl chr15:98,648,539...98,964,530 		JBrowse link
G IGFBP3 insulin like growth factor binding protein 3 decreases expression ISO Captan results in decreased expression of IGFBP3 mRNA CTD PMID:31558096 NCBI chr 7:45,912,245...45,921,272
Ensembl chr 7:45,912,245...45,921,874 		JBrowse link
G IGFBP6 insulin like growth factor binding protein 6 decreases expression ISO Captan results in decreased expression of IGFBP6 mRNA CTD PMID:31558096 NCBI chr12:53,097,667...53,102,340
Ensembl chr12:53,097,436...53,102,345 		JBrowse link
G IL1B interleukin 1 beta increases secretion EXP Captan results in increased secretion of IL1B protein CTD PMID:35395341 NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816 		JBrowse link
G IL1R1 interleukin 1 receptor type 1 decreases expression ISO Captan results in decreased expression of IL1R1 mRNA CTD PMID:31558096 NCBI chr 2:102,070,390...102,179,874
Ensembl chr 2:102,064,544...102,179,874 		JBrowse link
G IL6 interleukin 6 increases expression ISO Captan results in increased expression of IL6 protein CTD PMID:34303901 NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002 		JBrowse link
G INS-IGF2 INS-IGF2 readthrough multiple interactions ISO [Dietary Fats co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with thiacloprid co-treated with Thiophanate co-treated with Ziram] results in increased expression of INS1 protein CTD PMID:32745781 NCBI chr11:2,129,117...2,161,209
Ensembl chr11:2,132,538...2,161,209 		JBrowse link
G INSIG1 insulin induced gene 1 increases expression ISO Captan results in increased expression of INSIG1 mRNA CTD PMID:31558096 NCBI chr 7:155,297,878...155,310,235
Ensembl chr 7:155,297,776...155,310,235 		JBrowse link
G IQGAP1 IQ motif containing GTPase activating protein 1 increases expression ISO Captan results in increased expression of IQGAP1 mRNA CTD PMID:31558096 NCBI chr15:90,388,242...90,502,239
Ensembl chr15:90,388,242...90,502,239 		JBrowse link
G IRF6 interferon regulatory factor 6 decreases expression ISO Captan results in decreased expression of IRF6 mRNA CTD PMID:31558096 NCBI chr 1:209,785,617...209,806,142
Ensembl chr 1:209,785,617...209,806,175 		JBrowse link
G ITGAE integrin subunit alpha E decreases expression ISO Captan results in decreased expression of ITGAE mRNA CTD PMID:31558096 NCBI chr17:3,714,628...3,801,188
Ensembl chr17:3,714,628...3,801,188 		JBrowse link
G IYD iodotyrosine deiodinase increases expression ISO Captan results in increased expression of IYD mRNA CTD PMID:31558096 NCBI chr 6:150,369,012...150,405,969
Ensembl chr 6:150,368,892...150,405,969 		JBrowse link
G JUN Jun proto-oncogene, AP-1 transcription factor subunit increases expression ISO Captan results in increased expression of JUN mRNA CTD PMID:31558096 NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048 		JBrowse link
G KARS1 lysyl-tRNA synthetase 1 decreases expression ISO Captan results in decreased expression of KARS1 mRNA CTD PMID:31558096 NCBI chr16:75,627,724...75,647,665
Ensembl chr16:75,627,474...75,648,643 		JBrowse link
G KAT2A lysine acetyltransferase 2A decreases expression ISO Captan results in decreased expression of KAT2A mRNA CTD PMID:31558096 NCBI chr17:42,113,111...42,121,367
Ensembl chr17:42,113,111...42,121,367 		JBrowse link
G KCNK1 potassium two pore domain channel subfamily K member 1 decreases expression ISO Captan results in decreased expression of KCNK1 mRNA CTD PMID:31558096 NCBI chr 1:233,614,106...233,672,514
Ensembl chr 1:233,614,106...233,672,514 		JBrowse link
G KIF23 kinesin family member 23 decreases expression ISO Captan results in decreased expression of KIF23 mRNA CTD PMID:31558096 NCBI chr15:69,414,349...69,448,427
Ensembl chr15:69,414,246...69,448,427 		JBrowse link
G KLF2 KLF transcription factor 2 decreases expression ISO Captan results in decreased expression of KLF2 mRNA CTD PMID:31558096 NCBI chr19:16,324,826...16,328,685
Ensembl chr19:16,324,826...16,328,685 		JBrowse link
G KLF4 KLF transcription factor 4 increases expression ISO Captan results in increased expression of KLF4 mRNA CTD PMID:31558096 NCBI chr 9:107,484,852...107,489,769
Ensembl chr 9:107,484,852...107,490,482 		JBrowse link
G KLHL21 kelch like family member 21 decreases expression ISO Captan results in decreased expression of KLHL21 mRNA CTD PMID:31558096 NCBI chr 1:6,590,724...6,602,869
Ensembl chr 1:6,590,724...6,614,607 		JBrowse link
G KLHL24 kelch like family member 24 decreases expression ISO Captan results in decreased expression of KLHL24 mRNA CTD PMID:31558096 NCBI chr 3:183,635,623...183,684,519
Ensembl chr 3:183,635,610...183,684,519 		JBrowse link
G KLHL9 kelch like family member 9 decreases expression ISO Captan results in decreased expression of KLHL9 mRNA CTD PMID:31558096 NCBI chr 9:21,329,665...21,335,404
Ensembl chr 9:21,320,024...21,335,404 		JBrowse link
G KRT7 keratin 7 decreases expression ISO Captan results in decreased expression of KRT7 mRNA CTD PMID:31558096 NCBI chr12:52,233,243...52,255,853
Ensembl chr12:52,232,520...52,252,186 		JBrowse link
G KRT8 keratin 8 increases expression ISO Captan results in increased expression of KRT8 mRNA CTD PMID:31558096 NCBI chr12:52,897,191...52,949,860
Ensembl chr12:52,897,187...52,949,954 		JBrowse link
G L1CAM L1 cell adhesion molecule decreases expression ISO Captan results in decreased expression of L1CAM mRNA CTD PMID:31558096 NCBI chr  X:153,861,514...153,886,173
Ensembl chr  X:153,861,514...153,886,173 		JBrowse link
G LAMA2 laminin subunit alpha 2 decreases expression ISO Captan results in decreased expression of LAMA2 mRNA CTD PMID:31558096 NCBI chr 6:128,883,138...129,516,566
Ensembl chr 6:128,883,138...129,516,566 		JBrowse link
G LAMP1 lysosomal associated membrane protein 1 increases expression ISO Captan results in increased expression of LAMP1 mRNA CTD PMID:31558096 NCBI chr13:113,297,239...113,323,672
Ensembl chr13:113,297,239...113,323,672 		JBrowse link
G LDLR low density lipoprotein receptor increases expression ISO Captan results in increased expression of LDLR mRNA CTD PMID:31558096 NCBI chr19:11,089,463...11,133,820
Ensembl chr19:11,089,418...11,133,820 		JBrowse link
G LHCGR luteinizing hormone/choriogonadotropin receptor decreases expression ISO Captan results in decreased expression of LHCGR protein CTD PMID:34303901 NCBI chr 2:48,686,774...48,755,724
Ensembl chr 2:48,686,774...48,755,730 		JBrowse link
G LHFPL6 LHFPL tetraspan subfamily member 6 decreases expression ISO Captan results in decreased expression of LHFPL6 mRNA CTD PMID:31558096 NCBI chr13:39,342,892...39,603,193
Ensembl chr13:39,209,116...39,603,528 		JBrowse link
G LIPA lipase A, lysosomal acid type increases expression ISO Captan results in increased expression of LIPA mRNA CTD PMID:31558096 NCBI chr10:89,213,572...89,251,775
Ensembl chr10:89,213,569...89,414,557 		JBrowse link
G LPIN1 lipin 1 decreases expression ISO Captan results in decreased expression of LPIN1 mRNA CTD PMID:31558096 NCBI chr 2:11,677,544...11,827,409
Ensembl chr 2:11,677,595...11,827,409 		JBrowse link
G LRAT lecithin retinol acyltransferase decreases expression ISO Captan results in decreased expression of LRAT mRNA CTD PMID:31558096 NCBI chr 4:154,740,838...154,753,120
Ensembl chr 4:154,626,945...154,753,120 		JBrowse link
G LRRC41 leucine rich repeat containing 41 decreases expression ISO Captan results in decreased expression of LRRC41 mRNA CTD PMID:31558096 NCBI chr 1:46,277,462...46,303,616
Ensembl chr 1:46,261,196...46,303,616 		JBrowse link
G LTBR lymphotoxin beta receptor increases expression ISO Captan results in increased expression of LTBR mRNA CTD PMID:31558096 NCBI chr12:6,375,160...6,391,566
Ensembl chr12:6,375,045...6,391,571 		JBrowse link
G LUM lumican decreases expression ISO Captan results in decreased expression of LUM mRNA CTD PMID:31558096 NCBI chr12:91,102,629...91,111,494
Ensembl chr12:91,102,629...91,111,494 		JBrowse link
G LYZ lysozyme decreases expression ISO Captan results in decreased expression of LYZ2 mRNA CTD PMID:31558096 NCBI chr12:69,348,381...69,354,234
Ensembl chr12:69,348,381...69,354,234 		JBrowse link
G MAFF MAF bZIP transcription factor F increases expression ISO Captan results in increased expression of MAFF mRNA CTD PMID:31558096 NCBI chr22:38,201,994...38,216,511
Ensembl chr22:38,200,767...38,216,507 		JBrowse link
G MAOA monoamine oxidase A increases expression ISO Captan results in increased expression of MAOA mRNA CTD PMID:31558096 NCBI chr  X:43,655,006...43,746,817
Ensembl chr  X:43,654,907...43,746,817 		JBrowse link
G MAP4K4 mitogen-activated protein kinase kinase kinase kinase 4 decreases expression ISO Captan results in decreased expression of MAP4K4 mRNA CTD PMID:31558096 NCBI chr 2:101,697,707...101,894,690
Ensembl chr 2:101,696,850...101,894,690 		JBrowse link
G MAPK1IP1L mitogen-activated protein kinase 1 interacting protein 1 like increases expression ISO Captan results in increased expression of MAPK1IP1L mRNA CTD PMID:31558096 NCBI chr14:55,051,647...55,070,194
Ensembl chr14:55,051,647...55,070,194 		JBrowse link
G MAPK3 mitogen-activated protein kinase 3 increases expression ISO Captan results in increased expression of MAPK3 mRNA CTD PMID:31558096 NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506 		JBrowse link
G MAPK8 mitogen-activated protein kinase 8 increases phosphorylation ISO Captan results in increased phosphorylation of MAPK8 protein CTD PMID:34303901 NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360 		JBrowse link
G MBNL2 muscleblind like splicing regulator 2 increases expression ISO Captan results in increased expression of MBNL2 mRNA CTD PMID:31558096 NCBI chr13:97,141,834...97,394,120
Ensembl chr13:97,221,434...97,394,120 		JBrowse link
G MCM7 minichromosome maintenance complex component 7 decreases expression ISO Captan results in decreased expression of MCM7 mRNA CTD PMID:31558096 NCBI chr 7:100,092,728...100,101,397
Ensembl chr 7:100,092,233...100,101,940 		JBrowse link
G ME1 malic enzyme 1 increases expression ISO Captan results in increased expression of ME1 mRNA CTD PMID:31558096 NCBI chr 6:83,210,402...83,431,051
Ensembl chr 6:83,210,402...83,431,051 		JBrowse link
G MEIS2 Meis homeobox 2 increases expression ISO Captan results in increased expression of MEIS2 mRNA CTD PMID:31558096 NCBI chr15:36,889,204...37,101,311
Ensembl chr15:36,889,204...37,101,299 		JBrowse link
G MFSD10 major facilitator superfamily domain containing 10 decreases expression ISO Captan results in decreased expression of MFSD10 mRNA CTD PMID:31558096 NCBI chr 4:2,930,567...2,934,825
Ensembl chr 4:2,930,561...2,934,834 		JBrowse link
G MLEC malectin increases expression ISO Captan results in increased expression of MLEC mRNA CTD PMID:31558096 NCBI chr12:120,687,149...120,701,859
Ensembl chr12:120,687,149...120,704,282 		JBrowse link
G MNAT1 MNAT1 component of CDK activating kinase decreases expression ISO Captan results in decreased expression of MNAT1 mRNA CTD PMID:31558096 NCBI chr14:60,734,761...60,969,965
Ensembl chr14:60,734,742...60,969,965 		JBrowse link
G MOB1A MOB kinase activator 1A decreases expression ISO Captan results in decreased expression of MOB1A mRNA CTD PMID:31558096 NCBI chr 2:74,152,528...74,178,879
Ensembl chr 2:74,152,528...74,178,898 		JBrowse link
G MRPS2 mitochondrial ribosomal protein S2 decreases expression ISO Captan results in decreased expression of MRPS2 mRNA CTD PMID:31558096 NCBI chr 9:135,499,965...135,504,673
Ensembl chr 9:135,499,984...135,504,673 		JBrowse link
G MT1G metallothionein 1G increases expression EXP Captan results in increased expression of MT1G mRNA CTD PMID:32870474 NCBI chr16:56,666,730...56,668,065
Ensembl chr16:56,666,730...56,668,065 		JBrowse link
G MTA1 metastasis associated 1 decreases expression ISO Captan results in decreased expression of MTA1 mRNA CTD PMID:31558096 NCBI chr14:105,419,827...105,470,729
Ensembl chr14:105,419,820...105,470,729 		JBrowse link
G MTHFD1L methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 like increases expression ISO Captan results in increased expression of MTHFD1L mRNA CTD PMID:31558096 NCBI chr 6:150,865,702...151,101,887
Ensembl chr 6:150,865,679...151,101,887 		JBrowse link
G MVP major vault protein increases expression ISO Captan results in increased expression of MVP mRNA CTD PMID:31558096 NCBI chr16:29,820,394...29,848,039
Ensembl chr16:29,820,394...29,848,039 		JBrowse link
G MYC MYC proto-oncogene, bHLH transcription factor multiple interactions ISO [alachlor co-treated with Captan co-treated with Diazinon co-treated with Endosulfan co-treated with mancozeb co-treated with Maneb] results in increased expression of MYC protein CTD PMID:19883720 NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951 		JBrowse link
G MYCBP2 MYC binding protein 2 decreases expression ISO Captan results in decreased expression of MYCBP2 mRNA CTD PMID:31558096 NCBI chr13:77,044,657...77,327,094
Ensembl chr13:77,042,474...77,327,094 		JBrowse link
G MYL9 myosin light chain 9 decreases expression ISO Captan results in decreased expression of MYL9 mRNA CTD PMID:31558096 NCBI chr20:36,541,519...36,551,447
Ensembl chr20:36,541,497...36,551,447 		JBrowse link
G MYLK myosin light chain kinase decreases expression ISO Captan results in decreased expression of MYLK mRNA CTD PMID:31558096 NCBI chr 3:123,610,049...123,884,332
Ensembl chr 3:123,610,049...123,884,332 		JBrowse link
G NDUFB10 NADH:ubiquinone oxidoreductase subunit B10 increases expression ISO Captan results in increased expression of NDUFB10 mRNA CTD PMID:31558096 NCBI chr16:1,959,538...1,961,975
Ensembl chr16:1,959,538...1,961,975 		JBrowse link
G NDUFS7 NADH:ubiquinone oxidoreductase core subunit S7 decreases expression ISO Captan results in decreased expression of NDUFS7 mRNA CTD PMID:31558096 NCBI chr19:1,383,907...1,395,584
Ensembl chr19:1,383,527...1,395,589 		JBrowse link
G NDUFV2 NADH:ubiquinone oxidoreductase core subunit V2 decreases expression ISO Captan results in decreased expression of NDUFV2 mRNA CTD PMID:31558096 NCBI chr18:9,102,699...9,134,341
Ensembl chr18:9,102,630...9,134,345 		JBrowse link
G NDUFV3 NADH:ubiquinone oxidoreductase subunit V3 decreases expression ISO Captan results in decreased expression of NDUFV3 mRNA CTD PMID:31558096 NCBI chr21:42,893,309...42,913,299
Ensembl chr21:42,879,644...42,913,304 		JBrowse link
G NET1 neuroepithelial cell transforming 1 increases expression ISO Captan results in increased expression of NET1 mRNA CTD PMID:31558096 NCBI chr10:5,412,557...5,459,056
Ensembl chr10:5,412,557...5,459,056 		JBrowse link
G NFIL3 nuclear factor, interleukin 3 regulated decreases expression ISO Captan results in decreased expression of NFIL3 mRNA CTD PMID:31558096 NCBI chr 9:91,409,045...91,483,497
Ensembl chr 9:91,408,748...91,424,626 		JBrowse link
G NFKBIB NFKB inhibitor beta increases expression ISO Captan results in increased expression of NFKBIB mRNA CTD PMID:31558096 NCBI chr19:38,899,666...38,908,889
Ensembl chr19:38,899,700...38,908,893 		JBrowse link
G NHERF1 NHERF family PDZ scaffold protein 1 increases expression ISO Captan results in increased expression of NHERF1 mRNA CTD PMID:31558096 NCBI chr17:74,748,628...74,769,353
Ensembl chr17:74,748,628...74,769,353 		JBrowse link
G NME1 NME/NM23 nucleoside diphosphate kinase 1 decreases expression ISO Captan results in decreased expression of NME1 mRNA CTD PMID:31558096 NCBI chr17:51,153,559...51,162,168
Ensembl chr17:51,153,559...51,162,428 		JBrowse link
G NOSIP nitric oxide synthase interacting protein decreases expression ISO Captan results in decreased expression of NOSIP mRNA CTD PMID:31558096 NCBI chr19:49,555,468...49,580,556
Ensembl chr19:49,555,468...49,590,262 		JBrowse link
G NOTCH1 notch receptor 1 decreases expression ISO Captan results in decreased expression of NOTCH1 mRNA CTD PMID:31558096 NCBI chr 9:136,494,433...136,546,048
Ensembl chr 9:136,494,433...136,546,048 		JBrowse link
G NQO1 NAD(P)H quinone dehydrogenase 1 increases expression ISO
EXP 		Captan results in increased expression of NQO1 mRNA CTD PMID:31558096 PMID:35395341 NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668 		JBrowse link
G NR1I2 nuclear receptor subfamily 1 group I member 2 multiple interactions EXP [Omite co-treated with Diphenylamine co-treated with phosalone co-treated with Captan co-treated with N-dichlorofluoromethylthio-N',N'-dimethyl-N-p-tolylsulfamide] results in increased activity of NR1I2 protein CTD PMID:25028461 NCBI chr 3:119,782,101...119,818,487
Ensembl chr 3:119,780,484...119,818,487 		JBrowse link
G NR1I3 nuclear receptor subfamily 1 group I member 3 multiple interactions
increases expression 		ISO NR1I3 protein affects the susceptibility to [2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with Thiophanate co-treated with thiacloprid co-treated with Ziram]
Captan results in increased expression of NR1I3 mRNA 		CTD PMID:29950287 PMID:31558096 NCBI chr 1:161,229,669...161,238,203
Ensembl chr 1:161,229,666...161,238,244 		JBrowse link
G NRAP nebulin related anchoring protein increases expression ISO Captan results in increased expression of NRAP mRNA CTD PMID:31558096 NCBI chr10:113,588,714...113,664,041
Ensembl chr10:113,588,714...113,664,070 		JBrowse link
G NUCB2 nucleobindin 2 decreases expression ISO Captan results in decreased expression of NUCB2 mRNA CTD PMID:31558096 NCBI chr11:17,276,739...17,349,980
Ensembl chr11:17,208,153...17,349,980 		JBrowse link
G NUDCD3 NudC domain containing 3 decreases expression ISO Captan results in decreased expression of NUDCD3 mRNA CTD PMID:31558096 NCBI chr 7:44,379,119...44,490,658
Ensembl chr 7:44,379,119...44,490,658 		JBrowse link
G NUP37 nucleoporin 37 decreases expression ISO Captan results in decreased expression of NUP37 mRNA CTD PMID:31558096 NCBI chr12:102,073,103...102,120,114
Ensembl chr12:102,073,103...102,120,120 		JBrowse link
G NUP85 nucleoporin 85 decreases expression ISO Captan results in decreased expression of NUP85 mRNA CTD PMID:31558096 NCBI chr17:75,205,679...75,235,758
Ensembl chr17:75,205,659...75,235,758 		JBrowse link
G OASL 2'-5'-oligoadenylate synthetase like increases expression ISO Captan results in increased expression of OASL1 mRNA CTD PMID:31558096 NCBI chr12:121,017,761...121,039,246
Ensembl chr12:121,017,763...121,039,246 		JBrowse link
G OSGIN1 oxidative stress induced growth inhibitor 1 increases expression ISO Captan results in increased expression of OSGIN1 mRNA CTD PMID:31558096 NCBI chr16:83,953,240...83,966,332
Ensembl chr16:83,931,311...83,966,332 		JBrowse link
G OTX2 orthodenticle homeobox 2 multiple interactions EXP Captan promotes the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA] CTD PMID:32949729 NCBI chr14:56,799,905...56,810,479
Ensembl chr14:56,799,905...56,816,693 		JBrowse link
G OXCT1 3-oxoacid CoA-transferase 1 increases expression ISO Captan results in increased expression of OXCT1 mRNA CTD PMID:31558096 NCBI chr 5:41,730,065...41,870,425
Ensembl chr 5:41,730,065...41,870,425 		JBrowse link
G P3H3 prolyl 3-hydroxylase 3 decreases expression ISO Captan results in decreased expression of P3H3 mRNA CTD PMID:31558096 NCBI chr12:6,828,407...6,839,847
Ensembl chr12:6,828,407...6,839,847 		JBrowse link
G P4HB prolyl 4-hydroxylase subunit beta increases expression ISO Captan results in increased expression of P4HB mRNA CTD PMID:31558096 NCBI chr17:81,843,166...81,860,535
Ensembl chr17:81,843,159...81,860,856 		JBrowse link
G PAFAH1B3 platelet activating factor acetylhydrolase 1b catalytic subunit 3 decreases expression ISO Captan results in decreased expression of PAFAH1B3 mRNA CTD PMID:31558096 NCBI chr19:42,297,033...42,302,800
Ensembl chr19:42,297,033...42,303,546 		JBrowse link
G PAK4 p21 (RAC1) activated kinase 4 increases expression ISO Captan results in increased expression of PAK4 mRNA CTD PMID:31558096 NCBI chr19:39,125,786...39,182,816
Ensembl chr19:39,125,770...39,182,816 		JBrowse link
G PARK7 Parkinsonism associated deglycase decreases activity EXP Captan results in decreased activity of PARK7 protein CTD PMID:36842454 NCBI chr 1:7,961,711...7,985,505
Ensembl chr 1:7,954,291...7,985,505 		JBrowse link
G PBDC1 polysaccharide biosynthesis domain containing 1 increases expression ISO Captan results in increased expression of PBDC1 mRNA CTD PMID:31558096 NCBI chr  X:76,173,062...76,178,314
Ensembl chr  X:76,173,040...76,178,755 		JBrowse link
G PDGFRB platelet derived growth factor receptor beta multiple interactions ISO [Ziram co-treated with Thiophanate co-treated with Captan co-treated with Chlorpyrifos co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with thiacloprid] results in increased expression of PDGFRB protein CTD PMID:32736067 NCBI chr 5:150,113,839...150,155,845
Ensembl chr 5:150,113,839...150,155,872 		JBrowse link
G PDIA5 protein disulfide isomerase family A member 5 decreases expression ISO Captan results in decreased expression of PDIA5 mRNA CTD PMID:31558096 NCBI chr 3:123,067,025...123,162,104
Ensembl chr 3:123,067,025...123,225,227 		JBrowse link
G PDK4 pyruvate dehydrogenase kinase 4 affects expression EXP Captan affects the expression of PDK4 mRNA CTD PMID:32870474 NCBI chr 7:95,583,499...95,596,516
Ensembl chr 7:95,583,499...95,596,516 		JBrowse link
G PFKL phosphofructokinase, liver type increases expression ISO Captan results in increased expression of PFKL mRNA CTD PMID:31558096 NCBI chr21:44,300,053...44,327,373
Ensembl chr21:44,300,051...44,327,376 		JBrowse link
G PFN1 profilin 1 increases expression ISO Captan results in increased expression of PFN1 mRNA CTD PMID:31558096 NCBI chr17:4,945,652...4,948,530
Ensembl chr17:4,945,652...4,949,061 		JBrowse link
G PGLYRP1 peptidoglycan recognition protein 1 decreases expression ISO Captan results in decreased expression of PGLYRP1 mRNA CTD PMID:31558096 NCBI chr19:46,019,153...46,023,053
Ensembl chr19:46,019,153...46,023,053 		JBrowse link
G PGM2 phosphoglucomutase 2 increases expression ISO Captan results in increased expression of PGM2 mRNA CTD PMID:31558096 NCBI chr 4:37,826,686...37,862,937
Ensembl chr 4:37,826,660...37,862,937 		JBrowse link
G PGRMC1 progesterone receptor membrane component 1 increases expression ISO Captan results in increased expression of PGRMC1 mRNA CTD PMID:31558096 NCBI chr  X:119,236,285...119,244,466
Ensembl chr  X:119,236,245...119,244,466 		JBrowse link
G PIK3C2B phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta increases expression ISO Captan results in increased expression of PIK3C2B mRNA CTD PMID:31558096 NCBI chr 1:204,422,633...204,494,805
Ensembl chr 1:204,422,628...204,494,805 		JBrowse link
G PIK3CG phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma decreases expression ISO Captan results in decreased expression of PIK3CG mRNA CTD PMID:31558096 NCBI chr 7:106,865,282...106,908,980
Ensembl chr 7:106,865,278...106,908,980 		JBrowse link
G PLAU plasminogen activator, urokinase decreases expression ISO Captan results in decreased expression of PLAU mRNA CTD PMID:31558096 NCBI chr10:73,909,164...73,917,494
Ensembl chr10:73,909,177...73,917,496 		JBrowse link
G PNKP polynucleotide kinase 3'-phosphatase increases expression ISO Captan results in increased expression of PNKP mRNA CTD PMID:31558096 NCBI chr19:49,861,204...49,867,576
Ensembl chr19:49,859,882...49,878,351 		JBrowse link
G POLR1D RNA polymerase I and III subunit D increases expression ISO Captan results in increased expression of POLR1D mRNA CTD PMID:31558096 NCBI chr13:27,620,743...27,667,411
Ensembl chr13:27,620,742...27,744,237 		JBrowse link
G POLR2C RNA polymerase II subunit C decreases expression ISO Captan results in decreased expression of POLR2C mRNA CTD PMID:31558096 NCBI chr16:57,462,679...57,472,009
Ensembl chr16:57,462,660...57,472,009 		JBrowse link
G POLR3B RNA polymerase III subunit B decreases expression ISO Captan results in decreased expression of POLR3B mRNA CTD PMID:31558096 NCBI chr12:106,357,748...106,510,198
Ensembl chr12:106,357,748...106,510,198 		JBrowse link
G POR cytochrome p450 oxidoreductase increases expression ISO Captan results in increased expression of POR mRNA CTD PMID:31558096 NCBI chr 7:75,915,155...75,986,855
Ensembl chr 7:75,899,200...75,986,855 		JBrowse link
G PPARGC1A PPARG coactivator 1 alpha decreases expression ISO Captan results in decreased expression of PPARGC1A mRNA CTD PMID:31558096 NCBI chr 4:23,792,021...24,472,905
Ensembl chr 4:23,755,041...23,904,089 		JBrowse link
G PPIB peptidylprolyl isomerase B decreases expression ISO Captan results in decreased expression of PPIB mRNA CTD PMID:31558096 NCBI chr15:64,155,817...64,163,022
Ensembl chr15:64,155,740...64,163,134 		JBrowse link
G PPM1D protein phosphatase, Mg2+/Mn2+ dependent 1D decreases expression ISO Captan results in decreased expression of PPM1D mRNA CTD PMID:31558096 NCBI chr17:60,600,193...60,666,280
Ensembl chr17:60,600,193...60,666,280 		JBrowse link
G PPP1R13B protein phosphatase 1 regulatory subunit 13B decreases expression ISO Captan results in decreased expression of PPP1R13B mRNA CTD PMID:31558096 NCBI chr14:103,733,195...103,848,814
Ensembl chr14:103,733,195...103,847,575 		JBrowse link
G PRDX1 peroxiredoxin 1 increases expression ISO Captan results in increased expression of PRDX1 mRNA CTD PMID:31558096 NCBI chr 1:45,511,051...45,522,890
Ensembl chr 1:45,510,914...45,542,732 		JBrowse link
G PRKAB1 protein kinase AMP-activated non-catalytic subunit beta 1 decreases expression ISO Captan results in decreased expression of PRKAB1 mRNA CTD PMID:31558096 NCBI chr12:119,667,952...119,681,619
Ensembl chr12:119,667,864...119,681,624 		JBrowse link
G PRKAG2 protein kinase AMP-activated non-catalytic subunit gamma 2 decreases expression ISO Captan results in decreased expression of PRKAG2 mRNA CTD PMID:31558096 NCBI chr 7:151,556,127...151,877,115
Ensembl chr 7:151,556,124...151,877,214 		JBrowse link
G PRKCD protein kinase C delta increases expression ISO Captan results in increased expression of PRKCD mRNA CTD PMID:31558096 NCBI chr 3:53,161,209...53,192,717
Ensembl chr 3:53,156,009...53,192,717 		JBrowse link
G PRKCH protein kinase C eta decreases expression ISO Captan results in decreased expression of PRKCH mRNA CTD PMID:31558096 NCBI chr14:61,187,468...61,550,976
Ensembl chr14:61,187,559...61,550,980 		JBrowse link
G PRKG1 protein kinase cGMP-dependent 1 decreases expression ISO Captan results in decreased expression of PRKG1 mRNA CTD PMID:31558096 NCBI chr10:50,990,888...52,298,350
Ensembl chr10:50,990,888...52,298,423 		JBrowse link
G PSMC4 proteasome 26S subunit, ATPase 4 increases expression ISO Captan results in increased expression of PSMC4 mRNA CTD PMID:31558096 NCBI chr19:39,971,165...39,981,764
Ensembl chr19:39,971,165...39,981,764 		JBrowse link
G PSMD12 proteasome 26S subunit, non-ATPase 12 decreases expression ISO Captan results in decreased expression of PSMD12 mRNA CTD PMID:31558096 NCBI chr17:67,337,916...67,366,577
Ensembl chr17:67,337,916...67,366,605 		JBrowse link
G PSMD14 proteasome 26S subunit, non-ATPase 14 increases expression ISO Captan results in increased expression of PSMD14 mRNA CTD PMID:31558096 NCBI chr 2:161,308,425...161,411,717
Ensembl chr 2:161,308,425...161,411,717 		JBrowse link
G PSMD8 proteasome 26S subunit, non-ATPase 8 increases expression ISO Captan results in increased expression of PSMD8 mRNA CTD PMID:31558096 NCBI chr19:38,374,571...38,383,824
Ensembl chr19:38,374,563...38,383,850 		JBrowse link
G PTGER4 prostaglandin E receptor 4 increases expression ISO Captan results in increased expression of PTGER4 mRNA CTD PMID:31558096 NCBI chr 5:40,679,915...40,746,800
Ensembl chr 5:40,679,915...40,693,735 		JBrowse link
G PTK2B protein tyrosine kinase 2 beta multiple interactions ISO [alachlor co-treated with Captan co-treated with Diazinon co-treated with Endosulfan co-treated with mancozeb co-treated with Maneb] results in decreased expression of PTK2B protein modified form CTD PMID:19883720 NCBI chr 8:27,310,506...27,459,391
Ensembl chr 8:27,311,482...27,459,391 		JBrowse link
G PTPRK protein tyrosine phosphatase receptor type K decreases expression ISO Captan results in decreased expression of PTPRK mRNA CTD PMID:31558096 NCBI chr 6:127,968,785...128,520,599
Ensembl chr 6:127,968,785...128,520,616 		JBrowse link
G PWP1 PWP1 homolog, endonuclein decreases expression ISO Captan results in decreased expression of PWP1 mRNA CTD PMID:31558096 NCBI chr12:107,685,799...107,713,162
Ensembl chr12:107,685,799...107,713,162 		JBrowse link
G PXMP2 peroxisomal membrane protein 2 decreases expression ISO Captan results in decreased expression of PXMP2 mRNA CTD PMID:31558096 NCBI chr12:132,687,587...132,704,985
Ensembl chr12:132,687,587...132,704,985 		JBrowse link
G QDPR quinoid dihydropteridine reductase increases expression ISO Captan results in increased expression of QDPR mRNA CTD PMID:31558096 NCBI chr 4:17,486,395...17,512,090
Ensembl chr 4:17,460,261...17,512,206 		JBrowse link
G RAB11A RAB11A, member RAS oncogene family increases expression ISO Captan results in increased expression of RAB11A mRNA CTD PMID:31558096 NCBI chr15:65,869,491...65,891,989
Ensembl chr15:65,726,054...65,891,989 		JBrowse link
G RAB31 RAB31, member RAS oncogene family increases expression ISO Captan results in increased expression of RAB31 mRNA CTD PMID:31558096 NCBI chr18:9,708,301...9,862,551
Ensembl chr18:9,708,275...9,862,551 		JBrowse link
G RAC1 Rac family small GTPase 1 increases expression ISO Captan results in increased expression of RAC1 mRNA CTD PMID:31558096 NCBI chr 7:6,374,527...6,403,967
Ensembl chr 7:6,374,527...6,403,967 		JBrowse link
G RALB RAS like proto-oncogene B increases expression ISO Captan results in increased expression of RALB mRNA CTD PMID:31558096 NCBI chr 2:120,240,070...120,294,710
Ensembl chr 2:120,240,064...120,294,710 		JBrowse link
G RAP1GAP RAP1 GTPase activating protein decreases expression ISO Captan results in decreased expression of RAP1GAP mRNA CTD PMID:31558096 NCBI chr 1:21,596,221...21,669,357
Ensembl chr 1:21,596,221...21,669,357 		JBrowse link
G RB1 RB transcriptional corepressor 1 increases expression ISO Captan results in increased expression of RB1 mRNA CTD PMID:31558096 NCBI chr13:48,303,751...48,481,890
Ensembl chr13:48,303,744...48,599,436 		JBrowse link
G RBM6 RNA binding motif protein 6 increases expression ISO Captan results in increased expression of RBM6 mRNA CTD PMID:31558096 NCBI chr 3:49,940,150...50,077,249
Ensembl chr 3:49,940,007...50,100,045 		JBrowse link
G REG1A regenerating family member 1 alpha decreases expression ISO Captan results in decreased expression of REG1 mRNA CTD PMID:31558096 NCBI chr 2:79,120,488...79,123,409
Ensembl chr 2:79,120,362...79,123,409 		JBrowse link
G RELA RELA proto-oncogene, NF-kB subunit decreases expression
increases expression 		ISO Captan results in decreased expression of RELA mRNA
Captan results in increased expression of RELA protein 		CTD PMID:31558096 PMID:34303901 NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090 		JBrowse link
G RELB RELB proto-oncogene, NF-kB subunit decreases expression ISO Captan results in decreased expression of RELB mRNA CTD PMID:31558096 NCBI chr19:45,001,464...45,038,192
Ensembl chr19:45,001,461...45,038,192 		JBrowse link
G RFNG RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase decreases expression ISO Captan results in decreased expression of RFNG mRNA CTD PMID:31558096 NCBI chr17:82,047,902...82,051,811
Ensembl chr17:82,047,902...82,051,831 		JBrowse link
G RGS2 regulator of G protein signaling 2 decreases expression ISO Captan results in decreased expression of RGS2 mRNA CTD PMID:31558096 NCBI chr 1:192,809,039...192,812,275
Ensembl chr 1:192,809,039...192,812,275 		JBrowse link
G RIMS1 regulating synaptic membrane exocytosis 1 decreases expression ISO Captan results in decreased expression of RIMS1 mRNA CTD PMID:31558096 NCBI chr 6:71,886,550...72,403,145
Ensembl chr 6:71,886,550...72,403,150 		JBrowse link
G RNASEH2A ribonuclease H2 subunit A decreases expression ISO Captan results in decreased expression of RNASEH2A mRNA CTD PMID:31558096 NCBI chr19:12,806,584...12,813,640
Ensembl chr19:12,806,584...12,813,640 		JBrowse link
G RNF125 ring finger protein 125 decreases expression ISO Captan results in decreased expression of RNF125 mRNA CTD PMID:31558096 NCBI chr18:32,018,825...32,088,144
Ensembl chr18:32,018,825...32,088,144 		JBrowse link
G RPIA ribose 5-phosphate isomerase A decreases expression ISO Captan results in decreased expression of RPIA mRNA CTD PMID:31558096 NCBI chr 2:88,691,673...88,750,929
Ensembl chr 2:88,691,673...88,750,929 		JBrowse link
G RPLP0 ribosomal protein lateral stalk subunit P0 increases expression ISO Captan results in increased expression of RPLP0 mRNA CTD PMID:31558096 NCBI chr12:120,196,699...120,201,111
Ensembl chr12:120,196,699...120,201,235 		JBrowse link
G RRAGA Ras related GTP binding A decreases expression ISO Captan results in decreased expression of RRAGA mRNA CTD PMID:31558096 NCBI chr 9:19,049,427...19,051,025
Ensembl chr 9:19,049,427...19,051,025 		JBrowse link
G RUVBL1 RuvB like AAA ATPase 1 increases expression ISO Captan results in increased expression of RUVBL1 mRNA CTD PMID:31558096 NCBI chr 3:128,064,785...128,153,914
Ensembl chr 3:128,064,778...128,153,914 		JBrowse link
G S100A6 S100 calcium binding protein A6 increases expression ISO Captan results in increased expression of S100A6 mRNA CTD PMID:31558096 NCBI chr 1:153,534,599...153,535,991
Ensembl chr 1:153,534,599...153,536,244 		JBrowse link
G SAT1 spermidine/spermine N1-acetyltransferase 1 increases expression ISO Captan results in increased expression of SAT1 mRNA CTD PMID:31558096 NCBI chr  X:23,783,173...23,786,210
Ensembl chr  X:23,783,173...23,786,210 		JBrowse link
G SCG2 secretogranin II decreases expression ISO Captan results in decreased expression of SCG2 mRNA CTD PMID:31558096 NCBI chr 2:223,596,940...223,602,361
Ensembl chr 2:223,596,940...223,602,361 		JBrowse link
G SCP2 sterol carrier protein 2 increases expression ISO Captan results in increased expression of SCP2 mRNA CTD PMID:31558096 NCBI chr 1:52,927,276...53,051,698
Ensembl chr 1:52,927,276...53,051,698 		JBrowse link
G SEL1L SEL1L adaptor subunit of SYVN1 ubiquitin ligase decreases expression ISO Captan results in decreased expression of SEL1L mRNA CTD PMID:31558096 NCBI chr14:81,471,547...81,533,853
Ensembl chr14:81,471,547...81,533,853 		JBrowse link
G SERPINE1 serpin family E member 1 multiple interactions ISO [Dietary Fats co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with thiacloprid co-treated with Thiophanate co-treated with Ziram] results in increased expression of SERPINE1 mRNA CTD PMID:32745781 NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247 		JBrowse link
G SGK2 serum/glucocorticoid regulated kinase 2 increases expression ISO Captan results in increased expression of SGK2 mRNA CTD PMID:31558096 NCBI chr20:43,559,027...43,585,627
Ensembl chr20:43,558,968...43,588,237 		JBrowse link
G SH3GL2 SH3 domain containing GRB2 like 2, endophilin A1 increases expression ISO Captan results in increased expression of SH3GL2 mRNA CTD PMID:31558096 NCBI chr 9:17,579,066...17,797,124
Ensembl chr 9:17,579,066...17,797,124 		JBrowse link
G SLC11A2 solute carrier family 11 member 2 increases expression ISO Captan results in increased expression of SLC11A2 mRNA CTD PMID:31558096 NCBI chr12:50,952,263...51,028,886
Ensembl chr12:50,979,401...51,028,566 		JBrowse link
G SLC16A2 solute carrier family 16 member 2 multiple interactions ISO [Dietary Fats co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with thiacloprid co-treated with Thiophanate co-treated with Ziram] results in increased expression of SLC16A2 mRNA CTD PMID:32745781 NCBI chr  X:74,421,493...74,533,916
Ensembl chr  X:74,421,493...74,533,917 		JBrowse link
G SLC16A3 solute carrier family 16 member 3 increases expression ISO Captan results in increased expression of SLC16A3 mRNA CTD PMID:31558096 NCBI chr17:82,217,934...82,240,086
Ensembl chr17:82,217,934...82,261,129 		JBrowse link
G SLC1A3 solute carrier family 1 member 3 decreases expression ISO Captan results in decreased expression of SLC1A3 mRNA CTD PMID:31558096 NCBI chr 5:36,606,606...36,688,334
Ensembl chr 5:36,596,588...36,688,334 		JBrowse link
G SLC27A1 solute carrier family 27 member 1 decreases expression ISO Captan results in decreased expression of SLC27A1 mRNA CTD PMID:31558096 NCBI chr19:17,468,767...17,506,168
Ensembl chr19:17,468,769...17,506,168 		JBrowse link
G SLC30A5 solute carrier family 30 member 5 decreases expression ISO Captan results in decreased expression of SLC30A5 mRNA CTD PMID:31558096 NCBI chr 5:69,094,014...69,131,069
Ensembl chr 5:69,093,991...69,131,069 		JBrowse link
G SLC35A3 solute carrier family 35 member A3 decreases expression ISO Captan results in decreased expression of SLC35A3 mRNA CTD PMID:31558096 NCBI chr 1:99,969,996...100,035,634
Ensembl chr 1:99,969,351...100,035,634 		JBrowse link
G SLC47A1 solute carrier family 47 member 1 increases expression ISO Captan results in increased expression of SLC47A1 mRNA CTD PMID:31558096 NCBI chr17:19,533,854...19,579,034
Ensembl chr17:19,495,385...19,579,034 		JBrowse link
G SLC51A solute carrier family 51 member A increases expression ISO Captan results in increased expression of SLC51A mRNA CTD PMID:31558096 NCBI chr 3:196,216,534...196,233,427
Ensembl chr 3:196,211,487...196,243,178 		JBrowse link
G SLC6A8 solute carrier family 6 member 8 increases expression ISO Captan results in increased expression of SLC6A8 mRNA CTD PMID:31558096 NCBI chr  X:153,687,926...153,696,593
Ensembl chr  X:153,687,926...153,696,588 		JBrowse link
G SLC7A11 solute carrier family 7 member 11 increases expression ISO Captan results in increased expression of SLC7A11 mRNA CTD PMID:31558096 NCBI chr 4:138,164,097...138,312,671
Ensembl chr 4:138,164,097...138,242,349 		JBrowse link
G SMAD1 SMAD family member 1 decreases expression ISO Captan results in decreased expression of SMAD1 mRNA CTD PMID:31558096 NCBI chr 4:145,480,770...145,559,176
Ensembl chr 4:145,481,194...145,559,176 		JBrowse link
G SMARCD2 SWI/SNF related BAF chromatin remodeling complex subunit D2 decreases expression ISO Captan results in decreased expression of SMARCD2 mRNA CTD PMID:31558096 NCBI chr17:63,832,081...63,842,685
Ensembl chr17:63,832,081...63,843,065 		JBrowse link
G SNRNP40 small nuclear ribonucleoprotein U5 subunit 40 decreases expression ISO Captan results in decreased expression of SNRNP40 mRNA CTD PMID:31558096 NCBI chr 1:31,259,568...31,296,788
Ensembl chr 1:31,259,568...31,296,788 		JBrowse link
G SNRPE small nuclear ribonucleoprotein polypeptide E decreases expression ISO Captan results in decreased expression of SNRPE mRNA CTD PMID:31558096 NCBI chr 1:203,861,599...203,871,152
Ensembl chr 1:203,861,599...203,871,152 		JBrowse link
G SNX7 sorting nexin 7 increases expression ISO Captan results in increased expression of SNX7 mRNA CTD PMID:31558096 NCBI chr 1:98,661,319...98,760,500
Ensembl chr 1:98,661,701...98,760,500 		JBrowse link
G SOCS3 suppressor of cytokine signaling 3 increases expression ISO Captan results in increased expression of SOCS3 mRNA CTD PMID:31558096 NCBI chr17:78,356,778...78,360,925
Ensembl chr17:78,356,778...78,360,077 		JBrowse link
G SOD1 superoxide dismutase 1 increases expression ISO Captan results in increased expression of SOD1 mRNA CTD PMID:31558096 NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931 		JBrowse link
G SOD2 superoxide dismutase 2 increases expression ISO Captan results in increased expression of SOD2 mRNA CTD PMID:31558096 NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529 		JBrowse link
G SPCS3 signal peptidase complex subunit 3 decreases expression ISO Captan results in decreased expression of SPCS3 mRNA CTD PMID:31558096 NCBI chr 4:176,319,966...176,332,245
Ensembl chr 4:176,319,966...176,332,245 		JBrowse link
G SQLE squalene epoxidase increases expression ISO Captan results in increased expression of SQLE mRNA CTD PMID:31558096 NCBI chr 8:124,998,505...125,022,283
Ensembl chr 8:124,998,497...125,022,283 		JBrowse link
G SQOR sulfide quinone oxidoreductase increases expression ISO Captan results in increased expression of SQOR mRNA CTD PMID:31558096 NCBI chr15:45,631,148...45,691,281
Ensembl chr15:45,631,148...45,691,281 		JBrowse link
G SRC SRC proto-oncogene, non-receptor tyrosine kinase increases expression ISO Captan results in increased expression of SRC mRNA CTD PMID:31558096 NCBI chr20:37,344,699...37,406,050
Ensembl chr20:37,344,685...37,406,050 		JBrowse link
G SRXN1 sulfiredoxin 1 increases expression ISO Captan results in increased expression of SRXN1 mRNA CTD PMID:31558096 NCBI chr20:646,615...653,200
Ensembl chr20:646,615...653,200 		JBrowse link
G ST3GAL2 ST3 beta-galactoside alpha-2,3-sialyltransferase 2 decreases expression ISO Captan results in decreased expression of ST3GAL2 mRNA CTD PMID:31558096 NCBI chr16:70,375,977...70,439,100
Ensembl chr16:70,375,977...70,439,237 		JBrowse link
G ST6GALNAC2 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 decreases expression ISO Captan results in decreased expression of ST6GALNAC2 mRNA CTD PMID:31558096 NCBI chr17:76,565,377...76,585,860
Ensembl chr17:76,565,377...76,586,956 		JBrowse link
G STUB1 STIP1 homology and U-box containing protein 1 increases expression ISO Captan results in increased expression of STUB1 mRNA CTD PMID:31558096 NCBI chr16:680,410...682,801
Ensembl chr16:680,224...682,870 		JBrowse link
G SULT1B1 sulfotransferase family 1B member 1 multiple interactions
increases expression 		ISO [Dietary Fats co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with thiacloprid co-treated with Thiophanate co-treated with Ziram] results in increased expression of SULT1B1 mRNA
Captan results in increased expression of SULT1B1 mRNA 		CTD PMID:31558096 PMID:32745781 NCBI chr 4:69,721,167...69,760,620
Ensembl chr 4:69,721,167...69,787,961 		JBrowse link
G TALDO1 transaldolase 1 increases expression ISO Captan results in increased expression of TALDO1 mRNA CTD PMID:31558096 NCBI chr11:747,464...765,012
Ensembl chr11:747,415...765,012 		JBrowse link
G TAX1BP3 Tax1 binding protein 3 increases expression ISO Captan results in increased expression of TAX1BP3 mRNA CTD PMID:31558096 NCBI chr17:3,662,895...3,668,578
Ensembl chr17:3,662,895...3,668,679 		JBrowse link
G TCTA T cell leukemia translocation altered decreases expression ISO Captan results in decreased expression of TCTA mRNA CTD PMID:31558096 NCBI chr 3:49,412,423...49,416,476
Ensembl chr 3:49,412,212...49,416,476 		JBrowse link
G THRSP thyroid hormone responsive multiple interactions ISO [2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with thiacloprid co-treated with Thiophanate co-treated with Ziram] results in increased expression of THRSP mRNA; [Dietary Fats co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with thiacloprid co-treated with Thiophanate co-treated with Ziram] results in decreased expression of THRSP mRNA; Dietary Fats inhibits the reaction [[2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with thiacloprid co-treated with Thiophanate co-treated with Ziram] results in increased expression of THRSP mRNA] CTD PMID:32745781 NCBI chr11:78,063,861...78,068,351
Ensembl chr11:78,063,861...78,068,351 		JBrowse link
G TIGAR TP53 induced glycolysis regulatory phosphatase increases expression ISO Captan results in increased expression of TIGAR mRNA CTD PMID:31558096 NCBI chr12:4,321,213...4,360,028
Ensembl chr12:4,307,763...4,360,028 		JBrowse link
G TMED10 transmembrane p24 trafficking protein 10 decreases expression ISO Captan results in decreased expression of TMED10 mRNA CTD PMID:31558096 NCBI chr14:75,131,469...75,176,612
Ensembl chr14:75,131,469...75,176,612 		JBrowse link
G TMEM109 transmembrane protein 109 decreases expression ISO Captan results in decreased expression of TMEM109 mRNA CTD PMID:31558096 NCBI chr11:60,914,158...60,923,443
Ensembl chr11:60,913,907...60,923,443 		JBrowse link
G TNF tumor necrosis factor increases secretion EXP Captan results in increased secretion of TNF protein CTD PMID:35395341 NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336 		JBrowse link
G TNFRSF13B TNF receptor superfamily member 13B decreases expression ISO Captan results in decreased expression of TNFRSF13B mRNA CTD PMID:31558096 NCBI chr17:16,939,081...16,972,118
Ensembl chr17:16,929,816...16,972,118 		JBrowse link
G TNIP1 TNFAIP3 interacting protein 1 increases expression ISO Captan results in increased expression of TNIP1 mRNA CTD PMID:31558096 NCBI chr 5:151,029,943...151,087,685
Ensembl chr 5:151,029,945...151,093,577 		JBrowse link
G TOP2A DNA topoisomerase II alpha decreases activity ISO Captan results in decreased activity of TOP2A protein CTD PMID:12113771 NCBI chr17:40,388,525...40,417,896
Ensembl chr17:40,388,525...40,417,896 		JBrowse link
G TOR1A torsin family 1 member A increases expression ISO Captan results in increased expression of TOR1A mRNA CTD PMID:31558096 NCBI chr 9:129,812,942...129,824,136
Ensembl chr 9:129,812,942...129,824,244 		JBrowse link
G TP53INP2 tumor protein p53 inducible nuclear protein 2 decreases expression ISO Captan results in decreased expression of TRP53INP2 mRNA CTD PMID:31558096 NCBI chr20:34,704,344...34,713,436
Ensembl chr20:34,704,339...34,713,439 		JBrowse link
G TPI1 triosephosphate isomerase 1 increases expression ISO Captan results in increased expression of TPI1 mRNA CTD PMID:31558096 NCBI chr12:6,867,420...6,870,948
Ensembl chr12:6,867,119...6,870,948 		JBrowse link
G TRAP1 TNF receptor associated protein 1 decreases expression ISO Captan results in decreased expression of TRAP1 mRNA CTD PMID:31558096 NCBI chr16:3,658,037...3,717,524
Ensembl chr16:3,651,639...3,717,553 		JBrowse link
G TRIM28 tripartite motif containing 28 decreases expression ISO Captan results in decreased expression of TRIM28 mRNA CTD PMID:31558096 NCBI chr19:58,544,064...58,550,715
Ensembl chr19:58,544,064...58,550,722 		JBrowse link
G TSC2 TSC complex subunit 2 decreases expression ISO Captan results in decreased expression of TSC2 mRNA CTD PMID:31558096 NCBI chr16:2,047,985...2,089,491
Ensembl chr16:2,047,967...2,089,491 		JBrowse link
G TSC22D1 TSC22 domain family member 1 affects response to substance EXP TSC22D1 gene SNP affects the susceptibility to Captan CTD PMID:25622337 NCBI chr13:44,432,143...44,577,344
Ensembl chr13:44,432,143...44,577,147 		JBrowse link
G TSG101 tumor susceptibility 101 increases expression ISO Captan results in increased expression of TSG101 mRNA CTD PMID:31558096 NCBI chr11:18,480,311...18,526,942
Ensembl chr11:18,468,336...18,526,951 		JBrowse link
G TSKU tsukushi, small leucine rich proteoglycan increases expression ISO Captan results in increased expression of TSKU mRNA CTD PMID:31558096 NCBI chr11:76,782,280...76,798,144
Ensembl chr11:76,782,251...76,798,153 		JBrowse link
G TTC17 tetratricopeptide repeat domain 17 increases expression ISO Captan results in increased expression of TTC17 mRNA CTD PMID:31558096 NCBI chr11:43,358,920...43,494,931
Ensembl chr11:43,358,920...43,494,933 		JBrowse link
G TUBA4A tubulin alpha 4a increases expression ISO Captan results in increased expression of TUBA4A mRNA CTD PMID:31558096 NCBI chr 2:219,249,710...219,254,740
Ensembl chr 2:219,249,710...219,277,902 		JBrowse link
G TUBB2A tubulin beta 2A class IIa increases expression ISO Captan results in increased expression of TUBB2A mRNA CTD PMID:31558096 NCBI chr 6:3,153,666...3,157,544
Ensembl chr 6:3,153,497...3,157,544 		JBrowse link
G TUBB6 tubulin beta 6 class V decreases expression ISO Captan results in decreased expression of TUBB6 mRNA CTD PMID:31558096 NCBI chr18:12,307,669...12,329,826
Ensembl chr18:12,307,669...12,344,320 		JBrowse link
G TXNRD1 thioredoxin reductase 1 increases expression ISO Captan results in increased expression of TXNRD1 mRNA CTD PMID:31558096 NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307 		JBrowse link
G UGDH UDP-glucose 6-dehydrogenase increases expression ISO Captan results in increased expression of UGDH mRNA CTD PMID:31558096 NCBI chr 4:39,498,755...39,527,439
Ensembl chr 4:39,498,755...39,528,311 		JBrowse link
G UGT1A4 UDP glucuronosyltransferase family 1 member A4 increases expression ISO Captan results in increased expression of UGT1A5 mRNA CTD PMID:31558096 NCBI chr 2:233,718,736...233,773,300
Ensembl chr 2:233,718,736...233,773,300 		JBrowse link
G VAT1 vesicle amine transport 1 increases expression ISO Captan results in increased expression of VAT1 mRNA CTD PMID:31558096 NCBI chr17:43,014,607...43,022,385
Ensembl chr17:43,014,607...43,025,123 		JBrowse link
G VIM vimentin decreases expression ISO Captan results in decreased expression of VIM mRNA CTD PMID:31558096 NCBI chr10:17,228,241...17,237,593
Ensembl chr10:17,228,241...17,237,593 		JBrowse link
G VPS4A vacuolar protein sorting 4 homolog A increases expression ISO Captan results in increased expression of VPS4A mRNA CTD PMID:31558096 NCBI chr16:69,311,350...69,326,939
Ensembl chr16:69,311,336...69,326,939 		JBrowse link
G WDR3 WD repeat domain 3 decreases expression ISO Captan results in decreased expression of WDR3 mRNA CTD PMID:31558096 NCBI chr 1:117,929,739...117,966,543
Ensembl chr 1:117,929,720...117,966,543 		JBrowse link
G WIPF2 WAS/WASL interacting protein family member 2 increases expression ISO Captan results in increased expression of WIPF2 mRNA CTD PMID:31558096 NCBI chr17:40,219,304...40,284,136
Ensembl chr17:40,219,304...40,284,136 		JBrowse link
G XBP1 X-box binding protein 1 decreases expression ISO Captan results in decreased expression of XBP1 mRNA CTD PMID:31558096 NCBI chr22:28,794,560...28,800,569
Ensembl chr22:28,794,555...28,800,597 		JBrowse link
G YAP1 Yes1 associated transcriptional regulator decreases expression ISO Captan results in decreased expression of YAP1 mRNA CTD PMID:31558096 NCBI chr11:102,110,447...102,233,424
Ensembl chr11:102,110,447...102,233,424 		JBrowse link
G YARS2 tyrosyl-tRNA synthetase 2 decreases expression ISO Captan results in decreased expression of YARS2 mRNA CTD PMID:31558096 NCBI chr12:32,746,544...32,755,897
Ensembl chr12:32,727,490...32,755,897 		JBrowse link
G YKT6 YKT6 v-SNARE homolog increases expression ISO Captan results in increased expression of YKT6 mRNA CTD PMID:31558096 NCBI chr 7:44,200,978...44,214,294
Ensembl chr 7:44,200,959...44,214,294 		JBrowse link
G YTHDF1 YTH N6-methyladenosine RNA binding protein F1 decreases expression ISO Captan results in decreased expression of YTHDF1 mRNA CTD PMID:31558096 NCBI chr20:63,195,429...63,216,131
Ensembl chr20:63,195,429...63,216,139 		JBrowse link
G YWHAZ tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta increases expression ISO Captan results in increased expression of YWHAZ mRNA CTD PMID:31558096 NCBI chr 8:100,916,523...100,953,382
Ensembl chr 8:100,916,523...100,953,388 		JBrowse link
G ZBP1 Z-DNA binding protein 1 decreases expression ISO Captan results in decreased expression of ZBP1 mRNA CTD PMID:31558096 NCBI chr20:57,603,852...57,620,426
Ensembl chr20:57,603,846...57,620,576 		JBrowse link
G ZG16 zymogen granule protein 16 decreases expression ISO Captan results in decreased expression of ZG16 mRNA CTD PMID:31558096 NCBI chr16:29,778,256...29,782,973
Ensembl chr16:29,778,256...29,782,973 		JBrowse link
G ZNF395 zinc finger protein 395 decreases expression ISO Captan results in decreased expression of ZFP395 mRNA CTD PMID:31558096 NCBI chr 8:28,345,590...28,386,460
Ensembl chr 8:28,345,590...28,402,701 		JBrowse link
G ZNHIT6 zinc finger HIT-type containing 6 increases expression ISO Captan results in increased expression of ZNHIT6 mRNA CTD PMID:31558096 NCBI chr 1:85,649,417...85,708,433
Ensembl chr 1:85,649,417...85,708,433 		JBrowse link
chaetoglobosin A term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AKT1 AKT serine/threonine kinase 1 increases phosphorylation
multiple interactions 		ISO chaetoglobosins results in increased phosphorylation of AKT1 protein
wortmannin inhibits the reaction [chaetoglobosins results in increased phosphorylation of AKT1 protein] 		CTD PMID:18040759 NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,759 		JBrowse link
G GJA1 gap junction protein alpha 1 multiple interactions ISO chaetoglobosins inhibits the reaction [Dieldrin results in decreased phosphorylation of GJA1 protein]; chaetoglobosins inhibits the reaction [Hexachlorocyclohexane results in decreased phosphorylation of GJA1 protein] CTD PMID:18040759 NCBI chr 6:121,435,646...121,449,727
Ensembl chr 6:121,435,595...121,449,727 		JBrowse link
G GSK3B glycogen synthase kinase 3 beta increases phosphorylation
multiple interactions 		ISO chaetoglobosins results in increased phosphorylation of GSK3B protein
wortmannin inhibits the reaction [chaetoglobosins results in increased phosphorylation of GSK3B protein] 		CTD PMID:18040759 NCBI chr 3:119,821,321...120,094,447
Ensembl chr 3:119,821,321...120,094,994 		JBrowse link
G IFNB1 interferon beta 1 multiple interactions ISO chaetoglobosins inhibits the reaction [Lipopolysaccharides results in increased expression of IFNB1 mRNA] CTD PMID:33285210 NCBI chr 9:21,077,104...21,077,942
Ensembl chr 9:21,077,104...21,077,942 		JBrowse link
G IL1B interleukin 1 beta multiple interactions ISO chaetoglobosins inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA] CTD PMID:33285210 NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816 		JBrowse link
G IL6 interleukin 6 multiple interactions ISO chaetoglobosins inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; chaetoglobosins inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein] CTD PMID:33285210 NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002 		JBrowse link
G IRF7 interferon regulatory factor 7 multiple interactions ISO chaetoglobosins inhibits the reaction [Lipopolysaccharides results in increased expression of IRF7 mRNA] CTD PMID:33285210 NCBI chr11:612,555...615,950
Ensembl chr11:612,553...615,983 		JBrowse link
G MAPK1 mitogen-activated protein kinase 1 increases phosphorylation
multiple interactions 		ISO chaetoglobosins results in increased phosphorylation of MAPK1 protein
chaetoglobosins inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] 		CTD PMID:18040759 PMID:33285210 NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680 		JBrowse link
G MAPK3 mitogen-activated protein kinase 3 increases phosphorylation
multiple interactions 		ISO chaetoglobosins results in increased phosphorylation of MAPK3 protein
chaetoglobosins inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein] 		CTD PMID:18040759 PMID:33285210 NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506 		JBrowse link
G MYD88 MYD88 innate immune signal transduction adaptor multiple interactions ISO chaetoglobosins inhibits the reaction [Lipopolysaccharides results in increased expression of MYD88 mRNA] CTD PMID:33285210 NCBI chr 3:38,138,661...38,143,022
Ensembl chr 3:38,138,552...38,143,024 		JBrowse link
G NOS2 nitric oxide synthase 2 multiple interactions ISO chaetoglobosins inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; chaetoglobosins inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] CTD PMID:33285210 NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529 		JBrowse link
G PTGS2 prostaglandin-endoperoxide synthase 2 multiple interactions ISO chaetoglobosins inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; chaetoglobosins inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] CTD PMID:33285210 NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922 		JBrowse link
G RAF1 Raf-1 proto-oncogene, serine/threonine kinase decreases phosphorylation ISO chaetoglobosins results in decreased phosphorylation of RAF1 protein CTD PMID:18040759 NCBI chr 3:12,583,601...12,664,117
Ensembl chr 3:12,582,101...12,664,201 		JBrowse link
G RELA RELA proto-oncogene, NF-kB subunit multiple interactions ISO chaetoglobosins inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of RELA protein] CTD PMID:33285210 NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090 		JBrowse link
G TLR4 toll like receptor 4 multiple interactions ISO chaetoglobosins inhibits the reaction [Lipopolysaccharides results in increased expression of TLR4 mRNA] CTD PMID:33285210 NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735 		JBrowse link
G TNF tumor necrosis factor multiple interactions ISO chaetoglobosins inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; chaetoglobosins inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; chaetoglobosins results in increased expression of and results in increased secretion of TNF protein CTD PMID:28535995 PMID:33285210 NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336 		JBrowse link
chlorisondamine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CHGA chromogranin A multiple interactions ISO Chlorisondamine inhibits the reaction [Nicotine results in increased activity of CHGA promoter]; Chlorisondamine inhibits the reaction [Reserpine results in increased activity of CHGA promoter] CTD PMID:12799369 NCBI chr14:92,922,664...92,935,285
Ensembl chr14:92,923,150...92,935,285 		JBrowse link
G NPY neuropeptide Y multiple interactions ISO Chlorisondamine inhibits the reaction [Reserpine results in increased expression of NPY mRNA]; Chlorisondamine promotes the reaction [Reserpine results in increased expression of NPY mRNA] CTD PMID:1714554 NCBI chr 7:24,284,190...24,291,862
Ensembl chr 7:24,284,188...24,291,862 		JBrowse link
G PNMT phenylethanolamine N-methyltransferase multiple interactions ISO Chlorisondamine inhibits the reaction [Reserpine results in decreased expression of PNMT mRNA] CTD PMID:1714554 NCBI chr17:39,668,019...39,670,475
Ensembl chr17:39,667,981...39,670,475 		JBrowse link
G REN renin multiple interactions ISO Chlorisondamine inhibits the reaction [Yohimbine results in increased expression of REN protein] CTD PMID:6323192 NCBI chr 1:204,154,819...204,166,337
Ensembl chr 1:204,154,819...204,190,324 		JBrowse link
G TH tyrosine hydroxylase multiple interactions
increases expression 		ISO Chlorisondamine inhibits the reaction [Reserpine results in increased expression of TH mRNA]; Chlorisondamine promotes the reaction [Reserpine results in increased expression of TH mRNA]
Chlorisondamine results in increased expression of TH mRNA 		CTD PMID:1714554 NCBI chr11:2,163,929...2,171,815
Ensembl chr11:2,163,929...2,171,815 		JBrowse link
chlorthalidone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G FGFR3 fibroblast growth factor receptor 3 decreases expression ISO Chlorthalidone results in decreased expression of FGFR3 mRNA CTD PMID:20625077 NCBI chr 4:1,793,293...1,808,867
Ensembl chr 4:1,793,293...1,808,872 		JBrowse link
G NRP2 neuropilin 2 decreases expression ISO Chlorthalidone results in decreased expression of NRP2 mRNA CTD PMID:20625077 NCBI chr 2:205,682,501...205,798,131
Ensembl chr 2:205,681,990...205,798,133 		JBrowse link
G REN renin increases expression
increases activity 		EXP Chlorthalidone results in increased expression of REN protein modified form
Chlorthalidone results in increased activity of REN protein 		CTD PMID:796642 PMID:1116335 PMID:3319646 NCBI chr 1:204,154,819...204,166,337
Ensembl chr 1:204,154,819...204,190,324 		JBrowse link
G TGFB3 transforming growth factor beta 3 decreases expression ISO Chlorthalidone results in decreased expression of TGFB3 mRNA CTD PMID:20625077 NCBI chr14:75,958,097...75,983,011
Ensembl chr14:75,958,097...75,983,011 		JBrowse link
G VEGFC vascular endothelial growth factor C decreases expression
increases expression 		ISO Chlorthalidone results in decreased expression of VEGFC mRNA; Chlorthalidone results in decreased expression of VEGFC protein
Chlorthalidone results in increased expression of VEGFC protein 		CTD PMID:20625077 NCBI chr 4:176,683,538...176,792,922
Ensembl chr 4:176,683,538...176,792,922 		JBrowse link
cytochalasin B term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G BAX BCL2 associated X, apoptosis regulator multiple interactions
increases expression 		EXP 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Cytochalasin B results in increased expression of BAX protein] CTD PMID:27640744 NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798 		JBrowse link
G BCL2 BCL2 apoptosis regulator multiple interactions
decreases expression 		EXP 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Cytochalasin B results in decreased expression of BCL2 protein] CTD PMID:27640744 NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128 		JBrowse link
G C5 complement C5 multiple interactions EXP [Cytochalasin B co-treated with C5 protein] results in increased phosphorylation of and results in increased activity of MAPK1 protein; [Cytochalasin B co-treated with C5 protein] results in increased phosphorylation of and results in increased activity of MAPK3 protein; [Cytochalasin B co-treated with C5 protein] results in increased secretion of EPO protein; Dexamethasone analog inhibits the reaction [[Cytochalasin B co-treated with C5 protein] results in increased secretion of EPO protein]; resveratrol analog inhibits the reaction [[Cytochalasin B co-treated with C5 protein] results in increased phosphorylation of and results in increased activity of MAPK1 protein]; resveratrol analog inhibits the reaction [[Cytochalasin B co-treated with C5 protein] results in increased phosphorylation of and results in increased activity of MAPK3 protein]; resveratrol analog inhibits the reaction [[Cytochalasin B co-treated with C5 protein] results in increased secretion of EPO protein] CTD PMID:18776917 NCBI chr 9:120,952,335...121,074,865
Ensembl chr 9:120,932,987...121,075,195 		JBrowse link
G CASP3 caspase 3 increases cleavage EXP Cytochalasin B results in increased cleavage of CASP3 protein CTD PMID:27640744 NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062 		JBrowse link
G CASP9 caspase 9 increases cleavage EXP Cytochalasin B results in increased cleavage of CASP9 protein CTD PMID:27640744 NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534 		JBrowse link
G CAT catalase multiple interactions EXP Cytochalasin B inhibits the reaction [Dehydroascorbic Acid results in increased expression of CAT protein] CTD PMID:20166893 NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060 		JBrowse link
G CCNB1 cyclin B1 decreases expression EXP Cytochalasin B results in decreased expression of CCNB1 protein CTD PMID:27640744 NCBI chr 5:69,167,150...69,178,245
Ensembl chr 5:69,167,135...69,178,245 		JBrowse link
G CDK1 cyclin dependent kinase 1 decreases expression EXP Cytochalasin B results in decreased expression of CDK1 protein CTD PMID:27640744 NCBI chr10:60,778,331...60,794,852
Ensembl chr10:60,778,331...60,794,852 		JBrowse link
G CDKN1A cyclin dependent kinase inhibitor 1A increases expression EXP Cytochalasin B results in increased expression of CDKN1A protein CTD PMID:27640744 NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,397 		JBrowse link
G CDKN1B cyclin dependent kinase inhibitor 1B increases expression EXP Cytochalasin B results in increased expression of CDKN1B protein CTD PMID:27640744 NCBI chr12:12,717,368...12,722,369
Ensembl chr12:12,685,498...12,722,369 		JBrowse link
G CSF2 colony stimulating factor 2 multiple interactions EXP Cytochalasin B inhibits the reaction [kaempferol results in increased secretion of CSF2 protein]; Cytochalasin B inhibits the reaction [Quercetin results in increased secretion of CSF2 protein] CTD PMID:18346843 NCBI chr 5:132,073,789...132,076,170
Ensembl chr 5:132,073,789...132,076,170 		JBrowse link
G EGFR epidermal growth factor receptor multiple interactions EXP Cytochalasin B inhibits the reaction [Asbestos, Crocidolite results in decreased phosphorylation of EGFR protein] CTD PMID:15626777 NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628 		JBrowse link
G ELANE elastase, neutrophil expressed multiple interactions EXP [Cytochalasin B co-treated with N-Formylmethionine Leucyl-Phenylalanine] results in increased secretion of ELANE protein; pirinixic acid analog inhibits the reaction [[Cytochalasin B co-treated with N-Formylmethionine Leucyl-Phenylalanine] results in increased secretion of ELANE protein] CTD PMID:19686721 NCBI chr19:852,303...856,243
Ensembl chr19:851,014...856,247 		JBrowse link
G EPO erythropoietin multiple interactions EXP [Cytochalasin B co-treated with C5 protein] results in increased secretion of EPO protein; [Cytochalasin B co-treated with IL5 protein] results in increased secretion of EPO protein; Dexamethasone analog inhibits the reaction [[Cytochalasin B co-treated with C5 protein] results in increased secretion of EPO protein]; resveratrol analog inhibits the reaction [[Cytochalasin B co-treated with C5 protein] results in increased secretion of EPO protein]; resveratrol analog inhibits the reaction [[Cytochalasin B co-treated with IL5 protein] results in increased secretion of EPO protein] CTD PMID:18776917 NCBI chr 7:100,720,468...100,723,700
Ensembl chr 7:100,720,468...100,723,700 		JBrowse link
G FIS1 fission, mitochondrial 1 increases expression ISO Cytochalasin B results in increased expression of FIS1 protein CTD PMID:26732598 NCBI chr 7:101,239,472...101,245,081
Ensembl chr 7:101,239,458...101,252,316 		JBrowse link
G GUSB glucuronidase beta multiple interactions ISO [Platelet Activating Factor co-treated with Cytochalasin B] results in increased secretion of GUSB protein; IMMLG5521 inhibits the reaction [[Platelet Activating Factor co-treated with Cytochalasin B] results in increased secretion of GUSB protein] CTD PMID:23850278 NCBI chr 7:65,960,684...65,982,213
Ensembl chr 7:65,960,684...65,982,215 		JBrowse link
G HSPA5 heat shock protein family A (Hsp70) member 5 increases expression ISO Cytochalasin B results in increased expression of HSPA5 protein CTD PMID:26732598 NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382 		JBrowse link
G IL1B interleukin 1 beta multiple interactions EXP Cytochalasin B inhibits the reaction [[Alum Compounds co-treated with K-12 lipopolysaccharide] results in increased secretion of IL1B protein modified form]; Cytochalasin B inhibits the reaction [Asbestos, Crocidolite promotes the reaction [IL1B protein results in increased abundance of Nitric Oxide]]; Cytochalasin B inhibits the reaction [Asbestos, Serpentine promotes the reaction [IL1B protein results in increased abundance of Nitric Oxide]] CTD PMID:9698594 PMID:17404311 NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816 		JBrowse link
G IL5 interleukin 5 multiple interactions EXP [Cytochalasin B co-treated with IL5 protein] results in increased secretion of EPO protein; resveratrol analog inhibits the reaction [[Cytochalasin B co-treated with IL5 protein] results in increased secretion of EPO protein] CTD PMID:18776917 NCBI chr 5:132,541,445...132,556,815
Ensembl chr 5:132,541,445...132,556,838 		JBrowse link
G INS-IGF2 INS-IGF2 readthrough multiple interactions ISO Cytochalasin B inhibits the reaction [INS1 protein inhibits the reaction [Epinephrine results in increased transport of Fatty Acids, Nonesterified]]
Cytochalasin B inhibits the reaction [INS1 protein results in increased uptake of Glucose]; Cytochalasin B inhibits the reaction [mono-(2-ethylhexyl)phthalate promotes the reaction [INS1 protein results in increased uptake of Glucose]] 		CTD PMID:15172182 PMID:25543134 NCBI chr11:2,129,117...2,161,209
Ensembl chr11:2,132,538...2,161,209 		JBrowse link
G LPL lipoprotein lipase decreases activity ISO Cytochalasin B results in decreased activity of LPL protein CTD PMID:9414485 NCBI chr 8:19,939,253...19,967,259
Ensembl chr 8:19,901,717...19,967,259 		JBrowse link
G MAPK1 mitogen-activated protein kinase 1 multiple interactions EXP [Cytochalasin B co-treated with C5 protein] results in increased phosphorylation of and results in increased activity of MAPK1 protein; resveratrol analog inhibits the reaction [[Cytochalasin B co-treated with C5 protein] results in increased phosphorylation of and results in increased activity of MAPK1 protein] CTD PMID:18776917 NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680 		JBrowse link
G MAPK3 mitogen-activated protein kinase 3 multiple interactions EXP [Cytochalasin B co-treated with C5 protein] results in increased phosphorylation of and results in increased activity of MAPK3 protein; resveratrol analog inhibits the reaction [[Cytochalasin B co-treated with C5 protein] results in increased phosphorylation of and results in increased activity of MAPK3 protein] CTD PMID:18776917 NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506 		JBrowse link
G SLC2A1 solute carrier family 2 member 1 affects folding
affects binding
multiple interactions 		EXP
ISO 		Cytochalasin B affects the folding of SLC2A1 protein
Cytochalasin B binds to SLC2A1 protein
Cytochalasin B binds to and results in decreased activity of SLC2A1 protein; Cytochalasin B inhibits the reaction [SLC2A1 protein results in increased transport of Glucose]
oxophenylarsine inhibits the reaction [Cytochalasin B binds to SLC2A1 protein] 		CTD PMID:8457197 PMID:19686715 PMID:22363641 PMID:27078104 NCBI chr 1:42,925,353...42,958,868
Ensembl chr 1:42,925,353...42,958,893 		JBrowse link
G SLC2A2 solute carrier family 2 member 2 multiple interactions
affects binding 		EXP
ISO 		Cytochalasin B inhibits the reaction [SLC2A2 protein results in increased transport of Deoxyglucose]
Cytochalasin B binds to SLC2A2 protein
Cytochalasin B inhibits the reaction [SLC2A2 protein results in increased uptake of 3-O-Methylglucose]; Mercuric Chloride inhibits the reaction [Cytochalasin B binds to SLC2A2 protein] 		CTD PMID:8457197 PMID:10825458 NCBI chr 3:170,996,347...171,026,720
Ensembl chr 3:170,996,347...171,026,743 		JBrowse link
G SLC2A3 solute carrier family 2 member 3 multiple interactions EXP Cytochalasin B inhibits the reaction [SLC2A3 protein results in increased transport of Deoxyglucose] CTD PMID:8457197 NCBI chr12:7,919,230...7,936,187
Ensembl chr12:7,919,230...8,019,007 		JBrowse link
G SOD2 superoxide dismutase 2 multiple interactions EXP Cytochalasin B inhibits the reaction [Dehydroascorbic Acid results in increased expression of SOD2 protein] CTD PMID:20166893 NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529 		JBrowse link
G TP53 tumor protein p53 increases expression EXP Cytochalasin B results in increased expression of TP53 protein CTD PMID:27640744 NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,546 		JBrowse link
cytochalasin D term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABL1 ABL proto-oncogene 1, non-receptor tyrosine kinase multiple interactions
increases phosphorylation 		ISO EGF protein inhibits the reaction [Cytochalasin D results in increased phosphorylation of ABL1 protein] CTD PMID:21900236 NCBI chr 9:130,713,043...130,887,675
Ensembl chr 9:130,713,043...130,887,675 		JBrowse link
G ACTA2 actin alpha 2, smooth muscle multiple interactions
increases expression 		EXP
ISO 		Cytochalasin D inhibits the reaction [Oxygen results in increased expression of ACTA2 mRNA]; Cytochalasin D inhibits the reaction [Oxygen results in increased expression of ACTA2 protein]
Cytochalasin D results in increased expression of ACTA2 mRNA 		CTD PMID:11035001 PMID:23517783 NCBI chr10:88,935,074...88,991,337
Ensembl chr10:88,934,822...88,991,339 		JBrowse link
G ACTG1 actin gamma 1 multiple interactions EXP Cytochalasin D inhibits the reaction [UPF1 protein binds to ACTG1 protein]; Cytochalasin D inhibits the reaction [UPF2 protein binds to ACTG1 protein]; Cytochalasin D inhibits the reaction [UPF3B protein binds to ACTG1 protein] CTD PMID:28743738 NCBI chr17:81,509,971...81,512,799
Ensembl chr17:81,509,413...81,523,847 		JBrowse link
G CDH1 cadherin 1 multiple interactions
increases expression 		EXP [Cytochalasin D results in increased expression of CDH1 protein] which results in decreased activity of RHOA protein; RHOA protein mutant form affects the reaction [Cytochalasin D results in increased expression of CDH1 protein]
Cytochalasin D results in increased expression of CDH1 mRNA; Cytochalasin D results in increased expression of CDH1 protein 		CTD PMID:25756282 NCBI chr16:68,737,292...68,835,537
Ensembl chr16:68,737,292...68,835,537 		JBrowse link
G COL1A1 collagen type I alpha 1 chain multiple interactions EXP Cytochalasin D inhibits the reaction [Oxygen results in increased expression of COL1A1 mRNA] CTD PMID:23517783 NCBI chr17:50,184,101...50,201,631
Ensembl chr17:50,184,101...50,201,632 		JBrowse link
G COL1A2 collagen type I alpha 2 chain multiple interactions EXP Cytochalasin D inhibits the reaction [Oxygen results in increased expression of COL1A2 mRNA] CTD PMID:23517783 NCBI chr 7:94,394,895...94,431,227
Ensembl chr 7:94,394,895...94,431,227 		JBrowse link
G CSF2 colony stimulating factor 2 multiple interactions EXP Cytochalasin D inhibits the reaction [Particulate Matter results in increased secretion of CSF2 protein]; Cytochalasin D inhibits the reaction [Vehicle Emissions results in increased secretion of CSF2 protein] CTD PMID:10645887 NCBI chr 5:132,073,789...132,076,170
Ensembl chr 5:132,073,789...132,076,170 		JBrowse link
G CXCL8 C-X-C motif chemokine ligand 8 multiple interactions
increases stability 		EXP Cytochalasin D inhibits the reaction [Asbestos, Serpentine results in increased secretion of CXCL8 protein]; Cytochalasin D inhibits the reaction [Particulate Matter results in increased expression of CXCL8 protein]; Cytochalasin D inhibits the reaction [Smoke results in increased expression of CXCL8 mRNA]; Cytochalasin D inhibits the reaction [Smoke results in increased secretion of CXCL8 protein]; Cytochalasin D inhibits the reaction [Titanium results in increased secretion of CXCL8 protein]; Cytochalasin D inhibits the reaction [Vehicle Emissions results in increased expression of CXCL8 mRNA]; Cytochalasin D promotes the reaction [CXCL8 protein results in decreased expression of CXCR1 protein]; Cytochalasin D promotes the reaction [CXCL8 protein results in decreased expression of CXCR2 protein]
Cytochalasin D results in increased stability of CXCL8 mRNA 		CTD PMID:8089496 PMID:11145710 PMID:16392133 PMID:16499908 PMID:23670201 More... NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716 		JBrowse link
G CXCR1 C-X-C motif chemokine receptor 1 multiple interactions EXP Cytochalasin D promotes the reaction [CXCL8 protein results in decreased expression of CXCR1 protein] CTD PMID:11145710 NCBI chr 2:218,162,841...218,166,962
Ensembl chr 2:218,162,841...218,166,962 		JBrowse link
G CXCR2 C-X-C motif chemokine receptor 2 multiple interactions EXP Cytochalasin D promotes the reaction [CXCL8 protein results in decreased expression of CXCR2 protein] CTD PMID:11145710 NCBI chr 2:218,125,294...218,137,251
Ensembl chr 2:218,125,289...218,137,251 		JBrowse link
G EGF epidermal growth factor multiple interactions ISO EGF protein inhibits the reaction [Cytochalasin D results in increased phosphorylation of ABL1 protein] CTD PMID:21900236 NCBI chr 4:109,912,883...110,013,766
Ensembl chr 4:109,912,883...110,013,766 		JBrowse link
G EGFR epidermal growth factor receptor multiple interactions EXP Cytochalasin D inhibits the reaction [Asbestos, Crocidolite results in decreased phosphorylation of EGFR protein] CTD PMID:15626777 NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628 		JBrowse link
G F3 coagulation factor III, tissue factor multiple interactions EXP Cytochalasin D inhibits the reaction [Particulate Matter results in increased expression of F3 mRNA] CTD PMID:25858758 NCBI chr 1:94,529,173...94,541,759
Ensembl chr 1:94,529,173...94,541,759 		JBrowse link
G GPX1 glutathione peroxidase 1 affects localization EXP Cytochalasin D affects the localization of GPX1 mRNA mutant form CTD PMID:28743738 NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605 		JBrowse link
G ICAM1 intercellular adhesion molecule 1 multiple interactions EXP Cytochalasin D inhibits the reaction [TNF protein affects the localization of ICAM1 protein] CTD PMID:15034928 NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615 		JBrowse link
G IFNG interferon gamma multiple interactions EXP Cytochalasin D promotes the reaction [[IFNG protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of NOS2 mRNA] CTD PMID:12799187 NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740 		JBrowse link
G IKBKB inhibitor of nuclear factor kappa B kinase subunit beta increases phosphorylation
multiple interactions 		EXP Cytochalasin D results in increased phosphorylation of IKBKB protein
Cytochalasin D results in decreased localization of [IKBKB protein binds to NFKBIA protein] 		CTD PMID:17029595 NCBI chr 8:42,271,302...42,332,460
Ensembl chr 8:42,271,302...42,332,460 		JBrowse link
G IL1A interleukin 1 alpha multiple interactions ISO Cytochalasin D inhibits the reaction [Quartz results in increased import of IL1A protein]; Cytochalasin D promotes the reaction [Quartz results in increased secretion of IL1A protein] CTD PMID:36840754 NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493 		JBrowse link
G IL1B interleukin 1 beta multiple interactions EXP
ISO 		Cytochalasin D inhibits the reaction [[Lipopolysaccharides co-treated with Silicon Dioxide] results in increased cleavage of and results in increased secretion of IL1B protein]; Cytochalasin D inhibits the reaction [[Lipopolysaccharides co-treated with Uric Acid] results in increased cleavage of and results in increased secretion of IL1B protein]; Cytochalasin D inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with aluminum sulfate] results in increased secretion of IL1B protein]; Cytochalasin D inhibits the reaction [Asbestos, Crocidolite results in increased secretion of IL1B protein]; Cytochalasin D inhibits the reaction [Nanotubes, Carbon results in increased secretion of IL1B protein]; Cytochalasin D inhibits the reaction [titanium dioxide results in increased secretion of IL1B protein]; Cytochalasin D inhibits the reaction [Uric Acid results in increased secretion of IL1B protein]; Cytochalasin D promotes the reaction [[IFNG protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of NOS2 mRNA]
Cytochalasin D inhibits the reaction [[Air Pollutants results in increased abundance of Particulate Matter] which results in increased expression of IL1B mRNA]; Cytochalasin D inhibits the reaction [[Lipopolysaccharides co-treated with Silicon Dioxide] results in increased cleavage of and results in increased secretion of IL1B protein]; Cytochalasin D inhibits the reaction [[Lipopolysaccharides co-treated with Uric Acid] results in increased cleavage of and results in increased secretion of IL1B protein]; Cytochalasin D inhibits the reaction [Coal Ash results in increased secretion of IL1B protein] 		CTD PMID:12799187 PMID:18403674 PMID:18604214 PMID:24158569 PMID:24760326 More... NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816 		JBrowse link
G IL6 interleukin 6 decreases chemical synthesis
increases stability 		EXP Cytochalasin D results in decreased chemical synthesis of IL6 protein
Cytochalasin D results in increased stability of IL6 mRNA 		CTD PMID:16499908 NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002 		JBrowse link
G IVNS1ABP influenza virus NS1A binding protein increases response to substance ISO IVNS1ABP gene mutant form results in increased susceptibility to Cytochalasin D CTD PMID:15485691 NCBI chr 1:185,296,388...185,317,243
Ensembl chr 1:185,292,931...185,317,273 		JBrowse link
G LDHA lactate dehydrogenase A multiple interactions ISO Cytochalasin D inhibits the reaction [Quartz results in increased activity of and results in increased secretion of LDHA protein] CTD PMID:36840754 NCBI chr11:18,394,563...18,408,425
Ensembl chr11:18,394,560...18,408,425 		JBrowse link
G MMP9 matrix metallopeptidase 9 multiple interactions EXP Cytochalasin D promotes the reaction [TNF results in increased expression of MMP9 mRNA] CTD PMID:17560598 NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561 		JBrowse link
G MRTFA myocardin related transcription factor A multiple interactions EXP Cytochalasin D inhibits the reaction [Oxygen affects the localization of MRTFA protein] CTD PMID:23517783 NCBI chr22:40,410,289...40,636,719
Ensembl chr22:40,410,281...40,636,719 		JBrowse link
G NFATC4 nuclear factor of activated T cells 4 decreases localization EXP Cytochalasin D results in decreased localization of NFATC4 protein CTD PMID:17044076 NCBI chr14:24,366,911...24,379,604
Ensembl chr14:24,365,673...24,379,604 		JBrowse link
G NFKBIA NFKB inhibitor alpha increases phosphorylation
multiple interactions 		EXP Cytochalasin D results in increased phosphorylation of NFKBIA protein
Cytochalasin D results in decreased localization of [IKBKB protein binds to NFKBIA protein] 		CTD PMID:17029595 NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749 		JBrowse link
G NLRP3 NLR family pyrin domain containing 3 multiple interactions
decreases expression 		ISO Cytochalasin D inhibits the reaction [[Air Pollutants results in increased abundance of Particulate Matter] which results in increased expression of NLRP3 mRNA]
Cytochalasin D results in decreased expression of NLRP3 mRNA 		CTD PMID:37062408 NCBI chr 1:247,416,077...247,448,817
Ensembl chr 1:247,332,331...247,449,108 		JBrowse link
G NOS2 nitric oxide synthase 2 multiple interactions EXP Cytochalasin D promotes the reaction [[IFNG protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of NOS2 mRNA] CTD PMID:12799187 NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529 		JBrowse link
G P2RX1 purinergic receptor P2X 1 decreases activity EXP Cytochalasin D results in decreased activity of P2RX1 protein CTD PMID:21757694 NCBI chr17:3,896,592...3,916,465
Ensembl chr17:3,896,592...3,916,476 		JBrowse link
G PDX1 pancreatic and duodenal homeobox 1 decreases uptake EXP Cytochalasin D results in decreased uptake of PDX1 protein CTD PMID:16405074 NCBI chr13:27,920,000...27,926,313
Ensembl chr13:27,920,000...27,926,313 		JBrowse link
G PLAT plasminogen activator, tissue type increases expression EXP Cytochalasin D results in increased expression of PLAT CTD PMID:12371961 NCBI chr 8:42,174,718...42,207,565
Ensembl chr 8:42,174,718...42,207,709 		JBrowse link
G RHOA ras homolog family member A multiple interactions EXP [Cytochalasin D results in increased expression of CDH1 protein] which results in decreased activity of RHOA protein; RHOA protein mutant form affects the reaction [Cytochalasin D results in increased expression of CDH1 protein] CTD PMID:25756282 NCBI chr 3:49,359,145...49,411,976
Ensembl chr 3:49,359,139...49,412,998 		JBrowse link
G RS1 retinoschisin 1 decreases secretion EXP Cytochalasin D results in decreased secretion of RS1 protein CTD PMID:21738583 NCBI chr  X:18,639,688...18,672,108
Ensembl chr  X:18,639,688...18,672,108 		JBrowse link
G SLC31A1 solute carrier family 31 member 1 multiple interactions EXP Cytochalasin D inhibits the reaction [Cisplatin results in increased degradation of SLC31A1 protein] CTD PMID:17108132 NCBI chr 9:113,221,544...113,264,492
Ensembl chr 9:113,221,544...113,264,492 		JBrowse link
G SMAD1 SMAD family member 1 affects localization EXP Cytochalasin D affects the localization of SMAD1 protein CTD PMID:25756282 NCBI chr 4:145,480,770...145,559,176
Ensembl chr 4:145,481,194...145,559,176 		JBrowse link
G SMAD2 SMAD family member 2 affects localization EXP Cytochalasin D affects the localization of SMAD2 protein CTD PMID:25756282 NCBI chr18:47,808,957...47,930,872
Ensembl chr18:47,808,957...47,931,146 		JBrowse link
G SMAD3 SMAD family member 3 affects localization EXP Cytochalasin D affects the localization of SMAD3 protein CTD PMID:25756282 NCBI chr15:67,065,602...67,195,169
Ensembl chr15:67,063,763...67,195,173 		JBrowse link
G SNAI1 snail family transcriptional repressor 1 affects localization EXP Cytochalasin D affects the localization of SNAI1 protein CTD PMID:25756282 NCBI chr20:49,982,980...49,988,886
Ensembl chr20:49,982,980...49,988,886 		JBrowse link
G STAT1 signal transducer and activator of transcription 1 multiple interactions EXP Cytochalasin D deficiency results in decreased activity of and affects the localization of STAT1 protein CTD PMID:28086195 NCBI chr 2:190,969,149...191,014,171
Ensembl chr 2:190,908,460...191,020,960 		JBrowse link
G STAT3 signal transducer and activator of transcription 3 multiple interactions EXP Cytochalasin D deficiency results in decreased activity of and affects the localization of STAT3 protein CTD PMID:28086195 NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,568 		JBrowse link
G TAGLN transgelin increases expression ISO Cytochalasin D results in increased expression of TAGLN mRNA CTD PMID:11035001 NCBI chr11:117,199,294...117,207,465
Ensembl chr11:117,199,370...117,207,464 		JBrowse link
G TNF tumor necrosis factor multiple interactions EXP
ISO 		Cytochalasin D inhibits the reaction [TNF protein affects the localization of ICAM1 protein]; Cytochalasin D inhibits the reaction [TNF protein affects the localization of VCAM1 protein]; Cytochalasin D inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]; Cytochalasin D promotes the reaction [[IFNG protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of NOS2 mRNA]; Cytochalasin D promotes the reaction [TNF results in increased expression of MMP9 mRNA]
Cytochalasin D inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; Cytochalasin D inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] 		CTD PMID:8409756 PMID:12799187 PMID:15034928 PMID:17560598 NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336 		JBrowse link
G TXN thioredoxin multiple interactions EXP Cytochalasin D inhibits the reaction [Cadmium Chloride affects the localization of TXN protein] CTD PMID:22961094 NCBI chr 9:110,243,810...110,256,507
Ensembl chr 9:110,243,810...110,256,507 		JBrowse link
G UPF1 UPF1 RNA helicase and ATPase affects localization
multiple interactions 		EXP Cytochalasin D affects the localization of UPF1 protein
Cytochalasin D inhibits the reaction [UPF1 protein binds to ACTG1 protein] 		CTD PMID:28743738 NCBI chr19:18,831,959...18,868,230
Ensembl chr19:18,831,959...18,868,230 		JBrowse link
G UPF2 UPF2 regulator of nonsense mediated mRNA decay multiple interactions EXP Cytochalasin D inhibits the reaction [UPF2 protein binds to ACTG1 protein] CTD PMID:28743738 NCBI chr10:11,920,022...12,043,170
Ensembl chr10:11,920,022...12,043,170 		JBrowse link
G UPF3B UPF3B regulator of nonsense mediated mRNA decay multiple interactions EXP Cytochalasin D inhibits the reaction [UPF3B protein binds to ACTG1 protein] CTD PMID:28743738 NCBI chr  X:119,805,311...119,852,963
Ensembl chr  X:119,834,022...119,852,998 		JBrowse link
G VCAM1 vascular cell adhesion molecule 1 multiple interactions EXP Cytochalasin D inhibits the reaction [TNF protein affects the localization of VCAM1 protein]; Cytochalasin D inhibits the reaction [TNF protein results in increased expression of VCAM1 protein] CTD PMID:15034928 NCBI chr 1:100,719,742...100,739,045
Ensembl chr 1:100,719,742...100,739,045 		JBrowse link
Cytochalasin H term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G PCDH10 protocadherin 10 increases expression EXP cytochalasin H results in increased expression of PCDH10 mRNA CTD PMID:30507090 NCBI chr 4:133,149,294...133,208,606
Ensembl chr 4:133,149,294...133,208,606 		JBrowse link
G PLAU plasminogen activator, urokinase decreases expression EXP cytochalasin H results in decreased expression of PLAU mRNA CTD PMID:30507090 NCBI chr10:73,909,164...73,917,494
Ensembl chr10:73,909,177...73,917,496 		JBrowse link
Dialifor term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ACHE acetylcholinesterase (Yt blood group) decreases activity EXP dialifor metabolite results in decreased activity of ACHE protein; dialifor results in decreased activity of ACHE protein CTD PMID:33844597 NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974 		JBrowse link
G TP53 tumor protein p53 affects activity EXP dialifor metabolite affects the activity of TP53 protein CTD PMID:35435491 NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,546 		JBrowse link
Dihydrocytochalasin B term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G FGR FGR proto-oncogene, Src family tyrosine kinase multiple interactions EXP 1-Butanol inhibits the reaction [[N-Formylmethionine Leucyl-Phenylalanine co-treated with dihydrocytochalasin B] results in increased activity of FGR protein] CTD PMID:11078731 NCBI chr 1:27,612,064...27,635,185
Ensembl chr 1:27,612,064...27,635,185 		JBrowse link
folpet term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB1 ATP binding cassette subfamily B member 1 increases expression ISO folpet results in increased expression of ABCB1A mRNA CTD PMID:31558096 NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323 		JBrowse link
G ABCC3 ATP binding cassette subfamily C member 3 increases expression ISO folpet results in increased expression of ABCC3 mRNA CTD PMID:31558096 NCBI chr17:50,634,881...50,692,253
Ensembl chr17:50,634,777...50,692,253 		JBrowse link
G ABCC5 ATP binding cassette subfamily C member 5 increases expression ISO folpet results in increased expression of ABCC5 mRNA CTD PMID:31558096 NCBI chr 3:183,919,934...184,017,884
Ensembl chr 3:183,919,934...184,017,939 		JBrowse link
G ABCF1 ATP binding cassette subfamily F member 1 increases expression ISO folpet results in increased expression of ABCF1 mRNA CTD PMID:31558096 NCBI chr 6:30,571,442...30,591,522
Ensembl chr 6:30,571,393...30,597,179 		JBrowse link
G ABHD6 abhydrolase domain containing 6, acylglycerol lipase increases expression ISO folpet results in increased expression of ABHD6 mRNA CTD PMID:31558096 NCBI chr 3:58,237,792...58,294,734
Ensembl chr 3:58,237,532...58,295,693 		JBrowse link
G ACAA1 acetyl-CoA acyltransferase 1 increases expression ISO folpet results in increased expression of ACAA1B mRNA CTD PMID:31558096 NCBI chr 3:38,122,715...38,137,127
Ensembl chr 3:38,103,129...38,137,242 		JBrowse link
G ACAT2 acetyl-CoA acetyltransferase 2 increases expression ISO folpet results in increased expression of ACAT2 mRNA CTD PMID:31558096 NCBI chr 6:159,762,045...159,779,112
Ensembl chr 6:159,762,045...159,779,112 		JBrowse link
G ACD ACD shelterin complex subunit and telomerase recruitment factor decreases expression ISO folpet results in decreased expression of ACD mRNA CTD PMID:31558096 NCBI chr16:67,657,512...67,660,260
Ensembl chr16:67,657,512...67,660,810 		JBrowse link
G ACE angiotensin I converting enzyme decreases expression ISO folpet results in decreased expression of ACE mRNA CTD PMID:31558096 NCBI chr17:63,477,061...63,498,373
Ensembl chr17:63,477,061...63,498,380 		JBrowse link
G ACO2 aconitase 2 increases expression ISO folpet results in increased expression of ACO2 mRNA CTD PMID:31558096 NCBI chr22:41,469,117...41,528,974
Ensembl chr22:41,447,830...41,529,273 		JBrowse link
G ACOX1 acyl-CoA oxidase 1 increases expression ISO folpet results in increased expression of ACOX1 mRNA CTD PMID:31558096 NCBI chr17:75,941,507...75,979,166
Ensembl chr17:75,941,507...75,979,177 		JBrowse link
G ACTA2 actin alpha 2, smooth muscle decreases expression ISO folpet results in decreased expression of ACTA2 mRNA CTD PMID:31558096 NCBI chr10:88,935,074...88,991,337
Ensembl chr10:88,934,822...88,991,339 		JBrowse link
G ADCY6 adenylate cyclase 6 decreases expression ISO folpet results in decreased expression of ADCY6 mRNA CTD PMID:31558096 NCBI chr12:48,766,194...48,789,974
Ensembl chr12:48,766,194...48,789,089 		JBrowse link
G ADGRL4 adhesion G protein-coupled receptor L4 decreases expression ISO folpet results in decreased expression of ELTD1 mRNA CTD PMID:31558096 NCBI chr 1:78,889,764...79,006,730
Ensembl chr 1:78,889,764...79,282,124 		JBrowse link
G ADH5 alcohol dehydrogenase 5 (class III), chi polypeptide increases expression ISO folpet results in increased expression of ADH5 mRNA CTD PMID:31558096 NCBI chr 4:99,070,978...99,088,788
Ensembl chr 4:99,070,978...99,088,801 		JBrowse link
G AGMAT agmatinase (putative) decreases expression ISO folpet results in decreased expression of AGMAT mRNA CTD PMID:31558096 NCBI chr 1:15,571,699...15,585,051
Ensembl chr 1:15,571,699...15,585,051 		JBrowse link
G AHR aryl hydrocarbon receptor increases expression ISO folpet results in increased expression of AHR mRNA CTD PMID:31558096 NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152 		JBrowse link
G AKR1B10 aldo-keto reductase family 1 member B10 increases expression ISO folpet results in increased expression of AKR1B10 mRNA CTD PMID:31558096 NCBI chr 7:134,527,567...134,541,412
Ensembl chr 7:134,527,567...134,541,412 		JBrowse link
G ALAS1 5'-aminolevulinate synthase 1 increases expression ISO folpet results in increased expression of ALAS1 mRNA CTD PMID:31558096 NCBI chr 3:52,198,083...52,214,327
Ensembl chr 3:52,198,086...52,214,327 		JBrowse link
G ALDH1A1 aldehyde dehydrogenase 1 family member A1 increases expression ISO folpet results in increased expression of ALDH1A1 mRNA CTD PMID:31558096 NCBI chr 9:72,900,671...72,953,053
Ensembl chr 9:72,900,671...73,080,442 		JBrowse link
G ALDH2 aldehyde dehydrogenase 2 family member increases expression ISO folpet results in increased expression of ALDH2 mRNA CTD PMID:31558096 NCBI chr12:111,766,933...111,817,532
Ensembl chr12:111,766,887...111,817,532 		JBrowse link
G ALDH3A2 aldehyde dehydrogenase 3 family member A2 increases expression ISO folpet results in increased expression of ALDH3A2 mRNA CTD PMID:31558096 NCBI chr17:19,648,136...19,677,596
Ensembl chr17:19,648,136...19,685,760 		JBrowse link
G ALDH7A1 aldehyde dehydrogenase 7 family member A1 decreases expression ISO folpet results in decreased expression of ALDH7A1 mRNA CTD PMID:31558096 NCBI chr 5:126,541,841...126,595,219
Ensembl chr 5:126,531,200...126,595,362 		JBrowse link
G ALDOA aldolase, fructose-bisphosphate A increases expression ISO folpet results in increased expression of ALDOA mRNA CTD PMID:31558096 NCBI chr16:30,053,151...30,070,414
Ensembl chr16:30,053,090...30,070,420
Ensembl chr16:30,053,090...30,070,420
Ensembl chr16:30,053,090...30,070,420 		JBrowse link
G ALDOB aldolase, fructose-bisphosphate B increases expression ISO folpet results in increased expression of ALDOB mRNA CTD PMID:31558096 NCBI chr 9:101,420,560...101,435,774
Ensembl chr 9:101,420,560...101,449,664 		JBrowse link
G ALDOC aldolase, fructose-bisphosphate C increases expression ISO folpet results in increased expression of ALDOC mRNA CTD PMID:31558096 NCBI chr17:28,573,120...28,576,895
Ensembl chr17:28,573,115...28,576,948 		JBrowse link
G ALOX5AP arachidonate 5-lipoxygenase activating protein decreases expression ISO folpet results in decreased expression of ALOX5AP mRNA CTD PMID:31558096 NCBI chr13:30,713,485...30,764,426
Ensembl chr13:30,713,478...30,764,426 		JBrowse link
G AMDHD2 amidohydrolase domain containing 2 increases expression ISO folpet results in increased expression of AMDHD2 mRNA CTD PMID:31558096 NCBI chr16:2,520,371...2,531,417
Ensembl chr16:2,520,357...2,531,422 		JBrowse link
G AP2M1 adaptor related protein complex 2 subunit mu 1 increases expression ISO folpet results in increased expression of AP2M1 mRNA CTD PMID:31558096 NCBI chr 3:184,174,855...184,184,091
Ensembl chr 3:184,174,689...184,184,214 		JBrowse link
G APOA1 apolipoprotein A1 increases expression ISO folpet results in increased expression of APOA1 mRNA CTD PMID:31558096 NCBI chr11:116,835,751...116,837,622
Ensembl chr11:116,835,751...116,837,622 		JBrowse link
G APOC3 apolipoprotein C3 increases expression ISO folpet results in increased expression of APOC3 mRNA CTD PMID:31558096 NCBI chr11:116,829,907...116,833,072
Ensembl chr11:116,829,706...116,833,072 		JBrowse link
G APOE apolipoprotein E decreases expression ISO folpet results in decreased expression of APOE mRNA CTD PMID:31558096 NCBI chr19:44,905,796...44,909,393
Ensembl chr19:44,905,791...44,909,393 		JBrowse link
G APP amyloid beta precursor protein decreases expression ISO folpet results in decreased expression of APP mRNA CTD PMID:31558096 NCBI chr21:25,880,550...26,171,128
Ensembl chr21:25,880,535...26,171,128 		JBrowse link
G AQP1 aquaporin 1 (Colton blood group) decreases expression ISO folpet results in decreased expression of AQP1 mRNA CTD PMID:31558096 NCBI chr 7:30,911,853...30,925,516
Ensembl chr 7:30,911,853...30,925,517 		JBrowse link
G ARF1 ARF GTPase 1 increases expression ISO folpet results in increased expression of ARF1 mRNA CTD PMID:31558096 NCBI chr 1:228,082,708...228,099,212
Ensembl chr 1:228,082,708...228,099,212 		JBrowse link
G ARHGAP9 Rho GTPase activating protein 9 decreases expression ISO folpet results in decreased expression of ARHGAP9 mRNA CTD PMID:31558096 NCBI chr12:57,472,269...57,488,824
Ensembl chr12:57,472,264...57,488,814 		JBrowse link
G ARID4B AT-rich interaction domain 4B increases expression ISO folpet results in increased expression of ARID4B mRNA CTD PMID:31558096 NCBI chr 1:235,166,902...235,328,179
Ensembl chr 1:235,131,634...235,328,219 		JBrowse link
G ARL1 ARF like GTPase 1 increases expression ISO folpet results in increased expression of ARL1 mRNA CTD PMID:31558096 NCBI chr12:101,393,116...101,407,820
Ensembl chr12:101,393,116...101,407,772 		JBrowse link
G ARNT aryl hydrocarbon receptor nuclear translocator decreases expression ISO folpet results in decreased expression of ARNT mRNA CTD PMID:31558096 NCBI chr 1:150,809,713...150,876,599
Ensembl chr 1:150,809,713...150,876,708 		JBrowse link
G ARNT2 aryl hydrocarbon receptor nuclear translocator 2 increases expression ISO folpet results in increased expression of ARNT2 mRNA CTD PMID:31558096 NCBI chr15:80,404,382...80,597,933
Ensembl chr15:80,404,350...80,597,933 		JBrowse link
G ARPP19 cAMP regulated phosphoprotein 19 increases expression ISO folpet results in increased expression of ARPP19 mRNA CTD PMID:31558096 NCBI chr15:52,547,045...52,569,446
Ensembl chr15:52,547,045...52,569,883 		JBrowse link
G ARSA arylsulfatase A increases expression ISO folpet results in increased expression of ARSA mRNA CTD PMID:31558096 NCBI chr22:50,622,754...50,628,152
Ensembl chr22:50,622,754...50,628,173 		JBrowse link
G ATG3 autophagy related 3 increases expression ISO folpet results in increased expression of ATG3 mRNA CTD PMID:31558096 NCBI chr 3:112,532,510...112,561,962
Ensembl chr 3:112,532,510...112,562,046 		JBrowse link
G ATP11B ATPase phospholipid transporting 11B (putative) increases expression ISO folpet results in increased expression of ATP11B mRNA CTD PMID:31558096 NCBI chr 3:182,793,504...182,921,629
Ensembl chr 3:182,793,503...182,923,011 		JBrowse link
G ATP1A1 ATPase Na+/K+ transporting subunit alpha 1 decreases expression ISO folpet results in decreased expression of ATP1A1 mRNA CTD PMID:31558096 NCBI chr 1:116,373,244...116,404,774
Ensembl chr 1:116,372,668...116,410,261 		JBrowse link
G ATP5F1A ATP synthase F1 subunit alpha increases expression ISO folpet results in increased expression of ATP5F1A mRNA CTD PMID:31558096 NCBI chr18:46,080,248...46,104,227
Ensembl chr18:46,080,248...46,104,334 		JBrowse link
G ATP5F1B ATP synthase F1 subunit beta increases expression ISO folpet results in increased expression of ATP5F1B mRNA CTD PMID:31558096 NCBI chr12:56,638,175...56,645,984
Ensembl chr12:56,638,175...56,645,984 		JBrowse link
G ATP5F1E ATP synthase F1 subunit epsilon increases expression ISO folpet results in increased expression of ATP5F1E mRNA CTD PMID:31558096 NCBI chr20:59,025,475...59,032,335
Ensembl chr20:59,025,475...59,032,345 		JBrowse link
G ATP6V1D ATPase H+ transporting V1 subunit D increases expression ISO folpet results in increased expression of ATP6V1D mRNA CTD PMID:31558096 NCBI chr14:67,337,872...67,359,804
Ensembl chr14:67,294,371...67,360,265 		JBrowse link
G AXIN1 axin 1 increases expression ISO folpet results in increased expression of AXIN1 mRNA CTD PMID:31558096 NCBI chr16:287,440...352,723
Ensembl chr16:287,440...352,723 		JBrowse link
G B4GALT1 beta-1,4-galactosyltransferase 1 increases expression ISO folpet results in increased expression of B4GALT1 mRNA CTD PMID:31558096 NCBI chr 9:33,104,077...33,185,089
Ensembl chr 9:33,100,493...33,167,336 		JBrowse link
G BAD BCL2 associated agonist of cell death increases expression ISO folpet results in increased expression of BAD mRNA CTD PMID:31558096 NCBI chr11:64,269,828...64,284,704
Ensembl chr11:64,269,830...64,284,704 		JBrowse link
G BANF1 barrier to autointegration nuclear assembly factor 1 increases expression ISO folpet results in increased expression of BANF1 mRNA CTD PMID:31558096 NCBI chr11:66,002,079...66,004,149
Ensembl chr11:66,002,228...66,004,149 		JBrowse link
G BAX BCL2 associated X, apoptosis regulator multiple interactions EXP [Sulfur co-treated with folpet co-treated with penconazole] affects the expression of BAX mRNA; [Sulfur co-treated with folpet co-treated with penconazole] results in increased expression of BAX mRNA; [Sulfur co-treated with folpet] affects the expression of BAX mRNA CTD PMID:35564597 NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798 		JBrowse link
G BBC3 BCL2 binding component 3 decreases expression ISO folpet results in decreased expression of BBC3 mRNA CTD PMID:31558096 NCBI chr19:47,220,824...47,232,860
Ensembl chr19:47,220,822...47,232,766 		JBrowse link
G BCL2 BCL2 apoptosis regulator multiple interactions EXP [Sulfur co-treated with folpet] results in decreased expression of BCL2 mRNA CTD PMID:35564597 NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128 		JBrowse link
G BDH1 3-hydroxybutyrate dehydrogenase 1 decreases expression ISO folpet results in decreased expression of BDH1 mRNA CTD PMID:31558096 NCBI chr 3:197,509,783...197,573,343
Ensembl chr 3:197,509,783...197,573,323 		JBrowse link
G BECN1 beclin 1 increases expression ISO folpet results in increased expression of BECN1 mRNA CTD PMID:31558096 NCBI chr17:42,810,132...42,824,282
Ensembl chr17:42,810,134...42,833,350 		JBrowse link
G BGN biglycan decreases expression ISO folpet results in decreased expression of BGN mRNA CTD PMID:31558096 NCBI chr  X:153,494,980...153,509,546
Ensembl chr  X:153,494,980...153,509,546 		JBrowse link
G BHLHE40 basic helix-loop-helix family member e40 increases expression ISO folpet results in increased expression of BHLHE40 mRNA CTD PMID:31558096 NCBI chr 3:4,979,437...4,985,323
Ensembl chr 3:4,979,437...4,985,323 		JBrowse link
G BLOC1S2 biogenesis of lysosomal organelles complex 1 subunit 2 increases expression ISO folpet results in increased expression of BLOC1S2 mRNA CTD PMID:31558096 NCBI chr10:100,273,278...100,286,680
Ensembl chr10:100,273,280...100,286,680 		JBrowse link
G BLVRA biliverdin reductase A increases expression ISO folpet results in increased expression of BLVRA mRNA CTD PMID:31558096 NCBI chr 7:43,758,122...43,807,342
Ensembl chr 7:43,758,680...43,807,342 		JBrowse link
G BMP6 bone morphogenetic protein 6 decreases expression ISO folpet results in decreased expression of BMP6 mRNA CTD PMID:31558096 NCBI chr 6:7,726,099...7,881,728
Ensembl chr 6:7,726,099...7,881,728 		JBrowse link
G BNIP3 BCL2 interacting protein 3 increases expression ISO folpet results in increased expression of BNIP3 mRNA CTD PMID:31558096 NCBI chr10:131,967,684...131,981,923
Ensembl chr10:131,967,684...131,981,967 		JBrowse link
G BPNT1 3'(2'), 5'-bisphosphate nucleotidase 1 increases expression ISO folpet results in increased expression of BPNT1 mRNA CTD PMID:31558096 NCBI chr 1:220,057,482...220,089,788
Ensembl chr 1:220,057,482...220,090,462 		JBrowse link
G BSG basigin (Ok blood group) increases expression ISO folpet results in increased expression of BSG mRNA CTD PMID:31558096 NCBI chr19:571,283...583,493
Ensembl chr19:571,277...583,494 		JBrowse link
G BTG2 BTG anti-proliferation factor 2 increases expression ISO folpet results in increased expression of BTG2 mRNA CTD PMID:31558096 NCBI chr 1:203,305,519...203,309,602
Ensembl chr 1:203,305,491...203,309,602 		JBrowse link
G C1QA complement C1q A chain decreases expression ISO folpet results in decreased expression of C1QA mRNA CTD PMID:31558096 NCBI chr 1:22,636,463...22,639,678
Ensembl chr 1:22,635,077...22,639,678 		JBrowse link
G C1QB complement C1q B chain decreases expression ISO folpet results in decreased expression of C1QB mRNA CTD PMID:31558096 NCBI chr 1:22,653,236...22,661,637
Ensembl chr 1:22,652,762...22,661,637 		JBrowse link
G C1QC complement C1q C chain decreases expression ISO folpet results in decreased expression of C1QC mRNA CTD PMID:31558096 NCBI chr 1:22,643,633...22,648,108
Ensembl chr 1:22,643,014...22,648,110 		JBrowse link
G C2CD2 C2 calcium dependent domain containing 2 decreases expression ISO folpet results in decreased expression of C2CD2 mRNA CTD PMID:31558096 NCBI chr21:41,885,112...41,954,018
Ensembl chr21:41,885,112...41,954,018 		JBrowse link
G CA9 carbonic anhydrase 9 increases expression ISO folpet results in increased expression of CAR9 mRNA CTD PMID:31558096 NCBI chr 9:35,673,928...35,681,159
Ensembl chr 9:35,673,928...35,681,159 		JBrowse link
G CALCOCO1 calcium binding and coiled-coil domain 1 decreases expression ISO folpet results in decreased expression of CALCOCO1 mRNA CTD PMID:31558096 NCBI chr12:53,708,517...53,727,452
Ensembl chr12:53,708,517...53,727,745 		JBrowse link
G CANX calnexin decreases expression ISO folpet results in decreased expression of CANX mRNA CTD PMID:31558096 NCBI chr 5:179,678,656...179,731,641
Ensembl chr 5:179,678,628...179,731,641 		JBrowse link
G CAPG capping actin protein, gelsolin like increases expression ISO folpet results in increased expression of CAPG mRNA CTD PMID:31558096 NCBI chr 2:85,391,602...85,419,540
Ensembl chr 2:85,394,753...85,418,432 		JBrowse link
G CARMIL1 capping protein regulator and myosin 1 linker 1 increases expression ISO folpet results in increased expression of CARMIL1 mRNA CTD PMID:31558096 NCBI chr 6:25,279,374...25,620,530
Ensembl chr 6:25,279,078...25,620,530 		JBrowse link
G CASC3 CASC3 exon junction complex subunit decreases expression ISO folpet results in decreased expression of CASC3 mRNA CTD PMID:31558096 NCBI chr17:40,140,537...40,172,171
Ensembl chr17:40,140,318...40,172,183 		JBrowse link
G CASP7 caspase 7 increases expression ISO folpet results in increased expression of CASP7 mRNA CTD PMID:31558096 NCBI chr10:113,679,194...113,730,909
Ensembl chr10:113,679,162...113,730,907 		JBrowse link
G CAT catalase increases expression ISO folpet results in increased expression of CAT mRNA CTD PMID:31558096 NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060 		JBrowse link
G CAV1 caveolin 1 decreases expression ISO folpet results in decreased expression of CAV1 mRNA CTD PMID:31558096 NCBI chr 7:116,525,009...116,561,185
Ensembl chr 7:116,524,994...116,561,179 		JBrowse link
G CAVIN2 caveolae associated protein 2 decreases expression ISO folpet results in decreased expression of CAVIN2 mRNA CTD PMID:31558096 NCBI chr 2:191,834,310...191,847,088
Ensembl chr 2:191,834,310...191,847,088 		JBrowse link
G CBLB Cbl proto-oncogene B increases expression ISO folpet results in increased expression of CBLB mRNA CTD PMID:31558096 NCBI chr 3:105,655,461...105,869,449
Ensembl chr 3:105,655,461...105,869,552 		JBrowse link
G CBR1 carbonyl reductase 1 increases expression ISO folpet results in increased expression of CBR1 mRNA CTD PMID:31558096 NCBI chr21:36,070,024...36,073,164
Ensembl chr21:36,069,941...36,073,166 		JBrowse link
G CBR3 carbonyl reductase 3 increases expression ISO folpet results in increased expression of CBR3 mRNA CTD PMID:31558096 NCBI chr21:36,135,079...36,146,562
Ensembl chr21:36,135,079...36,146,562 		JBrowse link
G CCND2 cyclin D2 decreases expression ISO folpet results in decreased expression of CCND2 mRNA CTD PMID:31558096 NCBI chr12:4,273,762...4,305,353
Ensembl chr12:4,269,771...4,305,353 		JBrowse link
G CCNE2 cyclin E2 increases expression ISO folpet results in increased expression of CCNE2 mRNA CTD PMID:31558096 NCBI chr 8:94,880,224...94,896,693
Ensembl chr 8:94,879,770...94,896,678 		JBrowse link
G CCT6A chaperonin containing TCP1 subunit 6A decreases expression ISO folpet results in decreased expression of CCT6A mRNA CTD PMID:31558096 NCBI chr 7:56,051,765...56,063,989
Ensembl chr 7:56,051,685...56,063,989 		JBrowse link
G CD48 CD48 molecule decreases expression ISO folpet results in decreased expression of CD48 mRNA CTD PMID:31558096 NCBI chr 1:160,678,746...160,711,822
Ensembl chr 1:160,678,746...160,711,831 		JBrowse link
G CD74 CD74 molecule decreases expression ISO folpet results in decreased expression of CD74 mRNA CTD PMID:31558096 NCBI chr 5:150,401,639...150,412,910
Ensembl chr 5:150,401,637...150,412,969 		JBrowse link
G CDA cytidine deaminase increases expression ISO folpet results in increased expression of CDA mRNA CTD PMID:31558096 NCBI chr 1:20,589,097...20,618,903
Ensembl chr 1:20,589,086...20,618,903 		JBrowse link
G CDK19 cyclin dependent kinase 19 decreases expression ISO folpet results in decreased expression of CDK19 mRNA CTD PMID:31558096 NCBI chr 6:110,609,978...110,815,855
Ensembl chr 6:110,609,978...110,815,958 		JBrowse link
G CDK4 cyclin dependent kinase 4 decreases expression ISO folpet results in decreased expression of CDK4 mRNA CTD PMID:31558096 NCBI chr12:57,747,727...57,752,310
Ensembl chr12:57,747,727...57,756,013 		JBrowse link
G CDK7 cyclin dependent kinase 7 increases expression ISO folpet results in increased expression of CDK7 mRNA CTD PMID:31558096 NCBI chr 5:69,234,795...69,277,430
Ensembl chr 5:69,234,795...69,277,430 		JBrowse link
G CDKN1A cyclin dependent kinase inhibitor 1A increases expression ISO folpet results in increased expression of CDKN1A mRNA CTD PMID:31558096 NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,397 		JBrowse link
G CDKN1B cyclin dependent kinase inhibitor 1B decreases expression ISO folpet results in decreased expression of CDKN1B mRNA CTD PMID:31558096 NCBI chr12:12,717,368...12,722,369
Ensembl chr12:12,685,498...12,722,369 		JBrowse link
G CEACAM1 CEA cell adhesion molecule 1 decreases expression ISO folpet results in decreased expression of CEACAM1 mRNA CTD PMID:31558096 NCBI chr19:42,507,306...42,528,481
Ensembl chr19:42,507,304...42,561,234 		JBrowse link
G CEBPB CCAAT enhancer binding protein beta increases expression ISO folpet results in increased expression of CEBPB mRNA CTD PMID:31558096 NCBI chr20:50,190,583...50,192,690
Ensembl chr20:50,190,734...50,192,690 		JBrowse link
G CENPF centromere protein F decreases expression ISO folpet results in decreased expression of CENPF mRNA CTD PMID:31558096 NCBI chr 1:214,603,195...214,664,571
Ensembl chr 1:214,603,185...214,664,574 		JBrowse link
G CENPI centromere protein I decreases expression ISO folpet results in decreased expression of CENPI mRNA CTD PMID:31558096 NCBI chr  X:101,098,204...101,181,859
Ensembl chr  X:101,098,188...101,166,126 		JBrowse link
G CETN2 centrin 2 decreases expression ISO folpet results in decreased expression of CETN2 mRNA CTD PMID:31558096 NCBI chr  X:152,826,994...152,830,757
Ensembl chr  X:152,826,994...152,830,757 		JBrowse link
G CETN3 centrin 3 increases expression ISO folpet results in increased expression of CETN3 mRNA CTD PMID:31558096 NCBI chr 5:90,392,257...90,409,756
Ensembl chr 5:90,392,257...90,409,766 		JBrowse link
G CHMP6 charged multivesicular body protein 6 increases expression ISO folpet results in increased expression of CHMP6 mRNA CTD PMID:31558096 NCBI chr17:80,991,841...81,000,133
Ensembl chr17:80,991,598...81,009,517 		JBrowse link
G CIB1 calcium and integrin binding 1 increases expression ISO folpet results in increased expression of CIB1 mRNA CTD PMID:31558096 NCBI chr15:90,229,975...90,265,759
Ensembl chr15:90,229,975...90,234,047 		JBrowse link
G CIDEC cell death inducing DFFA like effector c increases expression ISO folpet results in increased expression of CIDEC mRNA CTD PMID:31558096 NCBI chr 3:9,866,710...9,880,253
Ensembl chr 3:9,866,711...9,880,255 		JBrowse link
G CIRBP cold inducible RNA binding protein decreases expression ISO folpet results in decreased expression of CIRBP mRNA CTD PMID:31558096 NCBI chr19:1,269,332...1,274,880
Ensembl chr19:1,259,384...1,274,880 		JBrowse link
G CKM creatine kinase, M-type decreases expression ISO folpet results in decreased expression of CKM mRNA CTD PMID:31558096 NCBI chr19:45,306,413...45,322,875
Ensembl chr19:45,306,413...45,322,875 		JBrowse link
G CLDN7 claudin 7 decreases expression ISO folpet results in decreased expression of CLDN7 mRNA CTD PMID:31558096 NCBI chr17:7,259,903...7,263,213
Ensembl chr17:7,259,903...7,263,983 		JBrowse link
G CLIP3 CAP-Gly domain containing linker protein 3 decreases expression ISO folpet results in decreased expression of CLIP3 mRNA CTD PMID:31558096 NCBI chr19:36,014,660...36,032,873
Ensembl chr19:36,014,660...36,033,343 		JBrowse link
G CLSTN1 calsyntenin 1 decreases expression ISO folpet results in decreased expression of CLSTN1 mRNA CTD PMID:31558096 NCBI chr 1:9,728,926...9,824,526
Ensembl chr 1:9,728,926...9,823,984 		JBrowse link
G CLTB clathrin light chain B increases expression ISO folpet results in increased expression of CLTB mRNA CTD PMID:31558096 NCBI chr 5:176,392,455...176,416,569
Ensembl chr 5:176,392,501...176,416,539 		JBrowse link
G CNDP2 carnosine dipeptidase 2 increases expression ISO folpet results in increased expression of CNDP2 mRNA CTD PMID:31558096 NCBI chr18:74,496,363...74,523,454
Ensembl chr18:74,495,816...74,523,454 		JBrowse link
G CNKSR3 CNKSR family member 3 decreases expression ISO folpet results in decreased expression of CNKSR3 mRNA CTD PMID:31558096 NCBI chr 6:154,387,515...154,510,685
Ensembl chr 6:154,387,515...154,510,685 		JBrowse link
G CNN1 calponin 1 decreases expression ISO folpet results in decreased expression of CNN1 mRNA CTD PMID:31558096 NCBI chr19:11,538,851...11,550,323
Ensembl chr19:11,538,767...11,550,323 		JBrowse link
G CNN3 calponin 3 decreases expression ISO folpet results in decreased expression of CNN3 mRNA CTD PMID:31558096 NCBI chr 1:94,896,957...94,927,110
Ensembl chr 1:94,896,949...94,927,223 		JBrowse link
G COG4 component of oligomeric golgi complex 4 increases expression ISO folpet results in increased expression of COG4 mRNA CTD PMID:31558096 NCBI chr16:70,480,567...70,523,554
Ensembl chr16:70,480,568...70,523,560 		JBrowse link
G COL1A1 collagen type I alpha 1 chain decreases expression ISO folpet results in decreased expression of COL1A1 mRNA CTD PMID:31558096 NCBI chr17:50,184,101...50,201,631
Ensembl chr17:50,184,101...50,201,632 		JBrowse link
G COL4A1 collagen type IV alpha 1 chain decreases expression ISO folpet results in decreased expression of COL4A1 mRNA CTD PMID:31558096 NCBI chr13:110,148,963...110,307,157
Ensembl chr13:110,148,963...110,307,202 		JBrowse link
G COL4A2 collagen type IV alpha 2 chain decreases expression ISO folpet results in decreased expression of COL4A2 mRNA CTD PMID:31558096 NCBI chr13:110,307,284...110,513,209
Ensembl chr13:110,305,812...110,513,209 		JBrowse link
G COL6A2 collagen type VI alpha 2 chain decreases expression ISO folpet results in decreased expression of COL6A2 mRNA CTD PMID:31558096 NCBI chr21:46,098,112...46,132,848
Ensembl chr21:46,098,112...46,132,848 		JBrowse link
G COL6A3 collagen type VI alpha 3 chain decreases expression ISO folpet results in decreased expression of COL6A3 mRNA CTD PMID:31558096 NCBI chr 2:237,324,018...237,414,164
Ensembl chr 2:237,324,003...237,414,328 		JBrowse link
G COMT catechol-O-methyltransferase increases expression ISO folpet results in increased expression of COMT mRNA CTD PMID:31558096 NCBI chr22:19,941,772...19,969,975
Ensembl chr22:19,941,371...19,969,975 		JBrowse link
G COPB2 COPI coat complex subunit beta 2 increases expression ISO folpet results in increased expression of COPB2 mRNA CTD PMID:31558096 NCBI chr 3:139,357,406...139,389,680
Ensembl chr 3:139,353,946...139,389,736 		JBrowse link
G COPS5 COP9 signalosome subunit 5 increases expression ISO folpet results in increased expression of COPS5 mRNA CTD PMID:31558096 NCBI chr 8:67,043,079...67,062,133
Ensembl chr 8:67,043,079...67,083,783 		JBrowse link
G COQ8A coenzyme Q8A decreases expression ISO folpet results in decreased expression of ADCK3 mRNA CTD PMID:31558096 NCBI chr 1:226,940,294...226,987,544
Ensembl chr 1:226,940,286...226,987,544 		JBrowse link
G COX6B1 cytochrome c oxidase subunit 6B1 increases expression ISO folpet results in increased expression of COX6B1 mRNA CTD PMID:31558096 NCBI chr19:35,648,323...35,658,782
Ensembl chr19:35,648,323...35,658,782 		JBrowse link
G CPS1 carbamoyl-phosphate synthase 1 increases expression ISO folpet results in increased expression of CPS1 mRNA CTD PMID:31558096 NCBI chr 2:210,477,685...210,679,107
Ensembl chr 2:210,477,682...210,679,107 		JBrowse link
G CREB1 cAMP responsive element binding protein 1 decreases expression ISO folpet results in decreased expression of CREB1 mRNA CTD PMID:31558096 NCBI chr 2:207,529,962...207,605,988
Ensembl chr 2:207,529,737...207,605,988 		JBrowse link
G CREB3L3 cAMP responsive element binding protein 3 like 3 increases expression ISO folpet results in increased expression of CREB3L3 mRNA CTD PMID:31558096 NCBI chr19:4,153,631...4,173,054
Ensembl chr19:4,153,631...4,173,054 		JBrowse link
G CREBBP CREB binding protein increases expression ISO folpet results in increased expression of CREBBP mRNA CTD PMID:31558096 NCBI chr16:3,725,054...3,880,713
Ensembl chr16:3,725,054...3,880,713 		JBrowse link
G CREG1 cellular repressor of E1A stimulated genes 1 increases expression ISO folpet results in increased expression of CREG1 mRNA CTD PMID:31558096 NCBI chr 1:167,541,013...167,553,762
Ensembl chr 1:167,529,117...167,553,805 		JBrowse link
G CRELD2 cysteine rich with EGF like domains 2 decreases expression ISO folpet results in decreased expression of CRELD2 mRNA CTD PMID:31558096 NCBI chr22:49,918,634...49,927,537
Ensembl chr22:49,918,167...49,927,540 		JBrowse link
G CRKL CRK like proto-oncogene, adaptor protein increases expression ISO folpet results in increased expression of CRKL mRNA CTD PMID:31558096 NCBI chr22:20,917,407...20,953,747
Ensembl chr22:20,917,407...20,953,747 		JBrowse link
G CRY1 cryptochrome circadian regulator 1 increases expression ISO folpet results in increased expression of CRY1 mRNA CTD PMID:31558096 NCBI chr12:106,991,364...107,093,549
Ensembl chr12:106,991,364...107,093,549 		JBrowse link
G CRYAB crystallin alpha B decreases expression ISO folpet results in decreased expression of CRYAB mRNA CTD PMID:31558096 NCBI chr11:111,908,564...111,923,740
Ensembl chr11:111,908,564...111,923,722 		JBrowse link
G CS citrate synthase increases expression ISO folpet results in increased expression of CS mRNA CTD PMID:31558096 NCBI chr12:56,271,699...56,300,330
Ensembl chr12:56,271,699...56,300,391 		JBrowse link
G CSF1R colony stimulating factor 1 receptor decreases expression ISO folpet results in decreased expression of CSF1R mRNA CTD PMID:31558096 NCBI chr 5:150,053,295...150,113,365
Ensembl chr 5:150,053,291...150,113,372 		JBrowse link
G CSRP1 cysteine and glycine rich protein 1 decreases expression ISO folpet results in decreased expression of CSRP1 mRNA CTD PMID:31558096 NCBI chr 1:201,483,530...201,507,123
Ensembl chr 1:201,483,530...201,509,456 		JBrowse link
G CTH cystathionine gamma-lyase increases expression ISO folpet results in increased expression of CTH mRNA CTD PMID:31558096 NCBI chr 1:70,411,268...70,439,851
Ensembl chr 1:70,411,218...70,439,851 		JBrowse link
G CTNND1 catenin delta 1 increases expression ISO folpet results in increased expression of CTNND1 mRNA CTD PMID:31558096 NCBI chr11:57,761,802...57,819,540
Ensembl chr11:57,753,243...57,819,546 		JBrowse link
G CTSS cathepsin S decreases expression ISO folpet results in decreased expression of CTSS mRNA CTD PMID:31558096 NCBI chr 1:150,730,188...150,765,778
Ensembl chr 1:150,730,079...150,765,957 		JBrowse link
G CXCL10 C-X-C motif chemokine ligand 10 decreases expression ISO folpet results in decreased expression of CXCL10 mRNA CTD PMID:31558096 NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497 		JBrowse link
G CYB561 cytochrome b561 increases expression ISO folpet results in increased expression of CYB561 mRNA CTD PMID:31558096 NCBI chr17:63,432,304...63,446,639
Ensembl chr17:63,432,304...63,446,354 		JBrowse link
G CYCS cytochrome c, somatic decreases expression ISO folpet results in decreased expression of CYCS mRNA CTD PMID:31558096 NCBI chr 7:25,118,656...25,125,260
Ensembl chr 7:25,118,656...25,125,260 		JBrowse link
G CYP1A1 cytochrome P450 family 1 subfamily A member 1 increases expression ISO folpet results in increased expression of CYP1A1 mRNA CTD PMID:31558096 NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536 		JBrowse link
G CYP2A6 cytochrome P450 family 2 subfamily A member 6 increases expression ISO folpet results in increased expression of CYP2A5 mRNA CTD PMID:31558096 NCBI chr19:40,843,541...40,850,447
Ensembl chr19:40,843,541...40,850,447 		JBrowse link
G CYP2C9 cytochrome P450 family 2 subfamily C member 9 increases expression ISO folpet results in increased expression of CYP2C65 mRNA CTD PMID:31558096 NCBI chr10:94,938,658...94,990,091
Ensembl chr10:94,938,658...94,990,091 		JBrowse link
G CYP3A7-CYP3A51P CYP3A7-CYP3A51P readthrough decreases expression ISO folpet results in decreased expression of CYP3A41A mRNA CTD PMID:31558096 NCBI chr 7:99,684,677...99,735,196
Ensembl chr 7:99,684,957...99,735,102 		JBrowse link
G DBP D-box binding PAR bZIP transcription factor increases expression ISO folpet results in increased expression of DBP mRNA CTD PMID:31558096 NCBI chr19:48,630,030...48,637,379
Ensembl chr19:48,630,030...48,637,379 		JBrowse link
G DCTPP1 dCTP pyrophosphatase 1 decreases expression ISO folpet results in decreased expression of DCTPP1 mRNA CTD PMID:31558096 NCBI chr16:30,423,615...30,430,030
Ensembl chr16:30,423,615...30,430,030 		JBrowse link
G DDIT3 DNA damage inducible transcript 3 increases expression ISO folpet results in increased expression of DDIT3 mRNA CTD PMID:31558096 NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737 		JBrowse link
G DDIT4 DNA damage inducible transcript 4 increases expression ISO folpet results in increased expression of DDIT4 mRNA CTD PMID:31558096 NCBI chr10:72,273,924...72,276,036
Ensembl chr10:72,273,919...72,276,036 		JBrowse link
G DERA deoxyribose-phosphate aldolase increases expression ISO folpet results in increased expression of DERA mRNA CTD PMID:31558096 NCBI chr12:15,911,332...16,037,381
Ensembl chr12:15,911,302...16,037,381 		JBrowse link
G DHFR dihydrofolate reductase increases expression ISO folpet results in increased expression of DHFR mRNA CTD PMID:31558096 NCBI chr 5:80,626,226...80,654,983
Ensembl chr 5:80,626,226...80,654,983 		JBrowse link
G DHX29 DExH-box helicase 29 decreases expression ISO folpet results in decreased expression of DHX29 mRNA CTD PMID:31558096 NCBI chr 5:55,256,055...55,307,694
Ensembl chr 5:55,256,055...55,307,694 		JBrowse link
G DIO1 iodothyronine deiodinase 1 decreases expression ISO folpet results in decreased expression of DIO1 mRNA CTD PMID:31558096 NCBI chr 1:53,894,187...53,911,086
Ensembl chr 1:53,891,239...53,911,086 		JBrowse link
G DKC1 dyskerin pseudouridine synthase 1 decreases expression ISO folpet results in decreased expression of DKC1 mRNA CTD PMID:31558096 NCBI chr  X:154,762,864...154,777,689
Ensembl chr  X:154,762,742...154,777,689 		JBrowse link
G DLG3 discs large MAGUK scaffold protein 3 decreases expression ISO folpet results in decreased expression of DLG3 mRNA CTD PMID:31558096 NCBI chr  X:70,444,835...70,505,490
Ensembl chr  X:70,444,835...70,505,490 		JBrowse link
G DNAJB6 DnaJ heat shock protein family (Hsp40) member B6 increases expression ISO folpet results in increased expression of DNAJB6 mRNA CTD PMID:31558096 NCBI chr 7:157,337,004...157,417,439
Ensembl chr 7:157,335,381...157,417,439 		JBrowse link
G DNTTIP2 deoxynucleotidyltransferase terminal interacting protein 2 decreases expression ISO folpet results in decreased expression of DNTTIP2 mRNA CTD PMID:31558096 NCBI chr 1:93,866,284...93,879,206
Ensembl chr 1:93,866,284...93,879,918 		JBrowse link
G DPPA5 developmental pluripotency associated 5 increases expression ISO folpet results in increased expression of DPPA5A mRNA CTD PMID:31558096 NCBI chr 6:73,353,063...73,354,276
Ensembl chr 6:73,353,063...73,354,276 		JBrowse link
G DPT dermatopontin decreases expression ISO folpet results in decreased expression of DPT mRNA CTD PMID:31558096 NCBI chr 1:168,695,468...168,729,206
Ensembl chr 1:168,695,468...168,729,206 		JBrowse link
G DSC2 desmocollin 2 increases expression ISO folpet results in increased expression of DSC2 mRNA CTD PMID:31558096 NCBI chr18:31,058,840...31,102,421
Ensembl chr18:31,058,545...31,102,600 		JBrowse link
G DTL denticleless E3 ubiquitin protein ligase homolog decreases expression ISO folpet results in decreased expression of DTL mRNA CTD PMID:31558096 NCBI chr 1:212,035,748...212,105,013
Ensembl chr 1:212,035,553...212,107,400 		JBrowse link
G DUSP3 dual specificity phosphatase 3 decreases expression ISO folpet results in decreased expression of DUSP3 mRNA CTD PMID:31558096 NCBI chr17:43,766,125...43,778,977
Ensembl chr17:43,766,125...43,778,977 		JBrowse link
G DUSP6 dual specificity phosphatase 6 increases expression ISO folpet results in increased expression of DUSP6 mRNA CTD PMID:31558096 NCBI chr12:89,347,235...89,352,501
Ensembl chr12:89,347,235...89,352,501 		JBrowse link
G DYNLT3 dynein light chain Tctex-type 3 increases expression ISO folpet results in increased expression of DYNLT3 mRNA CTD PMID:31558096 NCBI chr  X:37,838,836...37,847,571
Ensembl chr  X:37,836,757...37,847,571 		JBrowse link
G DYRK3 dual specificity tyrosine phosphorylation regulated kinase 3 decreases expression ISO folpet results in decreased expression of DYRK3 mRNA CTD PMID:31558096 NCBI chr 1:206,635,536...206,655,158
Ensembl chr 1:206,635,536...206,684,419 		JBrowse link
G E2F2 E2F transcription factor 2 decreases expression ISO folpet results in decreased expression of E2F2 mRNA CTD PMID:31558096 NCBI chr 1:23,505,212...23,531,233
Ensembl chr 1:23,506,438...23,531,233 		JBrowse link
G ECI1 enoyl-CoA delta isomerase 1 increases expression ISO folpet results in increased expression of ECI1 mRNA CTD PMID:31558096 NCBI chr16:2,239,402...2,251,587
Ensembl chr16:2,239,402...2,252,300 		JBrowse link
G ECM1 extracellular matrix protein 1 decreases expression ISO folpet results in decreased expression of ECM1 mRNA CTD PMID:31558096 NCBI chr 1:150,508,109...150,513,789
Ensembl chr 1:150,508,062...150,513,789 		JBrowse link
G EDEM1 ER degradation enhancing alpha-mannosidase like protein 1 decreases expression ISO folpet results in decreased expression of EDEM1 mRNA CTD PMID:31558096 NCBI chr 3:5,187,707...5,219,958
Ensembl chr 3:5,187,646...5,219,958 		JBrowse link
G EGR1 early growth response 1 decreases expression ISO folpet results in decreased expression of EGR1 mRNA CTD PMID:31558096 NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303 		JBrowse link
G EIF2AK2 eukaryotic translation initiation factor 2 alpha kinase 2 increases expression ISO folpet results in increased expression of EIF2AK2 mRNA CTD PMID:31558096 NCBI chr 2:37,099,210...37,156,980
Ensembl chr 2:37,099,210...37,157,522 		JBrowse link
G EIF2S3 eukaryotic translation initiation factor 2 subunit gamma decreases expression ISO folpet results in decreased expression of EIF2S3X mRNA CTD PMID:31558096 NCBI chr  X:24,054,956...24,078,810
Ensembl chr  X:24,054,946...24,078,810 		JBrowse link
G EIF3G eukaryotic translation initiation factor 3 subunit G decreases expression ISO folpet results in decreased expression of EIF3G mRNA CTD PMID:31558096 NCBI chr19:10,115,014...10,119,899
Ensembl chr19:10,115,014...10,119,918 		JBrowse link
G EIF3I eukaryotic translation initiation factor 3 subunit I decreases expression ISO folpet results in decreased expression of EIF3I mRNA CTD PMID:31558096 NCBI chr 1:32,222,407...32,236,170
Ensembl chr 1:32,221,077...32,245,397 		JBrowse link
G EIF4B eukaryotic translation initiation factor 4B increases expression ISO folpet results in increased expression of EIF4B mRNA CTD PMID:31558096 NCBI chr12:53,006,456...53,042,215
Ensembl chr12:53,006,282...53,042,215 		JBrowse link
G EIF4EBP1 eukaryotic translation initiation factor 4E binding protein 1 increases expression ISO folpet results in increased expression of EIF4EBP1 mRNA CTD PMID:31558096 NCBI chr 8:38,030,534...38,060,365
Ensembl chr 8:38,030,534...38,060,365 		JBrowse link
G EIF4G1 eukaryotic translation initiation factor 4 gamma 1 decreases expression ISO folpet results in decreased expression of EIF4G1 mRNA CTD PMID:31558096 NCBI chr 3:184,314,606...184,335,358
Ensembl chr 3:184,314,495...184,335,358 		JBrowse link
G ELAVL1 ELAV like RNA binding protein 1 decreases expression ISO folpet results in decreased expression of ELAVL1 mRNA CTD PMID:31558096 NCBI chr19:7,958,573...8,005,641
Ensembl chr19:7,958,573...8,005,659 		JBrowse link
G ELOVL5 ELOVL fatty acid elongase 5 decreases expression ISO folpet results in decreased expression of ELOVL5 mRNA CTD PMID:31558096 NCBI chr 6:53,267,404...53,348,950
Ensembl chr 6:53,267,398...53,349,179 		JBrowse link
G ELOVL6 ELOVL fatty acid elongase 6 increases expression ISO folpet results in increased expression of ELOVL6 mRNA CTD PMID:31558096 NCBI chr 4:110,045,846...110,199,202
Ensembl chr 4:110,045,846...110,199,199 		JBrowse link
G EML3 EMAP like 3 decreases expression ISO folpet results in decreased expression of EML3 mRNA CTD PMID:31558096 NCBI chr11:62,602,218...62,612,775
Ensembl chr11:62,602,218...62,612,775 		JBrowse link
G ENPP1 ectonucleotide pyrophosphatase/phosphodiesterase 1 decreases expression ISO folpet results in decreased expression of ENPP1 mRNA CTD PMID:31558096 NCBI chr 6:131,808,020...131,895,155
Ensembl chr 6:131,808,016...131,895,155 		JBrowse link
G EPHX1 epoxide hydrolase 1 increases expression ISO folpet results in increased expression of EPHX1 mRNA CTD PMID:31558096 NCBI chr 1:225,810,124...225,845,563
Ensembl chr 1:225,810,124...225,845,563 		JBrowse link
G EPHX2 epoxide hydrolase 2 increases expression ISO folpet results in increased expression of EPHX2 mRNA CTD PMID:31558096 NCBI chr 8:27,491,143...27,548,626
Ensembl chr 8:27,490,781...27,545,564 		JBrowse link
G ERBB2 erb-b2 receptor tyrosine kinase 2 decreases expression ISO folpet results in decreased expression of ERBB2 mRNA CTD PMID:31558096 NCBI chr17:39,688,094...39,728,658
Ensembl chr17:39,687,914...39,730,426 		JBrowse link
G ERBB3 erb-b2 receptor tyrosine kinase 3 affects expression ISO folpet affects the expression of ERBB3 mRNA CTD PMID:31558096 NCBI chr12:56,080,108...56,103,505
Ensembl chr12:56,076,799...56,103,505 		JBrowse link
G ERO1B endoplasmic reticulum oxidoreductase 1 beta decreases expression ISO folpet results in decreased expression of ERO1B mRNA CTD PMID:31558096 NCBI chr 1:236,215,101...236,281,958
Ensembl chr 1:236,214,681...236,282,019 		JBrowse link
G ETFB electron transfer flavoprotein subunit beta increases expression ISO folpet results in increased expression of ETFB mRNA CTD PMID:31558096 NCBI chr19:51,345,155...51,366,388
Ensembl chr19:51,345,169...51,366,388 		JBrowse link
G EVL Enah/Vasp-like decreases expression ISO folpet results in decreased expression of EVL mRNA CTD PMID:31558096 NCBI chr14:99,971,422...100,144,236
Ensembl chr14:99,971,449...100,144,236 		JBrowse link
G EXT1 exostosin glycosyltransferase 1 decreases expression ISO folpet results in decreased expression of EXT1 mRNA CTD PMID:31558096 NCBI chr 8:117,794,490...118,111,826
Ensembl chr 8:117,794,490...118,111,826 		JBrowse link
G F2R coagulation factor II thrombin receptor decreases expression ISO folpet results in decreased expression of F2R mRNA CTD PMID:31558096 NCBI chr 5:76,716,126...76,735,770
Ensembl chr 5:76,716,126...76,735,770 		JBrowse link
G FABP1 fatty acid binding protein 1 increases expression ISO folpet results in increased expression of FABP1 mRNA CTD PMID:31558096 NCBI chr 2:88,122,982...88,128,062
Ensembl chr 2:88,122,982...88,128,062 		JBrowse link
G FABP2 fatty acid binding protein 2 increases expression ISO folpet results in increased expression of FABP2 mRNA CTD PMID:31558096 NCBI chr 4:119,317,250...119,322,138
Ensembl chr 4:119,317,250...119,322,138 		JBrowse link
G FASN fatty acid synthase decreases expression ISO folpet results in decreased expression of FASN mRNA CTD PMID:31558096 NCBI chr17:82,078,338...82,098,236
Ensembl chr17:82,078,338...82,098,294 		JBrowse link
G FAT1 FAT atypical cadherin 1 increases expression ISO folpet results in increased expression of FAT1 mRNA CTD PMID:31558096 NCBI chr 4:186,587,794...186,726,696
Ensembl chr 4:186,587,794...186,726,722 		JBrowse link
G FBL fibrillarin decreases expression ISO folpet results in decreased expression of FBL mRNA CTD PMID:31558096 NCBI chr19:39,834,458...39,846,379
Ensembl chr19:39,834,458...39,846,379 		JBrowse link
G FBN1 fibrillin 1 decreases expression ISO folpet results in decreased expression of FBN1 mRNA CTD PMID:31558096 NCBI chr15:48,408,313...48,645,709
Ensembl chr15:48,408,313...48,645,721 		JBrowse link
G FBXO5 F-box protein 5 decreases expression ISO folpet results in decreased expression of FBXO5 mRNA CTD PMID:31558096 NCBI chr 6:152,970,535...152,983,579
Ensembl chr 6:152,970,519...152,983,579 		JBrowse link
G FCER2 Fc epsilon receptor II increases expression ISO folpet results in increased expression of FCER2A mRNA CTD PMID:31558096 NCBI chr19:7,688,776...7,702,131
Ensembl chr19:7,688,758...7,702,146 		JBrowse link
G FDFT1 farnesyl-diphosphate farnesyltransferase 1 increases expression ISO folpet results in increased expression of FDFT1 mRNA CTD PMID:31558096 NCBI chr 8:11,795,582...11,839,298
Ensembl chr 8:11,795,573...11,839,395 		JBrowse link
G FGF1 fibroblast growth factor 1 decreases expression ISO folpet results in decreased expression of FGF1 mRNA CTD PMID:31558096 NCBI chr 5:142,592,178...142,698,070
Ensembl chr 5:142,592,178...142,698,070 		JBrowse link
G FIS1 fission, mitochondrial 1 increases expression ISO folpet results in increased expression of FIS1 mRNA CTD PMID:31558096 NCBI chr 7:101,239,472...101,245,081
Ensembl chr 7:101,239,458...101,252,316 		JBrowse link
G FKBP4 FKBP prolyl isomerase 4 decreases expression ISO folpet results in decreased expression of FKBP4 mRNA CTD PMID:31558096 NCBI chr12:2,794,970...2,805,423
Ensembl chr12:2,794,970...2,805,423 		JBrowse link
G FKBP5 FKBP prolyl isomerase 5 increases expression ISO folpet results in increased expression of FKBP5 mRNA CTD PMID:31558096 NCBI chr 6:35,573,590...35,728,583
Ensembl chr 6:35,573,585...35,728,583 		JBrowse link
G FLNA filamin A decreases expression ISO folpet results in decreased expression of FLNA mRNA CTD PMID:31558096 NCBI chr  X:154,348,531...154,374,634
Ensembl chr  X:154,348,524...154,374,634 		JBrowse link
G FMO5 flavin containing dimethylaniline monoxygenase 5 increases expression ISO folpet results in increased expression of FMO5 mRNA CTD PMID:31558096 NCBI chr 1:147,184,305...147,227,284
Ensembl chr 1:147,175,351...147,243,050 		JBrowse link
G FN1 fibronectin 1 decreases expression ISO folpet results in decreased expression of FN1 mRNA CTD PMID:31558096 NCBI chr 2:215,360,865...215,436,068
Ensembl chr 2:215,360,440...215,436,073 		JBrowse link
G FOS Fos proto-oncogene, AP-1 transcription factor subunit increases expression ISO folpet results in increased expression of FOS mRNA CTD PMID:31558096 NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,283,190 		JBrowse link
G FOXJ3 forkhead box J3 increases expression ISO folpet results in increased expression of FOXJ3 mRNA CTD PMID:31558096 NCBI chr 1:42,176,548...42,335,880
Ensembl chr 1:42,176,539...42,335,877 		JBrowse link
G FPGS folylpolyglutamate synthase decreases expression ISO folpet results in decreased expression of FPGS mRNA CTD PMID:31558096 NCBI chr 9:127,802,858...127,814,506
Ensembl chr 9:127,794,597...127,814,494 		JBrowse link
G FRS2 fibroblast growth factor receptor substrate 2 increases expression ISO folpet results in increased expression of FRS2 mRNA CTD PMID:31558096 NCBI chr12:69,470,388...69,579,793
Ensembl chr12:69,470,349...69,579,793 		JBrowse link
G FYN FYN proto-oncogene, Src family tyrosine kinase decreases expression ISO folpet results in decreased expression of FYN mRNA CTD PMID:31558096 NCBI chr 6:111,660,332...111,873,452
Ensembl chr 6:111,660,332...111,873,452 		JBrowse link
G FZD7 frizzled class receptor 7 decreases expression ISO folpet results in decreased expression of FZD7 mRNA CTD PMID:31558096 NCBI chr 2:202,033,855...202,038,441
Ensembl chr 2:202,033,855...202,038,441 		JBrowse link
G G6PC1 glucose-6-phosphatase catalytic subunit 1 decreases expression ISO folpet results in decreased expression of G6PC1 mRNA CTD PMID:31558096 NCBI chr17:42,900,799...42,914,438
Ensembl chr17:42,900,797...42,914,438 		JBrowse link
G GAA alpha glucosidase decreases expression ISO folpet results in decreased expression of GAA mRNA CTD PMID:31558096 NCBI chr17:80,101,581...80,119,881
Ensembl chr17:80,101,533...80,119,881 		JBrowse link
G GABARAP GABA type A receptor-associated protein increases expression ISO folpet results in increased expression of GABARAP mRNA CTD PMID:31558096 NCBI chr17:7,240,008...7,242,449
Ensembl chr17:7,240,008...7,242,449 		JBrowse link
G GABRA4 gamma-aminobutyric acid type A receptor subunit alpha4 decreases expression ISO folpet results in decreased expression of GABRA4 mRNA CTD PMID:31558096 NCBI chr 4:46,918,900...46,993,581
Ensembl chr 4:46,918,900...46,993,581 		JBrowse link
G GADD45G growth arrest and DNA damage inducible gamma decreases expression ISO folpet results in decreased expression of GADD45G mRNA CTD PMID:31558096 NCBI chr 9:89,605,012...89,606,555
Ensembl chr 9:89,605,012...89,606,555 		JBrowse link
G GALE UDP-galactose-4-epimerase increases expression ISO folpet results in increased expression of GALE mRNA CTD PMID:31558096 NCBI chr 1:23,795,599...23,800,754
Ensembl chr 1:23,795,599...23,800,781 		JBrowse link
G GAPDH glyceraldehyde-3-phosphate dehydrogenase increases expression ISO folpet results in increased expression of GAPDH mRNA CTD PMID:31558096 NCBI chr12:6,534,517...6,538,371
Ensembl chr12:6,534,512...6,538,374 		JBrowse link
G GARS1 glycyl-tRNA synthetase 1 decreases expression ISO folpet results in decreased expression of GARS1 mRNA CTD PMID:31558096 NCBI chr 7:30,594,735...30,634,033
Ensembl chr 7:30,580,533...30,634,033 		JBrowse link
G GCLC glutamate-cysteine ligase catalytic subunit increases expression ISO folpet results in increased expression of GCLC mRNA CTD PMID:31558096 NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970 		JBrowse link
G GCLM glutamate-cysteine ligase modifier subunit increases expression ISO folpet results in increased expression of GCLM mRNA CTD PMID:31558096 NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456 		JBrowse link
G GDNF glial cell derived neurotrophic factor increases expression ISO folpet results in increased expression of GDNF mRNA CTD PMID:31558096 NCBI chr 5:37,812,677...37,840,041
Ensembl chr 5:37,812,677...37,840,041 		JBrowse link
G GFOD1 Gfo/Idh/MocA-like oxidoreductase domain containing 1 increases expression ISO folpet results in increased expression of GFOD1 mRNA CTD PMID:31558096 NCBI chr 6:13,357,830...13,487,600
Ensembl chr 6:13,357,830...13,487,662 		JBrowse link
G GIMAP4 GTPase, IMAP family member 4 decreases expression ISO folpet results in decreased expression of GIMAP4 mRNA CTD PMID:31558096 NCBI chr 7:150,567,390...150,573,953
Ensembl chr 7:150,567,369...150,573,953 		JBrowse link
G GIMAP6 GTPase, IMAP family member 6 decreases expression ISO folpet results in decreased expression of GIMAP6 mRNA CTD PMID:31558096 NCBI chr 7:150,625,375...150,632,385
Ensembl chr 7:150,625,375...150,632,648 		JBrowse link
G GLOD4 glyoxalase domain containing 4 increases expression ISO folpet results in increased expression of GLOD4 mRNA CTD PMID:31558096 NCBI chr17:759,330...785,895
Ensembl chr17:757,097...782,294 		JBrowse link
G GLRX glutaredoxin increases expression ISO folpet results in increased expression of GLRX mRNA CTD PMID:31558096 NCBI chr 5:95,813,849...95,822,726
Ensembl chr 5:95,751,319...95,822,726 		JBrowse link
G GLUL glutamate-ammonia ligase decreases expression ISO folpet results in decreased expression of GLUL mRNA CTD PMID:31558096 NCBI chr 1:182,378,098...182,391,790
Ensembl chr 1:182,378,098...182,392,206 		JBrowse link
G GNAI2 G protein subunit alpha i2 decreases expression ISO folpet results in decreased expression of GNAI2 mRNA CTD PMID:31558096 NCBI chr 3:50,227,068...50,263,358
Ensembl chr 3:50,226,292...50,259,362 		JBrowse link
G GOLT1B golgi transport 1B decreases expression ISO folpet results in decreased expression of GOLT1B mRNA CTD PMID:31558096 NCBI chr12:21,501,789...21,518,408
Ensembl chr12:21,501,781...21,518,408 		JBrowse link
G GPR17 G protein-coupled receptor 17 increases expression ISO folpet results in increased expression of GPR17 mRNA CTD PMID:31558096 NCBI chr 2:127,646,153...127,652,639
Ensembl chr 2:127,645,864...127,652,639 		JBrowse link
G GPX2 glutathione peroxidase 2 increases expression ISO folpet results in increased expression of GPX2 mRNA CTD PMID:31558096 NCBI chr14:64,939,158...64,942,745
Ensembl chr14:64,939,152...64,942,746 		JBrowse link
G GPX4 glutathione peroxidase 4 increases expression ISO folpet results in increased expression of GPX4 mRNA CTD PMID:31558096 NCBI chr19:1,103,994...1,106,779
Ensembl chr19:1,103,982...1,106,791 		JBrowse link
G GRB7 growth factor receptor bound protein 7 increases expression ISO folpet results in increased expression of GRB7 mRNA CTD PMID:31558096 NCBI chr17:39,737,938...39,747,285
Ensembl chr17:39,737,927...39,747,291 		JBrowse link
G GSR glutathione-disulfide reductase increases expression ISO folpet results in increased expression of GSR mRNA CTD PMID:31558096 NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846 		JBrowse link
G GSTA3 glutathione S-transferase alpha 3 increases expression ISO folpet results in increased expression of GSTA1 mRNA; folpet results in increased expression of GSTA2 mRNA; folpet results in increased expression of GSTA3 mRNA CTD PMID:31558096 NCBI chr 6:52,896,646...52,909,698
Ensembl chr 6:52,896,639...52,909,698 		JBrowse link
G GSTM2 glutathione S-transferase mu 2 increases expression ISO folpet results in increased expression of GSTM2 mRNA CTD PMID:31558096 NCBI chr 1:109,668,057...109,683,997
Ensembl chr 1:109,668,022...109,709,551 		JBrowse link
G GSTM3 glutathione S-transferase mu 3 increases expression ISO folpet results in increased expression of GSTM3 mRNA CTD PMID:31558096 NCBI chr 1:109,733,937...109,741,038
Ensembl chr 1:109,733,932...109,741,038 		JBrowse link
G GSTP1 glutathione S-transferase pi 1 increases expression ISO folpet results in increased expression of GSTP1 mRNA CTD PMID:31558096 NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656 		JBrowse link
G GSTT3P glutathione S-transferase theta 3, pseudogene increases expression ISO folpet results in increased expression of GSTT3 mRNA CTD PMID:31558096
G GXYLT1 glucoside xylosyltransferase 1 increases expression ISO folpet results in increased expression of GXYLT1 mRNA CTD PMID:31558096 NCBI chr12:42,081,845...42,144,874
Ensembl chr12:42,081,845...42,144,874 		JBrowse link
G GZMA granzyme A decreases expression ISO folpet results in decreased expression of GZMA mRNA CTD PMID:31558096 NCBI chr 5:55,102,646...55,110,252
Ensembl chr 5:55,102,646...55,110,252 		JBrowse link
G GZMB granzyme B decreases expression ISO folpet results in decreased expression of GZMB mRNA CTD PMID:31558096 NCBI chr14:24,630,954...24,634,190
Ensembl chr14:24,630,954...24,634,267 		JBrowse link
G H3C1 H3 clustered histone 1 decreases expression ISO folpet results in decreased expression of H3C1 mRNA CTD PMID:31558096 NCBI chr 6:26,020,451...26,020,958
Ensembl chr 6:26,020,451...26,020,958 		JBrowse link
G H3C3 H3 clustered histone 3 decreases expression ISO folpet results in decreased expression of H3C3 mRNA CTD PMID:31558096 NCBI chr 6:26,045,384...26,045,869
Ensembl chr 6:26,045,384...26,045,869 		JBrowse link
G HEATR1 HEAT repeat containing 1 decreases expression ISO folpet results in decreased expression of HEATR1 mRNA CTD PMID:31558096 NCBI chr 1:236,549,005...236,604,516
Ensembl chr 1:236,549,005...236,604,516 		JBrowse link
G HEBP1 heme binding protein 1 increases expression ISO folpet results in increased expression of HEBP1 mRNA CTD PMID:31558096 NCBI chr12:12,974,870...13,000,265
Ensembl chr12:12,974,870...13,000,265 		JBrowse link
G HERC6 HECT and RLD domain containing E3 ubiquitin protein ligase family member 6 decreases expression ISO folpet results in decreased expression of HERC6 mRNA CTD PMID:31558096 NCBI chr 4:88,378,852...88,443,097
Ensembl chr 4:88,378,739...88,443,097 		JBrowse link
G HES1 hes family bHLH transcription factor 1 decreases expression ISO folpet results in decreased expression of HES1 mRNA CTD PMID:31558096 NCBI chr 3:194,136,148...194,138,732
Ensembl chr 3:194,136,148...194,138,732 		JBrowse link
G HEXA hexosaminidase subunit alpha decreases expression ISO folpet results in decreased expression of HEXA mRNA CTD PMID:31558096 NCBI chr15:72,340,924...72,376,014
Ensembl chr15:72,340,924...72,376,420 		JBrowse link
G HJURP Holliday junction recognition protein increases expression ISO folpet results in increased expression of HJURP mRNA CTD PMID:31558096 NCBI chr 2:233,836,702...233,854,535
Ensembl chr 2:233,833,416...233,854,566 		JBrowse link
G HLA-DQA1 major histocompatibility complex, class II, DQ alpha 1 decreases expression ISO folpet results in decreased expression of H2-AA mRNA CTD PMID:31558096 NCBI chr 6:32,637,406...32,655,272
Ensembl chr 6:32,628,179...32,647,062 		JBrowse link
G HMG20B high mobility group 20B increases expression ISO folpet results in increased expression of HMG20B mRNA CTD PMID:31558096 NCBI chr19:3,572,944...3,579,083
Ensembl chr19:3,572,777...3,579,088 		JBrowse link
G HMGCS2 3-hydroxy-3-methylglutaryl-CoA synthase 2 decreases expression ISO folpet results in decreased expression of HMGCS2 mRNA CTD PMID:31558096 NCBI chr 1:119,747,996...119,768,932
Ensembl chr 1:119,748,002...119,768,905 		JBrowse link
G HNRNPH1 heterogeneous nuclear ribonucleoprotein H1 decreases expression ISO folpet results in decreased expression of HNRNPH1 mRNA CTD PMID:31558096 NCBI chr 5:179,614,178...179,634,784
Ensembl chr 5:179,614,178...179,634,784 		JBrowse link
G HOOK2 hook microtubule tethering protein 2 increases expression ISO folpet results in increased expression of HOOK2 mRNA CTD PMID:31558096 NCBI chr19:12,763,003...12,792,350
Ensembl chr19:12,763,003...12,872,740 		JBrowse link
G HOXB3 homeobox B3 decreases expression ISO folpet results in decreased expression of HOXB3 mRNA CTD PMID:31558096 NCBI chr17:48,548,870...48,590,241
Ensembl chr17:48,548,870...48,604,912 		JBrowse link
G HS2ST1 heparan sulfate 2-O-sulfotransferase 1 decreases expression ISO folpet results in decreased expression of HS2ST1 mRNA CTD PMID:31558096 NCBI chr 1:86,914,635...87,109,982
Ensembl chr 1:86,914,635...87,109,982 		JBrowse link
G HSD17B11 hydroxysteroid 17-beta dehydrogenase 11 increases expression ISO folpet results in increased expression of HSD17B11 mRNA CTD PMID:31558096 NCBI chr 4:87,336,515...87,391,188
Ensembl chr 4:87,336,515...87,391,188 		JBrowse link
G HSD3B1 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 increases expression ISO folpet results in increased expression of HSD3B2 mRNA CTD PMID:31558096 NCBI chr 1:119,507,203...119,515,058
Ensembl chr 1:119,507,198...119,515,054 		JBrowse link
G HSP90B1 heat shock protein 90 beta family member 1 decreases expression ISO folpet results in decreased expression of HSP90B1 mRNA CTD PMID:31558096 NCBI chr12:103,930,410...103,947,926
Ensembl chr12:103,930,107...103,953,931 		JBrowse link
G HSPA1B heat shock protein family A (Hsp70) member 1B increases expression ISO folpet results in increased expression of HSPA1B mRNA CTD PMID:31558096 NCBI chr 6:31,827,738...31,830,254
Ensembl chr 6:31,827,738...31,830,254 		JBrowse link
G HSPA8 heat shock protein family A (Hsp70) member 8 increases expression ISO folpet results in increased expression of HSPA8 mRNA CTD PMID:31558096 NCBI chr11:123,057,489...123,062,462
Ensembl chr11:123,057,489...123,063,230 		JBrowse link
G HSPB1 heat shock protein family B (small) member 1 decreases expression ISO folpet results in decreased expression of HSPB1 mRNA CTD PMID:31558096 NCBI chr 7:76,302,673...76,304,292
Ensembl chr 7:76,302,673...76,305,813 		JBrowse link
G HSPB6 heat shock protein family B (small) member 6 decreases expression ISO folpet results in decreased expression of HSPB6 mRNA CTD PMID:31558096 NCBI chr19:35,754,566...35,757,029
Ensembl chr19:35,754,566...35,758,079 		JBrowse link
G HSPD1 heat shock protein family D (Hsp60) member 1 decreases expression ISO folpet results in decreased expression of HSPD1 mRNA CTD PMID:31558096 NCBI chr 2:197,486,584...197,500,274
Ensembl chr 2:197,486,584...197,516,737 		JBrowse link
G HTRA1 HtrA serine peptidase 1 decreases expression ISO folpet results in decreased expression of HTRA1 mRNA CTD PMID:31558096 NCBI chr10:122,461,553...122,514,907
Ensembl chr10:122,458,551...122,514,907 		JBrowse link
G HYOU1 hypoxia up-regulated 1 decreases expression ISO folpet results in decreased expression of HYOU1 mRNA CTD PMID:31558096 NCBI chr11:119,044,188...119,057,205
Ensembl chr11:119,044,188...119,057,227 		JBrowse link
G ID4 inhibitor of DNA binding 4 decreases expression ISO folpet results in decreased expression of ID4 mRNA CTD PMID:31558096 NCBI chr 6:19,837,370...19,842,197
Ensembl chr 6:19,837,370...19,842,197 		JBrowse link
G IDH3G isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma increases expression ISO folpet results in increased expression of IDH3G mRNA CTD PMID:31558096 NCBI chr  X:153,785,768...153,794,375
Ensembl chr  X:153,785,766...153,794,512 		JBrowse link
G IFITM2 interferon induced transmembrane protein 2 decreases expression ISO folpet results in decreased expression of IFITM2 mRNA CTD PMID:31558096 NCBI chr11:307,816...309,395
Ensembl chr11:303,655...309,397 		JBrowse link
G IFITM3 interferon induced transmembrane protein 3 decreases expression ISO folpet results in decreased expression of IFITM3 mRNA CTD PMID:31558096 NCBI chr11:319,676...320,860
Ensembl chr11:319,676...329,475 		JBrowse link
G IGF1 insulin like growth factor 1 decreases expression ISO folpet results in decreased expression of IGF1 mRNA CTD PMID:31558096 NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744 		JBrowse link
G IGF1R insulin like growth factor 1 receptor decreases expression ISO folpet results in decreased expression of IGF1R mRNA CTD PMID:31558096 NCBI chr15:98,648,539...98,964,530
Ensembl chr15:98,648,539...98,964,530 		JBrowse link
G IGF2BP2 insulin like growth factor 2 mRNA binding protein 2 decreases expression ISO folpet results in decreased expression of IGF2BP2 mRNA CTD PMID:31558096 NCBI chr 3:185,643,130...185,825,042
Ensembl chr 3:185,643,130...185,825,042 		JBrowse link
G IGFBP3 insulin like growth factor binding protein 3 decreases expression ISO folpet results in decreased expression of IGFBP3 mRNA CTD PMID:31558096 NCBI chr 7:45,912,245...45,921,272
Ensembl chr 7:45,912,245...45,921,874 		JBrowse link
G IGFBP6 insulin like growth factor binding protein 6 decreases expression ISO folpet results in decreased expression of IGFBP6 mRNA CTD PMID:31558096 NCBI chr12:53,097,667...53,102,340
Ensembl chr12:53,097,436...53,102,345 		JBrowse link
G IGLC1 immunoglobulin lambda constant 1 decreases expression ISO folpet results in decreased expression of IGLC1 mRNA CTD PMID:31558096 NCBI chr22:22,895,375...22,895,694
Ensembl chr22:22,895,375...22,895,834 		JBrowse link
G IKBKB inhibitor of nuclear factor kappa B kinase subunit beta decreases expression ISO folpet results in decreased expression of IKBKB mRNA CTD PMID:31558096 NCBI chr 8:42,271,302...42,332,460
Ensembl chr 8:42,271,302...42,332,460 		JBrowse link
G IL18 interleukin 18 decreases expression ISO folpet results in decreased expression of IL18 mRNA CTD PMID:31558096 NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,251...112,164,096 		JBrowse link
G IL1R1 interleukin 1 receptor type 1 decreases expression ISO folpet results in decreased expression of IL1R1 mRNA CTD PMID:31558096 NCBI chr 2:102,070,390...102,179,874
Ensembl chr 2:102,064,544...102,179,874 		JBrowse link
G INPP4B inositol polyphosphate-4-phosphatase type II B decreases expression ISO folpet results in decreased expression of INPP4B mRNA CTD PMID:31558096 NCBI chr 4:142,023,160...142,846,535
Ensembl chr 4:142,023,160...142,847,432 		JBrowse link
G INPP5D inositol polyphosphate-5-phosphatase D decreases expression ISO folpet results in decreased expression of INPP5D mRNA CTD PMID:31558096 NCBI chr 2:233,060,342...233,207,903
Ensembl chr 2:233,059,967...233,207,903 		JBrowse link
G IQGAP1 IQ motif containing GTPase activating protein 1 increases expression ISO folpet results in increased expression of IQGAP1 mRNA CTD PMID:31558096 NCBI chr15:90,388,242...90,502,239
Ensembl chr15:90,388,242...90,502,239 		JBrowse link
G IRS1 insulin receptor substrate 1 increases expression ISO folpet results in increased expression of IRS1 mRNA CTD PMID:31558096 NCBI chr 2:226,731,312...226,799,820
Ensembl chr 2:226,731,312...226,799,820 		JBrowse link
G ITGAE integrin subunit alpha E decreases expression ISO folpet results in decreased expression of ITGAE mRNA CTD PMID:31558096 NCBI chr17:3,714,628...3,801,188
Ensembl chr17:3,714,628...3,801,188 		JBrowse link
G IYD iodotyrosine deiodinase increases expression ISO folpet results in increased expression of IYD mRNA CTD PMID:31558096 NCBI chr 6:150,369,012...150,405,969
Ensembl chr 6:150,368,892...150,405,969 		JBrowse link
G JMJD6 jumonji domain containing 6, arginine demethylase and lysine hydroxylase decreases expression ISO folpet results in decreased expression of JMJD6 mRNA CTD PMID:31558096 NCBI chr17:76,712,836...76,726,606
Ensembl chr17:76,712,832...76,726,799 		JBrowse link
G JUN Jun proto-oncogene, AP-1 transcription factor subunit increases expression ISO folpet results in increased expression of JUN mRNA CTD PMID:31558096 NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048 		JBrowse link
G KARS1 lysyl-tRNA synthetase 1 decreases expression ISO folpet results in decreased expression of KARS1 mRNA CTD PMID:31558096 NCBI chr16:75,627,724...75,647,665
Ensembl chr16:75,627,474...75,648,643 		JBrowse link
G KAT2A lysine acetyltransferase 2A decreases expression ISO folpet results in decreased expression of KAT2A mRNA CTD PMID:31558096 NCBI chr17:42,113,111...42,121,367
Ensembl chr17:42,113,111...42,121,367 		JBrowse link
G KAT6A lysine acetyltransferase 6A increases expression ISO folpet results in increased expression of KAT6A mRNA CTD PMID:31558096 NCBI chr 8:41,929,479...42,051,987
Ensembl chr 8:41,929,479...42,051,994 		JBrowse link
G KDM3A lysine demethylase 3A increases expression ISO folpet results in increased expression of KDM3A mRNA CTD PMID:31558096 NCBI chr 2:86,437,044...86,492,716
Ensembl chr 2:86,440,647...86,492,716 		JBrowse link
G KIF23 kinesin family member 23 decreases expression ISO folpet results in decreased expression of KIF23 mRNA CTD PMID:31558096 NCBI chr15:69,414,349...69,448,427
Ensembl chr15:69,414,246...69,448,427 		JBrowse link
G KLF2 KLF transcription factor 2 decreases expression ISO folpet results in decreased expression of KLF2 mRNA CTD PMID:31558096 NCBI chr19:16,324,826...16,328,685
Ensembl chr19:16,324,826...16,328,685 		JBrowse link
G KLF4 KLF transcription factor 4 increases expression ISO folpet results in increased expression of KLF4 mRNA CTD PMID:31558096 NCBI chr 9:107,484,852...107,489,769
Ensembl chr 9:107,484,852...107,490,482 		JBrowse link
G KLHL13 kelch like family member 13 decreases expression ISO folpet results in decreased expression of KLHL13 mRNA CTD PMID:31558096 NCBI chr  X:117,897,813...118,117,340
Ensembl chr  X:117,897,813...118,117,340 		JBrowse link
G KLHL24 kelch like family member 24 decreases expression ISO folpet results in decreased expression of KLHL24 mRNA CTD PMID:31558096 NCBI chr 3:183,635,623...183,684,519
Ensembl chr 3:183,635,610...183,684,519 		JBrowse link
G KLHL9 kelch like family member 9 decreases expression ISO folpet results in decreased expression of KLHL9 mRNA CTD PMID:31558096 NCBI chr 9:21,329,665...21,335,404
Ensembl chr 9:21,320,024...21,335,404 		JBrowse link
G KRT19 keratin 19 increases expression ISO folpet results in increased expression of KRT19 mRNA CTD PMID:31558096 NCBI chr17:41,523,617...41,528,308
Ensembl chr17:41,523,617...41,528,308 		JBrowse link
G KRT7 keratin 7 decreases expression ISO folpet results in decreased expression of KRT7 mRNA CTD PMID:31558096 NCBI chr12:52,233,243...52,255,853
Ensembl chr12:52,232,520...52,252,186 		JBrowse link
G KRT8 keratin 8 increases expression ISO folpet results in increased expression of KRT8 mRNA CTD PMID:31558096 NCBI chr12:52,897,191...52,949,860
Ensembl chr12:52,897,187...52,949,954 		JBrowse link
G LAMP1 lysosomal associated membrane protein 1 increases expression ISO folpet results in increased expression of LAMP1 mRNA CTD PMID:31558096 NCBI chr13:113,297,239...113,323,672
Ensembl chr13:113,297,239...113,323,672 		JBrowse link
G LHFPL6 LHFPL tetraspan subfamily member 6 decreases expression ISO folpet results in decreased expression of LHFPL6 mRNA CTD PMID:31558096 NCBI chr13:39,342,892...39,603,193
Ensembl chr13:39,209,116...39,603,528 		JBrowse link
G LIPA lipase A, lysosomal acid type increases expression ISO folpet results in increased expression of LIPA mRNA CTD PMID:31558096 NCBI chr10:89,213,572...89,251,775
Ensembl chr10:89,213,569...89,414,557 		JBrowse link
G LPGAT1 lysophosphatidylglycerol acyltransferase 1 decreases expression ISO folpet results in decreased expression of LPGAT1 mRNA CTD PMID:31558096 NCBI chr 1:211,743,457...211,830,763
Ensembl chr 1:211,743,457...211,830,763 		JBrowse link
G LRAT lecithin retinol acyltransferase decreases expression ISO folpet results in decreased expression of LRAT mRNA CTD PMID:31558096 NCBI chr 4:154,740,838...154,753,120
Ensembl chr 4:154,626,945...154,753,120 		JBrowse link
G LRRC41 leucine rich repeat containing 41 decreases expression ISO folpet results in decreased expression of LRRC41 mRNA CTD PMID:31558096 NCBI chr 1:46,277,462...46,303,616
Ensembl chr 1:46,261,196...46,303,616 		JBrowse link
G LSS lanosterol synthase increases expression ISO folpet results in increased expression of LSS mRNA CTD PMID:31558096 NCBI chr21:46,188,446...46,228,774
Ensembl chr21:46,188,141...46,228,824 		JBrowse link
G LTBR lymphotoxin beta receptor increases expression ISO folpet results in increased expression of LTBR mRNA CTD PMID:31558096 NCBI chr12:6,375,160...6,391,566
Ensembl chr12:6,375,045...6,391,571 		JBrowse link
G LYPLA1 lysophospholipase 1 increases expression ISO folpet results in increased expression of LYPLA1 mRNA CTD PMID:31558096 NCBI chr 8:54,042,987...54,101,947
Ensembl chr 8:54,046,367...54,102,017 		JBrowse link
G LYZ lysozyme decreases expression ISO folpet results in decreased expression of LYZ2 mRNA CTD PMID:31558096 NCBI chr12:69,348,381...69,354,234
Ensembl chr12:69,348,381...69,354,234 		JBrowse link
G MAFF MAF bZIP transcription factor F increases expression ISO folpet results in increased expression of MAFF mRNA CTD PMID:31558096 NCBI chr22:38,201,994...38,216,511
Ensembl chr22:38,200,767...38,216,507 		JBrowse link
G MAOA monoamine oxidase A increases expression ISO folpet results in increased expression of MAOA mRNA CTD PMID:31558096 NCBI chr  X:43,655,006...43,746,817
Ensembl chr  X:43,654,907...43,746,817 		JBrowse link
G MAPK1IP1L mitogen-activated protein kinase 1 interacting protein 1 like increases expression ISO folpet results in increased expression of MAPK1IP1L mRNA CTD PMID:31558096 NCBI chr14:55,051,647...55,070,194
Ensembl chr14:55,051,647...55,070,194 		JBrowse link
G MAPK3 mitogen-activated protein kinase 3 increases expression ISO folpet results in increased expression of MAPK3 mRNA CTD PMID:31558096 NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506 		JBrowse link
G MAT2A methionine adenosyltransferase 2A increases expression ISO folpet results in increased expression of MAT2A mRNA CTD PMID:31558096 NCBI chr 2:85,539,168...85,545,281
Ensembl chr 2:85,539,168...85,545,281 		JBrowse link
G MCM7 minichromosome maintenance complex component 7 decreases expression ISO folpet results in decreased expression of MCM7 mRNA CTD PMID:31558096 NCBI chr 7:100,092,728...100,101,397
Ensembl chr 7:100,092,233...100,101,940 		JBrowse link
G ME1 malic enzyme 1 increases expression ISO folpet results in increased expression of ME1 mRNA CTD PMID:31558096 NCBI chr 6:83,210,402...83,431,051
Ensembl chr 6:83,210,402...83,431,051 		JBrowse link
G MEIS2 Meis homeobox 2 decreases expression ISO folpet results in decreased expression of MEIS2 mRNA CTD PMID:31558096 NCBI chr15:36,889,204...37,101,311
Ensembl chr15:36,889,204...37,101,299 		JBrowse link
G MFSD10 major facilitator superfamily domain containing 10 decreases expression ISO folpet results in decreased expression of MFSD10 mRNA CTD PMID:31558096 NCBI chr 4:2,930,567...2,934,825
Ensembl chr 4:2,930,561...2,934,834 		JBrowse link
G MINDY1 MINDY lysine 48 deubiquitinase 1 increases expression ISO folpet results in increased expression of MINDY1 mRNA CTD PMID:31558096 NCBI chr 1:150,996,536...151,008,393
Ensembl chr 1:150,996,549...151,008,376 		JBrowse link
G MMP14 matrix metallopeptidase 14 decreases expression ISO folpet results in decreased expression of MMP14 mRNA CTD PMID:31558096 NCBI chr14:22,836,585...22,847,758
Ensembl chr14:22,836,560...22,849,041 		JBrowse link
G MNAT1 MNAT1 component of CDK activating kinase decreases expression ISO folpet results in decreased expression of MNAT1 mRNA CTD PMID:31558096 NCBI chr14:60,734,761...60,969,965
Ensembl chr14:60,734,742...60,969,965 		JBrowse link
G MOB1A MOB kinase activator 1A decreases expression ISO folpet results in decreased expression of MOB1A mRNA CTD PMID:31558096 NCBI chr 2:74,152,528...74,178,879
Ensembl chr 2:74,152,528...74,178,898 		JBrowse link
G MORF4L2 mortality factor 4 like 2 increases expression ISO folpet results in increased expression of MORF4L2 mRNA CTD PMID:31558096 NCBI chr  X:103,675,498...103,688,047
Ensembl chr  X:103,675,496...103,688,158 		JBrowse link
G MRPS16 mitochondrial ribosomal protein S16 increases expression ISO folpet results in increased expression of MRPS16 mRNA CTD PMID:31558096 NCBI chr10:73,248,849...73,252,644
Ensembl chr10:73,248,843...73,252,693 		JBrowse link
G MRPS2 mitochondrial ribosomal protein S2 decreases expression ISO folpet results in decreased expression of MRPS2 mRNA CTD PMID:31558096 NCBI chr 9:135,499,965...135,504,673
Ensembl chr 9:135,499,984...135,504,673 		JBrowse link
G MRPS34 mitochondrial ribosomal protein S34 increases expression ISO folpet results in increased expression of MRPS34 mRNA CTD PMID:31558096 NCBI chr16:1,771,895...1,773,134
Ensembl chr16:1,771,890...1,773,150 		JBrowse link
G MRPS6 mitochondrial ribosomal protein S6 increases expression ISO folpet results in increased expression of MRPS6 mRNA CTD PMID:31558096 NCBI chr21:34,073,578...34,143,030
Ensembl chr21:34,073,224...34,362,252 		JBrowse link
G MTA1 metastasis associated 1 decreases expression ISO folpet results in decreased expression of MTA1 mRNA CTD PMID:31558096 NCBI chr14:105,419,827...105,470,729
Ensembl chr14:105,419,820...105,470,729 		JBrowse link
G MTHFD1L methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 like increases expression ISO folpet results in increased expression of MTHFD1L mRNA CTD PMID:31558096 NCBI chr 6:150,865,702...151,101,887
Ensembl chr 6:150,865,679...151,101,887 		JBrowse link
G MVP major vault protein increases expression ISO folpet results in increased expression of MVP mRNA CTD PMID:31558096 NCBI chr16:29,820,394...29,848,039
Ensembl chr16:29,820,394...29,848,039 		JBrowse link
G MYCBP2 MYC binding protein 2 decreases expression ISO folpet results in decreased expression of MYCBP2 mRNA CTD PMID:31558096 NCBI chr13:77,044,657...77,327,094
Ensembl chr13:77,042,474...77,327,094 		JBrowse link
G MYL9 myosin light chain 9 decreases expression ISO folpet results in decreased expression of MYL9 mRNA CTD PMID:31558096 NCBI chr20:36,541,519...36,551,447
Ensembl chr20:36,541,497...36,551,447 		JBrowse link
G MYLK myosin light chain kinase decreases expression ISO folpet results in decreased expression of MYLK mRNA CTD PMID:31558096 NCBI chr 3:123,610,049...123,884,332
Ensembl chr 3:123,610,049...123,884,332 		JBrowse link
G NACA nascent polypeptide associated complex subunit alpha increases expression ISO folpet results in increased expression of NACA mRNA CTD PMID:31558096 NCBI chr12:56,712,427...56,725,299
Ensembl chr12:56,712,305...56,731,628 		JBrowse link
G NCK1 NCK adaptor protein 1 decreases expression ISO folpet results in decreased expression of NCK1 mRNA CTD PMID:31558096 NCBI chr 3:136,862,208...136,951,606
Ensembl chr 3:136,862,208...136,951,606 		JBrowse link
G NDUFA1 NADH:ubiquinone oxidoreductase subunit A1 increases expression ISO folpet results in increased expression of NDUFA1 mRNA CTD PMID:31558096 NCBI chr  X:119,871,832...119,876,662
Ensembl chr  X:119,871,832...119,876,662 		JBrowse link
G NDUFA9 NADH:ubiquinone oxidoreductase subunit A9 increases expression ISO folpet results in increased expression of NDUFA9 mRNA CTD PMID:31558096 NCBI chr12:4,649,114...4,694,317
Ensembl chr12:4,649,095...4,694,317 		JBrowse link
G NDUFB10 NADH:ubiquinone oxidoreductase subunit B10 increases expression ISO folpet results in increased expression of NDUFB10 mRNA CTD PMID:31558096 NCBI chr16:1,959,538...1,961,975
Ensembl chr16:1,959,538...1,961,975 		JBrowse link
G NDUFB5 NADH:ubiquinone oxidoreductase subunit B5 increases expression ISO folpet results in increased expression of NDUFB5 mRNA CTD PMID:31558096 NCBI chr 3:179,604,794...179,627,647
Ensembl chr 3:179,604,690...179,627,647 		JBrowse link
G NDUFB6 NADH:ubiquinone oxidoreductase subunit B6 increases expression ISO folpet results in increased expression of NDUFB6 mRNA CTD PMID:31558096 NCBI chr 9:32,553,001...32,573,159
Ensembl chr 9:32,553,001...32,573,184 		JBrowse link
G NDUFS7 NADH:ubiquinone oxidoreductase core subunit S7 decreases expression ISO folpet results in decreased expression of NDUFS7 mRNA CTD PMID:31558096 NCBI chr19:1,383,907...1,395,584
Ensembl chr19:1,383,527...1,395,589 		JBrowse link
G NDUFV3 NADH:ubiquinone oxidoreductase subunit V3 decreases expression ISO folpet results in decreased expression of NDUFV3 mRNA CTD PMID:31558096 NCBI chr21:42,893,309...42,913,299
Ensembl chr21:42,879,644...42,913,304 		JBrowse link
G NET1 neuroepithelial cell transforming 1 increases expression ISO folpet results in increased expression of NET1 mRNA CTD PMID:31558096 NCBI chr10:5,412,557...5,459,056
Ensembl chr10:5,412,557...5,459,056 		JBrowse link
G NFIL3 nuclear factor, interleukin 3 regulated decreases expression ISO folpet results in decreased expression of NFIL3 mRNA CTD PMID:31558096 NCBI chr 9:91,409,045...91,483,497
Ensembl chr 9:91,408,748...91,424,626 		JBrowse link
G NFKBIB NFKB inhibitor beta increases expression ISO folpet results in increased expression of NFKBIB mRNA CTD PMID:31558096 NCBI chr19:38,899,666...38,908,889
Ensembl chr19:38,899,700...38,908,893 		JBrowse link
G NHERF1 NHERF family PDZ scaffold protein 1 increases expression ISO folpet results in increased expression of NHERF1 mRNA CTD PMID:31558096 NCBI chr17:74,748,628...74,769,353
Ensembl chr17:74,748,628...74,769,353 		JBrowse link
G NME1 NME/NM23 nucleoside diphosphate kinase 1 decreases expression ISO folpet results in decreased expression of NME1 mRNA CTD PMID:31558096 NCBI chr17:51,153,559...51,162,168
Ensembl chr17:51,153,559...51,162,428 		JBrowse link
G NOTCH1 notch receptor 1 decreases expression ISO folpet results in decreased expression of NOTCH1 mRNA CTD PMID:31558096 NCBI chr 9:136,494,433...136,546,048
Ensembl chr 9:136,494,433...136,546,048 		JBrowse link
G NQO1 NAD(P)H quinone dehydrogenase 1 increases expression ISO folpet results in increased expression of NQO1 mRNA CTD PMID:31558096 NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668 		JBrowse link
G NR1I2 nuclear receptor subfamily 1 group I member 2 increases expression ISO folpet results in increased expression of NR1I2 mRNA CTD PMID:31558096 NCBI chr 3:119,782,101...119,818,487
Ensembl chr 3:119,780,484...119,818,487 		JBrowse link
G NR1I3 nuclear receptor subfamily 1 group I member 3 increases expression ISO folpet results in increased expression of NR1I3 mRNA CTD PMID:31558096 NCBI chr 1:161,229,669...161,238,203
Ensembl chr 1:161,229,666...161,238,244 		JBrowse link
G NR3C1 nuclear receptor subfamily 3 group C member 1 decreases expression ISO folpet results in decreased expression of NR3C1 mRNA CTD PMID:31558096 NCBI chr 5:143,277,931...143,435,512
Ensembl chr 5:143,277,931...143,435,512 		JBrowse link
G NRAP nebulin related anchoring protein increases expression ISO folpet results in increased expression of NRAP mRNA CTD PMID:31558096 NCBI chr10:113,588,714...113,664,041
Ensembl chr10:113,588,714...113,664,070 		JBrowse link
G NUCB2 nucleobindin 2 decreases expression ISO folpet results in decreased expression of NUCB2 mRNA CTD PMID:31558096 NCBI chr11:17,276,739...17,349,980
Ensembl chr11:17,208,153...17,349,980 		JBrowse link
G NUDCD3 NudC domain containing 3 decreases expression ISO folpet results in decreased expression of NUDCD3 mRNA CTD PMID:31558096 NCBI chr 7:44,379,119...44,490,658
Ensembl chr 7:44,379,119...44,490,658 		JBrowse link
G NUP37 nucleoporin 37 decreases expression ISO folpet results in decreased expression of NUP37 mRNA CTD PMID:31558096 NCBI chr12:102,073,103...102,120,114
Ensembl chr12:102,073,103...102,120,120 		JBrowse link
G NUP62 nucleoporin 62 decreases expression ISO folpet results in decreased expression of NUP62 mRNA CTD PMID:31558096 NCBI chr19:49,906,825...49,929,504
Ensembl chr19:49,906,825...49,929,764 		JBrowse link
G NUP85 nucleoporin 85 decreases expression ISO folpet results in decreased expression of NUP85 mRNA CTD PMID:31558096 NCBI chr17:75,205,679...75,235,758
Ensembl chr17:75,205,659...75,235,758 		JBrowse link
G OPN3 opsin 3 increases expression ISO folpet results in increased expression of OPN3 mRNA CTD PMID:31558096 NCBI chr 1:241,593,124...241,640,369
Ensembl chr 1:241,590,102...241,677,376
Ensembl chr 1:241,590,102...241,677,376 		JBrowse link
G OSGIN1 oxidative stress induced growth inhibitor 1 increases expression ISO folpet results in increased expression of OSGIN1 mRNA CTD PMID:31558096 NCBI chr16:83,953,240...83,966,332
Ensembl chr16:83,931,311...83,966,332 		JBrowse link
G OXCT1 3-oxoacid CoA-transferase 1 increases expression ISO folpet results in increased expression of OXCT1 mRNA CTD PMID:31558096 NCBI chr 5:41,730,065...41,870,425
Ensembl chr 5:41,730,065...41,870,425 		JBrowse link
G P3H3 prolyl 3-hydroxylase 3 decreases expression ISO folpet results in decreased expression of P3H3 mRNA CTD PMID:31558096 NCBI chr12:6,828,407...6,839,847
Ensembl chr12:6,828,407...6,839,847 		JBrowse link
G P4HB prolyl 4-hydroxylase subunit beta increases expression ISO folpet results in increased expression of P4HB mRNA CTD PMID:31558096 NCBI chr17:81,843,166...81,860,535
Ensembl chr17:81,843,159...81,860,856 		JBrowse link
G PAK4 p21 (RAC1) activated kinase 4 increases expression ISO folpet results in increased expression of PAK4 mRNA CTD PMID:31558096 NCBI chr19:39,125,786...39,182,816
Ensembl chr19:39,125,770...39,182,816 		JBrowse link
G PANK2 pantothenate kinase 2 decreases expression ISO folpet results in decreased expression of PANK2 mRNA CTD PMID:31558096 NCBI chr20:3,888,781...3,929,887
Ensembl chr20:3,888,839...3,929,887 		JBrowse link
G PANX1 pannexin 1 decreases expression ISO folpet results in decreased expression of PANX1 mRNA CTD PMID:31558096 NCBI chr11:94,128,841...94,181,968
Ensembl chr11:94,128,841...94,181,968 		JBrowse link
G PARK7 Parkinsonism associated deglycase decreases activity EXP folpet results in decreased activity of PARK7 protein CTD PMID:36842454 NCBI chr 1:7,961,711...7,985,505
Ensembl chr 1:7,954,291...7,985,505 		JBrowse link
G PARL presenilin associated rhomboid like increases expression ISO folpet results in increased expression of PARL mRNA CTD PMID:31558096 NCBI chr 3:183,826,489...183,884,880
Ensembl chr 3:183,829,271...183,884,933 		JBrowse link
G PBDC1 polysaccharide biosynthesis domain containing 1 increases expression ISO folpet results in increased expression of PBDC1 mRNA CTD PMID:31558096 NCBI chr  X:76,173,062...76,178,314
Ensembl chr  X:76,173,040...76,178,755 		JBrowse link
G PCCB propionyl-CoA carboxylase subunit beta increases expression ISO folpet results in increased expression of PCCB mRNA CTD PMID:31558096 NCBI chr 3:136,250,340...136,330,169
Ensembl chr 3:136,250,340...136,337,896 		JBrowse link
G PDIA5 protein disulfide isomerase family A member 5 decreases expression ISO folpet results in decreased expression of PDIA5 mRNA CTD PMID:31558096 NCBI chr 3:123,067,025...123,162,104
Ensembl chr 3:123,067,025...123,225,227 		JBrowse link
G PDLIM1 PDZ and LIM domain 1 increases expression ISO folpet results in increased expression of PDLIM1 mRNA CTD PMID:31558096 NCBI chr10:95,237,572...95,291,003
Ensembl chr10:95,237,572...95,291,012 		JBrowse link
G PFKL phosphofructokinase, liver type increases expression ISO folpet results in increased expression of PFKL mRNA CTD PMID:31558096 NCBI chr21:44,300,053...44,327,373
Ensembl chr21:44,300,051...44,327,376 		JBrowse link
G PFN1 profilin 1 increases expression ISO folpet results in increased expression of PFN1 mRNA CTD PMID:31558096 NCBI chr17:4,945,652...4,948,530
Ensembl chr17:4,945,652...4,949,061 		JBrowse link
G PGM2 phosphoglucomutase 2 increases expression ISO folpet results in increased expression of PGM2 mRNA CTD PMID:31558096 NCBI chr 4:37,826,686...37,862,937
Ensembl chr 4:37,826,660...37,862,937 		JBrowse link
G PGRMC1 progesterone receptor membrane component 1 increases expression ISO folpet results in increased expression of PGRMC1 mRNA CTD PMID:31558096 NCBI chr  X:119,236,285...119,244,466
Ensembl chr  X:119,236,245...119,244,466 		JBrowse link
G PHPT1 phosphohistidine phosphatase 1 increases expression ISO folpet results in increased expression of PHPT1 mRNA CTD PMID:31558096 NCBI chr 9:136,849,409...136,851,024
Ensembl chr 9:136,848,724...136,851,027 		JBrowse link
G PIGF phosphatidylinositol glycan anchor biosynthesis class F decreases expression ISO folpet results in decreased expression of PIGF mRNA CTD PMID:31558096 NCBI chr 2:46,580,937...46,617,041
Ensembl chr 2:46,580,937...46,617,055 		JBrowse link
G PIK3C2B phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta increases expression ISO folpet results in increased expression of PIK3C2B mRNA CTD PMID:31558096 NCBI chr 1:204,422,633...204,494,805
Ensembl chr 1:204,422,628...204,494,805 		JBrowse link
G PIK3CG phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma decreases expression ISO folpet results in decreased expression of PIK3CG mRNA CTD PMID:31558096 NCBI chr 7:106,865,282...106,908,980
Ensembl chr 7:106,865,278...106,908,980 		JBrowse link
G PLAU plasminogen activator, urokinase decreases expression ISO folpet results in decreased expression of PLAU mRNA CTD PMID:31558096 NCBI chr10:73,909,164...73,917,494
Ensembl chr10:73,909,177...73,917,496 		JBrowse link
G PLK3 polo like kinase 3 increases expression ISO folpet results in increased expression of PLK3 mRNA CTD PMID:31558096 NCBI chr 1:44,800,377...44,805,990
Ensembl chr 1:44,800,377...44,805,995 		JBrowse link
G PNKP polynucleotide kinase 3'-phosphatase increases expression ISO folpet results in increased expression of PNKP mRNA CTD PMID:31558096 NCBI chr19:49,861,204...49,867,576
Ensembl chr19:49,859,882...49,878,351 		JBrowse link
G PNP purine nucleoside phosphorylase decreases expression ISO folpet results in decreased expression of PNP2 mRNA CTD PMID:31558096 NCBI chr14:20,469,406...20,477,089
Ensembl chr14:20,461,992...20,477,094 		JBrowse link
G POLD4 DNA polymerase delta 4, accessory subunit increases expression ISO folpet results in increased expression of POLD4 mRNA CTD PMID:31558096 NCBI chr11:67,350,765...67,353,596
Ensembl chr11:67,350,772...67,356,972 		JBrowse link
G POLR1D RNA polymerase I and III subunit D increases expression ISO folpet results in increased expression of POLR1D mRNA CTD PMID:31558096 NCBI chr13:27,620,743...27,667,411
Ensembl chr13:27,620,742...27,744,237 		JBrowse link
G POLR1H RNA polymerase I subunit H decreases expression ISO folpet results in decreased expression of POLR1H mRNA CTD PMID:31558096 NCBI chr 6:30,060,062...30,064,907
Ensembl chr 6:30,058,899...30,064,909 		JBrowse link
G POLR2C RNA polymerase II subunit C decreases expression ISO folpet results in decreased expression of POLR2C mRNA CTD PMID:31558096 NCBI chr16:57,462,679...57,472,009
Ensembl chr16:57,462,660...57,472,009 		JBrowse link
G POLR3B RNA polymerase III subunit B decreases expression ISO folpet results in decreased expression of POLR3B mRNA CTD PMID:31558096 NCBI chr12:106,357,748...106,510,198
Ensembl chr12:106,357,748...106,510,198 		JBrowse link
G POR cytochrome p450 oxidoreductase increases expression ISO folpet results in increased expression of POR mRNA CTD PMID:31558096 NCBI chr 7:75,915,155...75,986,855
Ensembl chr 7:75,899,200...75,986,855 		JBrowse link
G PPARA peroxisome proliferator activated receptor alpha increases expression ISO folpet results in increased expression of PPARA mRNA CTD PMID:31558096 NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,755 		JBrowse link
G PPARGC1A PPARG coactivator 1 alpha decreases expression ISO folpet results in decreased expression of PPARGC1A mRNA CTD PMID:31558096 NCBI chr 4:23,792,021...24,472,905
Ensembl chr 4:23,755,041...23,904,089 		JBrowse link
G PPIB peptidylprolyl isomerase B decreases expression ISO folpet results in decreased expression of PPIB mRNA CTD PMID:31558096 NCBI chr15:64,155,817...64,163,022
Ensembl chr15:64,155,740...64,163,134 		JBrowse link
G PPP1R27 protein phosphatase 1 regulatory subunit 27 increases expression ISO folpet results in increased expression of PPP1R27 mRNA CTD PMID:31558096 NCBI chr17:81,833,492...81,835,050
Ensembl chr17:81,833,492...81,835,050 		JBrowse link
G PRC1 protein regulator of cytokinesis 1 decreases expression ISO folpet results in decreased expression of PRC1 mRNA CTD PMID:31558096 NCBI chr15:90,966,040...90,994,535
Ensembl chr15:90,966,040...90,995,629 		JBrowse link
G PRDX1 peroxiredoxin 1 increases expression ISO folpet results in increased expression of PRDX1 mRNA CTD PMID:31558096 NCBI chr 1:45,511,051...45,522,890
Ensembl chr 1:45,510,914...45,542,732 		JBrowse link
G PRDX3 peroxiredoxin 3 increases expression ISO folpet results in increased expression of PRDX3 mRNA CTD PMID:31558096 NCBI chr10:119,167,720...119,178,812
Ensembl chr10:119,167,720...119,178,812 		JBrowse link
G PRKAA2 protein kinase AMP-activated catalytic subunit alpha 2 increases expression ISO folpet results in increased expression of PRKAA2 mRNA CTD PMID:31558096 NCBI chr 1:56,645,314...56,715,335
Ensembl chr 1:56,645,314...56,715,335 		JBrowse link
G PRKAB1 protein kinase AMP-activated non-catalytic subunit beta 1 decreases expression ISO folpet results in decreased expression of PRKAB1 mRNA CTD PMID:31558096 NCBI chr12:119,667,952...119,681,619
Ensembl chr12:119,667,864...119,681,624 		JBrowse link
G PRKAG2 protein kinase AMP-activated non-catalytic subunit gamma 2 decreases expression ISO folpet results in decreased expression of PRKAG2 mRNA CTD PMID:31558096 NCBI chr 7:151,556,127...151,877,115
Ensembl chr 7:151,556,124...151,877,214 		JBrowse link
G PRKCA protein kinase C alpha increases expression ISO folpet results in increased expression of PRKCA mRNA CTD PMID:31558096 NCBI chr17:66,302,613...66,810,743
Ensembl chr17:66,302,613...66,810,743 		JBrowse link
G PRKCD protein kinase C delta increases expression ISO folpet results in increased expression of PRKCD mRNA CTD PMID:31558096 NCBI chr 3:53,161,209...53,192,717
Ensembl chr 3:53,156,009...53,192,717 		JBrowse link
G PRKCH protein kinase C eta decreases expression ISO folpet results in decreased expression of PRKCH mRNA CTD PMID:31558096 NCBI chr14:61,187,468...61,550,976
Ensembl chr14:61,187,559...61,550,980 		JBrowse link
G PRKG1 protein kinase cGMP-dependent 1 decreases expression ISO folpet results in decreased expression of PRKG1 mRNA CTD PMID:31558096 NCBI chr10:50,990,888...52,298,350
Ensembl chr10:50,990,888...52,298,423 		JBrowse link
G PRSS8 serine protease 8 decreases expression ISO folpet results in decreased expression of PRSS8 mRNA CTD PMID:31558096 NCBI chr16:31,131,433...31,135,727
Ensembl chr16:31,131,433...31,135,727 		JBrowse link
G PSEN1 presenilin 1 decreases expression ISO folpet results in decreased expression of PSEN1 mRNA CTD PMID:31558096 NCBI chr14:73,136,417...73,223,691
Ensembl chr14:73,136,418...73,223,691 		JBrowse link
G PSMC4 proteasome 26S subunit, ATPase 4 increases expression ISO folpet results in increased expression of PSMC4 mRNA CTD PMID:31558096 NCBI chr19:39,971,165...39,981,764
Ensembl chr19:39,971,165...39,981,764 		JBrowse link
G PSMD12 proteasome 26S subunit, non-ATPase 12 decreases expression ISO folpet results in decreased expression of PSMD12 mRNA CTD PMID:31558096 NCBI chr17:67,337,916...67,366,577
Ensembl chr17:67,337,916...67,366,605 		JBrowse link
G PSMD14 proteasome 26S subunit, non-ATPase 14 increases expression ISO folpet results in increased expression of PSMD14 mRNA CTD PMID:31558096 NCBI chr 2:161,308,425...161,411,717
Ensembl chr 2:161,308,425...161,411,717 		JBrowse link
G PSMD8 proteasome 26S subunit, non-ATPase 8 increases expression ISO folpet results in increased expression of PSMD8 mRNA CTD PMID:31558096 NCBI chr19:38,374,571...38,383,824
Ensembl chr19:38,374,563...38,383,850 		JBrowse link
G PSME2 proteasome activator subunit 2 increases expression ISO folpet results in increased expression of PSME2 mRNA CTD PMID:31558096 NCBI chr14:24,143,365...24,146,610
Ensembl chr14:24,143,362...24,147,570 		JBrowse link
G PSMG1 proteasome assembly chaperone 1 increases expression ISO folpet results in increased expression of PSMG1 mRNA CTD PMID:31558096 NCBI chr21:39,174,769...39,183,514
Ensembl chr21:39,174,769...39,183,488 		JBrowse link
G PSPH phosphoserine phosphatase increases expression ISO folpet results in increased expression of PSPH mRNA CTD PMID:31558096 NCBI chr 7:56,011,064...56,051,444
Ensembl chr 7:56,011,051...56,051,604 		JBrowse link
G PTGER4 prostaglandin E receptor 4 increases expression ISO folpet results in increased expression of PTGER4 mRNA CTD PMID:31558096 NCBI chr 5:40,679,915...40,746,800
Ensembl chr 5:40,679,915...40,693,735 		JBrowse link
G PTK2B protein tyrosine kinase 2 beta decreases expression ISO folpet results in decreased expression of PTK2B mRNA CTD PMID:31558096 NCBI chr 8:27,310,506...27,459,391
Ensembl chr 8:27,311,482...27,459,391 		JBrowse link
G PTPRC protein tyrosine phosphatase receptor type C decreases expression ISO folpet results in decreased expression of PTPRC mRNA CTD PMID:31558096 NCBI chr 1:198,638,713...198,757,476
Ensembl chr 1:198,638,457...198,759,342 		JBrowse link
G PTPRK protein tyrosine phosphatase receptor type K decreases expression ISO folpet results in decreased expression of PTPRK mRNA CTD PMID:31558096 NCBI chr 6:127,968,785...128,520,599
Ensembl chr 6:127,968,785...128,520,616 		JBrowse link
G PWP1 PWP1 homolog, endonuclein decreases expression ISO folpet results in decreased expression of PWP1 mRNA CTD PMID:31558096 NCBI chr12:107,685,799...107,713,162
Ensembl chr12:107,685,799...107,713,162 		JBrowse link
G QDPR quinoid dihydropteridine reductase increases expression ISO folpet results in increased expression of QDPR mRNA CTD PMID:31558096 NCBI chr 4:17,486,395...17,512,090
Ensembl chr 4:17,460,261...17,512,206 		JBrowse link
G RAB11A RAB11A, member RAS oncogene family increases expression ISO folpet results in increased expression of RAB11A mRNA CTD PMID:31558096 NCBI chr15:65,869,491...65,891,989
Ensembl chr15:65,726,054...65,891,989 		JBrowse link
G RAB31 RAB31, member RAS oncogene family increases expression ISO folpet results in increased expression of RAB31 mRNA CTD PMID:31558096 NCBI chr18:9,708,301...9,862,551
Ensembl chr18:9,708,275...9,862,551 		JBrowse link
G RAC1 Rac family small GTPase 1 increases expression ISO folpet results in increased expression of RAC1 mRNA CTD PMID:31558096 NCBI chr 7:6,374,527...6,403,967
Ensembl chr 7:6,374,527...6,403,967 		JBrowse link
G RAP1GAP RAP1 GTPase activating protein decreases expression ISO folpet results in decreased expression of RAP1GAP mRNA CTD PMID:31558096 NCBI chr 1:21,596,221...21,669,357
Ensembl chr 1:21,596,221...21,669,357 		JBrowse link
G RAPGEF2 Rap guanine nucleotide exchange factor 2 increases expression ISO folpet results in increased expression of RAPGEF2 mRNA CTD PMID:31558096 NCBI chr 4:159,103,079...159,360,173
Ensembl chr 4:159,103,013...159,360,174 		JBrowse link
G RB1 RB transcriptional corepressor 1 increases expression ISO folpet results in increased expression of RB1 mRNA CTD PMID:31558096 NCBI chr13:48,303,751...48,481,890
Ensembl chr13:48,303,744...48,599,436 		JBrowse link
G RBM15B RNA binding motif protein 15B decreases expression ISO folpet results in decreased expression of RBM15B mRNA CTD PMID:31558096 NCBI chr 3:51,391,285...51,397,908
Ensembl chr 3:51,391,285...51,397,908 		JBrowse link
G REG1A regenerating family member 1 alpha decreases expression ISO folpet results in decreased expression of REG1 mRNA CTD PMID:31558096 NCBI chr 2:79,120,488...79,123,409
Ensembl chr 2:79,120,362...79,123,409 		JBrowse link
G RELA RELA proto-oncogene, NF-kB subunit decreases expression ISO folpet results in decreased expression of RELA mRNA CTD PMID:31558096 NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090 		JBrowse link
G RELB RELB proto-oncogene, NF-kB subunit decreases expression ISO folpet results in decreased expression of RELB mRNA CTD PMID:31558096 NCBI chr19:45,001,464...45,038,192
Ensembl chr19:45,001,461...45,038,192 		JBrowse link
G RFNG RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase decreases expression ISO folpet results in decreased expression of RFNG mRNA CTD PMID:31558096 NCBI chr17:82,047,902...82,051,811
Ensembl chr17:82,047,902...82,051,831 		JBrowse link
G RGS2 regulator of G protein signaling 2 decreases expression ISO folpet results in decreased expression of RGS2 mRNA CTD PMID:31558096 NCBI chr 1:192,809,039...192,812,275
Ensembl chr 1:192,809,039...192,812,275 		JBrowse link
G RHEB Ras homolog, mTORC1 binding increases expression ISO folpet results in increased expression of RHEB mRNA CTD PMID:31558096 NCBI chr 7:151,466,012...151,519,895
Ensembl chr 7:151,466,012...151,520,120 		JBrowse link
G RIMS1 regulating synaptic membrane exocytosis 1 decreases expression ISO folpet results in decreased expression of RIMS1 mRNA CTD PMID:31558096 NCBI chr 6:71,886,550...72,403,145
Ensembl chr 6:71,886,550...72,403,150 		JBrowse link
G RNASEH2A ribonuclease H2 subunit A decreases expression ISO folpet results in decreased expression of RNASEH2A mRNA CTD PMID:31558096 NCBI chr19:12,806,584...12,813,640
Ensembl chr19:12,806,584...12,813,640 		JBrowse link
G RNF125 ring finger protein 125 decreases expression ISO folpet results in decreased expression of RNF125 mRNA CTD PMID:31558096 NCBI chr18:32,018,825...32,088,144
Ensembl chr18:32,018,825...32,088,144 		JBrowse link
G RPA1 replication protein A1 decreases expression ISO folpet results in decreased expression of RPA1 mRNA CTD PMID:31558096 NCBI chr17:1,830,005...1,900,082
Ensembl chr17:1,829,702...1,900,082 		JBrowse link
G RPLP0 ribosomal protein lateral stalk subunit P0 increases expression ISO folpet results in increased expression of RPLP0 mRNA CTD PMID:31558096 NCBI chr12:120,196,699...120,201,111
Ensembl chr12:120,196,699...120,201,235 		JBrowse link
G RPN1 ribophorin I decreases expression ISO folpet results in decreased expression of RPN1 mRNA CTD PMID:31558096 NCBI chr 3:128,619,969...128,650,818
Ensembl chr 3:128,619,969...128,681,075 		JBrowse link
G RPS6KA1 ribosomal protein S6 kinase A1 decreases expression ISO folpet results in decreased expression of RPS6KA1 mRNA CTD PMID:31558096 NCBI chr 1:26,529,761...26,575,025
Ensembl chr 1:26,529,761...26,575,030 		JBrowse link
G RRAGA Ras related GTP binding A decreases expression ISO folpet results in decreased expression of RRAGA mRNA CTD PMID:31558096 NCBI chr 9:19,049,427...19,051,025
Ensembl chr 9:19,049,427...19,051,025 		JBrowse link
G RRS1 ribosome biogenesis regulator 1 homolog decreases expression ISO folpet results in decreased expression of RRS1 mRNA CTD PMID:31558096 NCBI chr 8:66,429,014...66,430,733
Ensembl chr 8:66,429,014...66,430,733 		JBrowse link
G S100A11 S100 calcium binding protein A11 increases expression ISO folpet results in increased expression of S100A11 mRNA CTD PMID:31558096 NCBI chr 1:152,032,506...152,037,004
Ensembl chr 1:152,032,506...152,047,907 		JBrowse link
G S100A6 S100 calcium binding protein A6 increases expression ISO folpet results in increased expression of S100A6 mRNA CTD PMID:31558096 NCBI chr 1:153,534,599...153,535,991
Ensembl chr 1:153,534,599...153,536,244 		JBrowse link
G SCG2 secretogranin II decreases expression ISO folpet results in decreased expression of SCG2 mRNA CTD PMID:31558096 NCBI chr 2:223,596,940...223,602,361
Ensembl chr 2:223,596,940...223,602,361 		JBrowse link
G SCP2 sterol carrier protein 2 increases expression ISO folpet results in increased expression of SCP2 mRNA CTD PMID:31558096 NCBI chr 1:52,927,276...53,051,698
Ensembl chr 1:52,927,276...53,051,698 		JBrowse link
G SEL1L SEL1L adaptor subunit of SYVN1 ubiquitin ligase decreases expression ISO folpet results in decreased expression of SEL1L mRNA CTD PMID:31558096 NCBI chr14:81,471,547...81,533,853
Ensembl chr14:81,471,547...81,533,853 		JBrowse link
G SELENON selenoprotein N decreases expression ISO folpet results in decreased expression of SEPN1 mRNA CTD PMID:31558096 NCBI chr 1:25,800,193...25,818,221
Ensembl chr 1:25,800,193...25,818,221 		JBrowse link
G SENP6 SUMO specific peptidase 6 decreases expression ISO folpet results in decreased expression of SENP6 mRNA CTD PMID:31558096 NCBI chr 6:75,601,880...75,718,281
Ensembl chr 6:75,601,509...75,718,281 		JBrowse link
G SEPTIN5 septin 5 increases expression ISO folpet results in increased expression of SEPTIN5 mRNA CTD PMID:31558096 NCBI chr22:19,714,503...19,723,319
Ensembl chr22:19,714,503...19,724,224 		JBrowse link
G SERPING1 serpin family G member 1 decreases expression ISO folpet results in decreased expression of SERPING1 mRNA CTD PMID:31558096 NCBI chr11:57,597,685...57,614,848
Ensembl chr11:57,597,387...57,619,171 		JBrowse link
G SESN1 sestrin 1 decreases expression ISO folpet results in decreased expression of SESN1 mRNA CTD PMID:31558096 NCBI chr 6:108,984,309...109,094,846
Ensembl chr 6:108,984,309...109,094,846 		JBrowse link
G SH3GL2 SH3 domain containing GRB2 like 2, endophilin A1 increases expression ISO folpet results in increased expression of SH3GL2 mRNA CTD PMID:31558096 NCBI chr 9:17,579,066...17,797,124
Ensembl chr 9:17,579,066...17,797,124 		JBrowse link
G SKP1 S-phase kinase associated protein 1 increases expression ISO folpet results in increased expression of SKP1 mRNA CTD PMID:31558096 NCBI chr 5:134,148,935...134,176,950
Ensembl chr 5:134,148,935...134,176,964 		JBrowse link
G SLC11A2 solute carrier family 11 member 2 increases expression ISO folpet results in increased expression of SLC11A2 mRNA CTD PMID:31558096 NCBI chr12:50,952,263...51,028,886
Ensembl chr12:50,979,401...51,028,566 		JBrowse link
G SLC16A3 solute carrier family 16 member 3 increases expression ISO folpet results in increased expression of SLC16A3 mRNA CTD PMID:31558096 NCBI chr17:82,217,934...82,240,086
Ensembl chr17:82,217,934...82,261,129 		JBrowse link
G SLC1A2 solute carrier family 1 member 2 decreases expression ISO folpet results in decreased expression of SLC1A2 mRNA CTD PMID:31558096 NCBI chr11:35,251,205...35,420,507
Ensembl chr11:35,251,205...35,420,063 		JBrowse link
G SLC1A3 solute carrier family 1 member 3 decreases expression ISO folpet results in decreased expression of SLC1A3 mRNA CTD PMID:31558096 NCBI chr 5:36,606,606...36,688,334
Ensembl chr 5:36,596,588...36,688,334 		JBrowse link
G SLC27A1 solute carrier family 27 member 1 decreases expression ISO folpet results in decreased expression of SLC27A1 mRNA CTD PMID:31558096 NCBI chr19:17,468,767...17,506,168
Ensembl chr19:17,468,769...17,506,168 		JBrowse link
G SLC27A2 solute carrier family 27 member 2 decreases expression ISO folpet results in decreased expression of SLC27A2 mRNA CTD PMID:31558096 NCBI chr15:50,182,196...50,236,385
Ensembl chr15:50,182,196...50,236,385 		JBrowse link
G SLC30A5 solute carrier family 30 member 5 decreases expression ISO folpet results in decreased expression of SLC30A5 mRNA CTD PMID:31558096 NCBI chr 5:69,094,014...69,131,069
Ensembl chr 5:69,093,991...69,131,069 		JBrowse link
G SLC35A3 solute carrier family 35 member A3 decreases expression ISO folpet results in decreased expression of SLC35A3 mRNA CTD PMID:31558096 NCBI chr 1:99,969,996...100,035,634
Ensembl chr 1:99,969,351...100,035,634 		JBrowse link
G SLC47A1 solute carrier family 47 member 1 increases expression ISO folpet results in increased expression of SLC47A1 mRNA CTD PMID:31558096 NCBI chr17:19,533,854...19,579,034
Ensembl chr17:19,495,385...19,579,034 		JBrowse link
G SLC51A solute carrier family 51 member A increases expression ISO folpet results in increased expression of SLC51A mRNA CTD PMID:31558096 NCBI chr 3:196,216,534...196,233,427
Ensembl chr 3:196,211,487...196,243,178 		JBrowse link
G SLC6A8 solute carrier family 6 member 8 increases expression ISO folpet results in increased expression of SLC6A8 mRNA CTD PMID:31558096 NCBI chr  X:153,687,926...153,696,593
Ensembl chr  X:153,687,926...153,696,588 		JBrowse link
G SLC7A11 solute carrier family 7 member 11 increases expression ISO folpet results in increased expression of SLC7A11 mRNA CTD PMID:31558096 NCBI chr 4:138,164,097...138,312,671
Ensembl chr 4:138,164,097...138,242,349 		JBrowse link
G SLCO2B1 solute carrier organic anion transporter family member 2B1 decreases expression ISO folpet results in decreased expression of SLCO2B1 mRNA CTD PMID:31558096 NCBI chr11:75,151,107...75,206,549
Ensembl chr11:75,100,563...75,206,549 		JBrowse link
G SMAD1 SMAD family member 1 decreases expression ISO folpet results in decreased expression of SMAD1 mRNA CTD PMID:31558096 NCBI chr 4:145,480,770...145,559,176
Ensembl chr 4:145,481,194...145,559,176 		JBrowse link
G SMARCC1 SWI/SNF related BAF chromatin remodeling complex subunit C1 decreases expression ISO folpet results in decreased expression of SMARCC1 mRNA CTD PMID:31558096 NCBI chr 3:47,585,269...47,781,893
Ensembl chr 3:47,585,269...47,782,106 		JBrowse link
G SMARCD2 SWI/SNF related BAF chromatin remodeling complex subunit D2 decreases expression ISO folpet results in decreased expression of SMARCD2 mRNA CTD PMID:31558096 NCBI chr17:63,832,081...63,842,685
Ensembl chr17:63,832,081...63,843,065 		JBrowse link
G SNRPB small nuclear ribonucleoprotein polypeptides B and B1 increases expression ISO folpet results in increased expression of SNRPB mRNA CTD PMID:31558096 NCBI chr20:2,461,642...2,470,789
Ensembl chr20:2,461,634...2,470,853 		JBrowse link
G SNRPE small nuclear ribonucleoprotein polypeptide E decreases expression ISO folpet results in decreased expression of SNRPE mRNA CTD PMID:31558096 NCBI chr 1:203,861,599...203,871,152
Ensembl chr 1:203,861,599...203,871,152 		JBrowse link
G SNX7 sorting nexin 7 increases expression ISO folpet results in increased expression of SNX7 mRNA CTD PMID:31558096 NCBI chr 1:98,661,319...98,760,500
Ensembl chr 1:98,661,701...98,760,500 		JBrowse link
G SOCS2 suppressor of cytokine signaling 2 decreases expression ISO folpet results in decreased expression of SOCS2 mRNA CTD PMID:31558096 NCBI chr12:93,569,969...93,626,236
Ensembl chr12:93,569,814...93,583,487 		JBrowse link
G SOD1 superoxide dismutase 1 increases expression ISO folpet results in increased expression of SOD1 mRNA CTD PMID:31558096 NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931 		JBrowse link
G SPCS2 signal peptidase complex subunit 2 increases expression ISO folpet results in increased expression of SPCS2 mRNA CTD PMID:31558096 NCBI chr11:74,949,266...74,979,033
Ensembl chr11:74,949,261...74,979,033 		JBrowse link
G SPCS3 signal peptidase complex subunit 3 decreases expression ISO folpet results in decreased expression of SPCS3 mRNA CTD PMID:31558096 NCBI chr 4:176,319,966...176,332,245
Ensembl chr 4:176,319,966...176,332,245 		JBrowse link
G SPDEF SAM pointed domain containing ETS transcription factor decreases expression ISO folpet results in decreased expression of SPDEF mRNA CTD PMID:31558096 NCBI chr 6:34,537,802...34,556,329
Ensembl chr 6:34,537,802...34,556,333 		JBrowse link
G SQLE squalene epoxidase decreases expression ISO folpet results in decreased expression of SQLE mRNA CTD PMID:31558096 NCBI chr 8:124,998,505...125,022,283
Ensembl chr 8:124,998,497...125,022,283 		JBrowse link
G SQOR sulfide quinone oxidoreductase increases expression ISO folpet results in increased expression of SQOR mRNA CTD PMID:31558096 NCBI chr15:45,631,148...45,691,281
Ensembl chr15:45,631,148...45,691,281 		JBrowse link
G SRD5A1 steroid 5 alpha-reductase 1 increases expression ISO folpet results in increased expression of SRD5A1 mRNA CTD PMID:31558096 NCBI chr 5:6,633,440...6,674,386
Ensembl chr 5:6,633,290...6,676,539 		JBrowse link
G SRRT serrate, RNA effector molecule decreases expression ISO folpet results in decreased expression of SRRT mRNA CTD PMID:31558096 NCBI chr 7:100,875,103...100,888,664
Ensembl chr 7:100,875,103...100,888,664 		JBrowse link
G SRSF1 serine and arginine rich splicing factor 1 decreases expression ISO folpet results in decreased expression of SRSF1 mRNA CTD PMID:31558096 NCBI chr17:57,989,038...58,007,246
Ensembl chr17:58,000,919...58,007,346 		JBrowse link
G SRXN1 sulfiredoxin 1 increases expression ISO folpet results in increased expression of SRXN1 mRNA CTD PMID:31558096 NCBI chr20:646,615...653,200
Ensembl chr20:646,615...653,200 		JBrowse link
G ST14 ST14 transmembrane serine protease matriptase increases expression ISO folpet results in increased expression of ST14 mRNA CTD PMID:31558096 NCBI chr11:130,159,782...130,210,362
Ensembl chr11:130,159,782...130,210,362 		JBrowse link
G ST3GAL2 ST3 beta-galactoside alpha-2,3-sialyltransferase 2 decreases expression ISO folpet results in decreased expression of ST3GAL2 mRNA CTD PMID:31558096 NCBI chr16:70,375,977...70,439,100
Ensembl chr16:70,375,977...70,439,237 		JBrowse link
G STRBP spermatid perinuclear RNA binding protein increases expression ISO folpet results in increased expression of STRBP mRNA CTD PMID:31558096 NCBI chr 9:123,109,494...123,268,586
Ensembl chr 9:123,109,500...123,268,586 		JBrowse link
G STUB1 STIP1 homology and U-box containing protein 1 increases expression ISO folpet results in increased expression of STUB1 mRNA CTD PMID:31558096 NCBI chr16:680,410...682,801
Ensembl chr16:680,224...682,870 		JBrowse link
G STXBP2 syntaxin binding protein 2 increases expression ISO folpet results in increased expression of STXBP2 mRNA CTD PMID:31558096 NCBI chr19:7,629,793...7,647,873
Ensembl chr19:7,636,772...7,647,873 		JBrowse link
G SULT1B1 sulfotransferase family 1B member 1 increases expression ISO folpet results in increased expression of SULT1B1 mRNA CTD PMID:31558096 NCBI chr 4:69,721,167...69,760,620
Ensembl chr 4:69,721,167...69,787,961 		JBrowse link
G SUMF1 sulfatase modifying factor 1 decreases expression ISO folpet results in decreased expression of SUMF1 mRNA CTD PMID:31558096 NCBI chr 3:3,700,814...3,800,875
Ensembl chr 3:3,700,814...4,467,273 		JBrowse link
G TAB2 TGF-beta activated kinase 1 (MAP3K7) binding protein 2 decreases expression ISO folpet results in decreased expression of TAB2 mRNA CTD PMID:31558096 NCBI chr 6:149,217,926...149,411,607
Ensembl chr 6:149,218,641...149,411,613 		JBrowse link
G TALDO1 transaldolase 1 increases expression ISO folpet results in increased expression of TALDO1 mRNA CTD PMID:31558096 NCBI chr11:747,464...765,012
Ensembl chr11:747,415...765,012 		JBrowse link
G TAX1BP3 Tax1 binding protein 3 increases expression ISO folpet results in increased expression of TAX1BP3 mRNA CTD PMID:31558096 NCBI chr17:3,662,895...3,668,578
Ensembl chr17:3,662,895...3,668,679 		JBrowse link
G TBX2 T-box transcription factor 2 decreases expression ISO folpet results in decreased expression of TBX2 mRNA CTD PMID:31558096 NCBI chr17:61,399,843...61,409,466
Ensembl chr17:61,399,843...61,409,466 		JBrowse link
G TCF4 transcription factor 4 decreases expression ISO folpet results in decreased expression of TCF4 mRNA CTD PMID:31558096 NCBI chr18:55,222,185...55,635,957
Ensembl chr18:55,222,185...55,664,787 		JBrowse link
G TCP1 t-complex 1 increases expression ISO folpet results in increased expression of TCP1 mRNA CTD PMID:31558096 NCBI chr 6:159,778,498...159,789,602
Ensembl chr 6:159,778,498...159,789,703 		JBrowse link
G TESK1 testis associated actin remodelling kinase 1 decreases expression ISO folpet results in decreased expression of TESK1 mRNA CTD PMID:31558096 NCBI chr 9:35,605,262...35,610,033
Ensembl chr 9:35,605,262...35,610,041 		JBrowse link
G THBD thrombomodulin decreases expression ISO folpet results in decreased expression of THBD mRNA CTD PMID:31558096 NCBI chr20:23,045,633...23,049,672
Ensembl chr20:23,045,633...23,049,672 		JBrowse link
G THY1 Thy-1 cell surface antigen decreases expression ISO folpet results in decreased expression of THY1 mRNA CTD PMID:31558096 NCBI chr11:119,415,476...119,424,985
Ensembl chr11:119,415,476...119,424,985 		JBrowse link
G TIAM1 TIAM Rac1 associated GEF 1 decreases expression ISO folpet results in decreased expression of TIAM1 mRNA CTD PMID:31558096 NCBI chr21:31,118,418...31,559,087
Ensembl chr21:31,118,416...31,559,977 		JBrowse link
G TIGAR TP53 induced glycolysis regulatory phosphatase increases expression ISO folpet results in increased expression of TIGAR mRNA CTD PMID:31558096 NCBI chr12:4,321,213...4,360,028
Ensembl chr12:4,307,763...4,360,028 		JBrowse link
G TIMM17A translocase of inner mitochondrial membrane 17A increases expression ISO folpet results in increased expression of TIMM17A mRNA CTD PMID:31558096 NCBI chr 1:201,955,503...201,970,664
Ensembl chr 1:201,955,503...201,970,664 		JBrowse link
G TJP1 tight junction protein 1 decreases expression ISO folpet results in decreased expression of TJP1 mRNA CTD PMID:31558096 NCBI chr15:29,699,367...29,969,049
Ensembl chr15:29,699,367...29,968,915 		JBrowse link
G TM7SF3 transmembrane 7 superfamily member 3 decreases expression ISO folpet results in decreased expression of TM7SF3 mRNA CTD PMID:31558096 NCBI chr12:26,971,579...27,014,384
Ensembl chr12:26,971,579...27,014,434 		JBrowse link
G TM9SF3 transmembrane 9 superfamily member 3 decreases expression ISO folpet results in decreased expression of TM9SF3 mRNA CTD PMID:31558096 NCBI chr10:96,518,110...96,587,012
Ensembl chr10:96,518,110...96,587,452 		JBrowse link
G TMC7 transmembrane channel like 7 increases expression ISO folpet results in increased expression of TMC7 mRNA CTD PMID:31558096 NCBI chr16:18,983,934...19,063,942
Ensembl chr16:18,983,934...19,063,942 		JBrowse link
G TMEM109 transmembrane protein 109 decreases expression ISO folpet results in decreased expression of TMEM109 mRNA CTD PMID:31558096 NCBI chr11:60,914,158...60,923,443
Ensembl chr11:60,913,907...60,923,443 		JBrowse link
G TMEM97 transmembrane protein 97 decreases expression ISO folpet results in decreased expression of TMEM97 mRNA CTD PMID:31558096 NCBI chr17:28,319,200...28,328,685
Ensembl chr17:28,319,200...28,328,685 		JBrowse link
G TNIP1 TNFAIP3 interacting protein 1 increases expression ISO folpet results in increased expression of TNIP1 mRNA CTD PMID:31558096 NCBI chr 5:151,029,943...151,087,685
Ensembl chr 5:151,029,945...151,093,577 		JBrowse link
G TOR1A torsin family 1 member A increases expression ISO folpet results in increased expression of TOR1A mRNA CTD PMID:31558096 NCBI chr 9:129,812,942...129,824,136
Ensembl chr 9:129,812,942...129,824,244 		JBrowse link
G TP53INP2 tumor protein p53 inducible nuclear protein 2 decreases expression ISO folpet results in decreased expression of TRP53INP2 mRNA CTD PMID:31558096 NCBI chr20:34,704,344...34,713,436
Ensembl chr20:34,704,339...34,713,439 		JBrowse link
G TPI1 triosephosphate isomerase 1 increases expression ISO folpet results in increased expression of TPI1 mRNA CTD PMID:31558096 NCBI chr12:6,867,420...6,870,948
Ensembl chr12:6,867,119...6,870,948 		JBrowse link
G TRAP1 TNF receptor associated protein 1 decreases expression ISO folpet results in decreased expression of TRAP1 mRNA CTD PMID:31558096 NCBI chr16:3,658,037...3,717,524
Ensembl chr16:3,651,639...3,717,553 		JBrowse link
G TRGC2 T cell receptor gamma constant 2 decreases expression ISO folpet results in decreased expression of TRGC3 mRNA CTD PMID:31558096 NCBI chr 7:38,240,024...38,249,572
Ensembl chr 7:38,239,580...38,249,572 		JBrowse link
G TRIB1 tribbles pseudokinase 1 increases expression ISO folpet results in increased expression of TRIB1 mRNA CTD PMID:31558096 NCBI chr 8:125,430,358...125,438,403
Ensembl chr 8:125,430,358...125,438,403 		JBrowse link
G TRIM28 tripartite motif containing 28 decreases expression ISO folpet results in decreased expression of TRIM28 mRNA CTD PMID:31558096 NCBI chr19:58,544,064...58,550,715
Ensembl chr19:58,544,064...58,550,722 		JBrowse link
G TSC2 TSC complex subunit 2 decreases expression ISO folpet results in decreased expression of TSC2 mRNA CTD PMID:31558096 NCBI chr16:2,047,985...2,089,491
Ensembl chr16:2,047,967...2,089,491 		JBrowse link
G TSC22D3 TSC22 domain family member 3 increases expression ISO folpet results in increased expression of TSC22D3 mRNA CTD PMID:31558096 NCBI chr  X:107,713,221...107,775,988
Ensembl chr  X:107,713,221...107,777,342 		JBrowse link
G TSKU tsukushi, small leucine rich proteoglycan increases expression ISO folpet results in increased expression of TSKU mRNA CTD PMID:31558096 NCBI chr11:76,782,280...76,798,144
Ensembl chr11:76,782,251...76,798,153 		JBrowse link
G TSPAN6 tetraspanin 6 decreases expression ISO folpet results in decreased expression of TSPAN6 mRNA CTD PMID:31558096 NCBI chr  X:100,627,108...100,637,104
Ensembl chr  X:100,627,108...100,639,991 		JBrowse link
G TTC17 tetratricopeptide repeat domain 17 increases expression ISO folpet results in increased expression of TTC17 mRNA CTD PMID:31558096 NCBI chr11:43,358,920...43,494,931
Ensembl chr11:43,358,920...43,494,933 		JBrowse link
G TUBA4A tubulin alpha 4a increases expression ISO folpet results in increased expression of TUBA4A mRNA CTD PMID:31558096 NCBI chr 2:219,249,710...219,254,740
Ensembl chr 2:219,249,710...219,277,902 		JBrowse link
G TUBB2A tubulin beta 2A class IIa increases expression ISO folpet results in increased expression of TUBB2A mRNA CTD PMID:31558096 NCBI chr 6:3,153,666...3,157,544
Ensembl chr 6:3,153,497...3,157,544 		JBrowse link
G TUBB6 tubulin beta 6 class V decreases expression ISO folpet results in decreased expression of TUBB6 mRNA CTD PMID:31558096 NCBI chr18:12,307,669...12,329,826
Ensembl chr18:12,307,669...12,344,320 		JBrowse link
G TXNRD1 thioredoxin reductase 1 increases expression ISO folpet results in increased expression of TXNRD1 mRNA CTD PMID:31558096 NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307 		JBrowse link
G TXNRD2 thioredoxin reductase 2 increases expression ISO folpet results in increased expression of TXNRD2 mRNA CTD PMID:31558096 NCBI chr22:19,875,522...19,941,818
Ensembl chr22:19,875,517...19,941,820 		JBrowse link
G UGDH UDP-glucose 6-dehydrogenase increases expression ISO folpet results in increased expression of UGDH mRNA CTD PMID:31558096 NCBI chr 4:39,498,755...39,527,439
Ensembl chr 4:39,498,755...39,528,311 		JBrowse link
G UGT1A4 UDP glucuronosyltransferase family 1 member A4 increases expression ISO folpet results in increased expression of UGT1A5 mRNA CTD PMID:31558096 NCBI chr 2:233,718,736...233,773,300
Ensembl chr 2:233,718,736...233,773,300 		JBrowse link
G UQCRFS1 ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 increases expression ISO folpet results in increased expression of UQCRFS1 mRNA CTD PMID:31558096 NCBI chr19:29,205,320...29,213,151
Ensembl chr19:29,205,320...29,213,151 		JBrowse link
G UTP4 UTP4 small subunit processome component decreases expression ISO folpet results in decreased expression of UTP4 mRNA CTD PMID:31558096 NCBI chr16:69,132,649...69,169,021
Ensembl chr16:69,131,291...69,231,130 		JBrowse link
G VAT1 vesicle amine transport 1 increases expression ISO folpet results in increased expression of VAT1 mRNA CTD PMID:31558096 NCBI chr17:43,014,607...43,022,385
Ensembl chr17:43,014,607...43,025,123 		JBrowse link
G VDAC1 voltage dependent anion channel 1 increases expression ISO folpet results in increased expression of VDAC1 mRNA CTD PMID:31558096 NCBI chr 5:133,971,871...134,114,540
Ensembl chr 5:133,971,871...134,004,975 		JBrowse link
G VEGFA vascular endothelial growth factor A decreases expression ISO folpet results in decreased expression of VEGFA mRNA CTD PMID:31558096 NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487 		JBrowse link
G VIM vimentin decreases expression ISO folpet results in decreased expression of VIM mRNA CTD PMID:31558096 NCBI chr10:17,228,241...17,237,593
Ensembl chr10:17,228,241...17,237,593 		JBrowse link
G VPS4A vacuolar protein sorting 4 homolog A increases expression ISO folpet results in increased expression of VPS4A mRNA CTD PMID:31558096 NCBI chr16:69,311,350...69,326,939
Ensembl chr16:69,311,336...69,326,939 		JBrowse link
G WDR3 WD repeat domain 3 decreases expression ISO folpet results in decreased expression of WDR3 mRNA CTD PMID:31558096 NCBI chr 1:117,929,739...117,966,543
Ensembl chr 1:117,929,720...117,966,543 		JBrowse link
G WDTC1 WD and tetratricopeptide repeats 1 decreases expression ISO folpet results in decreased expression of WDTC1 mRNA CTD PMID:31558096 NCBI chr 1:27,234,441...27,308,636
Ensembl chr 1:27,234,632...27,308,636 		JBrowse link
G WIPF2 WAS/WASL interacting protein family member 2 increases expression ISO folpet results in increased expression of WIPF2 mRNA CTD PMID:31558096 NCBI chr17:40,219,304...40,284,136
Ensembl chr17:40,219,304...40,284,136 		JBrowse link
G XBP1 X-box binding protein 1 decreases expression ISO folpet results in decreased expression of XBP1 mRNA CTD PMID:31558096 NCBI chr22:28,794,560...28,800,569
Ensembl chr22:28,794,555...28,800,597 		JBrowse link
G XPO7 exportin 7 increases expression ISO folpet results in increased expression of XPO7 mRNA CTD PMID:31558096 NCBI chr 8:21,919,662...22,006,585
Ensembl chr 8:21,919,662...22,006,585 		JBrowse link
G YARS2 tyrosyl-tRNA synthetase 2 decreases expression ISO folpet results in decreased expression of YARS2 mRNA CTD PMID:31558096 NCBI chr12:32,746,544...32,755,897
Ensembl chr12:32,727,490...32,755,897 		JBrowse link
G YKT6 YKT6 v-SNARE homolog increases expression ISO folpet results in increased expression of YKT6 mRNA CTD PMID:31558096 NCBI chr 7:44,200,978...44,214,294
Ensembl chr 7:44,200,959...44,214,294 		JBrowse link
G YTHDF1 YTH N6-methyladenosine RNA binding protein F1 decreases expression ISO folpet results in decreased expression of YTHDF1 mRNA CTD PMID:31558096 NCBI chr20:63,195,429...63,216,131
Ensembl chr20:63,195,429...63,216,139 		JBrowse link
G YWHAZ tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta increases expression ISO folpet results in increased expression of YWHAZ mRNA CTD PMID:31558096 NCBI chr 8:100,916,523...100,953,382
Ensembl chr 8:100,916,523...100,953,388 		JBrowse link
G ZBP1 Z-DNA binding protein 1 decreases expression ISO folpet results in decreased expression of ZBP1 mRNA CTD PMID:31558096 NCBI chr20:57,603,852...57,620,426
Ensembl chr20:57,603,846...57,620,576 		JBrowse link
G ZG16 zymogen granule protein 16 decreases expression ISO folpet results in decreased expression of ZG16 mRNA CTD PMID:31558096 NCBI chr16:29,778,256...29,782,973
Ensembl chr16:29,778,256...29,782,973 		JBrowse link
G ZNF395 zinc finger protein 395 decreases expression ISO folpet results in decreased expression of ZFP395 mRNA CTD PMID:31558096 NCBI chr 8:28,345,590...28,386,460
Ensembl chr 8:28,345,590...28,402,701 		JBrowse link
G ZNHIT6 zinc finger HIT-type containing 6 increases expression ISO folpet results in increased expression of ZNHIT6 mRNA CTD PMID:31558096 NCBI chr 1:85,649,417...85,708,433
Ensembl chr 1:85,649,417...85,708,433 		JBrowse link
indoprofen term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AGER advanced glycosylation end-product specific receptor multiple interactions EXP Indoprofen inhibits the reaction [HMGB1 protein results in increased expression of AGER mRNA]; Indoprofen inhibits the reaction [HMGB1 protein results in increased expression of and affects the localization of AGER protein] CTD PMID:34755645 NCBI chr 6:32,180,969...32,184,253
Ensembl chr 6:32,180,968...32,184,322 		JBrowse link
G HMGB1 high mobility group box 1 multiple interactions EXP
ISO 		Indoprofen inhibits the reaction [HMGB1 protein results in increased expression of AGER mRNA]; Indoprofen inhibits the reaction [HMGB1 protein results in increased expression of and affects the localization of AGER protein]; Indoprofen inhibits the reaction [HMGB1 protein results in increased expression of PTGS2 protein]; Indoprofen inhibits the reaction [HMGB1 protein results in increased localization of TLR2 protein]; Indoprofen inhibits the reaction [HMGB1 protein results in increased localization of TLR4 protein]; Indoprofen inhibits the reaction [HMGB1 protein results in increased phosphorylation of MAPK1 protein]; Indoprofen inhibits the reaction [HMGB1 protein results in increased phosphorylation of MAPK3 protein]; Indoprofen inhibits the reaction [HMGB1 protein results in increased phosphorylation of NFKBIA protein]; Indoprofen inhibits the reaction [HMGB1 protein results in increased secretion of IL1B protein]; Indoprofen inhibits the reaction [HMGB1 protein results in increased secretion of IL6 protein]; Indoprofen inhibits the reaction [HMGB1 protein results in increased secretion of TNF protein]; Indoprofen inhibits the reaction [Lipopolysaccharides results in increased secretion of HMGB1 mRNA]; Indoprofen inhibits the reaction [Lipopolysaccharides results in increased secretion of HMGB1 protein]; Indoprofen inhibits the reaction [Poly I-C results in increased secretion of and affects the localization of HMGB1 protein]
Indoprofen inhibits the reaction [HMGB1 protein affects the localization of RELA protein]; Indoprofen inhibits the reaction [HMGB1 protein results in increased phosphorylation of MAPK1 protein]; Indoprofen inhibits the reaction [HMGB1 protein results in increased phosphorylation of MAPK3 protein]; Indoprofen inhibits the reaction [HMGB1 protein results in increased phosphorylation of NFKBIA protein] 		CTD PMID:34755645 NCBI chr13:30,456,704...30,617,597
Ensembl chr13:30,456,704...30,617,597 		JBrowse link
G IL1B interleukin 1 beta multiple interactions EXP Indoprofen inhibits the reaction [HMGB1 protein results in increased secretion of IL1B protein] CTD PMID:34755645 NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816 		JBrowse link
G IL6 interleukin 6 multiple interactions EXP Indoprofen inhibits the reaction [HMGB1 protein results in increased secretion of IL6 protein] CTD PMID:34755645 NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002 		JBrowse link
G MAPK1 mitogen-activated protein kinase 1 multiple interactions ISO
EXP 		Indoprofen inhibits the reaction [HMGB1 protein results in increased phosphorylation of MAPK1 protein] CTD PMID:34755645 NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680 		JBrowse link
G MAPK3 mitogen-activated protein kinase 3 multiple interactions ISO
EXP 		Indoprofen inhibits the reaction [HMGB1 protein results in increased phosphorylation of MAPK3 protein] CTD PMID:34755645 NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506 		JBrowse link
G NFKBIA NFKB inhibitor alpha multiple interactions EXP
ISO 		Indoprofen inhibits the reaction [HMGB1 protein results in increased phosphorylation of NFKBIA protein] CTD PMID:34755645 NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749 		JBrowse link
G NR1I2 nuclear receptor subfamily 1 group I member 2 increases activity EXP Indoprofen results in increased activity of NR1I2 protein CTD PMID:25455453 NCBI chr 3:119,782,101...119,818,487
Ensembl chr 3:119,780,484...119,818,487 		JBrowse link
G PTGS2 prostaglandin-endoperoxide synthase 2 multiple interactions EXP Indoprofen inhibits the reaction [HMGB1 protein results in increased expression of PTGS2 protein] CTD PMID:34755645 NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922 		JBrowse link
G RELA RELA proto-oncogene, NF-kB subunit multiple interactions ISO Indoprofen inhibits the reaction [HMGB1 protein affects the localization of RELA protein] CTD PMID:34755645 NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090 		JBrowse link
G TLR2 toll like receptor 2 multiple interactions EXP Indoprofen inhibits the reaction [HMGB1 protein results in increased localization of TLR2 protein] CTD PMID:34755645 NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,050...153,706,260 		JBrowse link
G TLR4 toll like receptor 4 multiple interactions EXP Indoprofen inhibits the reaction [HMGB1 protein results in increased localization of TLR4 protein] CTD PMID:34755645 NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735 		JBrowse link
G TNF tumor necrosis factor multiple interactions EXP Indoprofen inhibits the reaction [HMGB1 protein results in increased secretion of TNF protein] CTD PMID:34755645 NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336 		JBrowse link
G UGT1A10 UDP glucuronosyltransferase family 1 member A10 increases glucuronidation EXP UGT1A10 protein results in increased glucuronidation of Indoprofen CTD PMID:15117964 NCBI chr 2:233,636,448...233,773,300
Ensembl chr 2:233,636,448...233,773,300 		JBrowse link
G UGT1A3 UDP glucuronosyltransferase family 1 member A3 increases glucuronidation EXP UGT1A3 protein results in increased glucuronidation of Indoprofen CTD PMID:15117964 NCBI chr 2:233,729,042...233,773,300
Ensembl chr 2:233,729,042...233,773,300 		JBrowse link
G UGT1A7 UDP glucuronosyltransferase family 1 member A7 increases glucuronidation EXP UGT1A7 protein results in increased glucuronidation of Indoprofen CTD PMID:15117964 NCBI chr 2:233,681,901...233,773,300
Ensembl chr 2:233,681,901...233,773,300 		JBrowse link
G UGT1A8 UDP glucuronosyltransferase family 1 member A8 increases glucuronidation EXP UGT1A8 protein results in increased glucuronidation of Indoprofen CTD PMID:15117964 NCBI chr 2:233,617,633...233,773,300
Ensembl chr 2:233,617,633...233,773,300 		JBrowse link
lenalidomide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CASP1 caspase 1 multiple interactions ISO Lenalidomide inhibits the reaction [[Arsenic Trioxide co-treated with Lipopolysaccharides] results in increased cleavage of CASP1 protein] CTD PMID:30660605 NCBI chr11:105,025,443...105,036,686
Ensembl chr11:105,025,397...105,035,250 		JBrowse link
G CRBN cereblon multiple interactions
affects binding
increases response to substance 		EXP lenalidomide inhibits the reaction [CRBN protein binds to and results in increased ubiquitination of and results in increased degradation of MEIS2 protein]
lenalidomide binds to [CRBN protein binds to DDB1 protein]; lenalidomide binds to [SALL4 protein binds to CRBN protein]
CRBN results in increased susceptibility to lenalidomide 		CTD PMID:25043012 PMID:25108355 PMID:26186254 PMID:30067223 NCBI chr 3:3,149,633...3,179,717
Ensembl chr 3:3,144,628...3,179,727 		JBrowse link
G CSNK1A1 casein kinase 1 alpha 1 multiple interactions EXP lenalidomide results in increased degradation of and results in decreased expression of CSNK1A1 protein CTD PMID:30067223 NCBI chr 5:149,492,982...149,551,439
Ensembl chr 5:149,492,982...149,551,471 		JBrowse link
G DDB1 damage specific DNA binding protein 1 affects binding EXP lenalidomide binds to [CRBN protein binds to DDB1 protein] CTD PMID:25108355 NCBI chr11:61,299,451...61,333,105
Ensembl chr11:61,299,451...61,342,596 		JBrowse link
G F2R coagulation factor II thrombin receptor decreases expression EXP lenalidomide results in decreased expression of F2R mRNA; lenalidomide results in decreased expression of F2R protein CTD PMID:15618473 NCBI chr 5:76,716,126...76,735,770
Ensembl chr 5:76,716,126...76,735,770 		JBrowse link
G F3 coagulation factor III, tissue factor multiple interactions EXP [Dexamethasone co-treated with Lenalidomide co-treated with Bortezomib] results in increased expression of F3 mRNA; [Dexamethasone co-treated with Lenalidomide co-treated with Bortezomib] results in increased expression of F3 protein; [Dexamethasone co-treated with Lenalidomide] results in increased expression of F3 mRNA; [Dexamethasone co-treated with Lenalidomide] results in increased expression of F3 protein CTD PMID:23696885 NCBI chr 1:94,529,173...94,541,759
Ensembl chr 1:94,529,173...94,541,759 		JBrowse link
G FAM83F family with sequence similarity 83 member F multiple interactions EXP lenalidomide results in increased degradation of and results in decreased expression of FAM83F protein CTD PMID:30067223 NCBI chr22:39,994,954...40,043,534
Ensembl chr22:39,994,954...40,043,534 		JBrowse link
G FASLG Fas ligand multiple interactions ISO lenalidomide inhibits the reaction [SOD1 gene mutant form results in increased expression of FASL mRNA] CTD PMID:16510725 NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876 		JBrowse link
G FGFR1 fibroblast growth factor receptor 1 affects expression EXP Lenalidomide affects the expression of FGFR1 mRNA CTD PMID:30834740 NCBI chr 8:38,411,143...38,468,635
Ensembl chr 8:38,400,215...38,468,834 		JBrowse link
G FGFR2 fibroblast growth factor receptor 2 decreases expression EXP Lenalidomide results in decreased expression of FGFR2 mRNA; Lenalidomide results in decreased expression of FGFR2 protein CTD PMID:30834740 NCBI chr10:121,478,330...121,598,458
Ensembl chr10:121,478,332...121,598,458 		JBrowse link
G FGFR3 fibroblast growth factor receptor 3 decreases expression EXP Lenalidomide results in decreased expression of FGFR3 mRNA CTD PMID:30834740 NCBI chr 4:1,793,293...1,808,867
Ensembl chr 4:1,793,293...1,808,872 		JBrowse link
G IL12B interleukin 12B multiple interactions ISO lenalidomide inhibits the reaction [SOD1 gene mutant form results in increased expression of IL12B mRNA] CTD PMID:16510725 NCBI chr 5:159,314,780...159,330,487
Ensembl chr 5:159,314,780...159,330,863 		JBrowse link
G IL1A interleukin 1 alpha multiple interactions ISO lenalidomide inhibits the reaction [SOD1 gene mutant form results in increased expression of IL1A mRNA] CTD PMID:16510725 NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493 		JBrowse link
G IL1B interleukin 1 beta multiple interactions ISO lenalidomide inhibits the reaction [SOD1 gene mutant form results in increased expression of IL1B mRNA]
Lenalidomide inhibits the reaction [[Arsenic Trioxide co-treated with Lipopolysaccharides] results in increased expression of IL1B protein] 		CTD PMID:16510725 PMID:30660605 NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816 		JBrowse link
G IL1R1 interleukin 1 receptor type 1 decreases expression EXP lenalidomide results in decreased expression of IL1R1 mRNA CTD PMID:15618473 NCBI chr 2:102,070,390...102,179,874
Ensembl chr 2:102,064,544...102,179,874 		JBrowse link
G IL1RN interleukin 1 receptor antagonist multiple interactions ISO lenalidomide promotes the reaction [SOD1 gene mutant form results in increased expression of IL1RN mRNA] CTD PMID:16510725 NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016 		JBrowse link
G IL2 interleukin 2 multiple interactions EXP lenalidomide promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased secretion of IL2 protein] CTD PMID:16241859 NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725 		JBrowse link
G IL6ST interleukin 6 cytokine family signal transducer decreases expression EXP lenalidomide results in decreased expression of IL6ST mRNA CTD PMID:15618473 NCBI chr 5:55,935,095...55,994,963
Ensembl chr 5:55,935,095...55,995,022 		JBrowse link
G INS-IGF2 INS-IGF2 readthrough multiple interactions ISO Lenalidomide inhibits the reaction [Arsenic Trioxide inhibits the reaction [[Glucose co-treated with Lipopolysaccharides] results in increased secretion of INS1 protein]] CTD PMID:30660605 NCBI chr11:2,129,117...2,161,209
Ensembl chr11:2,132,538...2,161,209 		JBrowse link
G MEIS2 Meis homeobox 2 multiple interactions EXP lenalidomide inhibits the reaction [CRBN protein binds to and results in increased ubiquitination of and results in increased degradation of MEIS2 protein] CTD PMID:25043012 NCBI chr15:36,889,204...37,101,311
Ensembl chr15:36,889,204...37,101,299 		JBrowse link
G RAB28 RAB28, member RAS oncogene family multiple interactions EXP lenalidomide results in increased degradation of and results in decreased expression of RAB28 protein CTD PMID:30067223 NCBI chr 4:13,367,724...13,484,340
Ensembl chr 4:13,361,354...13,484,365 		JBrowse link
G SALL4 spalt like transcription factor 4 multiple interactions
affects binding 		EXP lenalidomide results in increased degradation of and results in decreased expression of SALL4 protein
lenalidomide binds to [SALL4 protein binds to CRBN protein] 		CTD PMID:30067223 NCBI chr20:51,782,331...51,802,521
Ensembl chr20:51,782,331...51,802,521 		JBrowse link
G SOD1 superoxide dismutase 1 multiple interactions ISO lenalidomide inhibits the reaction [SOD1 gene mutant form results in increased expression of FASL mRNA]; lenalidomide inhibits the reaction [SOD1 gene mutant form results in increased expression of IL12B mRNA]; lenalidomide inhibits the reaction [SOD1 gene mutant form results in increased expression of IL1A mRNA]; lenalidomide inhibits the reaction [SOD1 gene mutant form results in increased expression of IL1B mRNA]; lenalidomide inhibits the reaction [SOD1 gene mutant form results in increased expression of TNF mRNA]; lenalidomide promotes the reaction [SOD1 gene mutant form results in increased expression of IL1RN mRNA]; lenalidomide promotes the reaction [SOD1 gene mutant form results in increased expression of TGFB1 mRNA] CTD PMID:16510725 NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931 		JBrowse link
G TEK TEK receptor tyrosine kinase decreases expression EXP lenalidomide results in decreased expression of TEK mRNA CTD PMID:15618473 NCBI chr 9:27,109,225...27,230,174
Ensembl chr 9:27,109,141...27,230,174 		JBrowse link
G TGFB1 transforming growth factor beta 1 multiple interactions ISO lenalidomide promotes the reaction [SOD1 gene mutant form results in increased expression of TGFB1 mRNA] CTD PMID:16510725 NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922 		JBrowse link
G TGFBR1 transforming growth factor beta receptor 1 decreases expression EXP lenalidomide results in decreased expression of TGFBR1 mRNA; lenalidomide results in decreased expression of TGFBR1 protein CTD PMID:15618473 NCBI chr 9:99,103,647...99,154,192
Ensembl chr 9:99,104,038...99,154,192 		JBrowse link
G TNF tumor necrosis factor multiple interactions ISO lenalidomide inhibits the reaction [SOD1 gene mutant form results in increased expression of TNF mRNA]
Lenalidomide inhibits the reaction [[Arsenic Trioxide co-treated with Lipopolysaccharides] results in increased expression of TNF protein] 		CTD PMID:16510725 PMID:30660605 NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336 		JBrowse link
G TNFRSF1A TNF receptor superfamily member 1A decreases expression EXP lenalidomide results in decreased expression of TNFRSF1A mRNA CTD PMID:15618473 NCBI chr12:6,328,771...6,342,076
Ensembl chr12:6,328,757...6,342,114 		JBrowse link
G TNFRSF1B TNF receptor superfamily member 1B decreases expression EXP lenalidomide results in decreased expression of TNFRSF1B mRNA CTD PMID:15618473 NCBI chr 1:12,166,991...12,209,220
Ensembl chr 1:12,166,991...12,209,228 		JBrowse link
G ZNF827 zinc finger protein 827 multiple interactions EXP lenalidomide results in increased degradation of and results in decreased expression of ZNF827 protein CTD PMID:30067223 NCBI chr 4:145,757,627...145,938,823
Ensembl chr 4:145,757,627...145,938,823 		JBrowse link
phosmet term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ACHE acetylcholinesterase (Yt blood group) decreases activity EXP
ISO 		Phosmet metabolite results in decreased activity of ACHE protein; Phosmet results in decreased activity of ACHE protein CTD PMID:30625376 PMID:33720374 NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974 		JBrowse link
G IL13 interleukin 13 increases expression EXP Phosmet results in increased expression of IL13 mRNA CTD PMID:22265773 NCBI chr 5:132,656,522...132,661,110
Ensembl chr 5:132,656,263...132,661,110 		JBrowse link
G IL17A interleukin 17A increases expression EXP Phosmet results in increased expression of IL17A mRNA CTD PMID:22265773 NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638 		JBrowse link
G TNF tumor necrosis factor increases secretion EXP Phosmet results in increased secretion of TNF mRNA; Phosmet results in increased secretion of TNF protein CTD PMID:22265773 NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336 		JBrowse link
G TP53 tumor protein p53 affects activity EXP Phosmet metabolite affects the activity of TP53 protein CTD PMID:35435491 NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,546 		JBrowse link
phthalimide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G TNF tumor necrosis factor decreases expression
increases expression 		EXP phthalimide analog results in decreased expression of TNF protein
phthalimide analog results in increased expression of TNF protein 		CTD PMID:12729831 NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336 		JBrowse link
pomalidomide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G BRD4 bromodomain containing 4 multiple interactions EXP pomalidomide inhibits the reaction [ARV-825 results in increased degradation of BRD4 protein] CTD PMID:26051217 NCBI chr19:15,235,519...15,332,539
Ensembl chr19:15,235,519...15,332,545 		JBrowse link
G CASP3 caspase 3 multiple interactions EXP [afuresertib co-treated with pomalidomide co-treated with Dexamethasone] results in increased cleavage of CASP3 protein CTD PMID:29928335 NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062 		JBrowse link
G CASP8 caspase 8 multiple interactions EXP [afuresertib co-treated with pomalidomide co-treated with Dexamethasone] results in increased cleavage of CASP8 protein CTD PMID:29928335 NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836 		JBrowse link
G CCL2 C-C motif chemokine ligand 2 increases secretion EXP pomalidomide results in increased secretion of CCL2 protein CTD PMID:15292067 NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208 		JBrowse link
G CEBPA CCAAT enhancer binding protein alpha increases expression EXP pomalidomide results in increased expression of CEBPA mRNA CTD PMID:15292067 NCBI chr19:33,299,934...33,302,534
Ensembl chr19:33,299,934...33,302,534 		JBrowse link
G CEBPD CCAAT enhancer binding protein delta increases expression EXP pomalidomide results in increased expression of CEBPD mRNA CTD PMID:15292067 NCBI chr 8:47,736,913...47,738,164
Ensembl chr 8:47,736,913...47,738,164 		JBrowse link
G CEBPE CCAAT enhancer binding protein epsilon increases expression EXP pomalidomide results in increased expression of CEBPE mRNA CTD PMID:15292067 NCBI chr14:23,117,306...23,119,255
Ensembl chr14:23,117,036...23,120,256 		JBrowse link
G CRBN cereblon multiple interactions
affects binding
increases response to substance 		EXP [pomalidomide co-treated with Dexamethasone co-treated with afuresertib] results in increased expression of CRBN protein; [pomalidomide co-treated with Dexamethasone] results in increased expression of CRBN protein; pomalidomide inhibits the reaction [CRBN protein binds to and results in increased ubiquitination of and results in increased degradation of MEIS2 protein]
pomalidomide binds to [SALL4 protein binds to CRBN protein]
CRBN results in increased susceptibility to pomalidomide 		CTD PMID:25043012 PMID:26186254 PMID:29928335 PMID:30067223 NCBI chr 3:3,149,633...3,179,717
Ensembl chr 3:3,144,628...3,179,727 		JBrowse link
G CSF2 colony stimulating factor 2 decreases secretion EXP pomalidomide results in decreased secretion of CSF2 protein CTD PMID:15292067 NCBI chr 5:132,073,789...132,076,170
Ensembl chr 5:132,073,789...132,076,170 		JBrowse link
G CSF3 colony stimulating factor 3 increases secretion EXP pomalidomide results in increased secretion of CSF3 protein CTD PMID:15292067 NCBI chr17:40,015,440...40,017,813
Ensembl chr17:40,015,361...40,017,813 		JBrowse link
G CYP2C19 cytochrome P450 family 2 subfamily C member 19 increases oxidation EXP CYP2C19 protein results in increased oxidation of pomalidomide CTD PMID:24350712 NCBI chr10:94,762,681...94,855,547
Ensembl chr10:94,762,681...94,855,547 		JBrowse link
G CYP2J2 cytochrome P450 family 2 subfamily J member 2 increases oxidation EXP CYP2J2 protein results in increased oxidation of pomalidomide CTD PMID:24350712 NCBI chr 1:59,893,308...59,969,212
Ensembl chr 1:59,893,308...59,926,773 		JBrowse link
G CYP3A4 cytochrome P450 family 3 subfamily A member 4 increases oxidation EXP CYP3A4 protein results in increased oxidation of pomalidomide CTD PMID:24350712 NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248 		JBrowse link
G DTWD1 DTW domain containing 1 multiple interactions EXP pomalidomide results in increased degradation of and results in decreased expression of DTWD1 protein CTD PMID:30067223 NCBI chr15:49,621,048...49,656,232
Ensembl chr15:49,621,037...49,656,232 		JBrowse link
G EIF4EBP1 eukaryotic translation initiation factor 4E binding protein 1 multiple interactions EXP [pomalidomide co-treated with Dexamethasone] results in decreased phosphorylation of EIF4EBP1 protein; afuresertib promotes the reaction [[pomalidomide co-treated with Dexamethasone] results in decreased phosphorylation of EIF4EBP1 protein] CTD PMID:29928335 NCBI chr 8:38,030,534...38,060,365
Ensembl chr 8:38,030,534...38,060,365 		JBrowse link
G FAM83F family with sequence similarity 83 member F multiple interactions EXP pomalidomide results in increased degradation of and results in decreased expression of FAM83F protein CTD PMID:30067223 NCBI chr22:39,994,954...40,043,534
Ensembl chr22:39,994,954...40,043,534 		JBrowse link
G FGFR1 fibroblast growth factor receptor 1 decreases expression EXP pomalidomide results in decreased expression of FGFR1 mRNA CTD PMID:30834740 NCBI chr 8:38,411,143...38,468,635
Ensembl chr 8:38,400,215...38,468,834 		JBrowse link
G FGFR3 fibroblast growth factor receptor 3 affects expression EXP pomalidomide affects the expression of FGFR3 mRNA CTD PMID:30834740 NCBI chr 4:1,793,293...1,808,867
Ensembl chr 4:1,793,293...1,808,872 		JBrowse link
G FOXO1 forkhead box O1 multiple interactions EXP [pomalidomide co-treated with Dexamethasone] affects the phosphorylation of FOXO1 protein; afuresertib affects the reaction [[pomalidomide co-treated with Dexamethasone] affects the phosphorylation of FOXO1 protein] CTD PMID:29928335 NCBI chr13:40,555,667...40,666,641
Ensembl chr13:40,555,667...40,666,641 		JBrowse link
G GATA1 GATA binding protein 1 decreases expression EXP pomalidomide results in decreased expression of GATA1 mRNA; pomalidomide results in decreased expression of GATA1 protein CTD PMID:15292067 NCBI chr  X:48,786,590...48,794,311
Ensembl chr  X:48,786,540...48,794,311 		JBrowse link
G GATA2 GATA binding protein 2 decreases expression EXP pomalidomide results in decreased expression of GATA2 mRNA CTD PMID:15292067 NCBI chr 3:128,479,422...128,493,201
Ensembl chr 3:128,479,427...128,493,201 		JBrowse link
G GFI1 growth factor independent 1 transcriptional repressor increases expression EXP pomalidomide results in increased expression of GFI1 mRNA CTD PMID:15292067 NCBI chr 1:92,473,043...92,486,925
Ensembl chr 1:92,473,043...92,486,925 		JBrowse link
G GFI1B growth factor independent 1B transcriptional repressor decreases expression EXP pomalidomide results in decreased expression of GFI1B mRNA CTD PMID:15292067 NCBI chr 9:132,945,531...132,993,434
Ensembl chr 9:132,944,000...132,991,687 		JBrowse link
G ID1 inhibitor of DNA binding 1 increases expression EXP pomalidomide results in increased expression of ID1 mRNA CTD PMID:15292067 NCBI chr20:31,605,289...31,606,510
Ensembl chr20:31,573,014...31,606,515 		JBrowse link
G ID2 inhibitor of DNA binding 2 increases expression EXP pomalidomide results in increased expression of ID2 mRNA CTD PMID:15292067 NCBI chr 2:8,682,056...8,684,461
Ensembl chr 2:8,678,845...8,684,461 		JBrowse link
G IKZF1 IKAROS family zinc finger 1 multiple interactions EXP [pomalidomide co-treated with Dexamethasone] results in decreased expression of IKZF1 protein; afuresertib promotes the reaction [[pomalidomide co-treated with Dexamethasone] results in decreased expression of IKZF1 protein] CTD PMID:29928335 NCBI chr 7:50,303,455...50,405,101
Ensembl chr 7:50,304,068...50,405,101 		JBrowse link
G IKZF3 IKAROS family zinc finger 3 multiple interactions EXP [pomalidomide co-treated with Dexamethasone] results in decreased expression of IKZF3 protein; afuresertib promotes the reaction [[pomalidomide co-treated with Dexamethasone] results in decreased expression of IKZF3 protein] CTD PMID:29928335 NCBI chr17:39,757,715...39,864,312
Ensembl chr17:39,757,715...39,864,312 		JBrowse link
G IL10 interleukin 10 increases secretion EXP pomalidomide results in increased secretion of IL10 protein CTD PMID:15292067 NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541 		JBrowse link
G IL13 interleukin 13 decreases secretion EXP pomalidomide results in decreased secretion of IL13 protein CTD PMID:15292067 NCBI chr 5:132,656,522...132,661,110
Ensembl chr 5:132,656,263...132,661,110 		JBrowse link
G IL2 interleukin 2 multiple interactions EXP Go 6976 inhibits the reaction [pomalidomide promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2 protein]]; pomalidomide promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2 mRNA]; pomalidomide promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2 protein]; pomalidomide promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased secretion of IL2 protein]; rottlerin inhibits the reaction [pomalidomide promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2 protein]] CTD PMID:16241859 NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725 		JBrowse link
G IL5 interleukin 5 decreases secretion EXP pomalidomide results in decreased secretion of IL5 protein CTD PMID:15292067 NCBI chr 5:132,541,445...132,556,815
Ensembl chr 5:132,541,445...132,556,838 		JBrowse link
G IRF4 interferon regulatory factor 4 multiple interactions EXP [pomalidomide co-treated with Dexamethasone co-treated with afuresertib] results in decreased expression of IRF4 protein; [pomalidomide co-treated with Dexamethasone] results in decreased expression of IRF4 protein CTD PMID:29928335 NCBI chr 6:391,752...411,443
Ensembl chr 6:391,739...411,443 		JBrowse link
G JUND JunD proto-oncogene, AP-1 transcription factor subunit decreases expression EXP pomalidomide results in decreased expression of JUND mRNA CTD PMID:15292067 NCBI chr19:18,279,694...18,281,622
Ensembl chr19:18,279,694...18,281,622 		JBrowse link
G KLF1 KLF transcription factor 1 decreases expression EXP pomalidomide results in decreased expression of KLF1 mRNA CTD PMID:15292067 NCBI chr19:12,884,422...12,887,201
Ensembl chr19:12,884,422...12,887,201 		JBrowse link
G LMO2 LIM domain only 2 decreases expression EXP pomalidomide results in decreased expression of LMO2 mRNA CTD PMID:15292067 NCBI chr11:33,858,576...33,892,076
Ensembl chr11:33,858,576...33,892,076 		JBrowse link
G MEIS2 Meis homeobox 2 multiple interactions EXP pomalidomide inhibits the reaction [CRBN protein binds to and results in increased ubiquitination of and results in increased degradation of MEIS2 protein] CTD PMID:25043012 NCBI chr15:36,889,204...37,101,311
Ensembl chr15:36,889,204...37,101,299 		JBrowse link
G NFE2 nuclear factor, erythroid 2 decreases expression EXP pomalidomide results in decreased expression of NFE2 mRNA CTD PMID:15292067 NCBI chr12:54,292,111...54,301,015
Ensembl chr12:54,292,111...54,301,015 		JBrowse link
G PRKCQ protein kinase C theta multiple interactions EXP pomalidomide promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased activity of PRKCQ protein] CTD PMID:16241859 NCBI chr10:6,394,097...6,580,646
Ensembl chr10:6,427,143...6,580,301 		JBrowse link
G RAB28 RAB28, member RAS oncogene family multiple interactions EXP pomalidomide results in increased degradation of and results in decreased expression of RAB28 protein CTD PMID:30067223 NCBI chr 4:13,367,724...13,484,340
Ensembl chr 4:13,361,354...13,484,365 		JBrowse link
G SALL4 spalt like transcription factor 4 affects binding
multiple interactions 		EXP pomalidomide binds to [SALL4 protein binds to CRBN protein]
pomalidomide results in increased degradation of and results in decreased expression of SALL4 protein 		CTD PMID:30067223 NCBI chr20:51,782,331...51,802,521
Ensembl chr20:51,782,331...51,802,521 		JBrowse link
G SPI1 Spi-1 proto-oncogene increases expression
decreases expression 		EXP pomalidomide results in increased expression of SPI1 mRNA
pomalidomide results in decreased expression of SPI1 protein 		CTD PMID:15292067 PMID:16373662 NCBI chr11:47,354,860...47,378,547
Ensembl chr11:47,354,860...47,409,369 		JBrowse link
G WIZ WIZ zinc finger multiple interactions EXP pomalidomide results in increased degradation of and results in decreased expression of WIZ protein CTD PMID:30067223 NCBI chr19:15,419,978...15,449,956
Ensembl chr19:15,419,978...15,449,956 		JBrowse link
G ZBTB39 zinc finger and BTB domain containing 39 multiple interactions EXP pomalidomide results in increased degradation of and results in decreased expression of ZBTB39 protein CTD PMID:30067223 NCBI chr12:56,998,836...57,006,546
Ensembl chr12:56,998,836...57,006,546 		JBrowse link
G ZFP91 ZFP91 zinc finger protein, atypical E3 ubiquitin ligase multiple interactions EXP pomalidomide results in increased degradation of and results in decreased expression of ZFP91 protein CTD PMID:30067223 NCBI chr11:58,579,063...58,621,550
Ensembl chr11:58,579,063...58,621,550 		JBrowse link
G ZNF653 zinc finger protein 653 multiple interactions EXP pomalidomide results in increased degradation of and results in decreased expression of ZNF653 protein CTD PMID:30067223 NCBI chr19:11,483,429...11,505,839
Ensembl chr19:11,483,427...11,505,839 		JBrowse link
tetramethrin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AR androgen receptor multiple interactions
decreases expression 		EXP tetramethrin results in decreased activity of [Dihydrotestosterone results in increased activity of AR protein]
tetramethrin results in decreased expression of AR mRNA 		CTD PMID:12711008 PMID:16621434 NCBI chr  X:67,544,021...67,730,619
Ensembl chr  X:67,544,021...67,730,619 		JBrowse link
G BRCA1 BRCA1 DNA repair associated affects binding EXP tetramethrin binds to BRCA1 protein CTD PMID:32278787 NCBI chr17:43,044,295...43,170,327
Ensembl chr17:43,044,295...43,170,245 		JBrowse link
G CES2 carboxylesterase 2 multiple interactions
increases metabolic processing 		EXP CES2 protein inhibits the reaction [tetramethrin results in increased activity of NR1I2 protein]
CES2 protein results in increased metabolism of tetramethrin 		CTD PMID:19249324 NCBI chr16:66,934,471...66,945,096
Ensembl chr16:66,934,444...66,945,096 		JBrowse link
G CYP3A4 cytochrome P450 family 3 subfamily A member 4 increases metabolic processing EXP CYP3A4 protein results in increased metabolism of tetramethrin CTD PMID:19249324 NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248 		JBrowse link
G ESR1 estrogen receptor 1 decreases expression ISO tetramethrin results in decreased expression of ESR1 protein CTD PMID:16326440 NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619 		JBrowse link
G ESR2 estrogen receptor 2 increases expression ISO tetramethrin results in increased expression of ESR2 protein CTD PMID:16326440 NCBI chr14:64,226,707...64,338,613
Ensembl chr14:64,084,232...64,338,112 		JBrowse link
G FOLH1 folate hydrolase 1 decreases expression EXP tetramethrin results in decreased expression of FOLH1 mRNA CTD PMID:12711008 NCBI chr11:49,145,092...49,208,602
Ensembl chr11:49,145,092...49,208,638 		JBrowse link
G IGF1 insulin like growth factor 1 multiple interactions ISO tetramethrin inhibits the reaction [IGF1 protein results in increased import of Calcium] CTD PMID:1550224 PMID:2460452 PMID:2539779 NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744 		JBrowse link
G IGF2 insulin like growth factor 2 multiple interactions ISO tetramethrin inhibits the reaction [IGF2 protein results in increased import of Calcium] CTD PMID:2442157 PMID:2539779 NCBI chr11:2,129,117...2,149,566
Ensembl chr11:2,129,112...2,158,391 		JBrowse link
G KCNH2 potassium voltage-gated channel subfamily H member 2 decreases activity EXP tetramethrin results in decreased activity of KCNH2 protein CTD PMID:28551711 NCBI chr 7:150,944,961...150,978,321
Ensembl chr 7:150,944,961...150,978,321 		JBrowse link
G KLK3 kallikrein related peptidase 3 increases expression EXP tetramethrin results in increased expression of KLK3 mRNA CTD PMID:12711008 NCBI chr19:50,854,915...50,860,764
Ensembl chr19:50,854,915...50,860,764 		JBrowse link
G NKX3-1 NK3 homeobox 1 decreases expression EXP tetramethrin results in decreased expression of NKX3-1 mRNA CTD PMID:12711008 NCBI chr 8:23,678,693...23,682,938
Ensembl chr 8:23,678,697...23,682,938 		JBrowse link
G NR1I2 nuclear receptor subfamily 1 group I member 2 multiple interactions
increases activity 		EXP
ISO 		CES2 protein inhibits the reaction [tetramethrin results in increased activity of NR1I2 protein] CTD PMID:19249324 NCBI chr 3:119,782,101...119,818,487
Ensembl chr 3:119,780,484...119,818,487 		JBrowse link
G NR3C1 nuclear receptor subfamily 3 group C member 1 multiple interactions EXP [Diethylhexyl Phthalate co-treated with butylparaben co-treated with tetramethrin co-treated with propylparaben] results in increased activity of NR3C1 protein; [Diethylhexyl Phthalate co-treated with butylparaben co-treated with tetramethrin] results in increased activity of NR3C1 protein; [tetramethrin co-treated with propylparaben] results in increased activity of NR3C1 protein CTD PMID:25448277 NCBI chr 5:143,277,931...143,435,512
Ensembl chr 5:143,277,931...143,435,512 		JBrowse link
G S100G S100 calcium binding protein G decreases expression
multiple interactions 		ISO tetramethrin results in decreased expression of S100G mRNA
tetramethrin inhibits the reaction [Estradiol results in increased expression of S100G mRNA] 		CTD PMID:16326440 NCBI chr  X:16,650,158...16,654,670
Ensembl chr  X:16,650,158...16,654,670 		JBrowse link
G SHBG sex hormone binding globulin affects binding EXP tetramethrin binds to SHBG protein CTD PMID:32278787 NCBI chr17:7,614,064...7,633,372
Ensembl chr17:7,613,946...7,633,382 		JBrowse link
G TMPRSS2 transmembrane serine protease 2 increases expression EXP tetramethrin results in increased expression of TMPRSS2 mRNA CTD PMID:12711008 NCBI chr21:41,464,305...41,508,158
Ensembl chr21:41,464,300...41,531,116 		JBrowse link
thalidomide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AADAT aminoadipate aminotransferase decreases expression ISO Thalidomide results in decreased expression of AADAT mRNA CTD PMID:26217789 NCBI chr 4:170,060,222...170,094,292
Ensembl chr 4:170,060,222...170,091,699 		JBrowse link
G ABCA1 ATP binding cassette subfamily A member 1 increases response to substance EXP ABCA1 gene SNP results in increased susceptibility to Thalidomide CTD PMID:21245421 NCBI chr 9:104,781,006...104,928,155
Ensembl chr 9:104,781,006...104,928,155 		JBrowse link
G ABCB1 ATP binding cassette subfamily B member 1 decreases expression
decreases activity 		EXP Thalidomide results in decreased expression of ABCB1 mRNA; Thalidomide results in decreased expression of ABCB1 protein
Thalidomide results in decreased activity of ABCB1 protein 		CTD PMID:15920492 PMID:19840843 NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323 		JBrowse link
G ACP5 acid phosphatase 5, tartrate resistant multiple interactions EXP [Thalidomide co-treated with Dexamethasone] results in decreased expression of ACP5 protein CTD PMID:16079895 NCBI chr19:11,574,660...11,578,975
Ensembl chr19:11,574,653...11,579,993 		JBrowse link
G ACTA2 actin alpha 2, smooth muscle multiple interactions
decreases expression 		ISO [Thalidomide co-treated with Dimethylnitrosamine] results in decreased expression of ACTA2 protein; Thalidomide inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein]; Thalidomide inhibits the reaction [Dimethylnitrosamine results in increased expression of ACTA2 mRNA]; Thalidomide inhibits the reaction [Dimethylnitrosamine results in increased expression of ACTA2 protein]; Thalidomide inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]
Thalidomide results in decreased expression of ACTA2 protein 		CTD PMID:16604421 PMID:16943688 PMID:17030452 PMID:17174718 NCBI chr10:88,935,074...88,991,337
Ensembl chr10:88,934,822...88,991,339 		JBrowse link
G ACTN2 actinin alpha 2 decreases expression ISO Thalidomide results in decreased expression of ACTN2 mRNA CTD PMID:26006729 PMID:26217789 NCBI chr 1:236,686,499...236,764,631
Ensembl chr 1:236,664,141...236,764,631 		JBrowse link
G ACTR6 actin related protein 6 decreases expression ISO Thalidomide results in decreased expression of ACTR6 mRNA CTD PMID:26217789 NCBI chr12:100,200,815...100,224,424
Ensembl chr12:100,199,122...100,241,865 		JBrowse link
G ADSS1 adenylosuccinate synthase 1 decreases expression ISO Thalidomide results in decreased expression of ADSS1 mRNA CTD PMID:26217789 NCBI chr14:104,724,229...104,747,325
Ensembl chr14:104,724,174...104,747,325 		JBrowse link
G AFF2 ALF transcription elongation factor 2 decreases expression ISO Thalidomide results in decreased expression of AFF2 mRNA CTD PMID:26217789 NCBI chr  X:148,500,617...149,000,663
Ensembl chr  X:148,500,617...149,000,663 		JBrowse link
G AKT1 AKT serine/threonine kinase 1 decreases phosphorylation
decreases activity
increases phosphorylation 		EXP Thalidomide analog results in decreased phosphorylation of AKT1 protein
Thalidomide results in decreased activity of AKT1 protein
Thalidomide analog results in increased phosphorylation of AKT1 protein 		CTD PMID:15067094 PMID:15858615 NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,759 		JBrowse link
G ALDH1A2 aldehyde dehydrogenase 1 family member A2 decreases expression EXP Thalidomide results in decreased expression of ALDH1A2 mRNA CTD PMID:31711903 NCBI chr15:57,953,429...58,065,711
Ensembl chr15:57,953,424...58,497,866 		JBrowse link
G ALPI alkaline phosphatase, intestinal increases expression ISO Thalidomide results in increased expression of ALPI mRNA CTD PMID:26217789 NCBI chr 2:232,456,153...232,460,753
Ensembl chr 2:232,456,125...232,460,753 		JBrowse link
G AMACR alpha-methylacyl-CoA racemase decreases expression ISO Thalidomide results in decreased expression of AMACR mRNA CTD PMID:26217789 NCBI chr 5:33,986,165...34,008,050
Ensembl chr 5:33,986,165...34,008,104 		JBrowse link
G ANGPT2 angiopoietin 2 affects expression EXP Thalidomide affects the expression of ANGPT2 mRNA CTD PMID:15939924 NCBI chr 8:6,499,632...6,563,245
Ensembl chr 8:6,499,632...6,563,409 		JBrowse link
G ANKRD37 ankyrin repeat domain 37 decreases expression ISO Thalidomide results in decreased expression of ANKRD37 mRNA CTD PMID:26217789 NCBI chr 4:185,396,841...185,400,723
Ensembl chr 4:185,396,021...185,400,628 		JBrowse link
G ANXA2 annexin A2 decreases expression EXP Thalidomide results in decreased expression of ANXA2 mRNA; Thalidomide results in decreased expression of ANXA2 protein CTD PMID:19954599 NCBI chr15:60,347,151...60,397,986
Ensembl chr15:60,347,134...60,402,883 		JBrowse link
G APIP APAF1 interacting protein decreases expression ISO Thalidomide results in decreased expression of APIP mRNA CTD PMID:26217789 NCBI chr11:34,882,295...34,916,379
Ensembl chr11:34,853,094...34,916,379 		JBrowse link
G APLN apelin decreases expression ISO Thalidomide results in decreased expression of APLN mRNA CTD PMID:26217789 NCBI chr  X:129,645,259...129,654,956
Ensembl chr  X:129,645,259...129,654,956 		JBrowse link
G AQP4 aquaporin 4 increases expression ISO Thalidomide results in increased expression of AQP4 mRNA CTD PMID:26217789 NCBI chr18:26,852,038...26,865,803
Ensembl chr18:26,852,043...26,865,771 		JBrowse link
G AQP5 aquaporin 5 increases expression ISO Thalidomide results in increased expression of AQP5 mRNA CTD PMID:26217789 NCBI chr12:49,961,872...49,965,682
Ensembl chr12:49,961,872...49,965,682 		JBrowse link
G ARHGDIA Rho GDP dissociation inhibitor alpha increases expression ISO Thalidomide results in increased expression of ARHGDIA mRNA CTD PMID:26217789 NCBI chr17:81,867,721...81,871,337
Ensembl chr17:81,867,719...81,871,378 		JBrowse link
G ARPC4 actin related protein 2/3 complex subunit 4 decreases expression ISO Thalidomide results in decreased expression of ARPC4 mRNA CTD PMID:26217789 NCBI chr 3:9,792,518...9,807,101
Ensembl chr 3:9,792,495...9,807,101 		JBrowse link
G ARX aristaless related homeobox increases expression ISO Thalidomide results in increased expression of ARX mRNA CTD PMID:26217789 NCBI chr  X:25,003,694...25,015,965
Ensembl chr  X:25,003,694...25,016,420 		JBrowse link
G ASB12 ankyrin repeat and SOCS box containing 12 decreases expression ISO Thalidomide results in decreased expression of ASB12 mRNA CTD PMID:26217789 NCBI chr  X:64,224,194...64,230,607
Ensembl chr  X:64,224,194...64,230,607 		JBrowse link
G ATF3 activating transcription factor 3 increases expression EXP Thalidomide analog results in increased expression of ATF3 mRNA CTD PMID:20525221 NCBI chr 1:212,565,407...212,620,777
Ensembl chr 1:212,565,334...212,620,777 		JBrowse link
G AURKA aurora kinase A multiple interactions EXP [Azacitidine co-treated with Thalidomide] affects the expression of AURKA mRNA CTD PMID:18720364 NCBI chr20:56,369,390...56,392,215
Ensembl chr20:56,369,389...56,392,337 		JBrowse link
G BAX BCL2 associated X, apoptosis regulator increases expression
multiple interactions 		ISO Thalidomide results in increased expression of BAX mRNA
HDAC6 protein inhibits the reaction [Thalidomide inhibits the reaction [Paraquat results in increased expression of BAX protein]]; MIR141 promotes the reaction [Thalidomide inhibits the reaction [Paraquat results in increased expression of BAX protein]]; Thalidomide inhibits the reaction [Paraquat results in increased expression of BAX protein] 		CTD PMID:18291259 PMID:33015978 NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798 		JBrowse link
G BCAP29 B cell receptor associated protein 29 decreases expression ISO Thalidomide results in decreased expression of BCAP29 mRNA CTD PMID:26217789 NCBI chr 7:107,580,007...107,623,317
Ensembl chr 7:107,580,246...107,629,170 		JBrowse link
G BCL2 BCL2 apoptosis regulator multiple interactions
decreases expression 		EXP
ISO 		[oblimersen co-treated with Thalidomide co-treated with Dexamethasone] results in decreased expression of BCL2 mRNA; [oblimersen co-treated with Thalidomide co-treated with Dexamethasone] results in decreased expression of BCL2 protein
HDAC6 protein inhibits the reaction [Thalidomide inhibits the reaction [Paraquat results in decreased expression of BCL2 protein]]; MIR141 promotes the reaction [Thalidomide inhibits the reaction [Paraquat results in decreased expression of BCL2 protein]]; Thalidomide inhibits the reaction [Paraquat results in decreased expression of BCL2 protein]
Thalidomide results in decreased expression of BCL2 protein 		CTD PMID:15867202 PMID:15982930 PMID:33015978 NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128 		JBrowse link
G BCL2L1 BCL2 like 1 decreases expression EXP Thalidomide results in decreased expression of BCL2L1 protein CTD PMID:15986355 NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989 		JBrowse link
G BDKRB1 bradykinin receptor B1 multiple interactions ISO Thalidomide inhibits the reaction [bradykinin, des-Arg(9)- results in increased expression of BDKRB1 protein] CTD PMID:16039549 NCBI chr14:96,256,210...96,264,763
Ensembl chr14:96,256,210...96,268,967 		JBrowse link
G BECN1 beclin 1 multiple interactions EXP Thalidomide promotes the reaction [temozolomide results in increased expression of BECN1 protein] CTD PMID:19567134 NCBI chr17:42,810,132...42,824,282
Ensembl chr17:42,810,134...42,833,350 		JBrowse link
G BNIPL BCL2 interacting protein like increases expression ISO Thalidomide results in increased expression of BNIPL mRNA CTD PMID:26217789 NCBI chr 1:151,036,586...151,047,720
Ensembl chr 1:151,036,321...151,047,720 		JBrowse link
G BOD1 biorientation of chromosomes in cell division 1 decreases expression ISO Thalidomide results in decreased expression of BOD1 mRNA CTD PMID:26217789 NCBI chr 5:173,607,145...173,616,650
Ensembl chr 5:173,607,145...173,616,659 		JBrowse link
G BST2 bone marrow stromal cell antigen 2 decreases expression ISO Thalidomide results in decreased expression of BST2 mRNA CTD PMID:26217789 NCBI chr19:17,402,939...17,405,630
Ensembl chr19:17,402,939...17,405,630 		JBrowse link
G BUB1B BUB1 mitotic checkpoint serine/threonine kinase B multiple interactions EXP [Azacitidine co-treated with Thalidomide] affects the expression of BUB1B mRNA CTD PMID:18720364 NCBI chr15:40,161,069...40,221,123
Ensembl chr15:40,161,023...40,221,123 		JBrowse link
G C3 complement C3 decreases expression EXP Thalidomide results in decreased expression of C3 protein CTD PMID:2985516 NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562 		JBrowse link
G CACNA1C calcium voltage-gated channel subunit alpha1 C decreases expression ISO Thalidomide results in decreased expression of CACNA1C mRNA CTD PMID:26006729 PMID:26217789 NCBI chr12:1,970,780...2,697,950
Ensembl chr12:1,970,772...2,697,950 		JBrowse link
G CACNB4 calcium voltage-gated channel auxiliary subunit beta 4 decreases expression EXP Thalidomide results in decreased expression of CACNB4 mRNA CTD PMID:32756504 NCBI chr 2:151,832,771...152,099,167
Ensembl chr 2:151,832,771...152,099,167 		JBrowse link
G CALB1 calbindin 1 decreases expression EXP Thalidomide results in decreased expression of CALB1 mRNA CTD PMID:24154490 NCBI chr 8:90,058,608...90,082,879
Ensembl chr 8:90,058,608...90,095,475 		JBrowse link
G CASP3 caspase 3 decreases activity
increases expression
increases activity 		EXP
ISO 		Thalidomide results in decreased activity of CASP3 protein
Thalidomide results in increased expression of CASP3 mRNA
Thalidomide results in increased activity of CASP3 protein 		CTD PMID:14682394 PMID:15067094 PMID:18291259 NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062 		JBrowse link
G CASP8 caspase 8 increases cleavage
decreases expression 		EXP
ISO 		Thalidomide analog results in increased cleavage of CASP8 protein
Thalidomide results in decreased expression of CASP8 mRNA 		CTD PMID:15858615 PMID:26217789 NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836 		JBrowse link
G CASP9 caspase 9 decreases activity EXP Thalidomide results in decreased activity of CASP9 protein CTD PMID:15067094 NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534 		JBrowse link
G CASTOR1 cytosolic arginine sensor for mTORC1 subunit 1 decreases expression ISO Thalidomide results in decreased expression of CASTOR1 mRNA CTD PMID:26217789 NCBI chr22:30,285,117...30,289,505
Ensembl chr22:30,285,117...30,289,622 		JBrowse link
G CAT catalase multiple interactions EXP CAT protein inhibits the reaction [Thalidomide results in decreased activity of MYB protein] CTD PMID:16616857 NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060 		JBrowse link
G CBR1 carbonyl reductase 1 decreases expression ISO Thalidomide results in decreased expression of CBR1 mRNA CTD PMID:26217789 NCBI chr21:36,070,024...36,073,164
Ensembl chr21:36,069,941...36,073,166 		JBrowse link
G CCDC141 coiled-coil domain containing 141 decreases expression ISO Thalidomide results in decreased expression of CCDC141 mRNA CTD PMID:26217789 NCBI chr 2:178,814,978...179,050,137
Ensembl chr 2:178,829,757...179,050,137 		JBrowse link
G CCL2 C-C motif chemokine ligand 2 decreases expression EXP Thalidomide analog results in decreased expression of CCL2 mRNA CTD PMID:20525221 NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208 		JBrowse link
G CCL3 C-C motif chemokine ligand 3 increases expression ISO Thalidomide results in increased expression of CCL3 mRNA CTD PMID:16549389 NCBI chr17:36,088,256...36,090,143
Ensembl chr17:36,088,256...36,090,169 		JBrowse link
G CCNA2 cyclin A2 multiple interactions EXP [Azacitidine co-treated with Thalidomide] affects the expression of CCNA2 mRNA CTD PMID:18720364 NCBI chr 4:121,816,444...121,823,883
Ensembl chr 4:121,816,444...121,823,883 		JBrowse link
G CCNB1 cyclin B1 multiple interactions EXP [Azacitidine co-treated with Thalidomide] affects the expression of CCNB1 mRNA CTD PMID:18720364 NCBI chr 5:69,167,150...69,178,245
Ensembl chr 5:69,167,135...69,178,245 		JBrowse link
G CCND1 cyclin D1 decreases expression EXP Thalidomide analog results in decreased expression of CCND1 mRNA CTD PMID:20525221 NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474 		JBrowse link
G CCNO cyclin O increases expression ISO Thalidomide results in increased expression of CCNO mRNA CTD PMID:26217789 NCBI chr 5:55,231,152...55,233,608
Ensembl chr 5:55,231,152...55,233,608 		JBrowse link
G CD24 CD24 molecule affects expression ISO Thalidomide affects the expression of CD24A mRNA CTD PMID:26006729 NCBI chr 6:106,969,831...106,976,855
Ensembl chr 6:106,969,831...106,975,627 		JBrowse link
G CD274 CD274 molecule decreases expression
multiple interactions 		EXP Thalidomide results in decreased expression of CD274 protein
FGD5-AS1 inhibits the reaction [Thalidomide results in decreased expression of CD274 protein] 		CTD PMID:34520751 NCBI chr 9:5,450,542...5,470,554
Ensembl chr 9:5,450,503...5,470,566 		JBrowse link
G CDC20 cell division cycle 20 multiple interactions EXP [Azacitidine co-treated with Thalidomide] affects the expression of CDC20 mRNA CTD PMID:18720364 NCBI chr 1:43,358,981...43,363,203
Ensembl chr 1:43,358,981...43,363,203 		JBrowse link
G CDC42EP5 CDC42 effector protein 5 decreases expression ISO Thalidomide results in decreased expression of CDC42EP5 mRNA CTD PMID:26006729 PMID:26217789 NCBI chr19:54,465,026...54,473,296
Ensembl chr19:54,465,026...54,473,296 		JBrowse link
G CDH1 cadherin 1 multiple interactions
increases expression 		EXP FGD5-AS1 inhibits the reaction [Thalidomide results in increased expression of CDH1 protein] CTD PMID:34520751 NCBI chr16:68,737,292...68,835,537
Ensembl chr16:68,737,292...68,835,537 		JBrowse link
G CDH10 cadherin 10 decreases expression ISO Thalidomide results in decreased expression of CDH10 mRNA CTD PMID:26217789 NCBI chr 5:24,487,100...24,644,978
Ensembl chr 5:24,487,100...24,644,978 		JBrowse link
G CDH2 cadherin 2 multiple interactions
decreases expression 		EXP FGD5-AS1 inhibits the reaction [Thalidomide results in decreased expression of CDH2 protein] CTD PMID:34520751 NCBI chr18:27,932,879...28,177,130
Ensembl chr18:27,932,879...28,177,946 		JBrowse link
G CDH6 cadherin 6 increases expression EXP Thalidomide results in increased expression of CDH6 mRNA CTD PMID:32756504 NCBI chr 5:31,193,686...31,329,146
Ensembl chr 5:31,193,686...31,329,146 		JBrowse link
G CDK1 cyclin dependent kinase 1 multiple interactions EXP [Azacitidine co-treated with Thalidomide] affects the expression of CDK1 mRNA CTD PMID:18720364 NCBI chr10:60,778,331...60,794,852
Ensembl chr10:60,778,331...60,794,852 		JBrowse link
G CENPA centromere protein A multiple interactions EXP [Azacitidine co-treated with Thalidomide] affects the expression of CENPA mRNA CTD PMID:18720364 NCBI chr 2:26,786,056...26,794,589
Ensembl chr 2:26,764,289...26,801,067 		JBrowse link
G CENPF centromere protein F multiple interactions EXP [Azacitidine co-treated with Thalidomide] affects the expression of CENPF mRNA CTD PMID:18720364 NCBI chr 1:214,603,195...214,664,571
Ensembl chr 1:214,603,185...214,664,574 		JBrowse link
G CER1 cerberus 1, DAN family BMP antagonist decreases expression ISO Thalidomide results in decreased expression of CER1 mRNA CTD PMID:26217789 NCBI chr 9:14,717,326...14,722,733
Ensembl chr 9:14,719,724...14,722,733 		JBrowse link
G CFC1B cryptic, EGF-CFC family member 1B decreases expression ISO Thalidomide results in decreased expression of CFC1 mRNA CTD PMID:26217789 NCBI chr 2:130,521,222...130,528,603
Ensembl chr 2:130,521,197...130,528,604 		JBrowse link
G CFLAR CASP8 and FADD like apoptosis regulator decreases expression EXP Thalidomide results in decreased expression of CFLAR protein CTD PMID:15986355 NCBI chr 2:201,116,164...201,176,687
Ensembl chr 2:201,116,154...201,176,687 		JBrowse link
G CHUK component of inhibitor of nuclear factor kappa B kinase complex multiple interactions ISO Thalidomide inhibits the reaction [TNF protein results in increased expression of CHUK protein] CTD PMID:16604421 NCBI chr10:100,186,319...100,229,596
Ensembl chr10:100,188,300...100,229,596 		JBrowse link
G CHURC1 churchill domain containing 1 decreases expression ISO Thalidomide results in decreased expression of CHURC1 mRNA CTD PMID:26217789 NCBI chr14:64,914,455...64,935,368
Ensembl chr14:64,914,361...64,944,591 		JBrowse link
G CLDN4 claudin 4 increases expression ISO Thalidomide results in increased expression of CLDN4 mRNA CTD PMID:26217789 NCBI chr 7:73,830,996...73,832,690
Ensembl chr 7:73,799,542...73,832,690 		JBrowse link
G CLDND1 claudin domain containing 1 decreases expression ISO Thalidomide results in decreased expression of CLDND1 mRNA CTD PMID:26217789 NCBI chr 3:98,515,483...98,522,902
Ensembl chr 3:98,497,912...98,523,066 		JBrowse link
G CLEC9A C-type lectin domain containing 9A decreases expression ISO Thalidomide results in decreased expression of CLEC9A mRNA CTD PMID:26217789 NCBI chr12:10,030,682...10,066,031
Ensembl chr12:10,030,678...10,066,031 		JBrowse link
G COL1A1 collagen type I alpha 1 chain multiple interactions ISO Thalidomide inhibits the reaction [Paraquat results in increased expression of COL1A1 mRNA]; Thalidomide inhibits the reaction [Paraquat results in increased expression of COL1A1 protein] CTD PMID:26221080 NCBI chr17:50,184,101...50,201,631
Ensembl chr17:50,184,101...50,201,632 		JBrowse link
G COL1A2 collagen type I alpha 2 chain multiple interactions ISO Thalidomide inhibits the reaction [Dimethylnitrosamine results in increased expression of COL1A2 mRNA]; Thalidomide inhibits the reaction [TNF protein results in increased expression of COL1A2 mRNA] CTD PMID:16604421 NCBI chr 7:94,394,895...94,431,227
Ensembl chr 7:94,394,895...94,431,227 		JBrowse link
G CPLX3 complexin 3 decreases expression EXP Thalidomide results in decreased expression of CPLX3 mRNA CTD PMID:32756504 NCBI chr15:74,826,627...74,831,802
Ensembl chr15:74,826,627...74,831,802 		JBrowse link
G CRBN cereblon multiple interactions
affects binding
affects response to substance 		EXP
ISO 		Thalidomide inhibits the reaction [CRBN protein binds to and results in increased ubiquitination of and results in increased degradation of MEIS2 protein]
Thalidomide binds to [CRBN protein binds to DDB1 protein]
CRBN gene SNP affects the susceptibility to Thalidomide
Thalidomide binds to [SALL4 protein binds to CRBN protein]; Thalidomide binds to CRBN protein 		CTD PMID:25043012 PMID:25108355 PMID:27751757 PMID:30067223 NCBI chr 3:3,149,633...3,179,717
Ensembl chr 3:3,144,628...3,179,727 		JBrowse link
G CREB5 cAMP responsive element binding protein 5 decreases expression EXP Thalidomide results in decreased expression of CREB5 mRNA CTD PMID:32756504 NCBI chr 7:28,299,321...28,825,894
Ensembl chr 7:28,299,321...28,825,894 		JBrowse link
G CREBRF CREB3 regulatory factor increases expression EXP Thalidomide analog results in increased expression of CREBRF mRNA CTD PMID:20525221 NCBI chr 5:173,056,352...173,139,284
Ensembl chr 5:173,056,352...173,139,284 		JBrowse link
G CRIPTO cripto, EGF-CFC family member decreases expression ISO Thalidomide results in decreased expression of CRIPTO mRNA CTD PMID:26006729 PMID:26217789 NCBI chr 3:46,574,535...46,582,457
Ensembl chr 3:46,574,534...46,582,457 		JBrowse link
G CRP C-reactive protein decreases expression EXP Thalidomide results in decreased expression of CRP protein CTD PMID:11339241 NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589 		JBrowse link
G CSF2 colony stimulating factor 2 decreases activity EXP Thalidomide results in decreased activity of CSF2 protein CTD PMID:17557286 NCBI chr 5:132,073,789...132,076,170
Ensembl chr 5:132,073,789...132,076,170 		JBrowse link
G CSF3 colony stimulating factor 3 decreases activity EXP Thalidomide results in decreased activity of CSF3 protein CTD PMID:17557286 NCBI chr17:40,015,440...40,017,813
Ensembl chr17:40,015,361...40,017,813 		JBrowse link
G CSGALNACT2 chondroitin sulfate N-acetylgalactosaminyltransferase 2 decreases expression ISO Thalidomide results in decreased expression of CSGALNACT2 mRNA CTD PMID:26217789 NCBI chr10:43,138,445...43,185,308
Ensembl chr10:43,138,445...43,185,302 		JBrowse link
G CXCL10 C-X-C motif chemokine ligand 10 increases expression ISO Thalidomide results in increased expression of CXCL10 CTD PMID:17089043 NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497 		JBrowse link
G CXCL8 C-X-C motif chemokine ligand 8 multiple interactions
decreases activity 		EXP Thalidomide inhibits the reaction [TNF protein results in increased expression of CXCL8 mRNA]; Thalidomide inhibits the reaction [TNF protein results in increased expression of CXCL8 protein]
Thalidomide results in decreased activity of CXCL8 protein 		CTD PMID:15687330 PMID:17557286 NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716 		JBrowse link
G CXCR1 C-X-C motif chemokine receptor 1 decreases expression EXP Thalidomide results in decreased expression of CXCR1 protein CTD PMID:16344495 NCBI chr 2:218,162,841...218,166,962
Ensembl chr 2:218,162,841...218,166,962 		JBrowse link
G CXCR2 C-X-C motif chemokine receptor 2 decreases expression EXP Thalidomide results in decreased expression of CXCR2 protein CTD PMID:16344495 NCBI chr 2:218,125,294...218,137,251
Ensembl chr 2:218,125,289...218,137,251 		JBrowse link
G CYCS cytochrome c, somatic increases expression EXP Thalidomide results in increased expression of CYCS protein CTD PMID:15982930 NCBI chr 7:25,118,656...25,125,260
Ensembl chr 7:25,118,656...25,125,260 		JBrowse link
G CYP2B6 cytochrome P450 family 2 subfamily B member 6 increases expression EXP Thalidomide results in increased expression of CYP2B6 mRNA CTD PMID:24460184 PMID:28496040 NCBI chr19:40,991,282...41,018,398
Ensembl chr19:40,991,282...41,018,398 		JBrowse link
G CYP2C19 cytochrome P450 family 2 subfamily C member 19 multiple interactions
increases oxidation
increases hydroxylation 		EXP [CYP2C19 protein results in increased hydroxylation of Thalidomide] which results in increased chemical synthesis of 5'-hydroxythalidomide; [CYP2C19 protein results in increased hydroxylation of Thalidomide] which results in increased chemical synthesis of 5-hydroxythalidomide; [CYP2C19 protein results in increased oxidation of Thalidomide] which results in increased abundance of 5'-hydroxythalidomide; [CYP2C19 protein results in increased oxidation of Thalidomide] which results in increased abundance of 5-hydroxythalidomide CTD PMID:20443640 PMID:24350712 NCBI chr10:94,762,681...94,855,547
Ensembl chr10:94,762,681...94,855,547 		JBrowse link
G CYP3A4 cytochrome P450 family 3 subfamily A member 4 multiple interactions
increases metabolic processing
increases expression
increases hydroxylation 		EXP [CYP3A4 protein results in increased hydroxylation of Thalidomide] which results in increased chemical synthesis of 5-hydroxythalidomide
CYP3A4 protein results in increased metabolism of Thalidomide
Thalidomide results in increased expression of CYP3A4 mRNA; Thalidomide results in increased expression of CYP3A4 protein 		CTD PMID:20443640 PMID:24460184 PMID:28496040 PMID:28745489 NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248 		JBrowse link
G CYP3A5 cytochrome P450 family 3 subfamily A member 5 multiple interactions
increases metabolic processing
increases expression
increases hydroxylation 		EXP [CYP3A5 protein results in increased hydroxylation of Thalidomide] which results in increased chemical synthesis of 5-hydroxythalidomide
CYP3A5 protein results in increased metabolism of Thalidomide
Thalidomide results in increased expression of CYP3A5 mRNA 		CTD PMID:20443640 PMID:28496040 PMID:28745489 NCBI chr 7:99,648,194...99,679,996
Ensembl chr 7:99,648,194...99,679,996 		JBrowse link
G CYP3A7 cytochrome P450 family 3 subfamily A member 7 multiple interactions
increases hydroxylation 		EXP [CYP3A7 protein results in increased hydroxylation of Thalidomide] which results in increased chemical synthesis of 5-hydroxythalidomide CTD PMID:20443640 NCBI chr 7:99,705,036...99,735,196
Ensembl chr 7:99,705,036...99,735,196 		JBrowse link
G CYTH3 cytohesin 3 decreases expression ISO Thalidomide results in decreased expression of CYTH3 mRNA CTD PMID:26217789 NCBI chr 7:6,161,779...6,272,624
Ensembl chr 7:6,161,779...6,272,644 		JBrowse link
G DAAM2 dishevelled associated activator of morphogenesis 2 decreases expression ISO Thalidomide results in decreased expression of DAAM2 mRNA CTD PMID:26217789 NCBI chr 6:39,792,376...39,904,869
Ensembl chr 6:39,792,298...39,904,877 		JBrowse link
G DBT dihydrolipoamide branched chain transacylase E2 decreases expression ISO Thalidomide results in decreased expression of DBT mRNA CTD PMID:26217789 NCBI chr 1:100,186,919...100,249,834
Ensembl chr 1:100,186,919...100,249,834 		JBrowse link
G DDB1 damage specific DNA binding protein 1 affects binding ISO Thalidomide binds to [CRBN protein binds to DDB1 protein] CTD PMID:25108355 NCBI chr11:61,299,451...61,333,105
Ensembl chr11:61,299,451...61,342,596 		JBrowse link
G DDIT3 DNA damage inducible transcript 3 increases expression EXP Thalidomide analog results in increased expression of DDIT3 mRNA CTD PMID:20525221 NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737 		JBrowse link
G DEFA3 defensin alpha 3 increases expression ISO Thalidomide results in increased expression of DEFA3 mRNA CTD PMID:26217789 NCBI chr 8:7,015,869...7,018,297
Ensembl chr 8:7,015,869...7,018,297 		JBrowse link
G DEFB106B defensin beta 106B increases expression ISO Thalidomide results in increased expression of DEFB15 mRNA CTD PMID:26217789 NCBI chr 8:7,482,504...7,486,400
Ensembl chr 8:7,482,504...7,486,400
Ensembl chr 8:7,482,504...7,486,400 		JBrowse link
G DES desmin multiple interactions ISO Thalidomide inhibits the reaction [Carbon Tetrachloride results in increased expression of DES protein] CTD PMID:17030452 NCBI chr 2:219,418,377...219,426,734
Ensembl chr 2:219,418,377...219,426,735 		JBrowse link
G DEXI Dexi homolog increases expression ISO Thalidomide results in increased expression of DEXI mRNA CTD PMID:26217789 NCBI chr16:10,928,891...10,942,468
Ensembl chr16:10,928,891...10,942,468 		JBrowse link
G DLGAP5 DLG associated protein 5 decreases expression ISO Thalidomide results in decreased expression of DLGAP5 mRNA CTD PMID:26217789 NCBI chr14:55,148,135...55,191,585
Ensembl chr14:55,148,112...55,191,608 		JBrowse link
G DLK1 delta like non-canonical Notch ligand 1 decreases expression ISO Thalidomide results in decreased expression of DLK1 mRNA CTD PMID:26217789 NCBI chr14:100,726,892...100,738,224
Ensembl chr14:100,725,705...100,738,224 		JBrowse link
G DNAJB1 DnaJ heat shock protein family (Hsp40) member B1 increases expression EXP Thalidomide analog results in increased expression of DNAJB1 mRNA CTD PMID:20525221 NCBI chr19:14,514,769...14,560,391
Ensembl chr19:14,513,789...14,560,391 		JBrowse link
G DNAJB4 DnaJ heat shock protein family (Hsp40) member B4 increases expression EXP Thalidomide analog results in increased expression of DNAJB4 mRNA CTD PMID:20525221 NCBI chr 1:77,979,175...78,017,964
Ensembl chr 1:77,979,175...78,017,964 		JBrowse link
G DNAJB9 DnaJ heat shock protein family (Hsp40) member B9 increases expression EXP Thalidomide analog results in increased expression of DNAJB9 mRNA CTD PMID:20525221 NCBI chr 7:108,569,874...108,574,850
Ensembl chr 7:108,569,867...108,574,850 		JBrowse link
G DNAJC19 DnaJ heat shock protein family (Hsp40) member C19 decreases expression ISO Thalidomide results in decreased expression of DNAJC19 mRNA CTD PMID:26217789 NCBI chr 3:180,983,709...180,989,838
Ensembl chr 3:180,983,697...180,989,774 		JBrowse link
G DUS4L dihydrouridine synthase 4 like decreases expression ISO Thalidomide results in decreased expression of DUS4L mRNA CTD PMID:26217789 NCBI chr 7:107,563,971...107,578,523
Ensembl chr 7:107,563,484...107,578,523 		JBrowse link
G DUSP1 dual specificity phosphatase 1 increases expression EXP Thalidomide analog results in increased expression of DUSP1 mRNA CTD PMID:20525221 NCBI chr 5:172,768,096...172,771,195
Ensembl chr 5:172,768,096...172,771,195 		JBrowse link
G DUSP10 dual specificity phosphatase 10 increases expression EXP Thalidomide analog results in increased expression of DUSP10 mRNA CTD PMID:20525221 NCBI chr 1:221,701,424...221,742,089
Ensembl chr 1:221,701,424...221,742,089 		JBrowse link
G DUSP8 dual specificity phosphatase 8 increases expression EXP Thalidomide analog results in increased expression of DUSP8 mRNA CTD PMID:20525221 NCBI chr11:1,554,051...1,572,848
Ensembl chr11:1,554,051...1,572,271 		JBrowse link
G EEF1E1 eukaryotic translation elongation factor 1 epsilon 1 decreases expression ISO Thalidomide results in decreased expression of EEF1E1 mRNA CTD PMID:26217789 NCBI chr 6:8,073,360...8,102,548
Ensembl chr 6:8,073,360...8,102,559 		JBrowse link
G EFCAB2 EF-hand calcium binding domain 2 decreases expression ISO Thalidomide results in decreased expression of EFCAB2 mRNA CTD PMID:26217789 NCBI chr 1:244,969,682...245,125,229
Ensembl chr 1:244,969,682...245,127,164 		JBrowse link
G EIF1B eukaryotic translation initiation factor 1B decreases expression ISO Thalidomide results in decreased expression of EIF1B mRNA CTD PMID:26217789 NCBI chr 3:40,309,707...40,312,424
Ensembl chr 3:40,309,707...40,312,424 		JBrowse link
G EIF4E eukaryotic translation initiation factor 4E decreases expression ISO Thalidomide results in decreased expression of EIF4E protein CTD PMID:18291259 NCBI chr 4:98,879,276...98,929,133
Ensembl chr 4:98,879,276...98,929,133 		JBrowse link
G ELANE elastase, neutrophil expressed multiple interactions EXP Thalidomide inhibits the reaction [Lipopolysaccharides results in increased secretion of ELANE protein]; Thalidomide inhibits the reaction [lipoteichoic acid results in increased secretion of ELANE protein] CTD PMID:11302825 NCBI chr19:852,303...856,243
Ensembl chr19:851,014...856,247 		JBrowse link
G EMC8 ER membrane protein complex subunit 8 decreases expression ISO Thalidomide results in decreased expression of EMC8 mRNA CTD PMID:26217789 NCBI chr16:85,778,624...85,799,544
Ensembl chr16:85,771,758...85,799,608 		JBrowse link
G EPHA10 EPH receptor A10 decreases expression EXP Thalidomide results in decreased expression of EPHA10 mRNA CTD PMID:32756504 NCBI chr 1:37,713,880...37,765,120
Ensembl chr 1:37,713,880...37,765,133 		JBrowse link
G EPHB1 EPH receptor B1 decreases expression EXP Thalidomide results in decreased expression of EPHB1 mRNA CTD PMID:32756504 NCBI chr 3:134,795,260...135,260,467
Ensembl chr 3:134,795,260...135,260,467 		JBrowse link
G ERBB2 erb-b2 receptor tyrosine kinase 2 multiple interactions EXP [ERBB2 protein co-treated with PIK3CA protein mutant form] results in increased susceptibility to Thalidomide metabolite CTD PMID:28745489 NCBI chr17:39,688,094...39,728,658
Ensembl chr17:39,687,914...39,730,426 		JBrowse link
G ESD esterase D decreases expression ISO Thalidomide results in decreased expression of ESD mRNA CTD PMID:26217789 NCBI chr13:46,771,256...46,797,700
Ensembl chr13:46,771,256...46,797,420 		JBrowse link
G EYA1 EYA transcriptional coactivator and phosphatase 1 decreases expression EXP Thalidomide results in decreased expression of EYA1 mRNA CTD PMID:31711903 NCBI chr 8:71,197,433...71,548,094
Ensembl chr 8:71,197,433...71,592,025 		JBrowse link
G F2R coagulation factor II thrombin receptor decreases expression EXP Thalidomide results in decreased expression of F2R mRNA; Thalidomide results in decreased expression of F2R protein CTD PMID:15618473 NCBI chr 5:76,716,126...76,735,770
Ensembl chr 5:76,716,126...76,735,770 		JBrowse link
G FABP5 fatty acid binding protein 5 decreases expression ISO Thalidomide results in decreased expression of FABP5 mRNA CTD PMID:26217789 NCBI chr 8:81,280,536...81,284,775
Ensembl chr 8:81,280,536...81,284,777 		JBrowse link
G FABP7 fatty acid binding protein 7 affects expression ISO Thalidomide affects the expression of FABP7 mRNA CTD PMID:26217789 NCBI chr 6:122,749,201...122,784,074
Ensembl chr 6:122,779,716...122,784,074 		JBrowse link
G FAM174B family with sequence similarity 174 member B decreases expression ISO Thalidomide results in decreased expression of FAM174B mRNA CTD PMID:26217789 NCBI chr15:92,617,448...92,655,775
Ensembl chr15:92,617,448...92,809,884 		JBrowse link
G FAS Fas cell surface death receptor decreases expression
increases expression 		EXP
ISO 		Thalidomide results in decreased expression of FAS protein
Thalidomide results in increased expression of FAS mRNA 		CTD PMID:16531263 PMID:18291259 NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605 		JBrowse link
G FASLG Fas ligand multiple interactions
decreases expression 		ISO
EXP 		Thalidomide inhibits the reaction [SOD1 gene mutant form results in increased expression of FASL mRNA]
Thalidomide results in decreased expression of FASLG protein 		CTD PMID:16510725 PMID:16531263 NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876 		JBrowse link
G FEN1 flap structure-specific endonuclease 1 multiple interactions EXP [Azacitidine co-treated with Thalidomide] affects the expression of FEN1 mRNA CTD PMID:18720364 NCBI chr11:61,792,911...61,797,238
Ensembl chr11:61,792,911...61,797,238 		JBrowse link
G FGD3 FYVE, RhoGEF and PH domain containing 3 increases expression ISO Thalidomide results in increased expression of FGD3 mRNA CTD PMID:26217789 NCBI chr 9:92,947,523...93,036,233
Ensembl chr 9:92,947,523...93,036,236 		JBrowse link
G FGD5-AS1 FGD5 antisense RNA 1 affects response to substance
decreases expression
multiple interactions 		EXP FGD5-AS1 affects the susceptibility to Thalidomide
Thalidomide results in decreased expression of FGD5-AS1 mRNA
FGD5-AS1 inhibits the reaction [Thalidomide results in decreased expression of and results in decreased secretion of VEGFA protein]; FGD5-AS1 inhibits the reaction [Thalidomide results in decreased expression of CD274 protein]; FGD5-AS1 inhibits the reaction [Thalidomide results in decreased expression of CDH2 protein]; FGD5-AS1 inhibits the reaction [Thalidomide results in decreased expression of ZEB1 protein]; FGD5-AS1 inhibits the reaction [Thalidomide results in increased expression of CDH1 protein]; MIR454 mRNA affects the reaction [FGD5-AS1 affects the susceptibility to Thalidomide] 		CTD PMID:34520751 NCBI chr 3:14,942,779...14,948,441
Ensembl chr 3:14,920,347...14,948,424 		JBrowse link
G FGF2 fibroblast growth factor 2 increases response to substance
decreases expression
multiple interactions
decreases activity
affects secretion
affects expression 		EXP
ISO 		FGF2 protein results in increased susceptibility to Thalidomide
Thalidomide results in decreased expression of FGF2 protein
[Temozolomide co-treated with Thalidomide] results in decreased expression of FGF2 protein; HDAC6 protein inhibits the reaction [Thalidomide inhibits the reaction [Paraquat results in increased expression of FGF2 protein]]; MIR141 promotes the reaction [Thalidomide inhibits the reaction [Paraquat results in increased expression of FGF2 protein]]; Thalidomide inhibits the reaction [Paraquat results in increased expression of FGF2 protein]
Thalidomide results in decreased activity of FGF2 protein
Thalidomide promotes the reaction [FGF2 protein results in decreased expression of MMP2 protein]
Thalidomide affects the secretion of FGF2 protein
Thalidomide affects the expression of FGF2 mRNA; Thalidomide affects the expression of FGF2 protein 		CTD PMID:11555579 PMID:12644816 PMID:14558594 PMID:15863203 PMID:15939924 More... NCBI chr 4:122,826,682...122,898,236
Ensembl chr 4:122,826,682...122,898,236 		JBrowse link
G FGF8 fibroblast growth factor 8 increases expression EXP Thalidomide results in increased expression of FGF8 mRNA CTD PMID:31711903 NCBI chr10:101,770,109...101,780,369
Ensembl chr10:101,770,109...101,780,371 		JBrowse link
G FGFR1 fibroblast growth factor receptor 1 affects expression EXP Thalidomide affects the expression of FGFR1 mRNA CTD PMID:30834740 NCBI chr 8:38,411,143...38,468,635
Ensembl chr 8:38,400,215...38,468,834 		JBrowse link
G FGFR2 fibroblast growth factor receptor 2 decreases expression EXP Thalidomide results in decreased expression of FGFR2 mRNA; Thalidomide results in decreased expression of FGFR2 protein CTD PMID:30834740 NCBI chr10:121,478,330...121,598,458
Ensembl chr10:121,478,332...121,598,458 		JBrowse link
G FGFR3 fibroblast growth factor receptor 3 affects expression EXP Thalidomide affects the expression of FGFR3 mRNA CTD PMID:30834740 NCBI chr 4:1,793,293...1,808,867
Ensembl chr 4:1,793,293...1,808,872 		JBrowse link
G FOS Fos proto-oncogene, AP-1 transcription factor subunit increases expression EXP Thalidomide analog results in increased expression of FOS mRNA CTD PMID:20525221 NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,283,190 		JBrowse link
G FOSB FosB proto-oncogene, AP-1 transcription factor subunit increases expression EXP Thalidomide analog results in increased expression of FOSB mRNA CTD PMID:20525221 NCBI chr19:45,467,996...45,475,179
Ensembl chr19:45,467,995...45,475,179 		JBrowse link
G FOXC2 forkhead box C2 decreases expression EXP Thalidomide results in decreased expression of FOXC2 mRNA CTD PMID:31711903 NCBI chr16:86,566,829...86,569,728
Ensembl chr16:86,566,829...86,569,728 		JBrowse link
G FOXRED1 FAD dependent oxidoreductase domain containing 1 decreases expression ISO Thalidomide results in decreased expression of FOXRED1 mRNA CTD PMID:26217789 NCBI chr11:126,269,154...126,278,126
Ensembl chr11:126,269,024...126,278,131 		JBrowse link
G FZD8 frizzled class receptor 8 decreases expression EXP Thalidomide results in decreased expression of FZD8 mRNA CTD PMID:24154490 NCBI chr10:35,638,247...35,642,296
Ensembl chr10:35,638,247...35,642,296 		JBrowse link
G GAB3 GRB2 associated binding protein 3 decreases expression ISO Thalidomide results in decreased expression of GAB3 mRNA CTD PMID:26217789 NCBI chr  X:154,675,249...154,751,566
Ensembl chr  X:154,675,249...154,751,583 		JBrowse link
G GADD45B growth arrest and DNA damage inducible beta multiple interactions ISO Thalidomide inhibits the reaction [lipopolysaccharide A results in increased expression of GADD45B mRNA] CTD PMID:15797874 NCBI chr19:2,476,127...2,478,257
Ensembl chr19:2,476,122...2,478,805 		JBrowse link
G GALM galactose mutarotase decreases expression ISO Thalidomide results in decreased expression of GALM mRNA CTD PMID:26217789 NCBI chr 2:38,666,114...38,734,765
Ensembl chr 2:38,666,081...38,741,237 		JBrowse link
G GATA3 GATA binding protein 3 increases expression ISO Thalidomide results in increased expression of GATA3 protein CTD PMID:19428696 NCBI chr10:8,045,333...8,075,198
Ensembl chr10:8,045,378...8,075,198 		JBrowse link
G GCNT2 glucosaminyl (N-acetyl) transferase 2 (I blood group) decreases expression ISO Thalidomide results in decreased expression of GCNT2 mRNA CTD PMID:26217789 NCBI chr 6:10,521,351...10,629,368
Ensembl chr 6:10,492,223...10,629,368 		JBrowse link
G GEMIN2 gem nuclear organelle associated protein 2 decreases expression ISO Thalidomide results in decreased expression of GEMIN2 mRNA CTD PMID:26217789 NCBI chr14:39,114,323...39,136,973
Ensembl chr14:39,114,285...39,136,973 		JBrowse link
G GFRA2 GDNF family receptor alpha 2 decreases expression ISO Thalidomide results in decreased expression of GFRA2 mRNA CTD PMID:26217789 NCBI chr 8:21,690,398...21,812,345
Ensembl chr 8:21,690,398...21,812,357 		JBrowse link
G GOT1 glutamic-oxaloacetic transaminase 1 increases expression ISO Thalidomide results in increased expression of GOT1 mRNA CTD PMID:26217789 NCBI chr10:99,396,870...99,430,624
Ensembl chr10:99,396,870...99,430,624 		JBrowse link
G GP2 glycoprotein 2 increases expression ISO Thalidomide results in increased expression of GP2 mRNA CTD PMID:26217789 NCBI chr16:20,309,574...20,327,513
Ensembl chr16:20,309,574...20,327,808 		JBrowse link
G GPATCH4 G-patch domain containing 4 (gene/pseudogene) decreases expression ISO Thalidomide results in decreased expression of GPATCH4 mRNA CTD PMID:26217789 NCBI chr 1:156,594,301...156,601,479
Ensembl chr 1:156,594,301...156,601,496 		JBrowse link
G GPX1 glutathione peroxidase 1 multiple interactions ISO Thalidomide inhibits the reaction [Carbon Tetrachloride results in decreased activity of GPX1 protein] CTD PMID:17030452 NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605 		JBrowse link
G GPX8 glutathione peroxidase 8 (putative) decreases expression ISO Thalidomide results in decreased expression of GPX8 mRNA CTD PMID:26217789 NCBI chr 5:55,160,171...55,167,297
Ensembl chr 5:55,160,167...55,167,297 		JBrowse link
G GRIA3 glutamate ionotropic receptor AMPA type subunit 3 decreases expression EXP Thalidomide results in decreased expression of GRIA3 mRNA CTD PMID:32756504 NCBI chr  X:123,184,278...123,490,915
Ensembl chr  X:123,184,153...123,490,915 		JBrowse link
G GRIA4 glutamate ionotropic receptor AMPA type subunit 4 increases expression EXP Thalidomide results in increased expression of GRIA4 mRNA CTD PMID:32756504 NCBI chr11:105,609,616...105,982,090
Ensembl chr11:105,609,535...105,982,090 		JBrowse link
G GRIN2A glutamate ionotropic receptor NMDA type subunit 2A decreases expression EXP Thalidomide results in decreased expression of GRIN2A mRNA CTD PMID:32756504 NCBI chr16:9,753,404...10,182,908
Ensembl chr16:9,753,404...10,183,337 		JBrowse link
G GRIN2C glutamate ionotropic receptor NMDA type subunit 2C decreases expression EXP Thalidomide results in decreased expression of GRIN2C mRNA CTD PMID:32756504 NCBI chr17:74,842,023...74,861,532
Ensembl chr17:74,842,023...74,861,504 		JBrowse link
G GTF2E1 general transcription factor IIE subunit 1 decreases expression ISO Thalidomide results in decreased expression of GTF2E1 mRNA CTD PMID:26217789 NCBI chr 3:120,742,744...120,783,069
Ensembl chr 3:120,742,637...120,783,069 		JBrowse link
G GULP1 GULP PTB domain containing engulfment adaptor 1 decreases expression ISO Thalidomide results in decreased expression of GULP1 mRNA CTD PMID:26217789 NCBI chr 2:188,291,874...188,595,926
Ensembl chr 2:188,291,669...188,595,931 		JBrowse link
G H2AC15 H2A clustered histone 15 decreases expression ISO Thalidomide results in decreased expression of H2AC15 mRNA CTD PMID:26217789 NCBI chr 6:27,837,880...27,838,375
Ensembl chr 6:27,835,508...27,838,375 		JBrowse link
G H2BC12 H2B clustered histone 12 decreases expression ISO Thalidomide results in decreased expression of H2BC12 mRNA CTD PMID:26217789 NCBI chr 6:27,138,293...27,146,858
Ensembl chr 6:27,137,298...27,146,855 		JBrowse link
G H2BC27P H2B clustered histone 27, pseudogene decreases expression ISO Thalidomide results in decreased expression of H2BC27 mRNA CTD PMID:26217789 NCBI chr 1:228,464,170...228,464,575
Ensembl chr 1:228,464,213...228,464,594 		JBrowse link
G H2BC4 H2B clustered histone 4 decreases expression ISO Thalidomide results in decreased expression of H2BC4 mRNA CTD PMID:26217789 NCBI chr 6:26,113,170...26,123,926
Ensembl chr 6:26,086,317...26,123,926 		JBrowse link
G H3C1 H3 clustered histone 1 decreases expression ISO Thalidomide results in decreased expression of H3C1 mRNA CTD PMID:26217789 NCBI chr 6:26,020,451...26,020,958
Ensembl chr 6:26,020,451...26,020,958 		JBrowse link
G H3C15 H3 clustered histone 15 decreases expression ISO Thalidomide results in decreased expression of H3C15 mRNA CTD PMID:26217789 NCBI chr 1:149,852,608...149,853,125
Ensembl chr 1:149,852,608...149,853,125 		JBrowse link
G H4C11 H4 clustered histone 11 decreases expression ISO Thalidomide results in decreased expression of H4C11 mRNA CTD PMID:26217789 NCBI chr 6:27,824,092...27,824,480
Ensembl chr 6:27,824,092...27,824,480 		JBrowse link
G H4C14 H4 clustered histone 14 decreases expression ISO Thalidomide results in decreased expression of H4C14 mRNA CTD PMID:26217789 NCBI chr 1:149,832,657...149,833,052
Ensembl chr 1:149,832,657...149,839,767 		JBrowse link
G H4C3 H4 clustered histone 3 decreases expression ISO Thalidomide results in decreased expression of H4C3 mRNA; Thalidomide results in decreased expression of H4C4 mRNA CTD PMID:26217789 NCBI chr 6:26,103,933...26,104,337
Ensembl chr 6:26,103,933...26,104,337 		JBrowse link
G HCN1 hyperpolarization activated cyclic nucleotide gated potassium channel 1 decreases expression ISO Thalidomide results in decreased expression of HCN1 mRNA CTD PMID:26217789 NCBI chr 5:45,254,948...45,696,380
Ensembl chr 5:45,254,948...45,696,498 		JBrowse link
G HDAC6 histone deacetylase 6 multiple interactions ISO HDAC6 protein inhibits the reaction [Thalidomide inhibits the reaction [Paraquat results in decreased expression of BCL2 protein]]; HDAC6 protein inhibits the reaction [Thalidomide inhibits the reaction [Paraquat results in increased expression of BAX protein]]; HDAC6 protein inhibits the reaction [Thalidomide inhibits the reaction [Paraquat results in increased expression of FGF2 protein]]; HDAC6 protein inhibits the reaction [Thalidomide inhibits the reaction [Paraquat results in increased expression of IL6 protein]]; HDAC6 protein inhibits the reaction [Thalidomide inhibits the reaction [Paraquat results in increased expression of TNF protein]]; HDAC6 protein inhibits the reaction [Thalidomide inhibits the reaction [Paraquat results in increased phosphorylation of NFKBIA protein]]; HDAC6 protein inhibits the reaction [Thalidomide inhibits the reaction [Paraquat results in increased phosphorylation of RELA protein]]; Thalidomide inhibits the reaction [Paraquat results in increased expression of HDAC6 mRNA] CTD PMID:33015978 NCBI chr  X:48,801,398...48,824,982
Ensembl chr  X:48,801,377...48,824,982 		JBrowse link
G HERPUD1 homocysteine inducible ER protein with ubiquitin like domain 1 increases expression EXP Thalidomide analog results in increased expression of HERPUD1 mRNA CTD PMID:20525221 NCBI chr16:56,932,142...56,944,864
Ensembl chr16:56,932,142...56,944,864 		JBrowse link
G HGF hepatocyte growth factor affects expression
affects secretion
decreases activity 		EXP Thalidomide affects the expression of HGF mRNA; Thalidomide affects the expression of HGF protein
Thalidomide affects the secretion of HGF protein
Thalidomide results in decreased activity of HGF protein 		CTD PMID:15939924 PMID:17557286 NCBI chr 7:81,699,010...81,770,047
Ensembl chr 7:81,699,010...81,770,438 		JBrowse link
G HIRIP3 HIRA interacting protein 3 decreases expression ISO Thalidomide results in decreased expression of HIRIP3 mRNA CTD PMID:26217789 NCBI chr16:29,992,321...29,996,096
Ensembl chr16:29,992,330...29,996,074 		JBrowse link
G HLA-A major histocompatibility complex, class I, A increases expression ISO Thalidomide results in increased expression of H2-Q1 mRNA CTD PMID:26217789 NCBI chr 6:29,942,532...29,945,870
Ensembl chr 6:29,941,260...29,949,572 		JBrowse link
G HLA-E major histocompatibility complex, class I, E affects expression EXP Thalidomide affects the expression of HLA-E mRNA CTD PMID:25811541 NCBI chr 6:30,489,509...30,494,194
Ensembl chr 6:30,489,509...30,494,194 		JBrowse link
G HMGN5 high mobility group nucleosome binding domain 5 decreases expression ISO Thalidomide results in decreased expression of HMGN5 mRNA CTD PMID:26217789 NCBI chr  X:81,113,699...81,201,913
Ensembl chr  X:81,113,699...81,201,913 		JBrowse link
G HOXB7 homeobox B7 increases expression EXP Thalidomide results in increased expression of HOXB7 mRNA CTD PMID:31711903 NCBI chr17:48,607,232...48,611,017
Ensembl chr17:48,607,232...48,633,572 		JBrowse link
G HOXB9 homeobox B9 increases expression EXP Thalidomide results in increased expression of HOXB9 mRNA CTD PMID:31711903 NCBI chr17:48,621,156...48,626,358
Ensembl chr17:48,621,156...48,626,358 		JBrowse link
G HSD11B2 hydroxysteroid 11-beta dehydrogenase 2 decreases expression ISO Thalidomide results in decreased expression of HSD11B2 mRNA CTD PMID:26217789 NCBI chr16:67,429,801...67,437,553
Ensembl chr16:67,430,652...67,437,553 		JBrowse link
G HSF1 heat shock transcription factor 1 decreases expression ISO Thalidomide results in decreased expression of HSF1 mRNA CTD PMID:26006729 PMID:26217789 NCBI chr 8:144,291,604...144,314,720
Ensembl chr 8:144,291,591...144,314,720 		JBrowse link
G HSPB1 heat shock protein family B (small) member 1 decreases expression ISO Thalidomide results in decreased expression of HSPB1 mRNA CTD PMID:26217789 NCBI chr 7:76,302,673...76,304,292
Ensembl chr 7:76,302,673...76,305,813 		JBrowse link
G HSPH1 heat shock protein family H (Hsp110) member 1 increases expression EXP Thalidomide analog results in increased expression of HSPH1 mRNA CTD PMID:20525221 NCBI chr13:31,134,973...31,162,388
Ensembl chr13:31,134,973...31,162,388 		JBrowse link
G ICAM1 intercellular adhesion molecule 1 increases response to substance
decreases expression 		EXP
ISO 		ICAM1 gene SNP results in increased susceptibility to Thalidomide
Thalidomide results in decreased expression of ICAM1 mRNA; Thalidomide results in decreased expression of ICAM1 protein 		CTD PMID:17174718 PMID:21245421 NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615 		JBrowse link
G IDNK IDNK gluconokinase decreases expression ISO Thalidomide results in decreased expression of IDNK mRNA CTD PMID:26217789 NCBI chr 9:83,623,006...83,644,123
Ensembl chr 9:83,623,049...83,644,130 		JBrowse link
G IFNG interferon gamma multiple interactions
decreases expression
increases expression
affects expression 		ISO
EXP 		[Thalidomide co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IFNG protein
Thalidomide results in decreased expression of IFNG protein
Thalidomide inhibits the reaction [irinotecan results in increased expression of IFNG protein]; Thalidomide promotes the reaction [irinotecan results in increased expression of IFNG protein]
Thalidomide results in increased expression of IFNG; Thalidomide results in increased expression of IFNG protein
Thalidomide affects the expression of IFNG mRNA 		CTD PMID:15588918 PMID:16078585 PMID:16454849 PMID:16514283 PMID:16815871 More... NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740 		JBrowse link
G IFT27 intraflagellar transport 27 decreases expression ISO Thalidomide results in decreased expression of IFT27 mRNA CTD PMID:26006729 PMID:26217789 NCBI chr22:36,758,211...36,776,119
Ensembl chr22:36,758,202...36,776,256 		JBrowse link
G IFT70A intraflagellar transport 70A decreases expression ISO Thalidomide results in decreased expression of IFT70A1 mRNA CTD PMID:26217789 NCBI chr 2:177,612,999...177,618,742
Ensembl chr 2:177,612,999...177,618,742 		JBrowse link
G IFT74 intraflagellar transport 74 decreases expression ISO Thalidomide results in decreased expression of IFT74 mRNA CTD PMID:26217789 NCBI chr 9:26,947,110...27,066,134
Ensembl chr 9:26,947,039...27,066,134 		JBrowse link
G IGF1 insulin like growth factor 1 affects expression EXP Thalidomide affects the expression of IGF1 mRNA CTD PMID:15939924 NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744 		JBrowse link
G IGFBP3 insulin like growth factor binding protein 3 affects expression
decreases expression 		EXP
ISO 		Thalidomide affects the expression of IGFBP3 mRNA
Thalidomide results in decreased expression of IGFBP3 mRNA 		CTD PMID:15939924 PMID:26217789 NCBI chr 7:45,912,245...45,921,272
Ensembl chr 7:45,912,245...45,921,874 		JBrowse link
G IL10 interleukin 10 affects expression
decreases expression 		EXP
ISO 		Thalidomide affects the expression of IL10 mRNA
Thalidomide results in decreased expression of IL10 protein 		CTD PMID:16454849 PMID:16514283 NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541 		JBrowse link
G IL12A interleukin 12A multiple interactions EXP Thalidomide results in decreased expression of [IL12A protein binds to IL12B protein] CTD PMID:11788559 NCBI chr 3:159,988,835...159,996,019
Ensembl chr 3:159,988,835...159,996,019 		JBrowse link
G IL12B interleukin 12B multiple interactions EXP
ISO 		Thalidomide results in decreased expression of [IL12A protein binds to IL12B protein]
Thalidomide inhibits the reaction [SOD1 gene mutant form results in increased expression of IL12B mRNA] 		CTD PMID:11788559 PMID:16510725 NCBI chr 5:159,314,780...159,330,487
Ensembl chr 5:159,314,780...159,330,863 		JBrowse link
G IL18 interleukin 18 increases expression ISO Thalidomide results in increased expression of IL18 CTD PMID:17089043 NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,251...112,164,096 		JBrowse link
G IL1B interleukin 1 beta decreases expression
multiple interactions 		EXP
ISO 		Thalidomide results in decreased expression of IL1B protein
Thalidomide inhibits the reaction [[Ethanol co-treated with Hydrochloric Acid] results in increased expression of IL1B protein]; Thalidomide inhibits the reaction [Paraquat results in increased expression of IL1B mRNA]
Thalidomide inhibits the reaction [Irinotecan results in increased expression of IL1B protein]; Thalidomide promotes the reaction [Irinotecan results in increased expression of IL1B protein] 		CTD PMID:15863203 PMID:16815871 PMID:23510834 PMID:25478868 NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816 		JBrowse link
G IL1R1 interleukin 1 receptor type 1 decreases expression EXP Thalidomide results in decreased expression of IL1R1 mRNA CTD PMID:15618473 NCBI chr 2:102,070,390...102,179,874
Ensembl chr 2:102,064,544...102,179,874 		JBrowse link
G IL1RN interleukin 1 receptor antagonist multiple interactions ISO Thalidomide promotes the reaction [SOD1 gene mutant form results in increased expression of IL1RN mRNA] CTD PMID:16510725 NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016 		JBrowse link
G IL2 interleukin 2 multiple interactions
decreases expression 		ISO [Thalidomide co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IL2 protein
Thalidomide inhibits the reaction [irinotecan results in decreased expression of IL2 protein]; Thalidomide promotes the reaction [irinotecan results in decreased expression of IL2 protein]
Thalidomide results in decreased expression of IL2 protein 		CTD PMID:15588918 PMID:16815871 NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725 		JBrowse link
G IL4 interleukin 4 increases expression ISO Thalidomide results in increased expression of IL4 protein CTD PMID:16078585 NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678 		JBrowse link
G IL6 interleukin 6 decreases secretion
multiple interactions
decreases activity 		EXP
ISO 		Thalidomide analog results in decreased secretion of IL6 protein
Thalidomide inhibits the reaction [[Ethanol co-treated with Hydrochloric Acid] results in increased expression of IL6 protein]; Thalidomide inhibits the reaction [Paraquat results in increased expression of IL6 mRNA]
HDAC6 protein inhibits the reaction [Thalidomide inhibits the reaction [Paraquat results in increased expression of IL6 protein]]; MIR141 promotes the reaction [Thalidomide inhibits the reaction [Paraquat results in increased expression of IL6 protein]]; Thalidomide inhibits the reaction [Irinotecan results in increased expression of IL6 protein]; Thalidomide inhibits the reaction [Paraquat results in increased expression of IL6 mRNA]; Thalidomide inhibits the reaction [Paraquat results in increased expression of IL6 protein]
Thalidomide results in decreased activity of IL6 protein 		CTD PMID:15858615 PMID:16815871 PMID:17557286 PMID:23510834 PMID:25478868 More... NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002 		JBrowse link
G IL6ST interleukin 6 cytokine family signal transducer decreases expression EXP Thalidomide results in decreased expression of IL6ST mRNA CTD PMID:15618473 NCBI chr 5:55,935,095...55,994,963
Ensembl chr 5:55,935,095...55,995,022 		JBrowse link
G ING3 inhibitor of growth family member 3 increases expression EXP Thalidomide analog results in increased expression of ING3 mRNA CTD PMID:20525221 NCBI chr 7:120,950,777...120,977,216
Ensembl chr 7:120,950,763...120,977,216 		JBrowse link
G IPP intracisternal A particle-promoted polypeptide decreases expression ISO Thalidomide results in decreased expression of IPP mRNA CTD PMID:26217789 NCBI chr 1:45,694,324...45,750,653
Ensembl chr 1:45,694,324...45,750,653 		JBrowse link
G JUN Jun proto-oncogene, AP-1 transcription factor subunit increases expression EXP Thalidomide analog results in increased expression of JUN mRNA CTD PMID:20525221 NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048 		JBrowse link
G KALRN kalirin RhoGEF kinase decreases expression EXP Thalidomide results in decreased expression of KALRN mRNA CTD PMID:32756504 NCBI chr 3:124,033,369...124,726,325
Ensembl chr 3:124,033,369...124,726,325 		JBrowse link
G KDR kinase insert domain receptor multiple interactions EXP sphingosine 1-phosphate inhibits the reaction [Thalidomide results in decreased expression of KDR mRNA] CTD PMID:15741222 NCBI chr 4:55,078,481...55,125,595
Ensembl chr 4:55,078,481...55,125,595 		JBrowse link
G KIF2C kinesin family member 2C multiple interactions EXP [Azacitidine co-treated with Thalidomide] affects the expression of KIF2C mRNA CTD PMID:18720364 NCBI chr 1:44,739,837...44,767,767
Ensembl chr 1:44,739,818...44,767,767 		JBrowse link
G KLHL4 kelch like family member 4 decreases expression ISO Thalidomide results in decreased expression of KLHL4 mRNA CTD PMID:26217789 NCBI chr  X:87,517,802...87,670,050
Ensembl chr  X:87,517,409...87,670,050 		JBrowse link
G KLK1 kallikrein 1 decreases expression ISO Thalidomide results in decreased expression of KLK1 mRNA CTD PMID:26217789 NCBI chr19:50,819,146...50,823,787
Ensembl chr19:50,819,146...50,823,787 		JBrowse link
G KLK3 kallikrein related peptidase 3 decreases expression EXP Thalidomide results in decreased expression of KLK3 protein CTD PMID:12644816 NCBI chr19:50,854,915...50,860,764
Ensembl chr19:50,854,915...50,860,764 		JBrowse link
G KRTAP1-5 keratin associated protein 1-5 increases expression ISO Thalidomide results in increased expression of KRTAP1-4 mRNA CTD PMID:26217789 NCBI chr17:41,026,026...41,027,208
Ensembl chr17:41,026,026...41,027,208 		JBrowse link
G LATS2 large tumor suppressor kinase 2 increases expression EXP Thalidomide analog results in increased expression of LATS2 mRNA CTD PMID:20525221 NCBI chr13:20,973,036...21,061,586
Ensembl chr13:20,973,036...21,061,586 		JBrowse link
G LEFTY2 left-right determination factor 2 decreases expression ISO Thalidomide results in decreased expression of LEFTY2 mRNA CTD PMID:26217789 NCBI chr 1:225,936,603...225,941,220
Ensembl chr 1:225,936,598...225,941,383 		JBrowse link
G LRR1 leucine rich repeat protein 1 decreases expression ISO Thalidomide results in decreased expression of LRR1 mRNA CTD PMID:26217789 NCBI chr14:49,598,940...49,614,672
Ensembl chr14:49,598,761...49,614,672 		JBrowse link
G LTF lactotransferrin multiple interactions EXP Thalidomide inhibits the reaction [Lipopolysaccharides results in increased secretion of LTF protein]; Thalidomide inhibits the reaction [lipoteichoic acid results in increased secretion of LTF protein] CTD PMID:11302825 NCBI chr 3:46,435,645...46,485,234
Ensembl chr 3:46,435,645...46,485,234 		JBrowse link
G LY96 lymphocyte antigen 96 decreases expression ISO Thalidomide results in decreased expression of LY96 mRNA CTD PMID:26006729 PMID:26217789 NCBI chr 8:73,991,392...74,099,857
Ensembl chr 8:73,991,392...74,029,079 		JBrowse link
G LYRM2 LYR motif containing 2 decreases expression ISO Thalidomide results in decreased expression of LYRM2 mRNA CTD PMID:26217789 NCBI chr 6:89,632,224...89,638,747
Ensembl chr 6:89,568,144...89,638,749 		JBrowse link
G LYRM4 LYR motif containing 4 decreases expression ISO Thalidomide results in decreased expression of LYRM4 mRNA CTD PMID:26217789 NCBI chr 6:5,031,753...5,260,950
Ensembl chr 6:5,103,629...5,260,950 		JBrowse link
G MAP1LC3B microtubule associated protein 1 light chain 3 beta multiple interactions EXP Thalidomide promotes the reaction [temozolomide results in increased expression of MAP1LC3B protein] CTD PMID:19567134 NCBI chr16:87,392,336...87,404,774
Ensembl chr16:87,383,953...87,404,779 		JBrowse link
G MAPK1 mitogen-activated protein kinase 1 increases phosphorylation EXP Thalidomide analog results in increased phosphorylation of MAPK1 protein CTD PMID:15858615 NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680 		JBrowse link
G MAPK14 mitogen-activated protein kinase 14 increases phosphorylation EXP Thalidomide analog results in increased phosphorylation of MAPK14 protein CTD PMID:15858615 NCBI chr 6:36,027,808...36,124,214
Ensembl chr 6:36,027,752...36,122,511 		JBrowse link
G MAPK3 mitogen-activated protein kinase 3 increases phosphorylation EXP Thalidomide analog results in increased phosphorylation of MAPK3 protein CTD PMID:15858615 NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506 		JBrowse link
G MCL1 MCL1 apoptosis regulator, BCL2 family member decreases expression EXP Thalidomide analog results in decreased expression of MCL1 protein CTD PMID:15858615 NCBI chr 1:150,574,558...150,579,610
Ensembl chr 1:150,560,895...150,579,738 		JBrowse link
G MCM5 minichromosome maintenance complex component 5 multiple interactions EXP [Azacitidine co-treated with Thalidomide] affects the expression of MCM5 mRNA CTD PMID:18720364 NCBI chr22:35,400,140...35,455,031
Ensembl chr22:35,400,134...35,425,431 		JBrowse link
G MEIS2 Meis homeobox 2 multiple interactions EXP Thalidomide inhibits the reaction [CRBN protein binds to and results in increased ubiquitination of and results in increased degradation of MEIS2 protein] CTD PMID:25043012 NCBI chr15:36,889,204...37,101,311
Ensembl chr15:36,889,204...37,101,299 		JBrowse link
G MEOX1 mesenchyme homeobox 1 decreases expression EXP Thalidomide results in decreased expression of MEOX1 mRNA CTD PMID:31711903 NCBI chr17:43,640,389...43,661,922
Ensembl chr17:43,640,389...43,661,922 		JBrowse link
G MESP2 mesoderm posterior bHLH transcription factor 2 decreases expression EXP Thalidomide results in decreased expression of MESP2 mRNA CTD PMID:31711903 NCBI chr15:89,776,332...89,778,754
Ensembl chr15:89,760,591...89,778,754 		JBrowse link
G METTL5 methyltransferase 5, N6-adenosine decreases expression ISO Thalidomide results in decreased expression of METTL5 mRNA CTD PMID:26217789 NCBI chr 2:169,811,757...169,824,905
Ensembl chr 2:169,810,081...169,824,931 		JBrowse link
G MIR126 microRNA 126 multiple interactions ISO Thalidomide inhibits the reaction [Paraquat results in decreased expression of MIR126] CTD PMID:33015978 NCBI chr 9:136,670,602...136,670,686
Ensembl chr 9:136,670,602...136,670,686 		JBrowse link
G MIR141 microRNA 141 multiple interactions ISO MIR141 promotes the reaction [Thalidomide inhibits the reaction [Paraquat results in decreased expression of BCL2 protein]]; MIR141 promotes the reaction [Thalidomide inhibits the reaction [Paraquat results in increased expression of BAX protein]]; MIR141 promotes the reaction [Thalidomide inhibits the reaction [Paraquat results in increased expression of FGF2 protein]]; MIR141 promotes the reaction [Thalidomide inhibits the reaction [Paraquat results in increased expression of IL6 protein]]; MIR141 promotes the reaction [Thalidomide inhibits the reaction [Paraquat results in increased expression of TNF protein]]; Thalidomide inhibits the reaction [Paraquat results in decreased expression of MIR141] CTD PMID:33015978 NCBI chr12:6,964,097...6,964,191
Ensembl chr12:6,964,097...6,964,191 		JBrowse link
G MIR206 microRNA 206 multiple interactions ISO Thalidomide inhibits the reaction [Paraquat results in increased expression of MIR206] CTD PMID:33015978 NCBI chr 6:52,144,349...52,144,434
Ensembl chr 6:52,144,349...52,144,434 		JBrowse link
G MIR21 microRNA 21 multiple interactions ISO Thalidomide inhibits the reaction [Paraquat results in decreased expression of MIR21] CTD PMID:33015978 NCBI chr17:59,841,266...59,841,337
Ensembl chr17:59,841,266...59,841,337 		JBrowse link
G MIR221 microRNA 221 multiple interactions ISO Thalidomide inhibits the reaction [Paraquat results in increased expression of MIR221] CTD PMID:33015978 NCBI chr  X:45,746,157...45,746,266
Ensembl chr  X:45,746,157...45,746,266 		JBrowse link
G MIR222 microRNA 222 multiple interactions ISO Thalidomide inhibits the reaction [Paraquat results in increased expression of MIR222] CTD PMID:33015978 NCBI chr  X:45,747,015...45,747,124
Ensembl chr  X:45,747,015...45,747,124 		JBrowse link
G MIR301B microRNA 301b increases expression ISO Thalidomide results in increased expression of MIR301B mRNA CTD PMID:26217789 NCBI chr22:21,652,981...21,653,058
Ensembl chr22:21,652,981...21,653,058 		JBrowse link
G MIR30E microRNA 30e decreases expression ISO Thalidomide results in decreased expression of MIR30E mRNA CTD PMID:26217789 NCBI chr 1:40,754,355...40,754,446
Ensembl chr 1:40,754,355...40,754,446 		JBrowse link
G MIR449C microRNA 449c increases expression ISO Thalidomide results in increased expression of MIR449C mRNA CTD PMID:26217789 NCBI chr 5:55,172,262...55,172,353
Ensembl chr 5:55,172,262...55,172,353 		JBrowse link
G MIR454 microRNA 454 increases expression
multiple interactions 		EXP Thalidomide results in increased expression of MIR454 mRNA
MIR454 mRNA affects the reaction [FGD5-AS1 affects the susceptibility to Thalidomide] 		CTD PMID:34520751 NCBI chr17:59,137,758...59,137,872
Ensembl chr17:59,137,758...59,137,872 		JBrowse link
G MIXL1 Mix paired-like homeobox decreases expression ISO Thalidomide results in decreased expression of MIXL1 mRNA CTD PMID:26217789 NCBI chr 1:226,223,664...226,227,060
Ensembl chr 1:226,223,618...226,227,060 		JBrowse link
G MKI67 marker of proliferation Ki-67 multiple interactions
decreases expression 		EXP [Azacitidine co-treated with Thalidomide] affects the expression of MKI67 mRNA
Thalidomide results in decreased expression of MKI67 protein 		CTD PMID:18720364 PMID:34520751 NCBI chr10:128,096,659...128,126,423
Ensembl chr10:128,096,659...128,126,423 		JBrowse link
G MLF2 myeloid leukemia factor 2 decreases expression ISO Thalidomide results in decreased expression of MLF2 mRNA CTD PMID:26217789 NCBI chr12:6,747,996...6,753,141
Ensembl chr12:6,747,996...6,767,475 		JBrowse link
G MME membrane metalloendopeptidase decreases expression ISO Thalidomide results in decreased expression of MME mRNA CTD PMID:26217789 NCBI chr 3:155,024,202...155,183,729
Ensembl chr 3:155,024,124...155,183,704 		JBrowse link
G MMP2 matrix metallopeptidase 2 multiple interactions
decreases expression 		EXP Thalidomide promotes the reaction [FGF2 protein results in decreased expression of MMP2 protein]
Thalidomide results in decreased expression of MMP2 protein 		CTD PMID:14558594 PMID:15863203 NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691 		JBrowse link
G MMP9 matrix metallopeptidase 9 decreases expression EXP Thalidomide results in decreased expression of MMP9 protein CTD PMID:15863203 NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561 		JBrowse link
G MOXD1 monooxygenase DBH like 1 decreases expression ISO Thalidomide results in decreased expression of MOXD1 mRNA CTD PMID:26217789 NCBI chr 6:132,296,055...132,401,475
Ensembl chr 6:132,296,055...132,401,475 		JBrowse link
G MPO myeloperoxidase multiple interactions ISO Thalidomide inhibits the reaction [[Ethanol co-treated with Hydrochloric Acid] results in increased activity of MPO protein]; Thalidomide inhibits the reaction [Indomethacin results in increased activity of MPO protein] CTD PMID:15138204 PMID:25478868 NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935 		JBrowse link
G MPP1 MAGUK p55 scaffold protein 1 decreases expression ISO Thalidomide results in decreased expression of MPP1 mRNA CTD PMID:26217789 NCBI chr  X:154,778,684...154,805,485
Ensembl chr  X:154,778,684...154,821,007 		JBrowse link
G MRPL32 mitochondrial ribosomal protein L32 decreases expression ISO Thalidomide results in decreased expression of MRPL32 mRNA CTD PMID:26217789 NCBI chr 7:42,932,376...42,937,857
Ensembl chr 7:42,932,376...42,948,958 		JBrowse link
G MRPL34 mitochondrial ribosomal protein L34 decreases expression ISO Thalidomide results in decreased expression of MRPL34 mRNA CTD PMID:26217789 NCBI chr19:17,292,573...17,306,843
Ensembl chr19:17,292,609...17,306,843 		JBrowse link
G MRPL47 mitochondrial ribosomal protein L47 decreases expression ISO Thalidomide results in decreased expression of MRPL47 mRNA CTD PMID:26217789 NCBI chr 3:179,588,285...179,604,646
Ensembl chr 3:179,588,285...179,604,649 		JBrowse link
G MRPL52 mitochondrial ribosomal protein L52 decreases expression ISO Thalidomide results in decreased expression of MRPL52 mRNA CTD PMID:26217789 NCBI chr14:22,829,887...22,835,037
Ensembl chr14:22,829,879...22,835,037 		JBrowse link
G MRPS21 mitochondrial ribosomal protein S21 decreases expression ISO Thalidomide results in decreased expression of MRPS21 mRNA CTD PMID:26217789 NCBI chr 1:150,293,861...150,308,979
Ensembl chr 1:150,293,861...150,308,979 		JBrowse link
G MTFR2 mitochondrial fission regulator 2 decreases expression ISO Thalidomide results in decreased expression of MTFR2 mRNA CTD PMID:26217789 NCBI chr 6:136,231,034...136,250,311
Ensembl chr 6:136,231,024...136,250,335 		JBrowse link
G MYB MYB proto-oncogene, transcription factor multiple interactions
decreases phosphorylation
decreases activity 		EXP CAT protein inhibits the reaction [Thalidomide results in decreased activity of MYB protein]
Thalidomide results in decreased phosphorylation of MYB protein 		CTD PMID:16616857 NCBI chr 6:135,181,308...135,219,172
Ensembl chr 6:135,181,308...135,219,173 		JBrowse link
G MYBPC3 myosin binding protein C3 decreases expression ISO Thalidomide results in decreased expression of MYBPC3 mRNA CTD PMID:26006729 PMID:26217789 NCBI chr11:47,331,406...47,352,702
Ensembl chr11:47,331,406...47,352,702 		JBrowse link
G MYD88 MYD88 innate immune signal transduction adaptor decreases expression ISO Thalidomide results in decreased expression of MYD88 mRNA CTD PMID:26006729 PMID:26217789 NCBI chr 3:38,138,661...38,143,022
Ensembl chr 3:38,138,552...38,143,024 		JBrowse link
G MYH6 myosin heavy chain 6 affects expression ISO Thalidomide affects the expression of MYH6 mRNA CTD PMID:26006729 PMID:26217789 NCBI chr14:23,381,987...23,408,273
Ensembl chr14:23,381,982...23,408,273 		JBrowse link
G MYL3 myosin light chain 3 affects expression
decreases expression 		ISO Thalidomide affects the expression of MYL3 mRNA
Thalidomide results in decreased expression of MYL3 mRNA 		CTD PMID:26006729 PMID:26217789 NCBI chr 3:46,857,872...46,882,182
Ensembl chr 3:46,835,110...46,882,178 		JBrowse link
G MYL7 myosin light chain 7 decreases expression ISO Thalidomide results in decreased expression of MYL7 mRNA CTD PMID:26217789 NCBI chr 7:44,138,864...44,141,332
Ensembl chr 7:44,138,864...44,141,332 		JBrowse link
G MYLK myosin light chain kinase increases expression ISO Thalidomide results in increased expression of MYLK mRNA CTD PMID:26217789 NCBI chr 3:123,610,049...123,884,332
Ensembl chr 3:123,610,049...123,884,332 		JBrowse link
G MYOM1 myomesin 1 decreases expression ISO Thalidomide results in decreased expression of MYOM1 mRNA CTD PMID:26006729 PMID:26217789 NCBI chr18:3,066,807...3,247,376
Ensembl chr18:3,066,807...3,219,968 		JBrowse link
G NAA20 N-alpha-acetyltransferase 20, NatB catalytic subunit decreases expression ISO Thalidomide results in decreased expression of NAA20 mRNA CTD PMID:26217789 NCBI chr20:20,017,290...20,033,655
Ensembl chr20:20,017,310...20,033,655 		JBrowse link
G NANOG Nanog homeobox decreases expression ISO Thalidomide results in decreased expression of NANOG mRNA CTD PMID:26217789 NCBI chr12:7,789,402...7,799,146
Ensembl chr12:7,787,794...7,799,146 		JBrowse link
G NAXE NAD(P)HX epimerase decreases expression ISO Thalidomide results in decreased expression of NAXE mRNA CTD PMID:26217789 NCBI chr 1:156,591,776...156,594,299
Ensembl chr 1:156,591,756...156,609,507 		JBrowse link
G NDUFB8 NADH:ubiquinone oxidoreductase subunit B8 decreases expression ISO Thalidomide results in decreased expression of NDUFB8 mRNA CTD PMID:26217789 NCBI chr10:100,523,729...100,529,923
Ensembl chr10:100,523,668...100,530,000 		JBrowse link
G NEBL nebulette decreases expression ISO Thalidomide results in decreased expression of NEBL mRNA CTD PMID:26217789 NCBI chr10:20,779,973...21,293,050
Ensembl chr10:20,779,973...21,293,011 		JBrowse link
G NEUROD4 neuronal differentiation 4 increases expression ISO Thalidomide results in increased expression of NEUROD4 mRNA CTD PMID:26217789 NCBI chr12:55,019,974...55,030,017
Ensembl chr12:55,019,974...55,030,017 		JBrowse link
G NEUROG2 neurogenin 2 increases expression EXP Thalidomide results in increased expression of NEUROG2 mRNA CTD PMID:31711903 NCBI chr 4:112,513,516...112,516,180
Ensembl chr 4:112,513,516...112,516,180 		JBrowse link
G NFE2L2 NFE2 like bZIP transcription factor 2 multiple interactions ISO Thalidomide promotes the reaction [Paraquat results in increased expression of NFE2L2 mRNA]; Thalidomide promotes the reaction [Paraquat results in increased expression of NFE2L2 protein] CTD PMID:25579023 NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756 		JBrowse link
G NFKB1 nuclear factor kappa B subunit 1 multiple interactions
decreases expression 		EXP
ISO 		[resveratrol co-treated with Thalidomide] results in decreased activity of [RELA protein binds to NFKB1 protein]
Thalidomide results in decreased expression of NFKB1 protein 		CTD PMID:16333628 PMID:17164350 NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302 		JBrowse link
G NFKBIA NFKB inhibitor alpha multiple interactions
increases expression 		EXP
ISO 		Thalidomide inhibits the reaction [TGFB1 protein results in increased degradation of NFKBIA protein]; Thalidomide inhibits the reaction [TGFB1 protein results in increased phosphorylation of NFKBIA protein]; Thalidomide inhibits the reaction [TGFB1 protein results in increased transport of NFKBIA protein]; Thalidomide inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased degradation of NFKBIA protein]
Thalidomide results in increased expression of NFKBIA protein
HDAC6 protein inhibits the reaction [Thalidomide inhibits the reaction [Paraquat results in increased phosphorylation of NFKBIA protein]]; Thalidomide inhibits the reaction [Carbon Tetrachloride results in decreased expression of NFKBIA protein]; Thalidomide inhibits the reaction [Paraquat results in increased phosphorylation of NFKBIA protein]; Thalidomide inhibits the reaction [TNF protein results in increased phosphorylation of NFKBIA protein] 		CTD PMID:15687330 PMID:16288038 PMID:16604421 PMID:16943688 PMID:17174718 More... NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749 		JBrowse link
G NHLH1 nescient helix-loop-helix 1 increases expression ISO Thalidomide results in increased expression of NHLH1 mRNA CTD PMID:26217789 NCBI chr 1:160,367,071...160,372,846
Ensembl chr 1:160,367,071...160,372,846 		JBrowse link
G NMS neuromedin S increases expression ISO Thalidomide results in increased expression of NMS mRNA CTD PMID:26217789 NCBI chr 2:100,470,482...100,483,280
Ensembl chr 2:100,470,482...100,483,280 		JBrowse link
G NOS2 nitric oxide synthase 2 multiple interactions ISO Thalidomide inhibits the reaction [Dimethylnitrosamine results in increased expression of NOS2 mRNA] CTD PMID:16604421 NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529 		JBrowse link
G NPPB natriuretic peptide B multiple interactions EXP [Thalidomide co-treated with Dexamethasone] results in increased expression of NPPB protein CTD PMID:18414984 NCBI chr 1:11,857,464...11,858,945
Ensembl chr 1:11,857,464...11,858,945 		JBrowse link
G NQO2 N-ribosyldihydronicotinamide:quinone dehydrogenase 2 decreases expression ISO Thalidomide results in decreased expression of NQO2 mRNA CTD PMID:26217789 NCBI chr 6:2,999,894...3,019,755
Ensembl chr 6:2,987,987...3,019,755 		JBrowse link
G NR1H5P nuclear receptor subfamily 1 group H member 5, pseudogene decreases expression ISO Thalidomide results in decreased expression of NR1H5 mRNA CTD PMID:26217789 NCBI chr 1:114,834,456...114,851,544
Ensembl chr 1:114,837,227...114,851,453 		JBrowse link
G NR1I2 nuclear receptor subfamily 1 group I member 2 increases expression EXP Thalidomide results in increased expression of NR1I2 mRNA CTD PMID:28496040 NCBI chr 3:119,782,101...119,818,487
Ensembl chr 3:119,780,484...119,818,487 		JBrowse link
G NR4A1 nuclear receptor subfamily 4 group A member 1 increases expression EXP Thalidomide analog results in increased expression of NR4A1 mRNA CTD PMID:20525221 NCBI chr12:52,022,832...52,059,503
Ensembl chr12:52,022,832...52,059,507 		JBrowse link
G NR4A2 nuclear receptor subfamily 4 group A member 2 increases expression EXP Thalidomide analog results in increased expression of NR4A2 mRNA CTD PMID:20525221 NCBI chr 2:156,324,437...156,332,721
Ensembl chr 2:156,324,437...156,342,348 		JBrowse link
G NRP1 neuropilin 1 multiple interactions EXP sphingosine 1-phosphate inhibits the reaction [Thalidomide results in decreased expression of NRP1 mRNA] CTD PMID:15741222 NCBI chr10:33,177,493...33,334,667
Ensembl chr10:33,177,492...33,336,262 		JBrowse link
G NRP2 neuropilin 2 multiple interactions EXP sphingosine 1-phosphate inhibits the reaction [Thalidomide results in decreased expression of NRP2 mRNA] CTD PMID:15741222 NCBI chr 2:205,682,501...205,798,131
Ensembl chr 2:205,681,990...205,798,133 		JBrowse link
G NRXN1 neurexin 1 decreases expression EXP Thalidomide results in decreased expression of NRXN1 mRNA CTD PMID:32756504 NCBI chr 2:49,918,503...51,032,132
Ensembl chr 2:49,918,503...51,225,575 		JBrowse link
G NT5C3A 5'-nucleotidase, cytosolic IIIA decreases expression ISO Thalidomide results in decreased expression of NT5C3 mRNA CTD PMID:26217789 NCBI chr 7:33,014,113...33,062,776
Ensembl chr 7:33,014,113...33,062,796 		JBrowse link
G NT5E 5'-nucleotidase ecto decreases expression ISO Thalidomide results in decreased expression of NT5E mRNA CTD PMID:26217789 NCBI chr 6:85,450,083...85,495,784
Ensembl chr 6:85,449,584...85,495,791 		JBrowse link
G NTAN1 N-terminal asparagine amidase decreases expression ISO Thalidomide results in decreased expression of NTAN1 mRNA CTD PMID:26217789 NCBI chr16:15,037,857...15,056,074
Ensembl chr16:15,037,854...15,056,079 		JBrowse link
G NUDT14 nudix hydrolase 14 decreases expression ISO Thalidomide results in decreased expression of NUDT14 mRNA CTD PMID:26217789 NCBI chr14:105,172,939...105,181,312
Ensembl chr14:105,172,938...105,181,323 		JBrowse link
G NUDT22 nudix hydrolase 22 decreases expression ISO Thalidomide results in decreased expression of NUDT22 mRNA CTD PMID:26217789 NCBI chr11:64,226,258...64,230,269
Ensembl chr11:64,225,941...64,230,686 		JBrowse link
G NUP62CL nucleoporin 62 C-terminal like decreases expression ISO Thalidomide results in decreased expression of NUP62CL mRNA CTD PMID:26217789 NCBI chr  X:107,123,427...107,206,433
Ensembl chr  X:107,123,427...107,206,433 		JBrowse link
G NUSAP1 nucleolar and spindle associated protein 1 multiple interactions EXP [Azacitidine co-treated with Thalidomide] affects the expression of NUSAP1 mRNA CTD PMID:18720364 NCBI chr15:41,332,881...41,381,046
Ensembl chr15:41,320,794...41,381,050 		JBrowse link
G OAS1 2'-5'-oligoadenylate synthetase 1 decreases expression ISO Thalidomide results in decreased expression of OAS1G mRNA CTD PMID:26217789 NCBI chr12:112,906,962...112,933,219
Ensembl chr12:112,905,856...112,933,219 		JBrowse link
G OCLN occludin multiple interactions ISO Thalidomide inhibits the reaction [dinitrobenzenesulfonic acid results in decreased expression of OCLN protein] CTD PMID:16680017 NCBI chr 5:69,492,547...69,558,104
Ensembl chr 5:69,492,292...69,558,104 		JBrowse link
G OLIG2 oligodendrocyte transcription factor 2 increases expression ISO Thalidomide results in increased expression of OLIG2 mRNA CTD PMID:26217789 NCBI chr21:33,025,935...33,029,185
Ensembl chr21:33,025,935...33,029,196 		JBrowse link
G OLIG3 oligodendrocyte transcription factor 3 increases expression EXP Thalidomide results in increased expression of OLIG3 mRNA CTD PMID:31711903 NCBI chr 6:137,492,199...137,494,394
Ensembl chr 6:137,492,199...137,494,394 		JBrowse link
G OR10Q1 olfactory receptor family 10 subfamily Q member 1 increases expression ISO Thalidomide results in increased expression of OR10Q1 mRNA CTD PMID:26217789 NCBI chr11:58,227,882...58,228,918
Ensembl chr11:58,227,882...58,228,918 		JBrowse link
G OR1D2 olfactory receptor family 1 subfamily D member 2 increases expression ISO Thalidomide results in increased expression of OR1D2 mRNA CTD PMID:26217789 NCBI chr17:3,088,484...3,104,422
Ensembl chr17:3,088,484...3,104,422 		JBrowse link
G OR2AG1 olfactory receptor family 2 subfamily AG member 1 increases expression ISO Thalidomide results in increased expression of OR2AG1 mRNA CTD PMID:26217789 NCBI chr11:6,783,020...6,791,558
Ensembl chr11:6,783,020...6,791,558 		JBrowse link
G OR2Y1 olfactory receptor family 2 subfamily Y member 1 increases expression ISO Thalidomide results in increased expression of OR2Y1 mRNA CTD PMID:26217789 NCBI chr 5:180,739,123...180,740,058
Ensembl chr 5:180,739,123...180,740,058 		JBrowse link
G OR51Q1 olfactory receptor family 51 subfamily Q member 1 increases expression ISO Thalidomide results in increased expression of OR51Q1 mRNA CTD PMID:26217789 NCBI chr11:5,422,111...5,423,206
Ensembl chr11:5,422,111...5,423,206 		JBrowse link
G OR5I1 olfactory receptor family 5 subfamily I member 1 increases expression ISO Thalidomide results in increased expression of OR5I1 mRNA CTD PMID:26217789 NCBI chr11:55,935,456...55,936,400
Ensembl chr11:55,935,456...55,936,400 		JBrowse link
G OR5V1 olfactory receptor family 5 subfamily V member 1 increases expression ISO Thalidomide results in increased expression of OR5V1 mRNA CTD PMID:26217789 NCBI chr 6:29,353,749...29,368,865
Ensembl chr 6:29,353,749...29,431,967 		JBrowse link
G OR8A1 olfactory receptor family 8 subfamily A member 1 decreases expression ISO Thalidomide results in decreased expression of OR8A1B mRNA CTD PMID:26217789 NCBI chr11:124,569,997...124,571,374
Ensembl chr11:124,566,660...124,582,942 		JBrowse link
G OR8B3 olfactory receptor family 8 subfamily B member 3 increases expression ISO Thalidomide results in increased expression of OR8B3 mRNA CTD PMID:26217789 NCBI chr11:124,395,534...124,409,807
Ensembl chr11:124,395,534...124,399,024 		JBrowse link
G OR9K2 olfactory receptor family 9 subfamily K member 2 increases expression ISO Thalidomide results in increased expression of OR9K2 mRNA CTD PMID:26217789 NCBI chr12:55,126,406...55,132,750
Ensembl chr12:55,126,406...55,132,750 		JBrowse link
G OSTF1 osteoclast stimulating factor 1 decreases expression ISO Thalidomide results in decreased expression of OSTF1 mRNA CTD PMID:26217789 NCBI chr 9:75,088,514...75,147,265
Ensembl chr 9:75,088,514...75,147,265 		JBrowse link
G PABIR1 PP2A Aalpha (PPP2R1A) and B55A (PPP2R2A) interacting phosphatase regulator 1 decreases expression ISO Thalidomide results in decreased expression of PABIR1 mRNA CTD PMID:26217789 NCBI chr 9:68,780,065...68,785,566
Ensembl chr 9:68,780,065...68,785,566 		JBrowse link
G PARP1 poly(ADP-ribose) polymerase 1 multiple interactions
increases cleavage 		EXP [Curcumin co-treated with Thalidomide] results in increased cleavage of PARP1 protein
Thalidomide analog results in increased cleavage of PARP1 protein 		CTD PMID:15858615 PMID:19372569 NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154 		JBrowse link
G PAX3 paired box 3 decreases expression EXP Thalidomide results in decreased expression of PAX3 mRNA CTD PMID:31711903 NCBI chr 2:222,199,887...222,298,998
Ensembl chr 2:222,199,887...222,298,998 		JBrowse link
G PAX6 paired box 6 increases expression EXP Thalidomide results in increased expression of PAX6 mRNA CTD PMID:31711903 NCBI chr11:31,789,026...31,817,961
Ensembl chr11:31,784,779...31,817,961 		JBrowse link
G PDCD10 programmed cell death 10 decreases expression ISO Thalidomide results in decreased expression of PDCD10 mRNA CTD PMID:26217789 NCBI chr 3:167,683,298...167,734,892
Ensembl chr 3:167,683,298...167,734,939 		JBrowse link
G PDLIM3 PDZ and LIM domain 3 decreases expression ISO Thalidomide results in decreased expression of PDLIM3 mRNA CTD PMID:26217789 NCBI chr 4:185,500,660...185,535,507
Ensembl chr 4:185,500,660...185,535,507 		JBrowse link
G PECAM1 platelet and endothelial cell adhesion molecule 1 decreases expression ISO
EXP 		Thalidomide results in decreased expression of PECAM1 protein CTD PMID:18291259 PMID:34520751 NCBI chr17:64,319,415...64,390,860
Ensembl chr17:64,319,415...64,413,776 		JBrowse link
G PFDN6 prefoldin subunit 6 decreases expression ISO Thalidomide results in decreased expression of PFDN6 mRNA CTD PMID:26217789 NCBI chr 6:33,289,197...33,290,934
Ensembl chr 6:33,289,302...33,298,401 		JBrowse link
G PIK3CA phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha multiple interactions EXP [ERBB2 protein co-treated with PIK3CA protein mutant form] results in increased susceptibility to Thalidomide metabolite CTD PMID:28745489 NCBI chr 3:179,148,126...179,240,093
Ensembl chr 3:179,148,114...179,240,093 		JBrowse link
G PILRA paired immunoglobin like type 2 receptor alpha decreases expression ISO Thalidomide results in decreased expression of PILRA mRNA CTD PMID:26217789 NCBI chr 7:100,371,291...100,400,096
Ensembl chr 7:100,367,530...100,400,096 		JBrowse link
G PIM1 Pim-1 proto-oncogene, serine/threonine kinase decreases expression EXP Thalidomide results in decreased expression of PIM1 protein CTD PMID:16616857 NCBI chr 6:37,170,152...37,175,428
Ensembl chr 6:37,170,152...37,175,428 		JBrowse link
G PLAU plasminogen activator, urokinase decreases expression ISO Thalidomide results in decreased expression of PLAU protein CTD PMID:16288038 NCBI chr10:73,909,164...73,917,494
Ensembl chr10:73,909,177...73,917,496 		JBrowse link
G PLAUR plasminogen activator, urokinase receptor multiple interactions
decreases expression 		EXP
ISO 		Thalidomide inhibits the reaction [TGFB1 protein results in increased expression of PLAUR mRNA]; Thalidomide inhibits the reaction [TGFB1 protein results in increased expression of PLAUR protein]
Thalidomide results in decreased expression of PLAUR protein 		CTD PMID:16288038 NCBI chr19:43,646,095...43,670,169
Ensembl chr19:43,646,095...43,670,547 		JBrowse link
G PLTP phospholipid transfer protein decreases expression ISO Thalidomide results in decreased expression of PLTP mRNA CTD PMID:26217789 NCBI chr20:45,898,620...45,912,155
Ensembl chr20:45,898,621...45,912,155 		JBrowse link
G POLR2K RNA polymerase II, I and III subunit K decreases expression ISO Thalidomide results in decreased expression of POLR2K mRNA CTD PMID:26217789 NCBI chr 8:100,150,636...100,154,003
Ensembl chr 8:100,150,623...100,154,003 		JBrowse link
G POPDC2 popeye domain cAMP effector 2 decreases expression ISO Thalidomide results in decreased expression of POPDC2 mRNA CTD PMID:26217789 NCBI chr 3:119,642,056...119,660,883
Ensembl chr 3:119,636,457...119,665,324 		JBrowse link
G PPARD peroxisome proliferator activated receptor delta increases response to substance EXP PPARD gene SNP results in increased susceptibility to Thalidomide CTD PMID:21245421 NCBI chr 6:35,342,558...35,428,178
Ensembl chr 6:35,342,558...35,428,191 		JBrowse link
G PPP1R11 protein phosphatase 1 regulatory inhibitor subunit 11 decreases expression ISO Thalidomide results in decreased expression of PPP1R11 mRNA CTD PMID:26217789 NCBI chr 6:30,061,265...30,070,333
Ensembl chr 6:30,066,709...30,070,333 		JBrowse link
G PPP1R15A protein phosphatase 1 regulatory subunit 15A increases expression EXP Thalidomide analog results in increased expression of PPP1R15A mRNA CTD PMID:20525221 NCBI chr19:48,872,421...48,876,058
Ensembl chr19:48,872,212...48,876,059 		JBrowse link
G PPP1R1A protein phosphatase 1 regulatory inhibitor subunit 1A decreases expression ISO Thalidomide results in decreased expression of PPP1R1A mRNA CTD PMID:26217789 NCBI chr12:54,579,246...54,588,659
Ensembl chr12:54,575,387...54,588,659 		JBrowse link
G PRELID2 PRELI domain containing 2 decreases expression ISO Thalidomide results in decreased expression of PRELID2 mRNA CTD PMID:26217789 NCBI chr 5:145,228,985...145,835,342
Ensembl chr 5:145,471,799...145,835,369 		JBrowse link
G PRF1 perforin 1 increases expression ISO Thalidomide results in increased expression of PRF1 CTD PMID:17089043 NCBI chr10:70,597,348...70,602,741
Ensembl chr10:70,597,348...70,602,759 		JBrowse link
G PRKCD protein kinase C delta decreases expression EXP Thalidomide results in decreased expression of PRKCD mRNA CTD PMID:32756504 NCBI chr 3:53,161,209...53,192,717
Ensembl chr 3:53,156,009...53,192,717 		JBrowse link
G PRKG1 protein kinase cGMP-dependent 1 decreases expression ISO Thalidomide results in decreased expression of PRKG1 mRNA CTD PMID:26217789 NCBI chr10:50,990,888...52,298,350
Ensembl chr10:50,990,888...52,298,423 		JBrowse link
G PRR5 proline rich 5 decreases expression ISO Thalidomide results in decreased expression of PRR5 mRNA CTD PMID:26217789 NCBI chr22:44,668,751...44,737,681
Ensembl chr22:44,668,547...44,737,681 		JBrowse link
G PRXL2A peroxiredoxin like 2A decreases expression ISO Thalidomide results in decreased expression of PRXL2A mRNA CTD PMID:26217789 NCBI chr10:80,407,829...80,437,115
Ensembl chr10:80,407,829...80,437,115 		JBrowse link
G PSME2 proteasome activator subunit 2 increases expression ISO Thalidomide results in increased expression of PSME2 mRNA CTD PMID:26217789 NCBI chr14:24,143,365...24,146,610
Ensembl chr14:24,143,362...24,147,570 		JBrowse link
G PTEN phosphatase and tensin homolog increases expression EXP Thalidomide results in increased expression of PTEN protein CTD PMID:19567134 NCBI chr10:87,863,625...87,971,930
Ensembl chr10:87,862,638...87,971,930 		JBrowse link
G PTGS2 prostaglandin-endoperoxide synthase 2 increases degradation
decreases stability
multiple interactions
decreases expression 		EXP
ISO 		Thalidomide results in increased degradation of PTGS2 protein
Thalidomide results in decreased stability of PTGS2 mRNA
Thalidomide analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2]; Thalidomide inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Thalidomide inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]
Thalidomide inhibits the reaction [Ifosfamide results in increased expression of PTGS2 protein]
Thalidomide results in decreased expression of PTGS2 protein 		CTD PMID:11705847 PMID:15982930 PMID:17638016 NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922 		JBrowse link
G RAB2B RAB2B, member RAS oncogene family decreases expression ISO Thalidomide results in decreased expression of RAB2B mRNA CTD PMID:26006729 PMID:26217789 NCBI chr14:21,459,020...21,476,959
Ensembl chr14:21,459,020...21,476,960 		JBrowse link
G RAB8A RAB8A, member RAS oncogene family decreases expression ISO Thalidomide results in decreased expression of RAB8A mRNA CTD PMID:26006729 NCBI chr19:16,111,889...16,134,234
Ensembl chr19:16,111,889...16,134,234 		JBrowse link
G RAP1B RAP1B, member of RAS oncogene family decreases expression ISO Thalidomide results in decreased expression of RAP1B mRNA CTD PMID:26006729 NCBI chr12:68,610,899...68,671,901
Ensembl chr12:68,610,855...68,671,901 		JBrowse link
G RASSF9 Ras association domain family member 9 decreases expression ISO Thalidomide results in decreased expression of RASSF9 mRNA CTD PMID:26217789 NCBI chr12:85,800,703...85,836,409
Ensembl chr12:85,800,703...85,836,409 		JBrowse link
G RELA RELA proto-oncogene, NF-kB subunit multiple interactions
decreases expression 		EXP
ISO 		[irinotecan co-treated with Thalidomide co-treated with Celecoxib] results in increased expression of RELA protein; [irinotecan co-treated with Thalidomide] results in increased expression of RELA protein; [resveratrol co-treated with Thalidomide] results in decreased activity of [RELA protein binds to NFKB1 protein]; Thalidomide inhibits the reaction [TNF protein results in increased transport of RELA protein]
Thalidomide analog inhibits the reaction [Lipopolysaccharides results in increased expression of RELA protein]; Thalidomide inhibits the reaction [Lipopolysaccharides results in increased expression of RELA protein]; Thalidomide inhibits the reaction [Paraquat affects the localization of RELA protein]
Thalidomide results in decreased expression of RELA protein
[Thalidomide co-treated with Dimethylnitrosamine] results in decreased transport of RELA protein; HDAC6 protein inhibits the reaction [Thalidomide inhibits the reaction [Paraquat results in increased phosphorylation of RELA protein]]; Thalidomide inhibits the reaction [Carbon Tetrachloride results in increased expression of RELA mRNA]; Thalidomide inhibits the reaction [Carbon Tetrachloride results in increased expression of RELA protein]; Thalidomide inhibits the reaction [Paraquat results in increased phosphorylation of RELA protein]; Thalidomide inhibits the reaction [TNF protein results in increased expression of RELA mRNA] 		CTD PMID:15687330 PMID:16078585 PMID:16333628 PMID:16604421 PMID:16685529 More... NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090 		JBrowse link
G RELB RELB proto-oncogene, NF-kB subunit increases expression EXP Thalidomide analog results in increased expression of RELB mRNA CTD PMID:20525221 NCBI chr19:45,001,464...45,038,192
Ensembl chr19:45,001,461...45,038,192 		JBrowse link
G RFC3 replication factor C subunit 3 multiple interactions EXP [Azacitidine co-treated with Thalidomide] affects the expression of RFC3 mRNA CTD PMID:18720364 NCBI chr13:33,818,149...33,977,377
Ensembl chr13:33,818,069...33,966,558 		JBrowse link
G RHOA ras homolog family member A affects expression ISO Thalidomide affects the expression of RHOA mRNA CTD PMID:26006729 NCBI chr 3:49,359,145...49,411,976
Ensembl chr 3:49,359,139...49,412,998 		JBrowse link
G RNASEH2C ribonuclease H2 subunit C decreases expression ISO Thalidomide results in decreased expression of RNASEH2C mRNA CTD PMID:26217789 NCBI chr11:65,717,673...65,720,798
Ensembl chr11:65,714,005...65,720,818 		JBrowse link
G RNF138 ring finger protein 138 decreases expression ISO Thalidomide results in decreased expression of RNF138 mRNA CTD PMID:26217789 NCBI chr18:32,091,874...32,131,561
Ensembl chr18:32,091,874...32,131,561 		JBrowse link
G RNF166 ring finger protein 166 multiple interactions EXP Thalidomide results in increased degradation of and results in decreased expression of RNF166 protein CTD PMID:30067223 NCBI chr16:88,696,501...88,706,408
Ensembl chr16:88,696,499...88,706,408 		JBrowse link
G RPS15 ribosomal protein S15 increases expression ISO Thalidomide results in increased expression of RPS15 mRNA CTD PMID:26217789 NCBI chr19:1,438,396...1,440,495
Ensembl chr19:1,438,358...1,440,495 		JBrowse link
G RPS6KA2 ribosomal protein S6 kinase A2 decreases expression ISO Thalidomide results in decreased expression of RPS6KA2 mRNA CTD PMID:26217789 NCBI chr 6:166,409,364...166,862,773
Ensembl chr 6:166,409,364...166,906,451 		JBrowse link
G RRAS RAS related decreases expression ISO Thalidomide results in decreased expression of RRAS mRNA CTD PMID:26006729 PMID:26217789 NCBI chr19:49,635,292...49,640,143
Ensembl chr19:49,635,292...49,640,143 		JBrowse link
G RRM2 ribonucleotide reductase regulatory subunit M2 multiple interactions EXP [Azacitidine co-treated with Thalidomide] affects the expression of RRM2 mRNA CTD PMID:18720364 NCBI chr 2:10,122,568...10,211,010
Ensembl chr 2:10,120,698...10,211,725 		JBrowse link
G RTN2 reticulon 2 decreases expression ISO Thalidomide results in decreased expression of RTN2 mRNA CTD PMID:26217789 NCBI chr19:45,485,294...45,497,047
Ensembl chr19:45,485,294...45,497,055 		JBrowse link
G RYR2 ryanodine receptor 2 decreases expression ISO Thalidomide results in decreased expression of RYR2 mRNA CTD PMID:26006729 PMID:26217789 NCBI chr 1:237,042,184...237,833,988
Ensembl chr 1:237,042,184...237,833,988 		JBrowse link
G SALL4 spalt like transcription factor 4 affects binding
multiple interactions
increases expression 		EXP Thalidomide binds to [SALL4 protein binds to CRBN protein]
Bortezomib inhibits the reaction [Thalidomide results in increased degradation of and results in decreased expression of SALL4 protein]; pevonedistat inhibits the reaction [Thalidomide results in increased degradation of and results in decreased expression of SALL4 protein]; TAK-243 inhibits the reaction [Thalidomide results in increased degradation of and results in decreased expression of SALL4 protein]; Thalidomide results in increased degradation of and results in decreased expression of SALL4 protein
Thalidomide results in increased expression of SALL4 mRNA 		CTD PMID:30067223 NCBI chr20:51,782,331...51,802,521
Ensembl chr20:51,782,331...51,802,521 		JBrowse link
G SAP30 Sin3A associated protein 30 decreases expression ISO Thalidomide results in decreased expression of SAP30 mRNA CTD PMID:26217789 NCBI chr 4:173,370,954...173,377,532
Ensembl chr 4:173,369,969...173,377,532 		JBrowse link
G SAT1 spermidine/spermine N1-acetyltransferase 1 decreases expression ISO Thalidomide results in decreased expression of SAT1 mRNA CTD PMID:26217789 NCBI chr  X:23,783,173...23,786,210
Ensembl chr  X:23,783,173...23,786,210 		JBrowse link
G SCN7A sodium voltage-gated channel alpha subunit 7 decreases expression ISO Thalidomide results in decreased expression of SCN7A mRNA CTD PMID:26217789 NCBI chr 2:166,403,573...166,494,249
Ensembl chr 2:166,403,573...166,611,482 		JBrowse link
G SDHAF1 succinate dehydrogenase complex assembly factor 1 decreases expression ISO Thalidomide results in decreased expression of SDHAF1 mRNA CTD PMID:26217789 NCBI chr19:35,995,188...35,996,312
Ensembl chr19:35,995,188...35,996,312 		JBrowse link
G SDHC succinate dehydrogenase complex subunit C decreases expression ISO Thalidomide results in decreased expression of SDHC mRNA CTD PMID:26217789 NCBI chr 1:161,314,381...161,363,206
Ensembl chr 1:161,314,381...161,363,206 		JBrowse link
G SELENOS selenoprotein S decreases expression ISO Thalidomide results in decreased expression of SELENOS mRNA CTD PMID:26006729 NCBI chr15:101,270,809...101,277,485
Ensembl chr15:101,270,531...101,277,500 		JBrowse link
G SELL selectin L decreases expression EXP Thalidomide results in decreased expression of SELL protein CTD PMID:16344495 NCBI chr 1:169,690,667...169,711,620
Ensembl chr 1:169,690,665...169,711,702 		JBrowse link
G SERPINB2 serpin family B member 2 increases response to substance EXP SERPINB2 gene SNP results in increased susceptibility to Thalidomide CTD PMID:21245421 NCBI chr18:63,887,705...63,903,888
Ensembl chr18:63,871,692...63,903,888 		JBrowse link
G SFRP2 secreted frizzled related protein 2 increases expression ISO Thalidomide results in increased expression of SFRP2 mRNA CTD PMID:26217789 NCBI chr 4:153,780,591...153,789,083
Ensembl chr 4:153,780,591...153,789,083 		JBrowse link
G SH3BGR SH3 domain binding glutamate rich protein decreases expression ISO Thalidomide results in decreased expression of SH3BGR mRNA CTD PMID:26217789 NCBI chr21:39,445,865...39,515,506
Ensembl chr21:39,445,855...39,515,506 		JBrowse link
G SLC12A6 solute carrier family 12 member 6 increases response to substance EXP SLC12A6 gene SNP results in increased susceptibility to Thalidomide CTD PMID:21245421 NCBI chr15:34,229,784...34,338,057
Ensembl chr15:34,229,784...34,338,060 		JBrowse link
G SLC13A4 solute carrier family 13 member 4 decreases expression ISO Thalidomide results in decreased expression of SLC13A4 mRNA CTD PMID:26217789 NCBI chr 7:135,681,231...135,728,186
Ensembl chr 7:135,681,231...135,729,258 		JBrowse link
G SLC22A2 solute carrier family 22 member 2 multiple interactions EXP Thalidomide inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 NCBI chr 6:160,216,755...160,258,821
Ensembl chr 6:160,171,061...160,277,638 		JBrowse link
G SLC25A20 solute carrier family 25 member 20 decreases expression ISO Thalidomide results in decreased expression of SLC25A20 mRNA CTD PMID:26217789 NCBI chr 3:48,856,926...48,898,882
Ensembl chr 3:48,856,926...48,898,904 		JBrowse link
G SLC25A30 solute carrier family 25 member 30 decreases expression ISO Thalidomide results in decreased expression of SLC25A30 mRNA CTD PMID:26217789 NCBI chr13:45,393,316...45,434,016
Ensembl chr13:45,393,316...45,418,455 		JBrowse link
G SLC2A3 solute carrier family 2 member 3 increases expression ISO Thalidomide results in increased expression of SLC2A3 mRNA CTD PMID:26217789 NCBI chr12:7,919,230...7,936,187
Ensembl chr12:7,919,230...8,019,007 		JBrowse link
G SLC44A3 solute carrier family 44 member 3 decreases expression ISO Thalidomide results in decreased expression of SLC44A3 mRNA CTD PMID:26217789 NCBI chr 1:94,820,357...94,895,247
Ensembl chr 1:94,820,342...94,895,246 		JBrowse link
G SLC8A1 solute carrier family 8 member A1 decreases expression ISO Thalidomide results in decreased expression of SLC8A1 mRNA CTD PMID:26006729 PMID:26217789 NCBI chr 2:40,097,270...40,512,435
Ensembl chr 2:40,097,270...40,611,053 		JBrowse link
G SLCO4C1 solute carrier organic anion transporter family member 4C1 decreases expression ISO Thalidomide results in decreased expression of SLCO4C1 mRNA CTD PMID:26217789 NCBI chr 5:102,233,986...102,296,284
Ensembl chr 5:102,233,986...102,296,284 		JBrowse link
G SMPD2 sphingomyelin phosphodiesterase 2 multiple interactions EXP sphingosine 1-phosphate inhibits the reaction [Thalidomide results in increased activity of SMPD2 protein] CTD PMID:15741222 NCBI chr 6:109,440,724...109,443,919
Ensembl chr 6:109,440,724...109,443,919 		JBrowse link
G SMYD1 SET and MYND domain containing 1 decreases expression ISO Thalidomide results in decreased expression of SMYD1 mRNA CTD PMID:26006729 PMID:26217789 NCBI chr 2:88,067,825...88,113,384
Ensembl chr 2:88,067,825...88,113,384 		JBrowse link
G SNAP25 synaptosome associated protein 25 increases expression ISO Thalidomide results in increased expression of SNAP25 mRNA; Thalidomide results in increased expression of SNAP25 protein CTD PMID:27693314 NCBI chr20:10,218,830...10,307,418
Ensembl chr20:10,172,395...10,308,258 		JBrowse link
G SNORD104 small nucleolar RNA, C/D box 104 increases expression ISO Thalidomide results in increased expression of SNORD104 mRNA CTD PMID:26217789 NCBI chr17:64,146,078...64,146,157
Ensembl chr17:64,146,083...64,146,152 		JBrowse link
G SNORD111 small nucleolar RNA, C/D box 111 increases expression ISO Thalidomide results in increased expression of SNORD111 mRNA CTD PMID:26217789 NCBI chr16:70,538,005...70,538,098
Ensembl chr16:70,538,005...70,538,098 		JBrowse link
G SNORD123 small nucleolar RNA, C/D box 123 increases expression ISO Thalidomide results in increased expression of SNORD123 mRNA CTD PMID:26217789 NCBI chr 5:9,548,827...9,548,914
Ensembl chr 5:9,548,836...9,548,905 		JBrowse link
G SNRPD1 small nuclear ribonucleoprotein D1 polypeptide decreases expression ISO Thalidomide results in decreased expression of SNRPD1 mRNA CTD PMID:26217789 NCBI chr18:21,612,314...21,633,520
Ensembl chr18:21,612,314...21,633,524 		JBrowse link
G SNX16 sorting nexin 16 increases expression EXP Thalidomide analog results in increased expression of SNX16 mRNA CTD PMID:20525221 NCBI chr 8:81,799,583...81,842,185
Ensembl chr 8:81,799,581...81,842,866 		JBrowse link
G SNX24 sorting nexin 24 decreases expression ISO Thalidomide results in decreased expression of SNX24 mRNA CTD PMID:26217789 NCBI chr 5:122,845,613...123,029,318
Ensembl chr 5:122,843,439...123,029,354 		JBrowse link
G SOD1 superoxide dismutase 1 multiple interactions ISO Thalidomide inhibits the reaction [SOD1 gene mutant form results in increased expression of FASL mRNA]; Thalidomide inhibits the reaction [SOD1 gene mutant form results in increased expression of IL12B mRNA]; Thalidomide inhibits the reaction [SOD1 gene mutant form results in increased expression of TNF mRNA]; Thalidomide promotes the reaction [SOD1 gene mutant form results in increased expression of IL1RN mRNA]; Thalidomide promotes the reaction [SOD1 gene mutant form results in increased expression of TGFB1 mRNA]
Thalidomide inhibits the reaction [Carbon Tetrachloride results in decreased activity of SOD1 protein] 		CTD PMID:16510725 PMID:17030452 NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931 		JBrowse link
G SOX1 SRY-box transcription factor 1 decreases expression ISO Thalidomide results in decreased expression of SOX1 mRNA CTD PMID:26217789 NCBI chr13:112,067,149...112,071,706
Ensembl chr13:112,067,149...112,071,706 		JBrowse link
G SOX17 SRY-box transcription factor 17 decreases localization EXP Thalidomide results in decreased localization of SOX17 protein CTD PMID:24154490 NCBI chr 8:54,457,935...54,460,892
Ensembl chr 8:54,457,935...54,460,892 		JBrowse link
G SP1 Sp1 transcription factor decreases activity EXP Thalidomide results in decreased activity of SP1 protein CTD PMID:10533722 NCBI chr12:53,380,176...53,416,446
Ensembl chr12:53,380,176...53,416,446 		JBrowse link
G SP5 Sp5 transcription factor decreases expression ISO Thalidomide results in decreased expression of SP5 mRNA CTD PMID:26217789 NCBI chr 2:170,715,337...170,718,078
Ensembl chr 2:170,715,337...170,718,078 		JBrowse link
G SPA17 sperm autoantigenic protein 17 decreases expression ISO Thalidomide results in decreased expression of SPA17 mRNA CTD PMID:26217789 NCBI chr11:124,673,904...124,697,518
Ensembl chr11:124,673,844...124,697,518 		JBrowse link
G SPAG5 sperm associated antigen 5 multiple interactions EXP [Azacitidine co-treated with Thalidomide] affects the expression of SPAG5 mRNA CTD PMID:18720364 NCBI chr17:28,577,574...28,599,025
Ensembl chr17:28,577,565...28,599,025 		JBrowse link
G SPHKAP SPHK1 interactor, AKAP domain containing decreases expression ISO Thalidomide results in decreased expression of SPHKAP mRNA CTD PMID:26217789 NCBI chr 2:227,979,955...228,181,687
Ensembl chr 2:227,979,955...228,181,687 		JBrowse link
G SRRD SRR1 domain containing decreases expression ISO Thalidomide results in decreased expression of SRRD mRNA CTD PMID:26217789 NCBI chr22:26,483,877...26,494,658
Ensembl chr22:26,483,877...26,494,658 		JBrowse link
G STAT3 signal transducer and activator of transcription 3 decreases phosphorylation
multiple interactions 		EXP Thalidomide analog results in decreased phosphorylation of STAT3 protein
[Resveratrol co-treated with Thalidomide] results in decreased phosphorylation of STAT3 protein; Thalidomide promotes the reaction [Capsaicin results in decreased phosphorylation of and results in decreased activity of STAT3 protein] 		CTD PMID:15858615 PMID:17164350 PMID:17505005 NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,568 		JBrowse link
G STMN2 stathmin 2 decreases expression ISO Thalidomide results in decreased expression of STMN2 mRNA CTD PMID:26217789 NCBI chr 8:79,611,117...79,666,158
Ensembl chr 8:79,611,117...79,666,158 		JBrowse link
G SWSAP1 SWIM-type zinc finger 7 associated protein 1 decreases expression ISO Thalidomide results in decreased expression of SWSAP1 mRNA CTD PMID:26217789 NCBI chr19:11,374,666...11,376,169
Ensembl chr19:11,374,666...11,376,951 		JBrowse link
G SYNJ2BP synaptojanin 2 binding protein decreases expression ISO Thalidomide results in decreased expression of SYNJ2BP mRNA CTD PMID:26006729 NCBI chr14:70,366,499...70,417,090
Ensembl chr14:70,366,499...70,417,090 		JBrowse link
G SYT15 synaptotagmin 15 decreases expression EXP Thalidomide results in decreased expression of SYT15 mRNA CTD PMID:32756504 NCBI chr10:46,579,128...46,597,108
Ensembl chr10:46,578,217...46,594,173 		JBrowse link
G SYT4 synaptotagmin 4 increases expression EXP Thalidomide results in increased expression of SYT4 mRNA CTD PMID:32756504 NCBI chr18:43,267,892...43,277,490
Ensembl chr18:43,267,892...43,277,535 		JBrowse link
G TC2N tandem C2 domains, nuclear decreases expression ISO Thalidomide results in decreased expression of TC2N mRNA CTD PMID:26217789 NCBI chr14:91,779,746...91,867,536
Ensembl chr14:91,779,746...91,867,536 		JBrowse link
G TCF15 transcription factor 15 decreases expression EXP Thalidomide results in decreased expression of TCF15 mRNA CTD PMID:31711903 NCBI chr20:604,257...610,309
Ensembl chr20:604,257...610,309 		JBrowse link
G TDG thymine DNA glycosylase decreases expression ISO Thalidomide results in decreased expression of TDG mRNA CTD PMID:26217789 NCBI chr12:103,965,872...103,988,874
Ensembl chr12:103,965,822...103,988,874 		JBrowse link
G TEFM transcription elongation factor, mitochondrial decreases expression ISO Thalidomide results in decreased expression of TEFM mRNA CTD PMID:26217789 NCBI chr17:30,898,986...30,906,238
Ensembl chr17:30,897,336...30,906,238 		JBrowse link
G TEK TEK receptor tyrosine kinase decreases expression EXP Thalidomide results in decreased expression of TEK mRNA CTD PMID:15618473 NCBI chr 9:27,109,225...27,230,174
Ensembl chr 9:27,109,141...27,230,174 		JBrowse link
G TGFB1 transforming growth factor beta 1 multiple interactions
decreases expression 		EXP
ISO 		Thalidomide inhibits the reaction [TGFB1 protein results in increased degradation of NFKBIA protein]; Thalidomide inhibits the reaction [TGFB1 protein results in increased expression of PLAUR mRNA]; Thalidomide inhibits the reaction [TGFB1 protein results in increased expression of PLAUR protein]; Thalidomide inhibits the reaction [TGFB1 protein results in increased phosphorylation of NFKBIA protein]; Thalidomide inhibits the reaction [TGFB1 protein results in increased transport of NFKBIA protein]
Thalidomide results in decreased expression of TGFB1 mRNA
Thalidomide results in decreased expression of TGFB1 mRNA; Thalidomide results in decreased expression of TGFB1 protein
Thalidomide inhibits the reaction [Carbon Tetrachloride results in increased expression of TGFB1 mRNA]; Thalidomide inhibits the reaction [Carbon Tetrachloride results in increased expression of TGFB1 protein]; Thalidomide inhibits the reaction [Dimethylnitrosamine results in increased expression of TGFB1 mRNA]; Thalidomide inhibits the reaction [Paraquat results in increased expression of TGFB1 mRNA]; Thalidomide inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]; Thalidomide inhibits the reaction [Thioacetamide results in increased expression of TGFB1 mRNA]
Thalidomide promotes the reaction [SOD1 gene mutant form results in increased expression of TGFB1 mRNA] 		CTD PMID:15464241 PMID:16288038 PMID:16510725 PMID:16549389 PMID:16604421 More... NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922 		JBrowse link
G TGFBI transforming growth factor beta induced decreases expression ISO Thalidomide results in decreased expression of TGFBI mRNA CTD PMID:26006729 PMID:26217789 NCBI chr 5:136,028,988...136,063,818
Ensembl chr 5:136,028,988...136,063,818 		JBrowse link
G TGFBR1 transforming growth factor beta receptor 1 decreases expression EXP Thalidomide results in decreased expression of TGFBR1 mRNA; Thalidomide results in decreased expression of TGFBR1 protein CTD PMID:15618473 NCBI chr 9:99,103,647...99,154,192
Ensembl chr 9:99,104,038...99,154,192 		JBrowse link
G TIMP1 TIMP metallopeptidase inhibitor 1 multiple interactions ISO Thalidomide inhibits the reaction [Carbon Tetrachloride results in increased expression of TIMP1 mRNA]; Thalidomide inhibits the reaction [Carbon Tetrachloride results in increased expression of TIMP1 protein]; Thalidomide inhibits the reaction [Thioacetamide results in increased expression of TIMP1 mRNA] CTD PMID:15464241 PMID:17030452 NCBI chr  X:47,582,436...47,586,789
Ensembl chr  X:47,582,408...47,586,789 		JBrowse link
G TIMP2 TIMP metallopeptidase inhibitor 2 multiple interactions ISO Thalidomide inhibits the reaction [Thioacetamide results in increased expression of TIMP2 mRNA] CTD PMID:15464241 NCBI chr17:78,852,977...78,925,387
Ensembl chr17:78,852,977...78,925,387 		JBrowse link
G TINAGL1 tubulointerstitial nephritis antigen like 1 decreases expression ISO Thalidomide results in decreased expression of TINAGL1 mRNA CTD PMID:26217789 NCBI chr 1:31,576,515...31,587,686
Ensembl chr 1:31,576,485...31,587,686 		JBrowse link
G TJP1 tight junction protein 1 multiple interactions ISO Thalidomide inhibits the reaction [dinitrobenzenesulfonic acid results in decreased expression of TJP1 protein] CTD PMID:16680017 NCBI chr15:29,699,367...29,969,049
Ensembl chr15:29,699,367...29,968,915 		JBrowse link
G TM2D3 TM2 domain containing 3 decreases expression ISO Thalidomide results in decreased expression of TM2D3 mRNA CTD PMID:26217789 NCBI chr15:101,632,977...101,652,381
Ensembl chr15:101,621,444...101,652,391 		JBrowse link
G TMEM138 transmembrane protein 138 decreases expression ISO Thalidomide results in decreased expression of TMEM138 mRNA CTD PMID:26217789 NCBI chr11:61,362,374...61,376,870
Ensembl chr11:61,361,964...61,377,890 		JBrowse link
G TMEM176A transmembrane protein 176A decreases expression ISO Thalidomide results in decreased expression of TMEM176A mRNA CTD PMID:26217789 NCBI chr 7:150,800,769...150,805,118
Ensembl chr 7:150,800,403...150,805,118 		JBrowse link
G TMPO thymopoietin multiple interactions EXP [Azacitidine co-treated with Thalidomide] affects the expression of TMPO mRNA CTD PMID:18720364 NCBI chr12:98,515,573...98,550,351
Ensembl chr12:98,515,561...98,550,351 		JBrowse link
G TNF tumor necrosis factor multiple interactions
decreases expression
increases degradation
increases expression 		EXP
ISO 		Thalidomide analog inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Thalidomide inhibits the reaction [Endotoxins results in increased expression of TNF protein]; Thalidomide inhibits the reaction [lipophosphonoglycan results in increased secretion of TNF protein]; Thalidomide inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; Thalidomide inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Thalidomide inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]; Thalidomide inhibits the reaction [TNF protein results in increased expression of CXCL8 mRNA]; Thalidomide inhibits the reaction [TNF protein results in increased expression of CXCL8 protein]; Thalidomide inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; Thalidomide inhibits the reaction [TNF protein results in increased transport of RELA protein]
Thalidomide results in decreased expression of TNF protein
Thalidomide results in decreased expression of TNF mRNA; Thalidomide results in decreased expression of TNF protein
Thalidomide results in increased degradation of TNF mRNA
Thalidomide results in increased expression of TNF mRNA
HDAC6 protein inhibits the reaction [Thalidomide inhibits the reaction [Paraquat results in increased expression of TNF protein]]; MIR141 promotes the reaction [Thalidomide inhibits the reaction [Paraquat results in increased expression of TNF protein]]; Thalidomide inhibits the reaction [Carbon Tetrachloride results in increased expression of TNF protein]; Thalidomide inhibits the reaction [Dimethylnitrosamine results in increased expression of TNF mRNA]; Thalidomide inhibits the reaction [Irinotecan results in increased expression of TNF mRNA]; Thalidomide inhibits the reaction [Irinotecan results in increased expression of TNF protein]; Thalidomide inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Thalidomide inhibits the reaction [Paraquat results in increased expression of TNF mRNA]; Thalidomide inhibits the reaction [Paraquat results in increased expression of TNF protein]; Thalidomide inhibits the reaction [Thioacetamide results in increased expression of TNF mRNA]; Thalidomide inhibits the reaction [TNF protein results in increased expression of CHUK protein]; Thalidomide inhibits the reaction [TNF protein results in increased expression of COL1A2 mRNA]; Thalidomide inhibits the reaction [TNF protein results in increased expression of RELA mRNA]; Thalidomide inhibits the reaction [TNF protein results in increased phosphorylation of NFKBIA protein]; Thalidomide inhibits the reaction [Zymosan results in increased expression of TNF protein]
Thalidomide results in increased expression of TNF protein
Thalidomide analog inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Thalidomide inhibits the reaction [[Ethanol co-treated with Hydrochloric Acid] results in increased expression of TNF protein]; Thalidomide inhibits the reaction [dinitrobenzenesulfonic acid results in increased expression of TNF protein]; Thalidomide inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Thalidomide inhibits the reaction [Paraquat results in increased expression of TNF mRNA]; Thalidomide inhibits the reaction [SOD1 gene mutant form results in increased expression of TNF mRNA]; Thalidomide inhibits the reaction [Zymosan results in increased expression of TNF mRNA]; TNF protein affects the reaction [vadimezan affects the metabolism of Thalidomide] 		CTD PMID:9068814 PMID:9623511 PMID:10496904 PMID:10720640 PMID:11367517 More... NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336 		JBrowse link
G TNFRSF10A TNF receptor superfamily member 10a decreases expression EXP Thalidomide results in decreased expression of TNFRSF10A protein CTD PMID:16531263 NCBI chr 8:23,190,452...23,225,102
Ensembl chr 8:23,190,452...23,225,102 		JBrowse link
G TNFRSF10B TNF receptor superfamily member 10b decreases expression EXP Thalidomide results in decreased expression of TNFRSF10B protein CTD PMID:16531263 NCBI chr 8:23,020,133...23,069,031
Ensembl chr 8:23,020,133...23,069,031 		JBrowse link
G TNFRSF1A TNF receptor superfamily member 1A decreases expression EXP Thalidomide results in decreased expression of TNFRSF1A mRNA; Thalidomide results in decreased expression of TNFRSF1A protein CTD PMID:15618473 PMID:16344495 NCBI chr12:6,328,771...6,342,076
Ensembl chr12:6,328,757...6,342,114 		JBrowse link
G TNFRSF1B TNF receptor superfamily member 1B decreases expression EXP Thalidomide results in decreased expression of TNFRSF1B mRNA CTD PMID:15618473 NCBI chr 1:12,166,991...12,209,220
Ensembl chr 1:12,166,991...12,209,228 		JBrowse link
G TNFSF10 TNF superfamily member 10 decreases expression EXP Thalidomide results in decreased expression of TNFSF10 protein CTD PMID:16531263 NCBI chr 3:172,505,508...172,523,430
Ensembl chr 3:172,505,508...172,523,475 		JBrowse link
G TNFSF11 TNF superfamily member 11 multiple interactions EXP [Thalidomide co-treated with Dexamethasone] results in decreased expression of TNFSF11 protein CTD PMID:16079895 NCBI chr13:42,562,736...42,608,013
Ensembl chr13:42,562,736...42,608,013 		JBrowse link
G TNNC1 troponin C1, slow skeletal and cardiac type decreases expression ISO Thalidomide results in decreased expression of TNNC1 mRNA CTD PMID:26006729 PMID:26217789 NCBI chr 3:52,451,100...52,454,041
Ensembl chr 3:52,451,100...52,454,041 		JBrowse link
G TOP2A DNA topoisomerase II alpha multiple interactions EXP [Azacitidine co-treated with Thalidomide] affects the expression of TOP2A mRNA CTD PMID:18720364 NCBI chr17:40,388,525...40,417,896
Ensembl chr17:40,388,525...40,417,896 		JBrowse link
G TP53 tumor protein p53 increases expression EXP Thalidomide analog results in increased expression of TP53 mRNA CTD PMID:20525221 NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,546 		JBrowse link
G TRAM1L1 translocation associated membrane protein 1 like 1 decreases expression ISO Thalidomide results in decreased expression of TRAM1L1 mRNA CTD PMID:26217789 NCBI chr 4:117,083,554...117,085,576
Ensembl chr 4:117,083,554...117,085,576 		JBrowse link
G TRAPPC2L trafficking protein particle complex subunit 2L decreases expression ISO Thalidomide results in decreased expression of TRAPPC2L mRNA CTD PMID:26217789 NCBI chr16:88,856,220...88,862,678
Ensembl chr16:88,856,220...88,862,686 		JBrowse link
G TRIB3 tribbles pseudokinase 3 increases expression EXP Thalidomide analog results in increased expression of TRIB3 mRNA CTD PMID:20525221 NCBI chr20:380,760...397,559
Ensembl chr20:362,835...397,559 		JBrowse link
G TRIM55 tripartite motif containing 55 decreases expression ISO Thalidomide results in decreased expression of TRIM55 mRNA CTD PMID:26217789 NCBI chr 8:66,113,351...66,175,485
Ensembl chr 8:66,126,896...66,175,485 		JBrowse link
G TSPAN33 tetraspanin 33 decreases expression ISO Thalidomide results in decreased expression of TSPAN33 mRNA CTD PMID:26217789 NCBI chr 7:129,144,707...129,169,699
Ensembl chr 7:129,144,707...129,169,699 		JBrowse link
G TTC32 tetratricopeptide repeat domain 32 decreases expression ISO Thalidomide results in decreased expression of TTC32 mRNA CTD PMID:26217789 NCBI chr 2:19,896,631...19,901,983
Ensembl chr 2:19,896,631...19,901,983 		JBrowse link
G TTK TTK protein kinase multiple interactions EXP [Azacitidine co-treated with Thalidomide] affects the expression of TTK mRNA CTD PMID:18720364 NCBI chr 6:80,004,649...80,042,527
Ensembl chr 6:80,003,887...80,042,527 		JBrowse link
G TTN titin decreases expression ISO Thalidomide results in decreased expression of TTN mRNA CTD PMID:26006729 PMID:26217789 NCBI chr 2:178,525,989...178,807,423
Ensembl chr 2:178,525,989...178,830,802 		JBrowse link
G UBE2C ubiquitin conjugating enzyme E2 C multiple interactions EXP [Azacitidine co-treated with Thalidomide] affects the expression of UBE2C mRNA CTD PMID:18720364 NCBI chr20:45,812,644...45,816,952
Ensembl chr20:45,812,576...45,816,957 		JBrowse link
G UBXN1 UBX domain protein 1 decreases expression ISO Thalidomide results in decreased expression of UBXN1 mRNA CTD PMID:26217789 NCBI chr11:62,676,500...62,679,073
Ensembl chr11:62,676,498...62,679,117 		JBrowse link
G UCHL3 ubiquitin C-terminal hydrolase L3 decreases expression ISO Thalidomide results in decreased expression of UCHL3 mRNA CTD PMID:26217789 NCBI chr13:75,549,502...75,606,020
Ensembl chr13:75,549,483...75,606,020 		JBrowse link
G UNCX UNC homeobox decreases expression EXP Thalidomide results in decreased expression of UNCX mRNA CTD PMID:31711903 NCBI chr 7:1,232,872...1,237,326
Ensembl chr 7:1,232,872...1,237,326 		JBrowse link
G UPP1 uridine phosphorylase 1 decreases expression ISO Thalidomide results in decreased expression of UPP1 mRNA CTD PMID:26217789 NCBI chr 7:48,088,704...48,108,736
Ensembl chr 7:48,088,628...48,108,736 		JBrowse link
G UQCC5 ubiquinol-cytochrome c reductase complex assembly factor 5 decreases expression ISO Thalidomide results in decreased expression of UQCC5 mRNA CTD PMID:26217789 NCBI chr 3:52,536,605...52,541,890
Ensembl chr 3:52,534,013...52,579,237 		JBrowse link
G VCAM1 vascular cell adhesion molecule 1 decreases expression ISO Thalidomide results in decreased expression of VCAM1 mRNA; Thalidomide results in decreased expression of VCAM1 protein CTD PMID:17174718 NCBI chr 1:100,719,742...100,739,045
Ensembl chr 1:100,719,742...100,739,045 		JBrowse link
G VEGFA vascular endothelial growth factor A affects expression
multiple interactions
decreases expression
increases expression
decreases activity
decreases secretion
affects secretion 		EXP
ISO 		Thalidomide affects the expression of VEGFA mRNA; Thalidomide affects the expression of VEGFA protein
[Arsenic Trioxide co-treated with Thalidomide] results in decreased expression of VEGFA mRNA; FGD5-AS1 inhibits the reaction [Thalidomide results in decreased expression of and results in decreased secretion of VEGFA protein]; Thalidomide results in decreased expression of and results in decreased secretion of VEGFA protein
[temozolomide co-treated with Thalidomide] results in decreased expression of VEGFA protein
Thalidomide results in decreased expression of VEGFA protein
Thalidomide results in decreased expression of VEGFA mRNA
[Thalidomide co-treated with Paclitaxel] results in decreased expression of VEGFA mRNA
Thalidomide results in increased expression of VEGFA protein
Thalidomide results in decreased expression of VEGFA mRNA; Thalidomide results in decreased expression of VEGFA protein
Thalidomide results in decreased activity of VEGFA protein
Thalidomide analog results in decreased secretion of VEGFA protein
Thalidomide affects the secretion of VEGFA protein 		CTD PMID:15858615 PMID:15863203 PMID:15939924 PMID:15982930 PMID:16313753 More... NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487 		JBrowse link
G VEGFB vascular endothelial growth factor B multiple interactions
decreases expression 		EXP [Arsenic Trioxide co-treated with Thalidomide] results in decreased expression of VEGFB mRNA
Thalidomide results in decreased expression of VEGFB mRNA 		CTD PMID:29699374 NCBI chr11:64,234,584...64,239,264
Ensembl chr11:64,234,584...64,239,264 		JBrowse link
G VEGFC vascular endothelial growth factor C affects expression EXP Thalidomide affects the expression of VEGFC mRNA CTD PMID:29699374 NCBI chr 4:176,683,538...176,792,922
Ensembl chr 4:176,683,538...176,792,922 		JBrowse link
G VEGFD vascular endothelial growth factor D decreases expression
multiple interactions 		EXP Thalidomide results in decreased expression of VEGFD mRNA
[Arsenic Trioxide co-treated with Thalidomide] results in decreased expression of VEGFD mRNA 		CTD PMID:29699374 NCBI chr  X:15,345,596...15,384,413
Ensembl chr  X:15,345,596...15,384,413 		JBrowse link
G VTN vitronectin decreases expression ISO Thalidomide results in decreased expression of VTN mRNA CTD PMID:26217789 NCBI chr17:28,367,284...28,370,307
Ensembl chr17:28,367,284...28,373,091 		JBrowse link
G WNT5B Wnt family member 5B decreases expression EXP Thalidomide results in decreased expression of WNT5B mRNA CTD PMID:24154490 NCBI chr12:1,617,056...1,647,212
Ensembl chr12:1,529,891...1,647,212 		JBrowse link
G WNT8A Wnt family member 8A decreases expression ISO Thalidomide results in decreased expression of WNT8A mRNA CTD PMID:26217789 NCBI chr 5:138,077,367...138,092,365
Ensembl chr 5:138,083,990...138,092,365 		JBrowse link
G XIAP X-linked inhibitor of apoptosis decreases expression EXP Thalidomide analog results in decreased expression of XIAP protein CTD PMID:15858615 NCBI chr  X:123,859,708...123,913,972
Ensembl chr  X:123,859,712...123,913,972 		JBrowse link
G YJU2B YJU2 splicing factor homolog B decreases expression ISO Thalidomide results in decreased expression of YJU2B mRNA CTD PMID:26217789 NCBI chr19:13,731,752...13,763,289
Ensembl chr19:13,731,760...13,763,296 		JBrowse link
G ZCCHC17 zinc finger CCHC-type containing 17 increases expression ISO Thalidomide results in increased expression of ZCCHC17 mRNA CTD PMID:26217789 NCBI chr 1:31,297,032...31,364,936
Ensembl chr 1:31,296,982...31,364,953 		JBrowse link
G ZEB1 zinc finger E-box binding homeobox 1 multiple interactions
decreases expression 		EXP FGD5-AS1 inhibits the reaction [Thalidomide results in decreased expression of ZEB1 protein] CTD PMID:34520751 NCBI chr10:31,318,417...31,529,804
Ensembl chr10:31,318,495...31,529,814 		JBrowse link
G ZFPL1 zinc finger protein like 1 decreases expression ISO Thalidomide results in decreased expression of ZFPL1 mRNA CTD PMID:26217789 NCBI chr11:65,084,222...65,088,398
Ensembl chr11:65,084,210...65,088,398 		JBrowse link
G ZKSCAN5 zinc finger with KRAB and SCAN domains 5 decreases expression ISO Thalidomide results in decreased expression of ZKSCAN5 mRNA CTD PMID:26217789 NCBI chr 7:99,504,662...99,534,700
Ensembl chr 7:99,504,662...99,534,700 		JBrowse link
G ZMAT5 zinc finger matrin-type 5 decreases expression ISO Thalidomide results in decreased expression of ZMAT5 mRNA CTD PMID:26217789 NCBI chr22:29,730,956...29,767,007
Ensembl chr22:29,730,956...29,767,011 		JBrowse link
G ZNF506 zinc finger protein 506 decreases expression ISO Thalidomide results in decreased expression of ZFP953 mRNA CTD PMID:26217789 NCBI chr19:19,792,711...19,821,750
Ensembl chr19:19,761,038...19,821,751 		JBrowse link
G ZNF692 zinc finger protein 692 multiple interactions EXP Thalidomide results in increased degradation of and results in decreased expression of ZNF692 protein CTD PMID:30067223 NCBI chr 1:248,850,008...248,859,085
Ensembl chr 1:248,850,006...248,859,144 		JBrowse link
G ZNF780B zinc finger protein 780B decreases expression ISO Thalidomide results in decreased expression of ZFP780B mRNA CTD PMID:26217789 NCBI chr19:40,028,260...40,056,231
Ensembl chr19:40,028,260...40,056,231 		JBrowse link
G ZNRD2 zinc ribbon domain containing 2 decreases expression ISO Thalidomide results in decreased expression of ZNRD2 mRNA CTD PMID:26217789 NCBI chr11:65,570,477...65,571,888
Ensembl chr11:65,570,460...65,573,942 		JBrowse link
G ZSCAN12 zinc finger and SCAN domain containing 12 decreases expression ISO Thalidomide results in decreased expression of ZSCAN12 mRNA CTD PMID:26217789 NCBI chr 6:28,378,821...28,399,747
Ensembl chr 6:28,378,821...28,399,747 		JBrowse link
Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 26798
    chemical entity 26778
      atom 26774
        nonmetal atom 26082
          nitrogen atom 22768
            nitrogen molecular entity 22768
              organonitrogen compound 22167
                organonitrogen heterocyclic compound 20386
                  benzopyrrole 10337
                    isoindoles 1177
                      (+)-versicalin A 0
                      (+/-)-childinin C 0
                      (-)-asperglactam A 0
                      (-)-versicalin A 0
                      (11)-Cytochalasa-5,13,19-triene-l,21-dione-7-hydroperoxy-17-hydroxy-16,18-dimethyl-10-phenyl-(5Z*,7S*,13E,16S*,17R*,18S*,19E) 0
                      (11)-Cytochalasa-6(12),13,19-triene-1,21-dione-16,18-dimethyl-7-hydroxy-lO-phenyl-(7S*,13E,16S*,18R*,19E) 0
                      (11)-Cytochalasa-6(12),13,19-triene-l,17,21-trione-7,18-dihydroxy-16,18-dimethyl-lO-phenyl-(7S*,l3E,16S*,18R*,19E) 0
                      (11)-Cytochalasa-6(12),13-diene-1,21-dione-16,18-dimethyl-7-hydroxy-lO-phenyl-(7S*,13E,16S*,18S*) 0
                      (11)-Cytochalasa-6(12),13-diene-1,21-dione-7,9-dihydroxy-16,18-dimethyl-lO-phenyl-(7S*,13E,16S*,18R*,19R*) 0
                      (11)-Cytochalasa-6,13,19-triene-1,21-dione-12,18-dihydroxy-16,18-dimethyl-lO-phenyl-(6E,13E,16S*,18S*,19E) 0
                      (11)-Cytochalasa-6,13,19-triene-1,21-dione-17-hydroxy-16,18-dimethyl-10-phenyl-(6Z, 13E,16S*,17R*,18S*,19E) 0
                      (11)-cytochalasa-13,19-diene-1,21-dione-6,7-epoxy-18-hydroxy-16,18-dimethyl-10-phenyl-(7S*,13E,16S*,18S*,19E) 0
                      (11)-cytochalasa-13-ene-1,21-dione-6,7-epoxy-18,19-dihydroxy-16,18-dimethyl-10-phenyl-(7S*,13E,16S*,18S*,19R*) 0
                      (12E)-7,7,12,16,17-pentamethyl-19-(2-methylpropyl)-6,8-dioxa-20-azatetracyclo[12.7.0.01,18.05,9]henicosa-12,15-diene-2,21-dione 0
                      (16S*,18S*,19R*)-12,18-dihydroxy-19-methoxy-16,18-dimethyl-10-phenyl-[11]-cytochalasa-6(7),13(E)-diene-1,21-dione 0
                      (1S,5E,7R,9S,11E,13S,16S,17S,18S)-18-benzyl-7,14-dihydroxy-7,9,16-trimethyl-15-methylidene-2,4-dioxa-19-azatricyclo[11.7.0.01,17]icosa-5,11-diene-3,8,20-trione 0
                      (2R,3E,5R,7S,9E,11S,14R,15R,16R)-16-benzyl-2,5-dihydroxy-5,7,13,14-tetramethyl-17-azatricyclo[9.7.0.01,15]octadeca-3,9,12-triene-6,18-dione 0
                      (2R,3E,5S,7S,9E,11R,12S,15R,16R)-16-benzyl-2,12-dihydroxy-5,7,13,14-tetramethyl-17-azatricyclo[9.7.0.01,15]octadeca-3,9,13-triene-6,18-dione 0
                      (2R,3E,5S,7S,9E,11R,15R,16R)-16-benzyl-2-hydroxy-5,7,13,14-tetramethyl-17-azatricyclo[9.7.0.01,15]octadeca-3,9,13-triene-6,12,18-trione 0
                      (2S,3R)-2-[(3R,4aS,7R,8R,8aS)-3,4'-dihydroxy-4,4,7,8a-tetramethyl-6'-oxospiro[2,3,4a,5,6,7-hexahydro-1H-naphthalene-8,2'-3,8-dihydrouro[2,3-e]isoindole]-7'-yl]-3-hydroxybutanoic acid 0
                      (3R)-3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione 0
                      (3R,3'R,4'S,5'R)-5'-[2-[4-(2-hydroxyethyl)-1-triazolyl]ethyl]-4'-[(4-methoxyphenyl)-dimethylsilyl]-3'-methyl-5-(2-oxo-1-benzo[cd]indolyl)-1-prop-2-enyl-2-spiro[indole-3,2'-oxolane]one 0
                      (3S,3'S,4'R,5'S)-5'-[2-[4-(2-hydroxyethyl)-1-triazolyl]ethyl]-4'-[(4-methoxyphenyl)-dimethylsilyl]-3'-methyl-5-(2-oxo-1-benzo[cd]indolyl)-1-prop-2-enyl-2-spiro[indole-3,2'-oxolane]one 0
                      (5E,11E)-18-benzyl-7,14-dihydroxy-7,9,15,16-tetramethyl-2,4-dioxa-19-azatricyclo[11.7.0.01,17]icosa-5,11,15-triene-3,8,20-trione 0
                      (6R*,7S*,16S*,18S*,19R*)-6,7-epoxy-18-hydroxy-19-methoxy-16,18-dimethyl-10-phenyl-[11]-cytochalasa-13(E)-ene-1,21-dione 0
                      (6R,16S,18R,21R)-18,21-Dihydroxy-16,18-D 0
                      (7S*,16S*,18S*,19R*)-7,18-dihydroxy-19-O-(4-methyl-6(E),8(E)-hexadecadienoyl)-16,18-dimethyl-10-phenyl-[11]-cytochalasa-6(12),13(E)-diene-1,21-dione 0
                      (9E)-4-Methoxy-9,13,14-trimethyl-16-(2-methylpropyl)-17-azatricyclo[9.7.0.01,15]octadeca-9,12-diene-2,18-dione 0
                      (Z)-Narceine imide 0
                      0231A 0
                      0231B 0
                      1-ethyl-2-benzo[cd]indolone 0
                      10-Phenyl-[11]-cytochalasan B 0
                      10-Phenyl-[11]-cytochalasan E 0
                      10-Phenyl-[12]-cytochalasin Z16 0
                      18-Deoxy-19,20-epoxycytochalasin Q 0
                      18-Deoxy-19,20-epoxycytochalasin R 0
                      18-deoxy-21-oxo-deacetyl-19,20-epoxycytochalasin N 0
                      18-desoxycytochalasin C 0
                      19,20-Epoxycytochalasin C 0
                      19,20-Epoxycytochalasin D 0
                      19,20-Epoxycytochalasin N 0
                      19,20-Epoxycytochalasin Q 0
                      19,20-Epoxycytochalasin R 0
                      19,20-epoxy-cytochalasin C 0
                      19-epi-cytochalasin P1 0
                      2-(1,3-benzodioxol-5-ylmethyl)-3-(2,3-dihydro-1,4-benzodioxin-6-ylamino)-3H-isoindol-1-one 0
                      2-(2-ethoxyphenyl)-5,6-dimethyl-1,3-dihydroisoindole 0
                      2-(2-furanylmethyl)-3-[[2-(3-pyridinyl)-3H-benzimidazol-5-yl]amino]-3H-isoindol-1-one 0
                      2-(2-methoxyethyl)-7-[oxo-(4-propyl-1-piperazinyl)methyl]-3H-isoindol-1-one 0
                      2-(2-methylphenyl)-3H-isoindol-1-one 0
                      2-(2-oxo-1-benzo[cd]indolyl)-N-(2-oxolanylmethyl)acetamide 0
                      2-(3-\{(2-chloro-4-fluorophenyl)[1-(2-chlorophenyl)-6-oxo-1,6-dihydropyridazin-3-yl]amino\}propyl)-1H-isoindole-1,3(2H)-dione 0
                      2-(3-amino-1-isoindolylidene)-2-cyano-N-(2-methoxyethyl)acetamide 0
                      2-(4-Hydroxybenzyl)isoindole-1,3-dione 0
                      2-(4-methylphenyl)-1,9b-dihydropyrazolo[1,5-b]isoindol-5-one 0
                      2-(4-oxo-6,8-dioxabicyclo[3.2.1]octan-2-yl)-3a,4,7,7a-tetrahydroisoindole-1,3-dione 0
                      2-(5-chloro-2-pyridinyl)-3-(4-ethoxyanilino)-3H-isoindol-1-one 0
                      2-(5H-[1,2,4]triazolo[5,1-a]isoindol-2-yl)ethanethioamide 0
                      2-(6-methoxy-1-oxo-1,3-dihydro-2H-isoindol-2-yl)-N-[4-(piperazin-1-yl)pyridin-3-yl]-1,3-thiazole-4-carboxamide 0
                      2-amino-7-cyclohexyl-6,8-dioxo-4,5,5a,8a-tetrahydrothieno[2,3-e]isoindole-3-carboxylic acid ethyl ester 0
                      21-O-Deacetylcytochalasin Q 0
                      22-Oxa-(12)-cytochalasa-6(12),13,19-triene-1,21-dione-7,18-dihydroxy-16,18-dimethyl-10-phenyl-(7S*,13E,16S*,18S*,19E) 0
                      3,4'-Dihydroxy-7'-(2-hydroxyethyl)-4,4,7,8a-tetramethylspiro[2,3,4a,5,6,7-hexahydro-1H-naphthalene-8,2'-3,8-dihydrofuro[2,3-e]isoindole]-6'-one 0
                      3-(2-ethoxyanilino)-2-(2-furanylmethyl)-3H-isoindol-1-one 0
                      3-(4-ethylphenyl)imino-1-isoindolamine 0
                      3-[(5-chloro-2-pyridinyl)amino]-2-(2-pyridinyl)-3H-isoindol-1-one 0
                      3-[[2-(2-furanylmethyl)-3-oxo-1H-isoindol-1-yl]amino]benzoic acid ethyl ester 0
                      3-hydroxysperadine A 0
                      3alpha,4,5,7alpha-Tetrahydro-5-hydroxy-1H-isoindole-1,3(2H)-dione 0
                      3alpha,4,7,7alpha-Tetrahydro-4-hydroxy-1H-isoindole-1,3(2H)-dione 0
                      4,6-Dihydroxy-3-methyl-2,3-dihydroisoindol-1-one 0
                      4,6-dihydroxy-2,3-dihydro-1H-isoindol-1-one 0
                      4-(dimethylsulfamoyl)-N-(1-ethyl-2-oxo-6-benzo[cd]indolyl)benzamide 0
                      4-[(2R,3S,4aS,7R,8R,8aS)-2,3,4'-trihydroxy-4,4,7,8a-tetramethyl-6'-oxospiro[2,3,4a,5,6,7-hexahydro-1H-naphthalene-8,2'-3,8-dihydrouro[2,3-e]isoindole]-7'-yl]butanoic acid 0
                      4-[3-oxo-1-(3,4,5-trimethoxyanilino)-1H-isoindol-2-yl]-1-piperidinecarboxylic acid ethyl ester 0
                      4-[4-[[[1-(2-methylpropyl)-3-pyrrolidinyl]methylamino]-oxomethyl]-3-oxo-1H-isoindol-2-yl]-1-piperidinecarboxylic acid ethyl ester 0
                      4-[[3-oxo-2-(3-pyridinyl)-1H-isoindol-1-yl]amino]benzoic acid ethyl ester 0
                      4-[[[(1-ethyl-2-oxo-6-benzo[cd]indolyl)amino]-oxomethyl]amino]benzoic acid ethyl ester 0
                      4-[[[2-(4-methoxyphenyl)-3-oxo-1H-isoindol-4-yl]-oxomethyl]amino]-1-piperidinecarboxylic acid ethyl ester 0
                      4-chloro-2-(4,5-dihydro-1H-imidazol-2-yl)-1,3-dihydroisoindole 0
                      5-(2,2-diferuloylethen-1-yl)thalidomide 0
                      5-[2-(feruloyl)ethen-1-yl]thalidomide 0
                      6,7-dimethoxy-2-(2-thiazolyl)-3H-isoindol-1-one 0
                      6-(2,3-dihydroxy-3-methylbutoxy)-4-methoxy-5-methyl-2,3-dihydroisoindol-1-one 0
                      6-O-acetyl-6-epi-19,20-epoxycytochalasin P 0
                      6-[(2Z)-3,7-Dimethyl-5-oxoocta-2,6-dien-1-yl]-7-hydroxy-5-methoxy-2-(2-phenylethyl)-2,3-dihydro-1H-isoindol-1-one 0
                      6-epi-19,20-epoxycytochalasin P 0
                      7-O-acetyl-19,20-epoxycytochalasin C 0
                      7-O-acetyl-19,20-epoxycytochalasin D 0
                      7-O-acetyl-19-epi-cytochalasin P1 0
                      7-O-acetyl-6-epi-19,20-epoxycytochalasin P 0
                      7-deoxy-cytochalasin Z7 0
                      7-deoxy-cytochalasin Z9 0
                      7-hydroxy-10,14,15-trimethyl-17-(2-methylpropyl)-2-oxa-18-azatricyclo[10.7.0.01,16]nonadeca-4,10,13-triene-3,19-dione 0
                      8'-amino-1,1,4a,6-tetramethylspiro[3,4,6,7,8,8a-hexahydro-2H-naphthalene-5,2'-3,6-dihydrofuro[2,3-e]isoindole]-2,4'-diol 0
                      9-hydroxy-7,9-dimethoxy-13-methyl-10-azapentacyclo[9.7.1.02,10.03,8.015,19]nonadeca-1,3(8),4,6,11,13,15(19),16-octaen-18-one 0
                      Altercrasin C 0
                      Amiaspochalasin A 0
                      Amiaspochalasin B 0
                      Amiaspochalasin C 0
                      Amiaspochalasin F 0
                      Amiaspochalasin G 0
                      Amiaspochalasin I 0
                      Anhydrohapaloxindole A 0
                      Armochaetoglasin A 0
                      Armochaetoglasin F 0
                      Armochaetoglasin I 0
                      Armochaetoglobin C 0
                      Armochaetoglobin D 0
                      Armochaetoglobin E 0
                      Armochaetoglobin I 0
                      Arthriniumnin A 0
                      Arthriniumnin C 0
                      Arthriniumnin D 0
                      Asperchalasin A 0
                      Asperchalasin B 0
                      Asperchalasin C 0
                      Asperchalasin D 0
                      Asperchalasin E 0
                      Asperchalasin F 0
                      Aspergillin PZ 0
                      Asperorydine C 0
                      Asperorydine D 0
                      Asperorydine E 0
                      Asperorydine F 0
                      Asperorydine G 0
                      Asperorydine H 0
                      Asperorydine I 0
                      Asperorydine K 0
                      Asperorydine M 0
                      Aspochalasin A2 0
                      Aspochalasin H 0
                      Aspochalasin M 0
                      Aspochalasin R 0
                      Aspochalasin S 0
                      Aspochalasin T 0
                      Aspochalasin W 0
                      Aspochalasinol A 0
                      Aspochalasinol B 0
                      Aspochalasinol C 0
                      Aspochalasinol D 0
                      Azacoccone B 0
                      Azamonosporascone 0
                      Bhimamycin C 0
                      Biscogniauxone 0
                      CT3 0
                      Captan GlcA 0
                      Captan SO3 0
                      Chaetoglobolsin-510 0
                      Chaetoglobolsin-540 0
                      Chaetoglobolsin-542 0
                      Chaetoglobosin O 0
                      Chaetoglobosin Y 0
                      Chaetoglobosin Z 0
                      Chaetomadrasin A 0
                      Chaetomadrasin B 0
                      Chaetosisoindolinone 0
                      Chartarlactam B 0
                      Chartarlactam C 0
                      Chartarlactam E 0
                      Chartarlactam F 0
                      Chartarlactam G 0
                      Chartarlactam H 0
                      Chartarlactam I 0
                      Chartarlactam J 0
                      Chartarlactam K 0
                      Chartarlactam L 0
                      Chartarlactam M 0
                      Chartarlactam N 0
                      Chartarlactam O 0
                      Chartarlactam P 0
                      Chartarlactam Q 0
                      Chartarlactam R 0
                      Chartarlactam S 0
                      Chartarlactam T 0
                      Cis-1,2,3,6-Tetrahydrophthalimide 0
                      Clitocybin A 0
                      Corallocin B 0
                      Corallocin C 0
                      Curtachalasin G 0
                      Curtachalasin H 0
                      Curtachalasin M 0
                      Curtachalasin N 0
                      Curtachalasin O 0
                      Cyclopiamide B 0
                      Cyclopiamide C 0
                      Cyclopiamide D 0
                      Cyclopiamide E 0
                      Cyclopiamide F 0
                      Cyclopiamide H 0
                      Cyschalasin A 0
                      Cyschalasin B 0
                      Cytochalasin B3 0
                      Cytochalasin B4 0
                      Cytochalasin B5 0
                      Cytochalasin C 0
                      Cytochalasin C1 0
                      Cytochalasin D1 0
                      Cytochalasin J 0
                      Cytochalasin J2 0
                      Cytochalasin J3 0
                      Cytochalasin L 0
                      Cytochalasin P1 0
                      Cytochalasin R1 0
                      Cytochalasin V 0
                      Cytochalasin Z10 0
                      Cytochalasin Z11 0
                      Cytochalasin Z12 0
                      Cytochalasin Z13 0
                      Cytochalasin Z14 0
                      Cytochalasin Z15 0
                      Cytochalasin Z15E 0
                      Cytochalasin Z18 0
                      Cytochalasin Z19 0
                      Cytochalasin Z20 0
                      Cytochalasin Z21 0
                      Cytochalasin Z24 0
                      Cytochalasin Z25 0
                      Cytochalasin Z26 0
                      Cytochalasin Z27 0
                      Cytochalasin Z7 0
                      Cytochalasin Z8 0
                      Cytochalasin Z9 0
                      Cytochalazin Z1 0
                      Cytochalazin Z2 0
                      Cytoglobosin K 0
                      Cytoglobosin L 0
                      Daldinan C 0
                      Deacetyl-19,20-epoxy-cytochalasin C 0
                      Deacetyl-5,6-dihydro-7-oxo-19,20-epoxycytochalasin C 0
                      Deacetylcytochalasin C 0
                      Deoxaphomin B 0
                      Deoxaphomin C 0
                      Dialifor 2
                      Diaporthalasin 0
                      Diaporthichalasin 0
                      Dihydrocytochalasin B 1
                      Ditalimfos 0
                      Emerimidine A 0
                      Emerimidine B 0
                      Erinacerin A 0
                      Erinacerin C 0
                      Erinacerin D 0
                      Erinacerin G 0
                      Erinacerin H 0
                      Erinacerin I 0
                      Erinacerin J 0
                      Erinacerin Q 0
                      Erinacerin R 0
                      Erinacerin S 0
                      Erinacerin T 0
                      Erinacerin U 0
                      F1839-A 0
                      F1839-B 0
                      F1839-D 0
                      F1839-E 0
                      F1839-F 0
                      F1839-J 0
                      FGFC2 0
                      FGFC4 0
                      FGFC5 0
                      FGFC7 0
                      Flavichalasine N 0
                      Flavichalasine O 0
                      Flavipesine A 0
                      Flavipesine B 0
                      Frankiamide 0
                      Guanacastepene D 0
                      Guanacastepene H 0
                      Hericenone B 0
                      Hericerin 0
                      IIQ A 0
                      Irpexine 0
                      Isohericerin 0
                      LSM-17324 0
                      LSM-17343 0
                      LSM-19109 0
                      LSM-19437 0
                      LSM-20631 0
                      LSM-21149 0
                      LSM-25805 0
                      LSM-28383 0
                      LSM-32057 0
                      LSM-33609 0
                      LSM-36632 0
                      LSM-4844 0
                      Limamycin B 0
                      Longichalasin B 0
                      MBJ-0030 0
                      MBJ-0031 0
                      MGK 264 0
                      Mariline A1 0
                      Mariline A2 0
                      Mariline B 0
                      Mariline C 0
                      Methyl (2E,8E)-9-[3a-hydroxy-6,7-dimethyl-1-(2-methylpropyl)-3-oxo-2,4,7,7a-tetrahydro-1H-isoindol-4-yl]-4,5-dihydroxy-8-methylnona-2,8-dienoate 0
                      Meyeroguilline D 0
                      N-(1-ethyl-2-oxo-6-benzo[cd]indolyl)benzamide 0
                      N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-(2-methoxyethyl)-3-oxo-1H-isoindole-4-carboxamide 0
                      N-(2-furanylmethyl)-3-(2-furanylmethylimino)-1-isoindolamine 0
                      N-(4-bromophenyl)-2-\{4-[(4-bromophenyl)carbamoyl]phenyl\}-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxamide 0
                      N-(p-Nitrobenzyl)phthalimide 0
                      N-Benzylphthalimide 0
                      N-[(2-methoxyphenyl)methylideneamino]-4-[(2-oxo-1-benzo[cd]indolyl)methyl]benzamide 0
                      N-[3-[1-cyano-2-[2-(4-methoxyphenyl)ethylamino]-2-oxoethylidene]-1-isoindolyl]-2-thiophenecarboxamide 0
                      N-[3-[1-cyano-2-oxo-2-[(phenylmethyl)amino]ethylidene]-1-isoindolyl]-2-furancarboxamide 0
                      N-[[1,3-dioxo-2-(phenylmethyl)-7,7a-dihydro-3aH-octahydro-1H-4,7-epoxyisoindol-4-yl]methyl]-4-methoxybenzamide 0
                      N-cycloheptyl-1-hydroxy-3-oxo-2-propyl-1H-isoindole-5-carboxamide 0
                      N-de(phenylethyl)isohericerin 0
                      NCGC00169011-01 0
                      NCGC00381123-01 0
                      Nitricquinomycin A 0
                      Nitricquinomycin B 0
                      Nitricquinomycin C 0
                      Nitrobisabosqual A 0
                      Nitrobisabosqual B 0
                      Penochalasin J 0
                      Periconiasin A 0
                      Periconiasin B 0
                      Periconiasin C 0
                      Periconiasin E 0
                      Periconiasin F 0
                      Periconiasin G 0
                      Periconiasin H 0
                      Periconiasin I 0
                      Periconiasin J 0
                      Pestalachloride A 0
                      Phenochalasin B 0
                      Phomachalasin A 0
                      Phomachalasin B 0
                      Phomopchalasin A 0
                      Phomopchalasin B 0
                      Phomopchalasin C 0
                      Phomopsichalasin 0
                      Phomopsichalasin D 0
                      Phomopsichalasin E 0
                      Phomopsichalasin F 0
                      Phomopsichalasin G 0
                      Phomopsisin A 0
                      Pleosporallin G 0
                      Porritoxin sulfonic acid 0
                      Protophomine 0
                      Pyranterrone A 0
                      Pyranterrone B 0
                      Pyranterrone C 0
                      Pyromyxone A 0
                      Pyromyxone B 0
                      Pyromyxone C 0
                      Pyxipyrrolone A 0
                      Pyxipyrrolone B 0
                      Radianspene J 0
                      Radianspene K 0
                      Radianspene L 0
                      SMTP-1 0
                      SMTP-16 0
                      SMTP-2 0
                      SMTP-40 0
                      SMTP-42 0
                      Sclerotionigrin A 0
                      Sclerotionigrin B 0
                      Scoparasin A 0
                      Scoparasin C 0
                      Sorbicillasin A 0
                      Sorbicillasin B 0
                      Speradine A 0
                      Speradine B 0
                      Speradine C 0
                      Speradine D 0
                      Speradine E 0
                      Speradine G 0
                      Speradine H 0
                      Spirodihydrobenzofuranlactam I 0
                      Spirodihydrobenzofuranlactam II 0
                      Spirodihydrobenzofuranlactam III 0
                      Spirodihydrobenzofuranlactam VI 0
                      Spiropchaeglobosin A 0
                      Stachybocin A 0
                      Stachybocin B 0
                      Stachybocin E 0
                      Stachybocin F 0
                      Stachybocin c 0
                      Stachybonoid F 0
                      Stachybotramide 0
                      Stachybotrin B 0
                      Stachybotrin C 0
                      Stachybotrin D 0
                      Stachybotrin E 0
                      Stachybotrin H 0
                      Stachybotrylactam 0
                      Stachyin A 0
                      Stachyin B 0
                      Streptoxamine 0
                      TMC-169 0
                      Trichalasin E 0
                      Trichalasin F 0
                      Trichalasin H 0
                      Xylarisin B 0
                      Xylastriasan A 0
                      Xylobovatin 0
                      Zinnimidine 0
                      [(2R,3Z,5R,11R,12R,14R)-16-Benzyl-5,12-dihydroxy-5,7,14-trimethyl-13-methylidene-6,18-dioxo-17-azatricyclo[9.7.0.01,15]octadeca-3,9-dien-2-yl] acetate 0
                      [11]-cytochalasa-5(6),13-diene-1,21-dione-7,18-dihydroxy-16,18-dimethyl-10-phenyl-(7S*,13E,16S*,18R*) 0
                      albumycin 0
                      aspernidine A 0
                      captafol 8
                      captan 444
                      chlorisondamine 5
                      chlorthalidone 5
                      cichorine 0
                      cinidon ethyl 0
                      cytochalasin + 84
                      dWIZ-2 0
                      garenoxacin 0
                      indobufen 0
                      indoprofen 17
                      isoindole + 0
                      isoindolin-1-one 0
                      lenalidomide 30
                      onalespib 0
                      phthalimides + 1035
                      pomalidomide 45
Path 2
Term Annotations click to browse term
  CHEBI ontology 26798
    subatomic particle 26774
      composite particle 26774
        hadron 26774
          baryon 26774
            nucleon 26774
              atomic nucleus 26774
                atom 26774
                  main group element atom 26525
                    p-block element atom 26525
                      carbon group element atom 26002
                        carbon atom 25965
                          organic molecular entity 25965
                            organic molecule 25720
                              organic cyclic compound 24809
                                organic heterocyclic compound 22904
                                  organic heteropolycyclic compound 21985
                                    organic heterobicyclic compound 18609
                                      benzopyrrole 10337
                                        isoindoles 1177
                                          (+)-versicalin A 0
                                          (+/-)-childinin C 0
                                          (-)-asperglactam A 0
                                          (-)-versicalin A 0
                                          (11)-Cytochalasa-5,13,19-triene-l,21-dione-7-hydroperoxy-17-hydroxy-16,18-dimethyl-10-phenyl-(5Z*,7S*,13E,16S*,17R*,18S*,19E) 0
                                          (11)-Cytochalasa-6(12),13,19-triene-1,21-dione-16,18-dimethyl-7-hydroxy-lO-phenyl-(7S*,13E,16S*,18R*,19E) 0
                                          (11)-Cytochalasa-6(12),13,19-triene-l,17,21-trione-7,18-dihydroxy-16,18-dimethyl-lO-phenyl-(7S*,l3E,16S*,18R*,19E) 0
                                          (11)-Cytochalasa-6(12),13-diene-1,21-dione-16,18-dimethyl-7-hydroxy-lO-phenyl-(7S*,13E,16S*,18S*) 0
                                          (11)-Cytochalasa-6(12),13-diene-1,21-dione-7,9-dihydroxy-16,18-dimethyl-lO-phenyl-(7S*,13E,16S*,18R*,19R*) 0
                                          (11)-Cytochalasa-6,13,19-triene-1,21-dione-12,18-dihydroxy-16,18-dimethyl-lO-phenyl-(6E,13E,16S*,18S*,19E) 0
                                          (11)-Cytochalasa-6,13,19-triene-1,21-dione-17-hydroxy-16,18-dimethyl-10-phenyl-(6Z, 13E,16S*,17R*,18S*,19E) 0
                                          (11)-cytochalasa-13,19-diene-1,21-dione-6,7-epoxy-18-hydroxy-16,18-dimethyl-10-phenyl-(7S*,13E,16S*,18S*,19E) 0
                                          (11)-cytochalasa-13-ene-1,21-dione-6,7-epoxy-18,19-dihydroxy-16,18-dimethyl-10-phenyl-(7S*,13E,16S*,18S*,19R*) 0
                                          (12E)-7,7,12,16,17-pentamethyl-19-(2-methylpropyl)-6,8-dioxa-20-azatetracyclo[12.7.0.01,18.05,9]henicosa-12,15-diene-2,21-dione 0
                                          (16S*,18S*,19R*)-12,18-dihydroxy-19-methoxy-16,18-dimethyl-10-phenyl-[11]-cytochalasa-6(7),13(E)-diene-1,21-dione 0
                                          (1S,5E,7R,9S,11E,13S,16S,17S,18S)-18-benzyl-7,14-dihydroxy-7,9,16-trimethyl-15-methylidene-2,4-dioxa-19-azatricyclo[11.7.0.01,17]icosa-5,11-diene-3,8,20-trione 0
                                          (2R,3E,5R,7S,9E,11S,14R,15R,16R)-16-benzyl-2,5-dihydroxy-5,7,13,14-tetramethyl-17-azatricyclo[9.7.0.01,15]octadeca-3,9,12-triene-6,18-dione 0
                                          (2R,3E,5S,7S,9E,11R,12S,15R,16R)-16-benzyl-2,12-dihydroxy-5,7,13,14-tetramethyl-17-azatricyclo[9.7.0.01,15]octadeca-3,9,13-triene-6,18-dione 0
                                          (2R,3E,5S,7S,9E,11R,15R,16R)-16-benzyl-2-hydroxy-5,7,13,14-tetramethyl-17-azatricyclo[9.7.0.01,15]octadeca-3,9,13-triene-6,12,18-trione 0
                                          (2S,3R)-2-[(3R,4aS,7R,8R,8aS)-3,4'-dihydroxy-4,4,7,8a-tetramethyl-6'-oxospiro[2,3,4a,5,6,7-hexahydro-1H-naphthalene-8,2'-3,8-dihydrouro[2,3-e]isoindole]-7'-yl]-3-hydroxybutanoic acid 0
                                          (3R)-3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione 0
                                          (3R,3'R,4'S,5'R)-5'-[2-[4-(2-hydroxyethyl)-1-triazolyl]ethyl]-4'-[(4-methoxyphenyl)-dimethylsilyl]-3'-methyl-5-(2-oxo-1-benzo[cd]indolyl)-1-prop-2-enyl-2-spiro[indole-3,2'-oxolane]one 0
                                          (3S,3'S,4'R,5'S)-5'-[2-[4-(2-hydroxyethyl)-1-triazolyl]ethyl]-4'-[(4-methoxyphenyl)-dimethylsilyl]-3'-methyl-5-(2-oxo-1-benzo[cd]indolyl)-1-prop-2-enyl-2-spiro[indole-3,2'-oxolane]one 0
                                          (5E,11E)-18-benzyl-7,14-dihydroxy-7,9,15,16-tetramethyl-2,4-dioxa-19-azatricyclo[11.7.0.01,17]icosa-5,11,15-triene-3,8,20-trione 0
                                          (6R*,7S*,16S*,18S*,19R*)-6,7-epoxy-18-hydroxy-19-methoxy-16,18-dimethyl-10-phenyl-[11]-cytochalasa-13(E)-ene-1,21-dione 0
                                          (6R,16S,18R,21R)-18,21-Dihydroxy-16,18-D 0
                                          (7S*,16S*,18S*,19R*)-7,18-dihydroxy-19-O-(4-methyl-6(E),8(E)-hexadecadienoyl)-16,18-dimethyl-10-phenyl-[11]-cytochalasa-6(12),13(E)-diene-1,21-dione 0
                                          (9E)-4-Methoxy-9,13,14-trimethyl-16-(2-methylpropyl)-17-azatricyclo[9.7.0.01,15]octadeca-9,12-diene-2,18-dione 0
                                          (Z)-Narceine imide 0
                                          0231A 0
                                          0231B 0
                                          1-ethyl-2-benzo[cd]indolone 0
                                          10-Phenyl-[11]-cytochalasan B 0
                                          10-Phenyl-[11]-cytochalasan E 0
                                          10-Phenyl-[12]-cytochalasin Z16 0
                                          18-Deoxy-19,20-epoxycytochalasin Q 0
                                          18-Deoxy-19,20-epoxycytochalasin R 0
                                          18-deoxy-21-oxo-deacetyl-19,20-epoxycytochalasin N 0
                                          18-desoxycytochalasin C 0
                                          19,20-Epoxycytochalasin C 0
                                          19,20-Epoxycytochalasin D 0
                                          19,20-Epoxycytochalasin N 0
                                          19,20-Epoxycytochalasin Q 0
                                          19,20-Epoxycytochalasin R 0
                                          19,20-epoxy-cytochalasin C 0
                                          19-epi-cytochalasin P1 0
                                          2-(1,3-benzodioxol-5-ylmethyl)-3-(2,3-dihydro-1,4-benzodioxin-6-ylamino)-3H-isoindol-1-one 0
                                          2-(2-ethoxyphenyl)-5,6-dimethyl-1,3-dihydroisoindole 0
                                          2-(2-furanylmethyl)-3-[[2-(3-pyridinyl)-3H-benzimidazol-5-yl]amino]-3H-isoindol-1-one 0
                                          2-(2-methoxyethyl)-7-[oxo-(4-propyl-1-piperazinyl)methyl]-3H-isoindol-1-one 0
                                          2-(2-methylphenyl)-3H-isoindol-1-one 0
                                          2-(2-oxo-1-benzo[cd]indolyl)-N-(2-oxolanylmethyl)acetamide 0
                                          2-(3-\{(2-chloro-4-fluorophenyl)[1-(2-chlorophenyl)-6-oxo-1,6-dihydropyridazin-3-yl]amino\}propyl)-1H-isoindole-1,3(2H)-dione 0
                                          2-(3-amino-1-isoindolylidene)-2-cyano-N-(2-methoxyethyl)acetamide 0
                                          2-(4-Hydroxybenzyl)isoindole-1,3-dione 0
                                          2-(4-methylphenyl)-1,9b-dihydropyrazolo[1,5-b]isoindol-5-one 0
                                          2-(4-oxo-6,8-dioxabicyclo[3.2.1]octan-2-yl)-3a,4,7,7a-tetrahydroisoindole-1,3-dione 0
                                          2-(5-chloro-2-pyridinyl)-3-(4-ethoxyanilino)-3H-isoindol-1-one 0
                                          2-(5H-[1,2,4]triazolo[5,1-a]isoindol-2-yl)ethanethioamide 0
                                          2-(6-methoxy-1-oxo-1,3-dihydro-2H-isoindol-2-yl)-N-[4-(piperazin-1-yl)pyridin-3-yl]-1,3-thiazole-4-carboxamide 0
                                          2-amino-7-cyclohexyl-6,8-dioxo-4,5,5a,8a-tetrahydrothieno[2,3-e]isoindole-3-carboxylic acid ethyl ester 0
                                          21-O-Deacetylcytochalasin Q 0
                                          22-Oxa-(12)-cytochalasa-6(12),13,19-triene-1,21-dione-7,18-dihydroxy-16,18-dimethyl-10-phenyl-(7S*,13E,16S*,18S*,19E) 0
                                          3,4'-Dihydroxy-7'-(2-hydroxyethyl)-4,4,7,8a-tetramethylspiro[2,3,4a,5,6,7-hexahydro-1H-naphthalene-8,2'-3,8-dihydrofuro[2,3-e]isoindole]-6'-one 0
                                          3-(2-ethoxyanilino)-2-(2-furanylmethyl)-3H-isoindol-1-one 0
                                          3-(4-ethylphenyl)imino-1-isoindolamine 0
                                          3-[(5-chloro-2-pyridinyl)amino]-2-(2-pyridinyl)-3H-isoindol-1-one 0
                                          3-[[2-(2-furanylmethyl)-3-oxo-1H-isoindol-1-yl]amino]benzoic acid ethyl ester 0
                                          3-hydroxysperadine A 0
                                          3alpha,4,5,7alpha-Tetrahydro-5-hydroxy-1H-isoindole-1,3(2H)-dione 0
                                          3alpha,4,7,7alpha-Tetrahydro-4-hydroxy-1H-isoindole-1,3(2H)-dione 0
                                          4,6-Dihydroxy-3-methyl-2,3-dihydroisoindol-1-one 0
                                          4,6-dihydroxy-2,3-dihydro-1H-isoindol-1-one 0
                                          4-(dimethylsulfamoyl)-N-(1-ethyl-2-oxo-6-benzo[cd]indolyl)benzamide 0
                                          4-[(2R,3S,4aS,7R,8R,8aS)-2,3,4'-trihydroxy-4,4,7,8a-tetramethyl-6'-oxospiro[2,3,4a,5,6,7-hexahydro-1H-naphthalene-8,2'-3,8-dihydrouro[2,3-e]isoindole]-7'-yl]butanoic acid 0
                                          4-[3-oxo-1-(3,4,5-trimethoxyanilino)-1H-isoindol-2-yl]-1-piperidinecarboxylic acid ethyl ester 0
                                          4-[4-[[[1-(2-methylpropyl)-3-pyrrolidinyl]methylamino]-oxomethyl]-3-oxo-1H-isoindol-2-yl]-1-piperidinecarboxylic acid ethyl ester 0
                                          4-[[3-oxo-2-(3-pyridinyl)-1H-isoindol-1-yl]amino]benzoic acid ethyl ester 0
                                          4-[[[(1-ethyl-2-oxo-6-benzo[cd]indolyl)amino]-oxomethyl]amino]benzoic acid ethyl ester 0
                                          4-[[[2-(4-methoxyphenyl)-3-oxo-1H-isoindol-4-yl]-oxomethyl]amino]-1-piperidinecarboxylic acid ethyl ester 0
                                          4-chloro-2-(4,5-dihydro-1H-imidazol-2-yl)-1,3-dihydroisoindole 0
                                          5-(2,2-diferuloylethen-1-yl)thalidomide 0
                                          5-[2-(feruloyl)ethen-1-yl]thalidomide 0
                                          6,7-dimethoxy-2-(2-thiazolyl)-3H-isoindol-1-one 0
                                          6-(2,3-dihydroxy-3-methylbutoxy)-4-methoxy-5-methyl-2,3-dihydroisoindol-1-one 0
                                          6-O-acetyl-6-epi-19,20-epoxycytochalasin P 0
                                          6-[(2Z)-3,7-Dimethyl-5-oxoocta-2,6-dien-1-yl]-7-hydroxy-5-methoxy-2-(2-phenylethyl)-2,3-dihydro-1H-isoindol-1-one 0
                                          6-epi-19,20-epoxycytochalasin P 0
                                          7-O-acetyl-19,20-epoxycytochalasin C 0
                                          7-O-acetyl-19,20-epoxycytochalasin D 0
                                          7-O-acetyl-19-epi-cytochalasin P1 0
                                          7-O-acetyl-6-epi-19,20-epoxycytochalasin P 0
                                          7-deoxy-cytochalasin Z7 0
                                          7-deoxy-cytochalasin Z9 0
                                          7-hydroxy-10,14,15-trimethyl-17-(2-methylpropyl)-2-oxa-18-azatricyclo[10.7.0.01,16]nonadeca-4,10,13-triene-3,19-dione 0
                                          8'-amino-1,1,4a,6-tetramethylspiro[3,4,6,7,8,8a-hexahydro-2H-naphthalene-5,2'-3,6-dihydrofuro[2,3-e]isoindole]-2,4'-diol 0
                                          9-hydroxy-7,9-dimethoxy-13-methyl-10-azapentacyclo[9.7.1.02,10.03,8.015,19]nonadeca-1,3(8),4,6,11,13,15(19),16-octaen-18-one 0
                                          Altercrasin C 0
                                          Amiaspochalasin A 0
                                          Amiaspochalasin B 0
                                          Amiaspochalasin C 0
                                          Amiaspochalasin F 0
                                          Amiaspochalasin G 0
                                          Amiaspochalasin I 0
                                          Anhydrohapaloxindole A 0
                                          Armochaetoglasin A 0
                                          Armochaetoglasin F 0
                                          Armochaetoglasin I 0
                                          Armochaetoglobin C 0
                                          Armochaetoglobin D 0
                                          Armochaetoglobin E 0
                                          Armochaetoglobin I 0
                                          Arthriniumnin A 0
                                          Arthriniumnin C 0
                                          Arthriniumnin D 0
                                          Asperchalasin A 0
                                          Asperchalasin B 0
                                          Asperchalasin C 0
                                          Asperchalasin D 0
                                          Asperchalasin E 0
                                          Asperchalasin F 0
                                          Aspergillin PZ 0
                                          Asperorydine C 0
                                          Asperorydine D 0
                                          Asperorydine E 0
                                          Asperorydine F 0
                                          Asperorydine G 0
                                          Asperorydine H 0
                                          Asperorydine I 0
                                          Asperorydine K 0
                                          Asperorydine M 0
                                          Aspochalasin A2 0
                                          Aspochalasin H 0
                                          Aspochalasin M 0
                                          Aspochalasin R 0
                                          Aspochalasin S 0
                                          Aspochalasin T 0
                                          Aspochalasin W 0
                                          Aspochalasinol A 0
                                          Aspochalasinol B 0
                                          Aspochalasinol C 0
                                          Aspochalasinol D 0
                                          Azacoccone B 0
                                          Azamonosporascone 0
                                          Bhimamycin C 0
                                          Biscogniauxone 0
                                          CT3 0
                                          Captan GlcA 0
                                          Captan SO3 0
                                          Chaetoglobolsin-510 0
                                          Chaetoglobolsin-540 0
                                          Chaetoglobolsin-542 0
                                          Chaetoglobosin O 0
                                          Chaetoglobosin Y 0
                                          Chaetoglobosin Z 0
                                          Chaetomadrasin A 0
                                          Chaetomadrasin B 0
                                          Chaetosisoindolinone 0
                                          Chartarlactam B 0
                                          Chartarlactam C 0
                                          Chartarlactam E 0
                                          Chartarlactam F 0
                                          Chartarlactam G 0
                                          Chartarlactam H 0
                                          Chartarlactam I 0
                                          Chartarlactam J 0
                                          Chartarlactam K 0
                                          Chartarlactam L 0
                                          Chartarlactam M 0
                                          Chartarlactam N 0
                                          Chartarlactam O 0
                                          Chartarlactam P 0
                                          Chartarlactam Q 0
                                          Chartarlactam R 0
                                          Chartarlactam S 0
                                          Chartarlactam T 0
                                          Cis-1,2,3,6-Tetrahydrophthalimide 0
                                          Clitocybin A 0
                                          Corallocin B 0
                                          Corallocin C 0
                                          Curtachalasin G 0
                                          Curtachalasin H 0
                                          Curtachalasin M 0
                                          Curtachalasin N 0
                                          Curtachalasin O 0
                                          Cyclopiamide B 0
                                          Cyclopiamide C 0
                                          Cyclopiamide D 0
                                          Cyclopiamide E 0
                                          Cyclopiamide F 0
                                          Cyclopiamide H 0
                                          Cyschalasin A 0
                                          Cyschalasin B 0
                                          Cytochalasin B3 0
                                          Cytochalasin B4 0
                                          Cytochalasin B5 0
                                          Cytochalasin C 0
                                          Cytochalasin C1 0
                                          Cytochalasin D1 0
                                          Cytochalasin J 0
                                          Cytochalasin J2 0
                                          Cytochalasin J3 0
                                          Cytochalasin L 0
                                          Cytochalasin P1 0
                                          Cytochalasin R1 0
                                          Cytochalasin V 0
                                          Cytochalasin Z10 0
                                          Cytochalasin Z11 0
                                          Cytochalasin Z12 0
                                          Cytochalasin Z13 0
                                          Cytochalasin Z14 0
                                          Cytochalasin Z15 0
                                          Cytochalasin Z15E 0
                                          Cytochalasin Z18 0
                                          Cytochalasin Z19 0
                                          Cytochalasin Z20 0
                                          Cytochalasin Z21 0
                                          Cytochalasin Z24 0
                                          Cytochalasin Z25 0
                                          Cytochalasin Z26 0
                                          Cytochalasin Z27 0
                                          Cytochalasin Z7 0
                                          Cytochalasin Z8 0
                                          Cytochalasin Z9 0
                                          Cytochalazin Z1 0
                                          Cytochalazin Z2 0
                                          Cytoglobosin K 0
                                          Cytoglobosin L 0
                                          Daldinan C 0
                                          Deacetyl-19,20-epoxy-cytochalasin C 0
                                          Deacetyl-5,6-dihydro-7-oxo-19,20-epoxycytochalasin C 0
                                          Deacetylcytochalasin C 0
                                          Deoxaphomin B 0
                                          Deoxaphomin C 0
                                          Dialifor 2
                                          Diaporthalasin 0
                                          Diaporthichalasin 0
                                          Dihydrocytochalasin B 1
                                          Ditalimfos 0
                                          Emerimidine A 0
                                          Emerimidine B 0
                                          Erinacerin A 0
                                          Erinacerin C 0
                                          Erinacerin D 0
                                          Erinacerin G 0
                                          Erinacerin H 0
                                          Erinacerin I 0
                                          Erinacerin J 0
                                          Erinacerin Q 0
                                          Erinacerin R 0
                                          Erinacerin S 0
                                          Erinacerin T 0
                                          Erinacerin U 0
                                          F1839-A 0
                                          F1839-B 0
                                          F1839-D 0
                                          F1839-E 0
                                          F1839-F 0
                                          F1839-J 0
                                          FGFC2 0
                                          FGFC4 0
                                          FGFC5 0
                                          FGFC7 0
                                          Flavichalasine N 0
                                          Flavichalasine O 0
                                          Flavipesine A 0
                                          Flavipesine B 0
                                          Frankiamide 0
                                          Guanacastepene D 0
                                          Guanacastepene H 0
                                          Hericenone B 0
                                          Hericerin 0
                                          IIQ A 0
                                          Irpexine 0
                                          Isohericerin 0
                                          LSM-17324 0
                                          LSM-17343 0
                                          LSM-19109 0
                                          LSM-19437 0
                                          LSM-20631 0
                                          LSM-21149 0
                                          LSM-25805 0
                                          LSM-28383 0
                                          LSM-32057 0
                                          LSM-33609 0
                                          LSM-36632 0
                                          LSM-4844 0
                                          Limamycin B 0
                                          Longichalasin B 0
                                          MBJ-0030 0
                                          MBJ-0031 0
                                          MGK 264 0
                                          Mariline A1 0
                                          Mariline A2 0
                                          Mariline B 0
                                          Mariline C 0
                                          Methyl (2E,8E)-9-[3a-hydroxy-6,7-dimethyl-1-(2-methylpropyl)-3-oxo-2,4,7,7a-tetrahydro-1H-isoindol-4-yl]-4,5-dihydroxy-8-methylnona-2,8-dienoate 0
                                          Meyeroguilline D 0
                                          N-(1-ethyl-2-oxo-6-benzo[cd]indolyl)benzamide 0
                                          N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-(2-methoxyethyl)-3-oxo-1H-isoindole-4-carboxamide 0
                                          N-(2-furanylmethyl)-3-(2-furanylmethylimino)-1-isoindolamine 0
                                          N-(4-bromophenyl)-2-\{4-[(4-bromophenyl)carbamoyl]phenyl\}-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxamide 0
                                          N-(p-Nitrobenzyl)phthalimide 0
                                          N-Benzylphthalimide 0
                                          N-[(2-methoxyphenyl)methylideneamino]-4-[(2-oxo-1-benzo[cd]indolyl)methyl]benzamide 0
                                          N-[3-[1-cyano-2-[2-(4-methoxyphenyl)ethylamino]-2-oxoethylidene]-1-isoindolyl]-2-thiophenecarboxamide 0
                                          N-[3-[1-cyano-2-oxo-2-[(phenylmethyl)amino]ethylidene]-1-isoindolyl]-2-furancarboxamide 0
                                          N-[[1,3-dioxo-2-(phenylmethyl)-7,7a-dihydro-3aH-octahydro-1H-4,7-epoxyisoindol-4-yl]methyl]-4-methoxybenzamide 0
                                          N-cycloheptyl-1-hydroxy-3-oxo-2-propyl-1H-isoindole-5-carboxamide 0
                                          N-de(phenylethyl)isohericerin 0
                                          NCGC00169011-01 0
                                          NCGC00381123-01 0
                                          Nitricquinomycin A 0
                                          Nitricquinomycin B 0
                                          Nitricquinomycin C 0
                                          Nitrobisabosqual A 0
                                          Nitrobisabosqual B 0
                                          Penochalasin J 0
                                          Periconiasin A 0
                                          Periconiasin B 0
                                          Periconiasin C 0
                                          Periconiasin E 0
                                          Periconiasin F 0
                                          Periconiasin G 0
                                          Periconiasin H 0
                                          Periconiasin I 0
                                          Periconiasin J 0
                                          Pestalachloride A 0
                                          Phenochalasin B 0
                                          Phomachalasin A 0
                                          Phomachalasin B 0
                                          Phomopchalasin A 0
                                          Phomopchalasin B 0
                                          Phomopchalasin C 0
                                          Phomopsichalasin 0
                                          Phomopsichalasin D 0
                                          Phomopsichalasin E 0
                                          Phomopsichalasin F 0
                                          Phomopsichalasin G 0
                                          Phomopsisin A 0
                                          Pleosporallin G 0
                                          Porritoxin sulfonic acid 0
                                          Protophomine 0
                                          Pyranterrone A 0
                                          Pyranterrone B 0
                                          Pyranterrone C 0
                                          Pyromyxone A 0
                                          Pyromyxone B 0
                                          Pyromyxone C 0
                                          Pyxipyrrolone A 0
                                          Pyxipyrrolone B 0
                                          Radianspene J 0
                                          Radianspene K 0
                                          Radianspene L 0
                                          SMTP-1 0
                                          SMTP-16 0
                                          SMTP-2 0
                                          SMTP-40 0
                                          SMTP-42 0
                                          Sclerotionigrin A 0
                                          Sclerotionigrin B 0
                                          Scoparasin A 0
                                          Scoparasin C 0
                                          Sorbicillasin A 0
                                          Sorbicillasin B 0
                                          Speradine A 0
                                          Speradine B 0
                                          Speradine C 0
                                          Speradine D 0
                                          Speradine E 0
                                          Speradine G 0
                                          Speradine H 0
                                          Spirodihydrobenzofuranlactam I 0
                                          Spirodihydrobenzofuranlactam II 0
                                          Spirodihydrobenzofuranlactam III 0
                                          Spirodihydrobenzofuranlactam VI 0
                                          Spiropchaeglobosin A 0
                                          Stachybocin A 0
                                          Stachybocin B 0
                                          Stachybocin E 0
                                          Stachybocin F 0
                                          Stachybocin c 0
                                          Stachybonoid F 0
                                          Stachybotramide 0
                                          Stachybotrin B 0
                                          Stachybotrin C 0
                                          Stachybotrin D 0
                                          Stachybotrin E 0
                                          Stachybotrin H 0
                                          Stachybotrylactam 0
                                          Stachyin A 0
                                          Stachyin B 0
                                          Streptoxamine 0
                                          TMC-169 0
                                          Trichalasin E 0
                                          Trichalasin F 0
                                          Trichalasin H 0
                                          Xylarisin B 0
                                          Xylastriasan A 0
                                          Xylobovatin 0
                                          Zinnimidine 0
                                          [(2R,3Z,5R,11R,12R,14R)-16-Benzyl-5,12-dihydroxy-5,7,14-trimethyl-13-methylidene-6,18-dioxo-17-azatricyclo[9.7.0.01,15]octadeca-3,9-dien-2-yl] acetate 0
                                          [11]-cytochalasa-5(6),13-diene-1,21-dione-7,18-dihydroxy-16,18-dimethyl-10-phenyl-(7S*,13E,16S*,18R*) 0
                                          albumycin 0
                                          aspernidine A 0
                                          captafol 8
                                          captan 444
                                          chlorisondamine 5
                                          chlorthalidone 5
                                          cichorine 0
                                          cinidon ethyl 0
                                          cytochalasin + 84
                                          dWIZ-2 0
                                          garenoxacin 0
                                          indobufen 0
                                          indoprofen 17
                                          isoindole + 0
                                          isoindolin-1-one 0
                                          lenalidomide 30
                                          onalespib 0
                                          phthalimides + 1035
                                          pomalidomide 45
paths to the root